
<html lang="en"     class="pb-page"  data-request-id="5672fb7a-c6f2-46c8-a5c3-9b0a05ac4538"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-7;article:article:10.1021/acs.jmedchem.6b01065"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects" /></meta><meta name="dc.Creator" content="Mercedes  Martín-Martínez" /></meta><meta name="dc.Creator" content="Felipe L.  Pérez-Gordillo" /></meta><meta name="dc.Creator" content="Diego  Álvarez de la Rosa" /></meta><meta name="dc.Creator" content="Yoel  Rodríguez" /></meta><meta name="dc.Creator" content="Guillermo  Gerona-Navarro" /></meta><meta name="dc.Creator" content="Rosario  González-Muñiz" /></meta><meta name="dc.Creator" content="Ming-Ming  Zhou" /></meta><meta name="dc.Description" content="Steroidal mineralocorticoid receptor (MR) antagonists are used for treatment of a range of human diseases, but they present challenging issues of complex chemical synthesis, undesirable physical pr..." /></meta><meta name="Description" content="Steroidal mineralocorticoid receptor (MR) antagonists are used for treatment of a range of human diseases, but they present challenging issues of complex chemical synthesis, undesirable physical pr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 24, 2017" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01065" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01065" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01065" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01065" /></link>
        
    
    

<title>Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01065" /></meta><meta property="og:title" content="Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0053.jpeg" /></meta><meta property="og:description" content="Steroidal mineralocorticoid receptor (MR) antagonists are used for treatment of a range of human diseases, but they present challenging issues of complex chemical synthesis, undesirable physical properties, and poor selectivity along with unwanted side effects. Therefore, there is a great interest in the discovery of non-steroidal ligands able to bind to the ligand-binding domain of the MR and recruit different co-regulators to produce tissue-specific therapeutic effects. Several academic groups and pharmaceutical companies have been developing a series of non-steroidal ligands that consist of different chemical scaffolds, yielding MR antagonists currently evaluated in clinical studies for the treatment of congestive heart failure, hypertension, or diabetic nephropathy. The main focus of this Perspective is to review the reported structure–activity relationships of the different series of compounds, as well as the structural studies that contribute to a better understanding of the receptor active site and are also helpful for optimization processes." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01065"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01065">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01065&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01065&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01065&amp;href=/doi/10.1021/acs.jmedchem.6b01065" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2629-2650</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00085" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b00299" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mercedes++Mart%C3%ADn-Mart%C3%ADnez">Mercedes Martín-Martínez</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6449-0905" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Felipe+L.++P%C3%A9rez-Gordillo">Felipe L. Pérez-Gordillo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diego++%C3%81lvarez+de+la+Rosa">Diego Álvarez de la Rosa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoel++Rodr%C3%ADguez">Yoel Rodríguez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guillermo++Gerona-Navarro">Guillermo Gerona-Navarro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosario++Gonz%C3%A1lez-Mu%C3%B1iz">Rosario González-Muñiz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming-Ming++Zhou">Ming-Ming Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Instituto de Química Médica (IQM-CSIC), Juan de la Cierva, 3, 28006 Madrid, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institute of Biomedical Technologies and Department of Physiology, Campus de Ciencias de la Salud, Facultad de Medicina, Universidad de La Laguna, 38204 Tenerife, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Natural Sciences, Hostos Community College of CUNY, 475 Grand Concourse, Bronx, New York 10451, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Chemistry, Brooklyn College, 2900 Bedford Avenue, Brooklyn, New York 11210, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#f69b93849593929385b69f879bd895859f95d89385"><span class="__cf_email__" data-cfemail="97faf2e5f4f2f3f2e4d7fee6fab9f4e4fef4b9f2e4">[email protected]</span></a>. Telephone: +34 912587478.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01065&amp;href=/doi/10.1021%2Facs.jmedchem.6b01065" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2629–2650</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 4, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 July 2016</li><li><span class="item_label"><b>Published</b> online</span>24 January 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01065" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01065</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2629%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMercedes%2BMart%25C3%25ADn-Mart%25C3%25ADnez%252C%2BFelipe%2BL.%2BP%25C3%25A9rez-Gordillo%252C%2BDiego%2B%25C3%2581lvarez%2Bde%2Bla%2BRosa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D7%26contentID%3Dacs.jmedchem.6b01065%26title%3DModulating%2BMineralocorticoid%2BReceptor%2Bwith%2BNon-steroidal%2BAntagonists.%2BNew%2BOpportunities%2Bfor%2Bthe%2BDevelopment%2Bof%2BPotent%2Band%2BSelective%2BLigands%2Bwithout%2BOff-Target%2BSide%2BEffects%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2650%26publicationDate%3DApril%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01065"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1293</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01065" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mercedes&quot;,&quot;last_name&quot;:&quot;Martín-Martínez&quot;},{&quot;first_name&quot;:&quot;Felipe&quot;,&quot;last_name&quot;:&quot;L. Pérez-Gordillo&quot;},{&quot;first_name&quot;:&quot;Diego&quot;,&quot;last_name&quot;:&quot;Álvarez de la Rosa&quot;},{&quot;first_name&quot;:&quot;Yoel&quot;,&quot;last_name&quot;:&quot;Rodríguez&quot;},{&quot;first_name&quot;:&quot;Guillermo&quot;,&quot;last_name&quot;:&quot;Gerona-Navarro&quot;},{&quot;first_name&quot;:&quot;Rosario&quot;,&quot;last_name&quot;:&quot;González-Muñiz&quot;},{&quot;first_name&quot;:&quot;Ming-Ming&quot;,&quot;last_name&quot;:&quot;Zhou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2629-2650&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01065&quot;},&quot;abstract&quot;:&quot;Steroidal mineralocorticoid receptor (MR) antagonists are used for treatment of a range of human diseases, but they present challenging issues of complex chemical synthesis, undesirable physical properties, and poor selectivity along with unwanted side effects. Therefore, there is a great interest in the discovery of non-steroidal ligands able to bind to the ligand-binding domain of the MR and recruit different co-regulators to produce tissue-specific therapeutic effects. Several academic groups and pharmaceutical companies have been developing a series of non-steroidal ligands that consist of different chemical scaffolds, yielding MR antagonists currently evaluated in clinical studies for the treatment of congestive heart failure, hypertension, or diabetic nephropathy. The main focus of this Perspective is to review the reported structure–activity relationships of the different series of compounds, as well as the structural studies that contribute to a better understanding of the receptor active site and are&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01065&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01065" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01065&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01065" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01065&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01065" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01065&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01065&amp;href=/doi/10.1021/acs.jmedchem.6b01065" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01065" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01065" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01065%26sid%3Dliteratum%253Aachs%26pmid%3D28051871%26genre%3Darticle%26aulast%3DMart%25C3%25ADn-Mart%25C3%25ADnez%26date%3D2017%26atitle%3DModulating%2BMineralocorticoid%2BReceptor%2Bwith%2BNon-steroidal%2BAntagonists.%2BNew%2BOpportunities%2Bfor%2Bthe%2BDevelopment%2Bof%2BPotent%2Band%2BSelective%2BLigands%2Bwithout%2BOff-Target%2BSide%2BEffects%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D7%26spage%3D2629%26epage%3D2650%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/jmcmar.2017.60.issue-7/20170413/jmcmar.2017.60.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0053.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Steroidal mineralocorticoid receptor (MR) antagonists are used for treatment of a range of human diseases, but they present challenging issues of complex chemical synthesis, undesirable physical properties, and poor selectivity along with unwanted side effects. Therefore, there is a great interest in the discovery of non-steroidal ligands able to bind to the ligand-binding domain of the MR and recruit different co-regulators to produce tissue-specific therapeutic effects. Several academic groups and pharmaceutical companies have been developing a series of non-steroidal ligands that consist of different chemical scaffolds, yielding MR antagonists currently evaluated in clinical studies for the treatment of congestive heart failure, hypertension, or diabetic nephropathy. The main focus of this Perspective is to review the reported structure–activity relationships of the different series of compounds, as well as the structural studies that contribute to a better understanding of the receptor active site and are also helpful for optimization processes.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The mineralocorticoid receptor (MR) is a member of the nuclear receptor superfamily of transcription factors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The main physiological role of the MR is to transduce the effects of aldosterone, a steroid hormone produced in the adrenal gland in response to intravascular volume depletion or hyperkalemia. Aldosterone interaction with MR initiates homeostatic responses that oppose the original imbalance. During volume depletion, aldosterone/MR increases renal NaCl reabsorption by activation of the epithelial Na<sup>+</sup> channel (ENaC) and the Na<sup>+</sup>/Cl<sup>–</sup> co-transporter (NCC). In hyperkalemia, aldosterone-mediated ENaC activation provides an electrical gradient in the renal tubule that potentiates K<sup>+</sup> and H<sup>+</sup> excretion. Consistent with this fundamental physiological role, inherited gain- or loss-of-function mutations in MR, ENaC, and their regulatory proteins cause genetic diseases characterized by disturbances in blood pressure homeostasis and mineral metabolism.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">In addition, during the past few years it has become apparent that MR medium- and long-term systemic actions are far wider than previously thought.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Regulated MR function is essential not only to blood pressure and mineral homeostasis but also to organ and tissue differentiation and morphological and functional tissue remodeling in health and disease. These include, but are not limited to, (a) morphological remodeling in epithelia such as the kidney and distal colon; (b) direct modulation of cardiac and vascular function and remodeling; (c) regulation of nervous system activity and its control of the cardiovascular and renal systems; (d) regulation of energy metabolism; and (e) immune responses. Underlying the wide variety of MR physiological and pathological roles are two factors. First, the MR is widely expressed in different tissues. Second, glucocorticoids such as cortisol can also act as agonists of the receptor,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> particularly in those tissues that lack the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2), which metabolizes cortisol to cortisone, an inactive metabolite.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">As all other members of the steroid receptor family, the MR displays a modular architecture. The NH<sub>2</sub>-terminal domain (NTD) mediates the interaction with transcriptional co-regulators and displays the highest level of sequence dissimilarity with other steroid receptors, an essential feature to determine selectivity in mineralocorticoid responses. Following the NTD in the MR primary sequence, there is a central DNA binding domain (DBD) formed by two zinc fingers. The DBD interacts with specific DNA sequences named hormone response elements (HREs). The DBD of the MR is 90–94% identical to DBDs of other steroid receptors such as glucocorticoid, progesterone, and androgen receptors, implying that HREs recognized by them are highly similar. A hinge domain separates the DBD from a COOH-terminal portion that harbors the ligand-binding domain (LBD) and an additional region that serves a transcriptional activation function in a ligand-dependent manner. Steroid receptor LBDs present moderate identity between them (50–60%), and while they allow for specific activation by different hormones, there is some degree of cross-reactivity between them. For instance, the MR shows the same affinity for aldosterone and for glucocorticoids such as cortisol or corticosterone (<i>K</i><sub>d</sub> = 0.5–2 nM), although the half-maximal effective concentration (EC<sub>50</sub>) of aldosterone is 100-fold lower, which has been explained due to a much lower off-rate of aldosterone from the MR.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Other steroids such as progesterone act as antagonists of the MR. High-resolution crystal structures of the MR LBD in combination with agonists<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> or antagonists<a onclick="showRef(event, 'ref6 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref8 ref9">(6, 8, 9)</a> are available. In addition, a naturally occurring mutant that causes pregnancy-related hypertension<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and converts progesterone into an agonist has also been crystallized.<a onclick="showRef(event, 'ref6 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref11">(6, 11)</a> Therefore, a good deal of information about the structural determinants involved in ligand binding to the MR LBD is available.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p last">For many years, the main focus of drug discovery targeting the MR has been on the use of its antagonist spironolactone in the context of primary hyperaldosteronism or as potassium-sparing diuretics to be used in combination with loop diuretics and thiazides.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Spironolactone displays undesired side effects, particularly producing sexual dysfunction and gynecomastia in men. In these cases, an alternative is to treat patients with chemically unrelated drugs such as amiloride or triamterene, which target a downstream target of the MR, the epithelial sodium channel (ENaC).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> However, renewed interest in MR antagonists has been triggered by a combination of new findings in the last two decades. First, the realization that aldosteronism is more widespread in the human population than previously thought indicates that MR antagonism will probably expand its scope. Second, it has been firmly established that the MR is expressed outside classic aldosterone target epithelia and can be considered a ubiquitous receptor. Pioneering work from Weber’s laboratory using animal models suggested that the MR was an important mediator in the development of direct, blood pressure-independent heart fibrosis and inflammation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This prompted a clinical trial (RALES) where patients with severe heart failure received the aldosterone antagonist spironolactone at doses that did not significantly affect blood pressure. The treatment quickly demonstrated very beneficial effects, with significant decreases in morbidity and mortality.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> On the other hand, the discovery of eplerenone, a steroid MR antagonist with improved selectivity over other steroid receptors and therefore displaying less sexual side effects, triggered a second large clinical trial, EPHESUS, which further demonstrated the utility of MR antagonism.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Recent studies on non-epithelial aldosterone/MR effects has expanded the interest in this signaling system to related pathophysiological settings, such as the vasculature,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> oxidative stress, inflammation, and metabolic diseases related to obesity. Given the already important and expanding clinical applications, the obvious question is whether new MR antagonists are needed.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The main adverse effects of MR antagonists can be divided in two categories. The already mentioned sexual side effects, due to the close similarity in the LBDs of MR and related steroid receptors, make it difficult to develop steroid-derived drugs with high specificity for the MR over the progesterone or androgen receptors. The second category of the MR adverse effects can be ascribed to the undesired interference with aldosterone classical function in regulating electrolyte homeostasis, particularly in promoting K<sup>+</sup> excretion in the kidney tubule. Indeed, it has been observed that inappropriate dosage of spironolactone can lead to hyperkalemia, which in turn is a risk factor for cardiac complications, particularly in patients with renal insufficiency.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> On the other hand, hypokalemia also worsens outcomes in patients with severe heart failure, and therefore the tendency of MR antagonists to increase plasma K<sup>+</sup> levels may be desirable under controlled circumstances.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> To overcome these two types of adverse effects, the focus of MR pharmacology has shifted toward developing non-steroidal inhibitors that ideally would have tissue-specific properties. A third generation of MR antagonists based on non-steroidal compounds is currently being developed, and some of these products, like the dihydropyridine-like compound finerenone (see below), are currently under clinical trials.<a onclick="showRef(event, 'ref18 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref21 ref22">(18, 21, 22)</a> In this Perspective we examine the described non-steroidal ligands collected either in papers or patents. The review aims to be a useful tool for structure–activity relationship (SAR) studies, and therefore includes different families of non-steroid ligands able to bind to the MR, and several compounds within each family.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Non-steroidal Mineralocorticoid Receptor Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">1 1,4-Dihydropyridine and 1,4-Dihydro-1,6-naphthyridinamide Compounds as MR Ligands</h3><div class="NLM_p">1,4-Dihydropyridines (DHP) represent an interesting scaffold for the search of non-steroidal MR antagonis and have attracted the interest of several pharmaceutical companies.</div><div class="NLM_p">Pfizer, through a screening of its in-house collection, identified a series of DHPs, previously recognized as calcium channel blockers (CCBs), as MR antagonists.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Among them, nimodipine and felodipine competed for aldosterone binding and were only slightly less active than eplerenone. As stereoselective issues affect calcium channel activity, it was investigated whether the CCB and the MR activities resided in the same DHP stereoisomer. The study of the CCB-asymmetric DHP mebudipine (<b>1a</b>) indicated that the 4<i>R</i> enantiomer was responsible for the MR antagonist activity, while the 4S enantiomer had the CCB activity (<a class="ref internalNav" href="#tbl1a" aria-label="Table 1.1">Table 1.1</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In agreement with this result, a cyano DHP, identified at Bayer, showed a preference for the <i>R</i> configuration in its binding to the MR. However, this was also the more active isomer for L-type Ca<sup>2+</sup> channels.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Moreover, it was also observed that the cyano group at R<sup>3</sup> position induced high selectivity against CCB and good selectivity against other nuclear hormone receptors (NHRs).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Based on these results, a library of DHP was prepared to perform SAR studies. Substitution at the DHP NH group decreased activity, suggesting a potential hydrogen bond with the MR.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Similar results were also reported by Bayer.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Regarding the aromatic phenyl ring at position 4, small, nonpolar substituents like F, Cl, or CF<sub>3</sub> were suitable at the ortho or the para position, with a 2-chloro,4-fluorophenyl moiety giving the best results (<b>1b</b>–<b>1e</b>, <a class="ref internalNav" href="#tbl1a" aria-label="Table 1.1">Table 1.1</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> A voluminous R<sup>1</sup> group like phenyl or benzyl decreased potency, while smaller C<sub>2</sub>–C<sub>4</sub> alkyl groups were adequate (<b>1c</b>). However, a methylene linker tethering an imidazole, <b>1d</b>, triazole or tetrazole, <b>1e</b>, maintained potency while increasing selectivity against other NHRs. The tetrazole derivative <b>1e</b> showed an <i>in vitro</i> pharmacokinetic (PK) profile adequate for <i>in vivo</i> studies (CL = 14.1 mL/min/kg, <i>T</i><sub>1/2</sub> = 4.84 h). Compound <b>1e</b> was able to reduce blood pressure and renal injury in rats <i>in vivo</i>. Induced fit docking (IFD) studies of this compound suggested partial overlapping with the native corticosterone MR binding pocket.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_table-wrap" id="tbl1a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1.1. Selected Pfizer DHP MR Antagonists and Their IC<sub>50</sub> Values<a onclick="showRef(event, 'ref24 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref26">(24, 26)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1afn1"><div class="footnote" id="t1afn1"><sup>Table a</sup><p class="last">Determined using a Gal4/MR LBD (Gal4/LBD) reporter assay in HUH7 human hepatocyte cells.</p></div><div class="footnote" id="t1afn2"><sup>Table b</sup><p class="last">Chiral resolution of <b>1e</b> afforded the <i>R</i>-enantiomer (IC<sub>50</sub> = 52 nM).</p></div></div><div></div></div><div class="NLM_p">Bayer Pharma, in an ultra-high-throughput screening of almost one million compounds, found a single cluster of around one hundred MR-modulating compounds, including dihydropyridines.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Among them, <b>1f</b> was identified as a selective sub-micromolar MR antagonist (<a class="ref internalNav" href="#tbl1b" aria-label="Table 1.2">Table 1.2</a>), but it was associated with a number of liabilities, such as low metabolic stability in microsomes and significant interaction with L-type Ca<sup>2+</sup> channels.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> As previously observed, the <i>R</i> configuration at the DHP core was preferred, and <i>N</i>-alkylation led to loss of potency. Other modifications that also decreased potency were the dehydrogenation of the DHP nucleus to pyridine, the change of the DHP ring by similar scaffolds as 1,4-dihydropyrimidines, 1,4-dihydropyridazines, and 3,4-dihydropyrimidin-2-ones, or the attachment of highly hydrophilic groups to various positions of the DHP core.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Several substituents had been analyzed at C4 position (<a class="ref internalNav" href="#tbl1b" aria-label="Table 1.2">Table 1.2</a>), with the fluorenyl moiety B (compound <b>1g</b>) leading to an increase in potency with respect to the quinoline analogue <b>1f</b>.<a onclick="showRef(event, 'ref25 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref28">(25, 28)</a> Subsequent attempts to decrease 4-Ar size and lipophilicity allowed the identification of chromenone derivatives (<b>1h</b>, Ar = C), at the cost of lower activity.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In this latter subseries, the potency could be restored by modulating R<sup>1</sup> and R<sup>2</sup> substituents (<b>1i</b>–<b>1m</b>).<a onclick="showRef(event, 'ref25 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref29">(25, 29)</a> Because of the low bioavailability of <b>1j</b>, the less lipophilic ethyl ester BR-4628 (<i>R</i>-<b>1k</b>) was preferred due to its favorable PK profile.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><i>R</i>-<b>1k</b>, a potent MR LBD antagonist, 160-fold more selective for the MR over the AR and with low CCB activity, was considered a drug candidate. Different from spironolactone and eplerenone, <i>R</i>-<b>1k</b> retained its antagonist character at the MR<sub>S810L</sub> mutant. <i>In vivo</i> assays in rats probed that it increased the urinary sodium/potassium ratio in a dose-dependent manner, with effect for a dose as low as 1 mg/kg.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><i>R</i>-<b>1k</b> also prevented the aldosterone-induced increased expression of connective tissue growth factor and hydroxyproline in cardiac fibroblasts, thus suggesting that the MR could be a biological target for the treatment of fibrosis in the atrial myocardium.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_table-wrap" id="tbl1b"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1.2. MR Activity of DHP by Bayer Pharma<a onclick="showRef(event, 'ref25 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref29">(25, 29)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0014.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1bfn1"><div class="footnote" id="t1bfn1"><sup>Table a</sup><p class="last">Gal4/LBD reporter assay in CHO-K1 cells.</p></div><div class="footnote" id="t1bfn2"><sup>Table b</sup><p class="last">c-Bu = cyclobutyl.</p></div></div><div></div></div><div class="NLM_p">The binding mode of DHP antagonists has been studied by means of induced-fit-molecular docking against available MR-LBD X-ray structures, such as MR-LBD complexed with corticosterone (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A3I">2A3I</a>),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> for derivatives <b>1b</b> and <b>1e</b>, or with deoxycorticosterone (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ABI">2ABI</a>) to study <i>R</i>-<b>1k</b>.<a onclick="showRef(event, 'ref24 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref26 ref27">(24, 26, 27)</a> The helix 12 of the MR LBD was truncated, since the binding pocket was too small to accommodate the branched ligands. These studies have identified key phamachophore points within the 1,4-DHP derivatives, namely a hydrogen bond acceptor (e.g., donor DHP-NH), an aromatic moiety at the 4-position, which resides in the known A-ring binding pocket of the steroid MR antagonist binding mode, and lipophilic moieties at 3- and/or 5-positions (e.g., alkyl esters). Specifically, the NH group of the 1,4-DHP ring (e.g., compounds <i>R</i>-<b>1b</b> and <i>R</i>-<b>1e</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and <i>R</i>-<b>1k</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) forms a hydrogen bond with H3 helix Asn770.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The hydrophobic ester group fills the α-face pocket formed by hydrophobic residues Leu814, Leu827, Phe829, Met845, Cys849, Met852, and Leu938 (e.g., compounds <i>R</i>-<b>1b</b>, <i>R</i>-<b>1e</b>, and <i>R</i>-<b>1k</b>). On the other hand, substituents at the opposite site, a methyl and either a CN or COMe group, protrude toward the β-face pocket (e.g., Ala773, Trp806, Ser810, and Leu 960), either directly impinging on Leu960 in H12 helix or indirectly by perturbing Trp806 in H5 helix (e.g., compounds <i>R</i>-<b>1b</b>, <i>R</i>-<b>1e</b>, and <i>R</i>-<b>1k</b>). The 4-aryl groups occupy the A-ring pocket, and depending on the DHP derivatives, they interact with Phe829 (e.g., compounds <i>R</i>-<b>1b</b> and <i>R</i>-<b>1e</b>), Arg817, or Gln776 (e.g., compound <i>R</i>-<b>1k</b>). The formation of hydrogen bonds between the DHP derivatives and Arg817 and Gln776 indicates that the 4-aryl groups are equivalent to the steroid C3-carbonyl in the A-ring moiety. It has also been shown that DHPs partially overlap with the steroidal skeleton of MR antagonists. Interestingly, the proposed DHP derivatives binding mode fails to overlap the entire steroid D-ring region, impeding the stabilizing contacts with the H11 helix, including Thr945. Thus, it has been suggested that the incomplete occupancy and stabilization of the receptor-binding pocket, as well as the steric clashes caused by the branched DHPs, explain the passive MR antagonism of these ligands.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> These binding modes have been supported by site-directed mutagenesis studies.<a onclick="showRef(event, 'ref25 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref27">(25, 27)</a> The high selectivity has been linked to the fact that the MR is the only oxosteroid receptor having an alanine residue (Ala773) in the H3 helix and a serine residue (Ser810) in the H5 helix, while the AR, GR, and PR have glycine and methionine at their corresponding positions, respectively.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> For example, the DHP derivative <i>R</i>-<b>1k</b> is able to form contacts with Ala773 and Ser810, while neither glycine nor methionine is able to make contacts in AR, PR, and GR, thereby explaining their high selectivity toward the MR.</div><div class="NLM_p">The SAR was further extended with a series of heterobicyclic analogues. Among them, 1,4-dihydro-1,6-naphthyridine derivatives, as <b>1n</b>, can be considered as conformationally frozen bioisosteres of 1,4-DHP esters (<a class="ref internalNav" href="#tbl1c" aria-label="Table 1.3">Table 1.3</a>).<a onclick="showRef(event, 'ref5 ref33'); return false;" href="javascript:void(0);" class="ref ref5 ref33">(5, 33)</a> In an effort to improve selectivity vs other NHRs, a methyl group was introduced at positions 7 and 8 (e.g., <b>1o</b>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Interestingly, the replacement of the 3-cyano group by a primary amide led to a potent MR antagonist with remarkable selectivity toward GR, AR, and PR (finerenone, BAY 94-8862, <b>1p</b>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This compound has higher selectivity than spironolactone and improved affinity for the MR than eplerenone. Compound <b>1p</b> was explored on 65 different enzyme and ion channel assays without significant effects at 10 μM.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Clinical studies with <b>1p</b> suggested that, in comparison with spironolactone, a lower dose may be at least as effective in reducing ventricular remodeling, with lower incidence of hyperkalemia and renal adverse events.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> More recently it was shown that it was able to protect rats from cardiorenal injury.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> These findings provided impetus for further clinical evaluation of <b>1p</b>, which entered in phase II studies for the treatment of congestive heart failure and diabetic nephropathy. The latter phase II trial focused on the effect of <b>1p</b> on albuminuria in patients with diabetic nephropathy receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker. The data showed that administration of <b>1p</b> led to an improvement in the urinary albumin-creatinine ratio, with a dose-dependent reduction at day 90 ranging from 21% to 38% when compared to placebo in the dosage group of 7.5 to 20 mg/d compared with placebo.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36-38)</a> In the second phase II trial, <b>1p</b> was studied in patients with worsening heart failure, who also had diabetes mellitus and/or chronic kidney disease.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> These patients are at higher risk of developing hyperkalemia, so they are less likely to receive steroidal MR antagonists. The overall result of these studies indicated that <b>1p</b> reduces the levels of pro-B-type natriuretic peptide (NT-proBNP), as shown by the decrease of over 30% from baseline found in 38.8% and 34.2% of the patients in the 10 → 20 mg and 15 → 20 mg <b>1p</b> groups, respectively (initial dose → up-titrated dose), a similar extent to that of eplerenone. Moreover, and similar to eplerenone, <b>1p</b> showed a good safety profile, with hyperkalemia (serum potassium concentrations ≥5.6 mmol/L) only observed in 4.3% of the patients. This study also indicated that 10 → 20 mg of <b>1p</b> is the most suitable dosage. The promising results of these phase II studies have allowed the clinical development program for <b>1p</b> to be expanded with phase III studies for chronic heart failure and diabetic kidney disease, as recently announced by Bayer in September 2015.</div><div class="NLM_table-wrap" id="tbl1c"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1.3. IC<sub>50</sub> of Naphthyridinamide Derivatives on Several Steroid Hormone Receptors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0015.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="​" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="​">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1cfn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char="​">MR</th><th class="colsep0 rowsep0" align="center">GR</th><th class="colsep0 rowsep0" align="center" char=".">AR</th><th class="colsep0 rowsep0" align="center" char=".">PR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1n</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="​">100</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>-<b>1n</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="​">47</td><td class="colsep0 rowsep0" align="center">6900</td><td class="colsep0 rowsep0" align="char" char=".">2800</td><td class="colsep0 rowsep0" align="char" char=".">5400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>-<b>1o</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="​">26</td><td class="colsep0 rowsep0" align="center">5800</td><td class="colsep0 rowsep0" align="char" char=".">2400</td><td class="colsep0 rowsep0" align="char" char=".">4200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><i>S</i>-<b>1p</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" rowspan="2" align="left">H</td><td class="colsep0 rowsep0" rowspan="2" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="​">18<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></td><td class="colsep0 rowsep0" rowspan="2" align="center">≥10000</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">≥10000</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">≥10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="​">(58)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1cfn1"><div class="footnote" id="t1cfn1"><sup>a</sup><p class="last">Functional cell-based transactivation assay. Luciferase assay.</p></div></div></div><div class="NLM_p">Docking studies of <i>S</i>-<b>1p</b> at the MR LBD X-ray structure (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ABI">2ABI</a><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> devoid of helix 12) indicated a similar binding mode as the above-mentioned for other DHP derivatives, forming hydrogen bonds with Asn770, Gln776, and Arg817.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Moreover, it confirmed the key roles of Ala773 and Ser810 for the high MR selectivity over the AR, PR, and GR. These structural studies also found that the binding pocket of the MR LBD in its agonistic conformation seems to be too small to accommodate non-steroidal ligands, thereby suggesting that the DHP-type MR antagonists act as bulky antagonists. This latter docking model of MR LBD complexed with <i>S</i>-<b>1p</b> was validated by carrying out point mutations within the binding pocket. Strikingly, both A773G and S810M mutations led to a dramatic decrease in the <i>S</i>-<b>1p</b> antagonistic potency. IC<sub>50</sub> value increased respectively by ∼24- and 88-fold for MR<sub>WT</sub>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> These results strongly corroborate that Ala773 and Ser810 favor the selective binding of <i>S</i>-<b>1p</b> to the MR, while glycine and methionine at these respective positions, as in the AR, PR, and GR, impair <i>S</i>-<b>1p</b> binding.</div><div class="NLM_p">Merck also claimed a number of 1,4-DHPs as MR modulators. After the analysis of different substituents at every position of the DHP ring, they discovered several compounds with sub-micromolar binding affinity (e.g., <b>1q</b>–<b>1t</b>, <a class="ref internalNav" href="#tbl1d" aria-label="Table 1.4">Table 1.4</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_table-wrap" id="tbl1d"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1.4. Binding Affinity of Selected Merck DHPs for the MR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0017.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0018.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1dfn1"><div class="footnote" id="t1dfn1"><sup>Table a</sup><p class="last">Binding affinity was determined using a competitive binding assay with <sup>3</sup>H-aldosterone and recombinant rhesus MR.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2 Five-Membered Nitrogen Heterocyclic Rings as Central Scaffolds in MR Ligands</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">2.1 Pyrrole Derivatives</h4><div class="NLM_p">Exelixis developed a series of compounds with a common structural pyrrole motif. One of them, CS-3150 (<b>2k</b>), entered in phase III clinical trials in 2016.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> This work started from a series of derivatives able to modulate 50% of the MR activity at concentrations below 500 nM (<b>2a</b>–<b>2e</b>, <a class="ref internalNav" href="#tbl2a" aria-label="Table 2.1">Table 2.1</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> These compounds presented a 1H-pyrrole-3-carboxamide or a 1<i>H</i>-pyrrole-2-carboxamide structural core with different substituents attached.</div><div class="NLM_table-wrap" id="tbl2a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2.1. Pyrrole Derivatives as MR Antagonist (IC<sub>50</sub> < 500 nM)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0019.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0020.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2afn1"><div class="footnote" id="t2afn1"><sup>Table a</sup><p class="last">Gal4/LBD cell-based reporter assay.</p></div></div><div></div></div><div class="NLM_p">In March 2006, Exelixis and Daiichi Sankyo entered into a joint research agreement to develop modulators of the MR, which led to two patents in 2010. These new 1<i>H</i>-pyrrole-3-carboxamide compounds showed atropisomerism (<b>2f</b>–<b>2k</b>, <a class="ref internalNav" href="#tbl2b" aria-label="Table 2.2">Table 2.2</a>), and only one of the atropisomers exhibited high MR antagonist action.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> The pharmacological profile of compound <b>2k</b> was further investigated.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In these studies <b>2k</b> showed a good selectivity profile over other human steroid hormone receptors (at least 1000-fold more selective for MR over GR, AR, and PR), which could result in reduced sex-hormone-related side effects. Compound <b>2k</b> also showed more potent MR antagonism and longer-lasting activity than the two currently marketed drugs, since it was able to inhibit the aldosterone-induced decrease in urinary Na<sup>+</sup>/K<sup>+</sup> ratio in rats by 56% at 20 h, whereas spironolactone inhibited the decrease at 20 h by less than 20% and eplerenone at 8 h by around 8%, following oral administration to rats. Moreover, compound <b>2k</b> exhibits more potent antihypertensive and cardiorenal protective effects in a Dahl salt-sensitive hypertensive rat model than the two marketed drugs.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Indeed, 3 mg/kg of <b>2k</b> inhibited the elevation in systolic blood pressure in DOCA/salt-loading rats, whereas spironolactone and eplerenone did not show significant effects at 30 mg/kg. The overall results prompted the initiation of phase II clinical trials to treat patients with hypertension and diabetic nephropathy. In March 2016 this compound started phase III clinical trials in essential hypertension.</div><div class="NLM_table-wrap" id="tbl2b"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2.2. IC<sub>50</sub> Values of 1<i>H</i>-Pyrrole 3-Carboxamide MR Inhibition</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0021.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0022.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2bfn1"><div class="footnote" id="t2bfn1"><sup>Table a</sup><p class="last">Gal4/LBD cell-based reporter assay.</p></div><div class="footnote" id="t2bfn2"><sup>Table b</sup><p class="last">Mixture of atropisomers A and B.</p></div><div class="footnote" id="t2bfn3"><sup>Table c</sup><p class="last">The corresponding <b>2f</b>–<b>2k</b> atropisomers have an IC<sub>50</sub> > 1000 nM.</p></div></div><div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">2.2 Pyrazoline Derivatives</h4><div class="NLM_p">Pfizer identified pyrazoline <b>2l</b> (<a class="ref internalNav" href="#fig2a" aria-label="Figure 2.1">Figure 2.1</a>) as an acceptable MR antagonist during a high-throughput screening (HTS) campaign.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Starting from this hit, and in an effort to improve activity and solubility, they analyzed substituents at the pyrazoline 1, 3, and 5 positions. Regarding the aromatic moiety at N1, the cyano substituent was the most appropriate replacement for the nitro group (<a class="ref internalNav" href="#tbl2c" aria-label="Table 2.3">Table 2.3</a>), while a small nonpolar substituent at R<sup>2</sup> brought a 2-fold improvement in potency (<b>2m</b> vs <b>2n</b> and <b>2o</b>, <a class="ref internalNav" href="#tbl2c" aria-label="Table 2.3">Table 2.3</a>).<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> As for the aromatic ring at position 3, the introduction of a 4-carboxylate group led to potent MR antagonists with reduced hERG channel inhibitory potency. At position 5, the <i>R</i> configuration was the most favored (<i>R</i>-<b>2m</b> vs <i>S</i>-<b>2m</b>, <a class="ref internalNav" href="#tbl2c" aria-label="Table 2.3">Table 2.3</a>), and the replacement of the 4-fluorophenyl group by a cyclopentyl moiety led to a slight improvement in potency (<b>2m</b> vs <b>2p</b>, <b>2n</b> vs <b>2q</b>).<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> Further modifications by addition of alkoxy groups resulted also in potency enhancement for <b>2r</b>–<b>2t</b>.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a></div><figure id="fig2a" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2.1. Pfizer pyrazoline derivative <b>2l</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig2a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2c"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2.3. MR Pyrazoline Antagonists</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0023.gif" alt="" id="fx12" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0024.gif" alt="" id="fx13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2cfn1"><div class="footnote" id="t2cfn1"><sup>Table a</sup><p class="last">Gal4/LBD cell-based reporter assay.</p></div></div><div></div></div><div class="NLM_p">A related series resulted from the conformational restriction through cycling the phenyl ring at position 3 to the pyrazoline scaffold. A six-membered ring (<b>2u</b>–<b>2w</b>, <a class="ref internalNav" href="#tbl2d" aria-label="Table 2.4">Table 2.4</a>) was preferred over the corresponding lower five-membered homologue.<a onclick="showRef(event, 'ref47 ref49'); return false;" href="javascript:void(0);" class="ref ref47 ref49">(47, 49)</a> As in the non-restricted series, the stereochemistry at C3 was essential for potency, whereas that of C3a was only of marginal importance. Compound PF-3882845 (3<i>S</i>,3a<i>R</i>-<b>2w</b>) displayed high affinity for the MR, selectivity over other steroid receptors (PR IC<sub>50</sub> = 416 nM, AR IC<sub>50</sub> = 8960 nM, GR and ER IC<sub>50</sub> > 10000 nM) as well as a good pharmacokinetic profile.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Moreover, 3<i>S</i>,3a<i>R</i>-<b>2w</b> reduced blood pressure and protected the kidneys in a preclinical model of hypertension induced in Dahl salt-sensitive rats. 3<i>S</i>,3a<i>R</i>-<b>2w</b> entered clinical trials for diabetic nephropathy,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> but its development was discontinued in 2012.</div><div class="NLM_table-wrap" id="tbl2d"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2.4. IC<sub>50</sub> Values of Conformationally Restricted Pyrazoline Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0025.gif" alt="" id="fx14" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0026.gif" alt="" id="fx15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2dfn1"><div class="footnote" id="t2dfn1"><sup>Table a</sup><p class="last">Gal4/LBD cell-based reporter assay.</p></div></div><div></div></div><div class="NLM_p">Molecular docking studies has been carried out to get insights into the binding pocket of <b>2w</b>.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Unlike the DHP compounds, pyrazoline derivatives do not make the stabilizing contact to Asn770 residue (H3 helix). This binding feature by itself could explain their MR antagonism, because it has previously been suggested that MR steroidal activation, in addition to the C3-ketone group, requires ligands able to engage in hydrogen bonding to Asn770 (H3 helix) and Thr945 (H11 helix).<a onclick="showRef(event, 'ref23 ref47'); return false;" href="javascript:void(0);" class="ref ref23 ref47">(23, 47)</a> Similarly to the binding mode of some DHP derivatives (e.g., <i>S</i>-<b>1p</b>), the cyano phenyl group of <b>2w</b> sits in the A-ring pocket forming hydrogen bonds, with Gln776 (H3 helix) and Arg817 (H5 helix), thus mimicking the A-ring C3-carbonyl group of steroidal ligands (e.g., corticosterone).</div><div class="NLM_p">In spite of the good properties of 3<i>S</i>,3a<i>R</i>-<b>2w</b>, there was still room for improvement. To this end, Pfizer focused again on non-conformationally restricted pyrazoline analogues, in particular <i>R</i>-<b>2r</b>, because of its increased selectivity over PR and its improved solubility.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The MR potency and selectivity rose upon the replacement of the 1-(3-chlorophenyl) ring by the corresponding 3-methyl-substituted analogue, and even more upon incorporation of a nitrogen in the benzoic acid moiety, resulting in compound <b>2x</b>, with a selectivity over PR >500-fold (<a class="ref internalNav" href="#tbl2e" aria-label="Table 2.5">Table 2.5</a>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The incorporation of a nitrogen within the aromatic ring displaying the nitrile (<b>2y</b>) did not change significantly the MR activity or solubility.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The replacement of the carboxylic acid by amide derivatives did not improve the MR potency or the selectivity over the PR and decreased kinetic solubility (<b>2x</b> vs <b>2z</b>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In contrast, acylsulfonamide analogues (<b>2aa</b>, <b>2ab</b>) increased the MR potency while maintaining low PR activity.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Thus, compound <b>2aa</b> displayed >800-fold selectivity for the MR over the PR. However, the high <i>in vitro</i> liver microsomal intrinsic clearance of <b>2aa</b> (Cl<sub>int</sub> = 175 μL/min/mg) motivated the authors to focus additional efforts on <b>2x</b> (Cl<sub>int</sub> < 14 μL/min/mg). Oral administration of <b>2x</b> in rats significantly increased the urinary Na<sup>+</sup>/K<sup>+</sup> ratio at the doses of 10 and 30 mg/kg. The effect of <b>2x</b> was dose-dependent. This compound behaved as a MR antagonist, with good selectivity over other NHRs and improved solubility in comparison with <b>2w</b>, and showed <i>in vivo</i> efficacy. Therefore, <b>2x</b> was selected for further preclinical profiling.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_table-wrap" id="tbl2e"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2.5. Activity of Pyrazoline Derivatives in the MR and the PR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0016.gif" alt="" id="fx16" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2efn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">MR</th><th class="colsep0 rowsep0" align="center" char=".">PR</th><th class="colsep0 rowsep0" align="center" char=".">solubility<a class="ref internalNav" href="#t2efn2" aria-label="b">b</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2x</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">2530</td><td class="colsep0 rowsep0" align="char" char=".">312</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2y</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="char" char=".">1590</td><td class="colsep0 rowsep0" align="char" char=".">324</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2z</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">494</td><td class="colsep0 rowsep0" align="char" char="."><25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2aa</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">NHSO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">2480</td><td class="colsep0 rowsep0" align="char" char=".">239</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2ab</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">NHSO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">831</td><td class="colsep0 rowsep0" align="char" char=".">39</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2efn1"><div class="footnote" id="t2efn1"><sup>a</sup><p class="last">Gal4/LBD cell-based reporter assay.</p></div><div class="footnote" id="t2efn2"><sup>b</sup><p class="last">Kinetic solubility determined as previously described.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></p></div></div></div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">2.3 Imidazole Derivatives</h4><div class="NLM_p">In 2008, Merck patented several imidazole derivatives with antagonist MR activity (some representative examples, <b>2ac</b>–<b>2ae</b>, are collected in <a class="ref internalNav" href="#tbl2f" aria-label="Table 2.6">Table 2.6</a>).<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> Compound <b>2ae</b> was selected to test a protocol for determining the anti-mineralocorticoid activity of compounds dosed in rats. This compound was active at a 30 mg/kg subcutaneous dose but showed lower activity than spironolactone at 10 mg/kg.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><div class="NLM_table-wrap" id="tbl2f"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2.6. MR Binding Affinity of Imidazole Derivatives (<i>K</i><sub>i</sub> Values)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0027.gif" alt="" id="fx17" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">MR <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t2ffn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2ac</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">134.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2ad</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3,5-di-Cl-Ph-CONH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">161.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2ae</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">285</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2ffn1"><div class="footnote" id="t2ffn1"><sup>a</sup><p class="last">Binding affinity was determined using a competitive binding assay with <sup>3</sup>H-aldosterone and recombinant rhesus MR.</p></div></div></div></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">2.4 Oxazolidinedione Derivatives</h4><div class="NLM_p">Merck Research Laboratories recently described the discovery of a new class of MR antagonists based on the oxazolidine-2,4-dione scaffold. Starting from a HTS of an in-house collection, compound <b>2af</b> was selected as a modest MR ligand for a thorough optimization strategy (<a class="ref internalNav" href="#tbl2g" aria-label="Table 2.7">Table 2.7</a>).<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> First, the importance of the absolute configuration of <b>2af</b> was recognized, as its enantiomer was inactive (IC<sub>50</sub> > 40 μM), as well as the positive contribution of a methyl group as R<sup>1</sup> substituent (<b>2ag</b>–<b>2ai</b>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> According to molecular modeling studies, this methyl plays a key role in favoring the conformation which is preferred for receptor binding. The incorporation of fluoro or chloro substituents on the R<sup>1</sup> phenyl ring (<b>2ai</b>), as well as the introduction of a ring fused to the phenyl group (<b>2aj</b>) maintained the affinity.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The benzyl group at position 5 of the oxazolidinedione ring was also an important element, as its replacement by H led to an inactive compound. The optimization of the group attached to the amide bond revealed that certain substituents on the benzyl moiety (R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>) increased the affinity, as in <b>2ag</b> and <b>2ah</b>. In contrast, the incorporation of monocyclic or fused bicyclic aryl or heteroaryl moieties generally led to a decreased MR activity. Interestingly, an increase in activity was observed for the cyclohexyl analogue <b>2ak</b>, the most potent compound within this series.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Finally, attempts to change the oxazolidinedione core led to inactive analogues. Theoretical studies suggested that this scaffold was essential to place the pharmacophore groups in the right pocket regions. Compound <b>2ai</b> showed an acceptable selectivity profile against several nuclear receptors, including GR, AR, ERα, ERβ, and PRβ (EC<sub>50</sub> agonist mode assay values >20 μM and IC<sub>50</sub> antagonist mode assay >8 μM).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_table-wrap" id="tbl2g"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2.7. MR Ligands with an Oxazolidinedione Central Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0028.gif" alt="" id="fx18" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0029.gif" alt="" id="fx19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2gfn1"><div class="footnote" id="t2gfn1"><sup>Table a</sup><p class="last">Values obtained using a commercially available protein–protein interaction cell-based assay.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></p></div></div><div></div></div><div class="NLM_p">Next, aiming at improving physicochemical and ADME (absorption, distribution, metabolism, and excretion) properties and safety profiles, the cyclization of the amide moiety was explored (<b>2al</b>–<b>2aq</b>, <a class="ref internalNav" href="#tbl2h" aria-label="Table 2.8">Table 2.8</a>) as a way of avoiding amide hydrolysis, one of the primary metabolic pathways of these compounds.<a onclick="showRef(event, 'ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59">(57-59)</a> The authors analyzed different rings, among them imidazole, oxazole, triazole, oxadiazole, and benzimidazole. Imidazole and 1,3,4-oxadiazole derivatives, <b>2an</b> and <b>2ap</b>, showed improved potency and lipophilic ligand efficiency (LLE) compared with the 1,2,4-triazole, <b>2ao</b>. The inclusion of a cyclopropyl ring at the benzylic position, as in <b>2aq</b>, led to an enhancement in human metabolic stability. Both <b>2ap</b> and <b>2aq</b> showed significant selectivity over other NRs (IC<sub>50</sub> > 5 μm), ion channels (IC<sub>50</sub> > 6 μm), and CYPs (IC<sub>50</sub> > 19 μm) as well as a reasonable rat PK profile.<a onclick="showRef(event, 'ref57 ref59'); return false;" href="javascript:void(0);" class="ref ref57 ref59">(57, 59)</a> As previously observed, the incorporation of a 3,5-dimethoxyphenyl substituent at position R increased potency (<b>2an</b> vs <b>2am</b>).</div><div class="NLM_table-wrap" id="tbl2h"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2.8. IC<sub>50</sub> of Oxazolidinedione-Derived MR Ligands with Heteroaromatic Substituents at Position 5</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0030.gif" alt="" id="fx20" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0031.gif" alt="" id="fx21" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2hfn1"><div class="footnote" id="t2hfn1"><sup>Table a</sup><p class="last">Commercially available protein–protein interaction cell-based assay.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></p></div></div><div></div></div><div class="NLM_p">Authors also envisaged the benzimidazole as a replacement of the amide moiety of compounds like <b>2ag</b>. These benzimidazole-based oxazolidine derivatives combined similar MR potency with improved rat liver microsomal activity (<a class="ref internalNav" href="#tbl2i" aria-label="Table 2.9">Table 2.9</a>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The SAR studies with respect to R<sup>1</sup> and R<sup>2</sup> showed that small substituents such as halides (<b>2ar</b>, <b>2ax</b>, <b>2ay</b>) or trifluoromethyl (<b>2az</b>) led to modest MR activity, whereas the incorporation of heteroaryls or heterocycles at R<sup>2</sup> led to several compounds with improved IC<sub>50</sub> values (<b>2as</b>–<b>2aw</b>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> These derivatives had acceptable human microsomal stability (>50% of parent compound remaining after 30 min of incubation). Moreover, in a natriuresis rat model the effect of compound <b>2au</b> at 100 mg/kg was comparable to that of spironolactone at 30 or 100 mg/kg. Authors noted that previous monocyclic heteroaryls (<a class="ref internalNav" href="#tbl2h" aria-label="Table 2.8">Table 2.8</a>) exhibited much weaker efficacy in the same model.</div><div class="NLM_table-wrap" id="tbl2i"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2.9. MR Activity of Benzimidazole-Based Oxazolidine Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0032.gif" alt="" id="fx22" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0033.gif" alt="" id="fx23" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2ifn1"><div class="footnote" id="t2ifn1"><sup>Table a</sup><p class="last">Commercially available protein–protein interaction cell-based assay.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></p></div><div class="footnote" id="t2ifn2"><sup>Table b</sup><p class="last">Percentage of compound (1 μM) remaining at 0.5 h and incubation in human (hLM) and rat (rLM) liver microsomes.</p></div></div><div></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">3 Aryl Sulfonamide Derivatives as MR Antagonists</h3><div class="NLM_p">Pfizer identified an aryl sulfonamide based MR antagonist, <b>3a</b>, through a HTS of its in-house collection (<a class="ref internalNav" href="#fig3a" aria-label="Figure 3.1">Figure 3.1</a>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Subsequent studies revealed that the replacement of the thiophene ring by a phenyl ring led to a modest improvement in MR binding affinity, as in derivative <b>3b</b> (<a class="ref internalNav" href="#tbl3a" aria-label="Table 3.1">Table 3.1</a>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> However, both compounds had a low lipophilic efficiency (LipE). Consequently, an optimization process was carried out to improve this parameter and the metabolic stability. Modifications of the R<sup>1</sup> substituent led to compound <b>3c</b> that showed the best balance of LipE and metabolic stability.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> To improve affinity over <b>3c</b> a sulfonamide library was prepared, from which the replacement of the isoxazole ring with substituted phenyls afforded derivatives with improved properties, like <b>3d</b> and <b>3e</b>.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Compound <b>3e</b> was considered a promising lead for optimization because it was selective against PR (>48-fold selectivity), AR (no antagonist activity up to 10 μM), and GR (>11-fold selectivity) and exhibited good passive permeability (RRCK, <i>P</i><sub>app</sub> = 10<sup>–6</sup> cm/s, 15.4) and metabolic stability (CL<sub>int,app</sub> = 9.6 μM/min/million cells).</div><figure id="fig3a" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3.1. Sulfonamide-based MR antagonist identified through HTS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig3a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3.1. MR Binding (IC<sub>50</sub>) and Physicochemical Properties of Aryl Sulfonamide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0034.gif" alt="" id="fx24" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0035.gif" alt="" id="fx25" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3afn1"><div class="footnote" id="t3afn1"><sup>Table a</sup><p class="last">Competitive binding assays using [<sup>3</sup>H]aldosterone.</p></div><div class="footnote" id="t3afn2"><sup>Table b</sup><p class="last">LipE = Pic<sub>50</sub> – elogD.</p></div></div><div></div></div><div class="NLM_p">The sulfonamide moiety is also within a series of biaryl amide derivatives, developed by Dainippon Sumitomo Pharma, which also provided molecules able to bind to the MR.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> They explored a wide variety of substituents at the aromatic rings by preparing more than five hundred compounds. The methoxy and sulfamide substituents were always among those with the higher activity (<a class="ref internalNav" href="#tbl3b" aria-label="Table 3.2">Table 3.2</a>). Additionally, different R<sup>1</sup> and R<sup>2</sup> groups could be incorporated while keeping high affinity (e.g., <b>3f</b>–<b>3k</b>), whereas substituents at other positions rendered less active compounds (<a class="ref internalNav" href="#tbl3b" aria-label="Table 3.2">Table 3.2</a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_table-wrap" id="tbl3b"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3.2. MR IC<sub>50</sub> Values for Representative Sulfonamide-Substituted Biaryl Amide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0036.gif" alt="" id="fx26" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0037.gif" alt="" id="fx27" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3bfn1"><div class="footnote" id="t3bfn1"><sup>Table a</sup><p class="last">Competitive binding assays using [<sup>3</sup>H]aldosterone in a rat renal soluble fraction in the presence of RU-486 to avoid binding to the glucocorticoid receptor.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">4 Pyridyl Ureas as MR Antagonists</h3><div class="NLM_p">Boehringer Ingelheim International GMBH studied a series of compounds involving a pyridyl urea linked to a phenyl moiety by a pyrazole, <b>4a</b> (<a class="ref internalNav" href="#fig4a" aria-label="Figure 4.1">Figure 4.1</a>), or an ethylene spacer, <b>4b</b>–<b>4g</b> (<a class="ref internalNav" href="#tbl4a" aria-label="Table 4.1">Table 4.1</a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> In general, the best results were obtained with the ethylene linker, particularly in the functional assay (<a class="ref internalNav" href="#tbl4a" aria-label="Table 4.1">Table 4.1</a>). A variety of substituents are permitted on the ethylene moiety, at R<sup>1</sup>, such as aliphatic chains or aromatic moieties (<b>4c</b>, <b>4d</b>, <a class="ref internalNav" href="#tbl4a" aria-label="Table 4.1">Table 4.1</a>). The incorporation of F at R<sup>3</sup>, as in <b>4e</b>, improved binding affinity and led to derivatives with binding IC<sub>50</sub> values below 30 nM, whereas substitution by CH<sub>3</sub>, CF<sub>3</sub>, or OCH<sub>3</sub> led to values over 100 nM, as in compound <b>4f</b>.</div><figure id="fig4a" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4.1. Example of a [(pyrazol-3-yl)pyridin-2-yl]urea MR antagonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig4a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4.1. IC<sub>50</sub> Values of MR Binding and Functional Assays of Pyridyl Ureas</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0038.gif" alt="" id="fx28" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">MR binding<a class="ref internalNav" href="#t4afn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MR functional<a class="ref internalNav" href="#t4afn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">480</td><td class="colsep0 rowsep0" align="char" char=".">2800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">97</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4afn1"><div class="footnote" id="t4afn1"><sup>a</sup><p class="last">MR competitive molecular binding assay based on the binding and displacement of a TAMRA-labeled dexamethasone probe with fluorescence polarization (FP) detection.</p></div><div class="footnote" id="t4afn2"><sup>b</sup><p class="last">Commercially available Gal4/LBD cell-based reporter assay (GeneBLAzer UAS-bla HEK 293 cell line).</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">5 Indole- and Indazole-Derived MR Ligands</h3><div class="NLM_p">Eli Lilly and Company, in a search for non-steroidal human MR antagonists, and on the basis of screening, identified a series of indole derivatives with interesting properties. They reported two series, one with a 3,3-bisaryloxoindol skeleton, and the other with a quaternary carbon serving as the scaffold supporting an indole ring and at least another aromatic group.</div><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">5.1 3,3-Bisaryloxoindole Derivatives</h4><div class="NLM_p">SAR studies on the oxoindole derivative <b>5a</b>, a human MR (hMR) ligand identified through screening (<a class="ref internalNav" href="#tbl5a" aria-label="Table 5.1">Table 5.1</a>),<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> showed the importance of the phenol substituents, in particular of hydroxy groups, as their replacement with H or OMe, led to inactive derivatives. An increase in potency and selectivity was observed when the phenyl ring was directly attached to the nitrogen atom of the oxoindole core (<b>5b</b>), and particularly when a <i>meta</i>-substituent was present, <b>5c</b> and <b>5d</b>.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Unsymmetrical phenol derivatives, like <b>5e</b>–<b>5g</b>, showed good selectivity for the MR compared to other steroid receptors (GR, PR, AR, and ER).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The authors suggested that the presence of a hydroxy group at R<sup>4</sup> forces a conformation that allowed the discrimination between the binding pockets of MR and GR. The isolation of the <b>5g</b> enantiomers showed that the (−)-isomer was more potent and selective than the (+)-isomer.</div><div class="NLM_table-wrap" id="tbl5a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5.1. hMR Binding of Bisaryloxoindole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0039.gif" alt="" id="fx29" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="​" /></col><col align="char" char="​" /></col><col align="char" char="​" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char="."><i>K</i><sub>i</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center" char=".">hMR<a class="ref internalNav" href="#t5afn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="​">hGR</th><th class="colsep0 rowsep0" align="center" char="​">hPR</th><th class="colsep0 rowsep0" align="center" char="​">hAR</th><th class="colsep0 rowsep0" align="center" char=".">hERα</th><th class="colsep0 rowsep0" align="center" char=".">hERβ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5a</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="char" char="​">–</td><td class="colsep0 rowsep0" align="char" char="​">–</td><td class="colsep0 rowsep0" align="char" char="​">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5b</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char="​">147</td><td class="colsep0 rowsep0" align="char" char="​">44%<a class="ref internalNav" href="#t5afn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="​">41%<a class="ref internalNav" href="#t5afn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">733</td><td class="colsep0 rowsep0" align="char" char=".">>1100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5c</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char="​">84</td><td class="colsep0 rowsep0" align="char" char="​">138</td><td class="colsep0 rowsep0" align="char" char="​">306</td><td class="colsep0 rowsep0" align="char" char=".">183</td><td class="colsep0 rowsep0" align="char" char=".">844</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5d</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char="​">51</td><td class="colsep0 rowsep0" align="char" char="​">715</td><td class="colsep0 rowsep0" align="char" char="​">402</td><td class="colsep0 rowsep0" align="char" char=".">242</td><td class="colsep0 rowsep0" align="char" char=".">930</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5e</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="​">793<a class="ref internalNav" href="#t5afn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="​">678</td><td class="colsep0 rowsep0" align="char" char="​">19%<a class="ref internalNav" href="#t5afn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">>1100</td><td class="colsep0 rowsep0" align="char" char=".">>1100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5f</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="​">693<a class="ref internalNav" href="#t5afn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="​">395</td><td class="colsep0 rowsep0" align="char" char="​">1105</td><td class="colsep0 rowsep0" align="char" char=".">>1100</td><td class="colsep0 rowsep0" align="char" char=".">>1100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5g</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char="​">334</td><td class="colsep0 rowsep0" align="char" char="​">245</td><td class="colsep0 rowsep0" align="char" char="​">37%</td><td class="colsep0 rowsep0" align="char" char=".">579</td><td class="colsep0 rowsep0" align="char" char=".">>1100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5g(−)</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="​">582</td><td class="colsep0 rowsep0" align="char" char="​">33%</td><td class="colsep0 rowsep0" align="char" char="​">16%<a class="ref internalNav" href="#t5afn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">359</td><td class="colsep0 rowsep0" align="char" char=".">>1100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5g(+)</b></td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char="​">686<a class="ref internalNav" href="#t5afn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="​">49%</td><td class="colsep0 rowsep0" align="char" char="​">20%</td><td class="colsep0 rowsep0" align="char" char=".">519</td><td class="colsep0 rowsep0" align="char" char=".">>1100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5afn1"><div class="footnote" id="t5afn1"><sup>a</sup><p class="last">Competitive binding assay using [<sup>3</sup>H]aldosterone</p></div><div class="footnote" id="t5afn2"><sup>b</sup><p class="last">Percentage of inhibition at 1 μM antagonist concentration.</p></div><div class="footnote" id="t5afn3"><sup>c</sup><p class="last">One determination.</p></div></div></div></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">5.2 Indol-7-yl-methanesulfonamide Derivatives</h4><div class="NLM_p">Bell et al. explored the use of indole-derived compounds as modulators of steroid hormone nuclear receptors.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In particular, they focused on the MR and the GR. It is worth noting that the great majority of the compounds reported interact with both the MR and the GR with <i>K</i><sub>i</sub> values lower than 500 nM (<a class="ref internalNav" href="#tbl5b" aria-label="Table 5.2">Table 5.2</a>). In general, these compounds have two substituents on the indole ring at positions 3 and 7, the latter quite frequently a methane sulfonamide moiety. A thorough exploration was carried out at the indole position 3: through this position the indole ring was attached to a tetrasubstituted carbon, which, in general, bear another aromatic ring and two aliphatic chains. As for the aromatic substituent, a wide variety of mono- or bicyclic aromatic and heterocyclic moieties have been explored. Among them, phenyl, thiophene, furan, benzofuran, indole, benzothiophene, benzodioxin, benzodioxole, benzimidazole, benzothiazole, benzooxazole, indazole, and biphenyl led to affinity below 500 nM (e.g., compounds <b>5h</b>, <b>5k</b>–<b>5m</b>, <a class="ref internalNav" href="#tbl5b" aria-label="Table 5.2">Table 5.2</a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> These aromatic moieties supported in some cases an extra substituent, such as methyl, chlorine or fluorine (<b>5i</b>, <b>5j</b>, <b>5o</b>–<b>5q</b>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Regarding the other two substituents in derivatives with significant <i>K</i><sub>i</sub>, both groups could be equal or different, and generally they were aliphatic groups, such as methyl (<b>5n</b>–<b>5q</b>), ethyl (<b>5h</b>–<b>5m</b>), propyl, cyclopropyl (<b>5n</b>–<b>5q</b>), or cyclobutyl, or both substituents were within a five- or six-membered ring.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> From the series of compounds with a <i>K</i><sub>i</sub> < 500 nM, the SAR studies showed the favorable effect of a proton donor at position 7 of the indole ring, particularly a methane sulfonamide moiety, and the best combination for the dialkyl substituents was methyl/cyclopropyl (<b>5n</b>–<b>5q</b><a class="ref internalNav" href="#tbl5b" aria-label="Table 5.2">Table 5.2</a>).</div><div class="NLM_table-wrap" id="tbl5b"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5.2. Indol-7-ylmethanesulfonamide Derivatives with <i>K</i><sub>i</sub> Equal to or Lower than 500 nM for the MR<a class="ref internalNav" href="#tbl5b-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0040.gif" alt="" id="fx30" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5b-fn1"><div class="footnote" id="tbl5b-fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values were calculated with a competitive binding assay using radioligands.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a>.</p></div></div><div></div></div><div class="NLM_p last">Derivative <b>5p</b> was further studied, showing that the <i>S</i>-enantiomer behaved as a potent, selective, and orally efficacious antagonist of the MR.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Furthermore, in a rat model of hypertension, <i>S</i>-<b>5p</b> was more potent than the marketed drug eplerenone and showed a better <i>in vitro</i> selectivity profile than spironolactone.</div></div><div id="sec2_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">5.3 Indazole Derivatives</h4><div class="NLM_p">Merck Sharp & Dohme Corp. described a series of indazole derivatives which display MR antagonist activity. Although the diastereoisomers and enantiomers were isolated, their stereochemistry was not disclosed within the patent. In <a class="ref internalNav" href="#tbl5c" aria-label="Table 5.3">Table 5.3</a>, representative examples <b>5r</b>–<b>5y</b> are collected.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compounds <b>5r</b>, <b>5t</b>, and <b>5w</b> have good metabolic stability in liver microsomes and hepatocytes as well as good PK profiles in rats (<a class="ref internalNav" href="#tbl5d" aria-label="Table 5.4">Table 5.4</a>).</div><div class="NLM_table-wrap" id="tbl5c"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5.3. MR Antagonist Activity of Indazole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0041.gif" alt="" id="fx32" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center">R<sup>5</sup></th><th class="colsep0 rowsep0" align="center" char=".">MR IP (nM)<a class="ref internalNav" href="#t5cfn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t5cfn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5r</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5s</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5t</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5u</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5v</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5w</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5x</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5y</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5cfn1"><div class="footnote" id="t5cfn1"><sup>a</sup><p class="last">Inflection point of the nonlinear regression curve. The IP value is equal to the IC<sub>50</sub> value when the slope is 1, the minimum is 0, and the maximum is 100.</p></div><div class="footnote" id="t5cfn2"><sup>b</sup><p class="last">Commercially available protein–protein interaction cell-based assay.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></p></div></div></div><div class="NLM_table-wrap" id="tbl5d"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5.4. PK Profile in Rats and Metabolic Stability for Indazole Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">stability, <i>t</i><sub>1/2</sub> (min)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">human liver microsome</th><th class="colsep0 rowsep0" align="center" char=".">human hepatocyte</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5r</b></td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5t</b></td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">>90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5w</b></td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">9.9</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">>90</td></tr></tbody></table></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35">6 Benzoxazinones-Derived MR Ligands</h3><div id="sec2_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">6.1 1,4-Benzoxazin-3-ones</h4><div class="NLM_p">The 1,4-benzoxazin-3-one bicycle is an interesting moiety in the search of non-steroidal MR antagonists whose use has been explored by several pharmaceutical companies. In 2006, Novartis patented a series of 333 derivatives with a benzoxazin-3-one central core, bearing a great variety of large substituents attached either directly or through a linker to position 6 (R<sup>2</sup>), including aromatic and heteroaromatic rings (<a class="ref internalNav" href="#tbl6a" aria-label="Table 6.1">Table 6.1</a>). Positions 5, 7, and 8 were less explored and had smaller substituents, such as methyl or fluorine. Several of these derivatives were able to bind to the MR (<a class="ref internalNav" href="#tbl6a" aria-label="Table 6.1">Table 6.1</a>, compounds <b>6a</b>–<b>6c</b>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> In 2016, Vitae pharmaceuticals performed a SAR study with derivatives having variable substituents at position 6, finding several compounds with an acceptable MR affinity, derivatives <b>6d</b> and <b>6e</b>.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_table-wrap" id="tbl6a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6.1. Binding Data of a Series of 1,4-Benzoxazin-3-ones Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0042.gif" alt="" id="fx33" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0043.gif" alt="" id="fx34" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6afn1"><div class="footnote" id="t6afn1"><sup>Table a</sup><p class="last">Gal4/LBD cell-based functional assay in HEK293 cells.</p></div><div class="footnote" id="t6afn2"><sup>Table b</sup><p class="last">Competitive binding assay using <sup>3</sup>H-cortisol.</p></div></div><div></div></div><div class="NLM_p">Toru Iijima et al., from Tanabe Seiyaku Co., focused on substituents at positions 2, 4, and 7 of the 1,4-benzoxazin-3-one scaffold (<a class="ref internalNav" href="#fig6a" aria-label="Figure 6.1">Figure 6.1</a>, <b>I</b>). Several derivatives were reported as having MR <i>K</i><sub>i</sub> values lower or equal to 500 nM, and in general, they had two methyl groups at position 2 and either NHSO<sub>2</sub>Me or NH<sub>2</sub> at position 7.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> More variety could be found at position 4, with aromatic or heteroaromatic rings, as 4-fluorophenyl, 4-fluoro-3-methylphenyl, 3,5-dichloropyridin-2-yl, benzyl, and so forth.</div><figure id="fig6a" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 6.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6.1. General formulas of 1,4-benzoxazine-containing derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig6a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The benzoxazin-3-one ring is also within more complex structures, having monocyclic aromatic rings or fused-heterocycles as central scaffold (<a class="ref internalNav" href="#fig6a" aria-label="Figure 6.1">Figure 6.1</a>, <b>II</b>). These compounds, described in 2009, showed inhibition rates up to 70% at 10 μM.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> It was observed that the central scaffold A was tolerant to modification, while keeping significant MR binding activity. Thus, Takeda pharmaceuticals studied different skeletons as replacement of this central scaffold. Starting from a HTS hit and guided by docking studies, they identified compound <b>6f</b>, with a triazolothiadiazine skeleton as the central scaffold (<a class="ref internalNav" href="#tbl6b" aria-label="Table 6.2">Table 6.2</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Even more, they solved the X-ray structure of the complex between <b>6f</b> and the MR<sub>C808S/S810L</sub>-LBD (1.35 Å, PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHV">3VHV</a>)—the first X-ray structure of a non-steroidal compound bound to the MR (<a class="ref internalNav" href="#fig6b" aria-label="Figure 6.2">Figure 6.2</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This structure revealed the binding mode of the benzoxazin-3-one ring, in which the NH group and the carbonyl oxygen of this moiety form hydrogen bonds to Asn770. Also, the nitrogen atoms of the triazole scaffold establish hydrogen bonds to Gln776 and through a water molecule to Arg817. The aryl group at the 2-position of the triazolothiadiazine ring partially filled the α-face pocket providing the bases for further chemical optimization.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> After superimposing the crystal structures of compound <b>6d</b> and spironolactone bound to the MR-LBD binding-site cavity, it was found that both compounds have similar binding modes. The 3D structure showed a small space around the phenyl group; thereby, derivatives <b>6g</b> and <b>6h</b> were prepared.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Compound <b>6h</b> showed improved affinity and better selectivity over other steroid hormone receptors than <b>6f</b>.</div><div class="NLM_table-wrap" id="tbl6b"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6.2. MR IC<sub>50</sub> Values of 1,4-Benzoxazin-3-one-Containing Triazolothidiazine Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0044.gif" alt="" id="fx35" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">MR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6bfn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">510</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">310</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">270</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6bfn1"><div class="footnote" id="t6bfn1"><sup>a</sup><p class="last">Competitive binding assay using [<sup>3</sup>H]-aldosterone.</p></div></div></div><figure id="fig6b" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6.2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6.2. (A) Close-up view of the X-ray structure of the MR<sub>C808S/S810L</sub>-LBD double mutant bound to compound <b>6f</b> showing its binding mode. (B) Superimposition of the X-ray structures of compound <b>6f</b> (yellow) and spironolactone (orange) bound to the MR<sub>C808S/S810L</sub>-LBD (PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHV">3VHV</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHU">3VHU</a>, respectively). The hydrogen bonds and water molecules are depicted as yellow dashed lines and red spheres, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig6b"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The poor PK profile of <b>6h</b> (metabolic clearance in rat microsomes 60 μL/min/mg) led to the investigation of alternative scaffolds without metabolically labile groups.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The replacement of the triazolothiadiazine ring by thiazole or imidazole led to a decrease in the activity. In contrast, derivatives <b>6i</b>–<b>6m</b> with a pyrazole scaffold showed interesting results (<a class="ref internalNav" href="#tbl6c" aria-label="Table 6.3">Table 6.3</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The X-ray structure of the triazolothiadiazine derivative <b>6f</b> was useful in the lead optimization of this pyrazole series, in which a trifluoromethyl group was attached to the 3-position of the pyrazole ring (as in <b>6i</b>–<b>6m</b>) to fill the space of the triazolothiadiazine ring (as in <b>6f</b>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Subsequent optimization of the substituents on the benzene and benzoxazine rings showed that the introduction of a methyl group as R<sup>1</sup> substituent (compound <b>6j</b>) considerably enhanced binding affinity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Further increases in affinity were achieved by adding fluorine at R<sup>2</sup>, and chlorine or methyl at R<sup>3</sup> (compounds <b>6k</b>–<b>6m</b>). Compound <b>6k</b> showed a good PK profile in SD rats [CL = 1328 mL/h/kg, Vd<sub>ss</sub> = 4626 mL/kg], as well as the best balance of potency and selectivity (binding IC<sub>50</sub> for AR, PR, and GR was 2500 nM or higher), and was selected for <i>in vivo</i> evaluation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These studies showed that <b>6k</b> behaved as an MR antagonist with blood-pressure-lowering effect similar to that of spironolactone.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_table-wrap" id="tbl6c"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6.3. MR Binding IC<sub>50</sub> of 1,4-Benzoxazin-3-one-Containing Pyrazole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0045.gif" alt="" id="fx36" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">MR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6cfn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">260</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6j</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6k</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6l</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6m</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6cfn1"><div class="footnote" id="t6cfn1"><sup>a</sup><p class="last">Competitive binding assay using [<sup>3</sup>H]-aldosterone.</p></div></div></div><div class="NLM_p">Taken together, the SAR studies on benzoxazin-3-one derivatives identified three main key pharmacophores, namely a benzoxazin-3-one moiety, a 4-fluorobenzene ring, and a central scaffold linking these two aromatic rings at adjacent positions, which can be exploited to develop more potent and selective MR antagonists.<a onclick="showRef(event, 'ref8 ref73'); return false;" href="javascript:void(0);" class="ref ref8 ref73">(8, 73)</a> Accordingly, a novel benzoxazin-3-one derivative, having a dihydrofuran-2-one moiety as the central scaffold, was selected as lead compound (<a class="ref internalNav" href="#tbl6d" aria-label="Table 6.4">Table 6.4</a>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_table-wrap" id="tbl6d"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6.4. IC<sub>50</sub> Binding to MR, PR, and GR of Dihydrofuran-2-one and Dihydropyrrol-2-one Derivatives Containing a 1,4-Benzoxazin-3-one Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0046.gif" alt="" id="fx37" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6dfn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">MR</th><th class="colsep0 rowsep0" align="center" char=".">PR</th><th class="colsep0 rowsep0" align="center" char=".">GR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6n</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">660</td><td class="colsep0 rowsep0" align="char" char=".">4600</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6o</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="char" char=".">740</td><td class="colsep0 rowsep0" align="char" char=".">3800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6p</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N-Et</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">770</td><td class="colsep0 rowsep0" align="char" char=".">1600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6q</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N-c-Pr<a class="ref internalNav" href="#t6dfn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="char" char=".">400</td><td class="colsep0 rowsep0" align="char" char=".">2200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6r</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">5600</td><td class="colsep0 rowsep0" align="char" char=".">9100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6s</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">1600</td><td class="colsep0 rowsep0" align="char" char=".">1100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6t</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">4900</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6dfn1"><div class="footnote" id="t6dfn1"><sup>a</sup><p class="last">Competitive binding assay using [<sup>3</sup>H]-aldosterone, [<sup>3</sup>H]-progesterone, or [<sup>3</sup>H]-dexamethasone to test binding to MR, PR, and GR, respectively. IC<sub>50</sub> binding to AR was >10 000 nM in all cases.</p></div><div class="footnote" id="t6dfn2"><sup>b</sup><p class="last">c-Pr = cyclopropyl.</p></div></div></div><div class="NLM_p">An X-ray co-crystal structure of the MR LBD/compound <b>6n</b> complex (2.05 Å, PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFF">3WFF</a><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a>) revealed the binding mode of dihydrofuran-2-one derivatives and guided the lead optimization of the new benzoxazin-3-one-based compounds (<a class="ref internalNav" href="#fig6c" aria-label="Figure 6.3">Figure 6.3</a>A). As expected, compound <b>6n</b> binds to the MR-LBD in a similar way as compound <b>6f</b>. The NH group and the carbonyl oxygen of the benzoxazin-3-one moiety forms hydrogen bonds to Asn770, and its carbonyl oxygen established a new hydrogen bond to Thr945. The carbonyl oxygen in the dihydrofuran-2-one scaffold establishes hydrogen bonds to Arg817 and Gln776 through a water molecule. It was also observed the existence of three lipophilic spaces that could be filled with adequate groups at X, R<sup>1</sup>, and R<sup>2</sup>.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> At dihydrofuran position 5, a methyl substituent (<b>6o</b>) was optimal, whereas a bigger ethyl group led to a decrease in binding activity.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The binding mode of compound <b>6o</b> is similar to that of compound <b>6n</b>, as observed in the solution of the crystal structure of the MR-LBD/compound <b>6o</b><i>S</i>-enantiomer complex (1.40 Å, PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFG">3WFG</a><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a>) (<a class="ref internalNav" href="#fig6c" aria-label="Figure 6.3">Figure 6.3</a>B). The X-ray co-structure of compound <b>6o</b> in the MR LBD suggested that the <i>S</i>-enantiomer should be more potent than its <i>R</i> counterpart, and that a lipophilic group should be adequate at position 1 (<a class="ref internalNav" href="#tbl6d" aria-label="Table 6.4">Table 6.4</a>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Therefore, the central scaffold was replaced by a dihydropyrrol-2-one ring. As indicated in <a class="ref internalNav" href="#tbl6d" aria-label="Table 6.4">Table 6.4</a>, ethyl and cyclopropyl derivatives <b>6p</b> and <b>6q</b> showed increased binding activity.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Unexpectedly, the unsubstituted NH derivative <b>6r</b> exhibited high binding activity, which could be explained by the increased electron density of the carbonyl group in the dihydropyrrol-2-one scaffold compared to the dihydrofuran-2-one framework, reinforcing the water-mediated hydrogen bonds with Arg817 and/or Gln776.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Regarding the high selectivity of <b>6r</b> over the AR, PR, and GR compared to <b>6p</b> and <b>6q</b> (<a class="ref internalNav" href="#tbl6d" aria-label="Table 6.4">Table 6.4</a>), its <i>N</i>-unsubstituted dihydropyrrol-2-one ring was shown to be a key scaffold for such a property compared to the dihydrofuran-2-one moiety. Further efforts were focused on compound <b>6r</b> to study the R<sup>3</sup> substituent. Compounds <b>6s</b> and <b>6t</b> showed higher MR activity and were equipotent to spironolactone.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Moreover, the methyl derivative <b>6t</b> has decreased PR activity compared with <b>6r</b> (<a class="ref internalNav" href="#tbl6d" aria-label="Table 6.4">Table 6.4</a>).</div><figure id="fig6c" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6.3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6.3. Close-up views of the MR<sub>C808S/S810L</sub>-LBD double mutant bound to benzoxazin-3-one-based compounds: (A) <b>6n</b> (magenta), (B) <b>6o</b> (<i>S</i>-enantiomer, pink), and (C) <b>6z</b> (blue) (PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFF">3WFF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFG">3WFG</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PF3">4PF3</a>, respectively). The hydrogen bonds and water molecules are depicted as yellow dashed lines and red spheres, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig6c"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In functional assays, compound <b>6t</b> and most of the dihydropyrrol-2-one derivatives showed also moderate partial agonistic activity at high concentrations (20–30% at 10 μM), whereas the values obtained for pyrazole analogues, such as <b>6k</b>, were low. The X-ray structure of the MR LBD bound to <b>6o</b> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFG">3WFG</a>),<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> close analogue of <b>6t</b>, suggested a role of the central ring carbonyl group in a water-mediated hydrogen bonding network. Since this network was considered not to be present in <b>6k</b>, it was assumed that it was important for the partial agonist effect. As the clinical efficacy and safety of partial agonists remain unclear, other azole rings, with no possibility to form these water-mediated hydrogen bonds, were selected, with the pyrazole scaffold providing the best MR activities (<b>6u</b>–<b>6z</b>, <a class="ref internalNav" href="#tbl6e" aria-label="Table 6.5">Table 6.5</a>).<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74, 75)</a> However, derivatives <b>6v</b>–<b>6x</b> also showed high metabolic clearance in rat microsomes (>100 μL/mg/min), which was attributed to their high lipophilicity (logD > 3). Design of less lipophilic derivatives allowed the identification of several potent compounds that have significantly reduced partial agonistic activities and high selectivity over other steroid receptors, like <b>6y</b> and <b>6z</b> (binding IC<sub>50</sub> AR and PR > 10 000 nM, GR > 1700 nM).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Compound <b>6z</b> showed an acceptable metabolic clearance (42 μL/mg/min), and it was able to lower the blood pressure in DOCA-salt hypertensive rats, without antiandrogenic effect. The crystal structure of the complex between <b>6z</b> and the MR LBD (1.10 Å, PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PF3">4PF3</a>)<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> showed that it binds to the steroid binding pocket of the MR. As expected, the binding mode of compound <b>6z</b> is similar to that of compounds <b>6n</b> (<a class="ref internalNav" href="#fig6c" aria-label="Figure 6.3">Figure 6.3</a>C). The NH group and the carbonyl oxygen of the benzoxazin-3-one moiety form hydrogen bonds to Asn770 and Thr945, and the 4-fluorobenzene ring occupies the α-face hydrophobic pocket. The ligand side chain at the 1-position of the pyrazole ring, the 2,2-difluoropropyl-3-hydroxy group, points out toward Arg817 and Gln776. Its hydroxyl group directly forms a hydrogen bond to Gln776. The two fluorine atoms do not form any specific hydrogen bonding interactions suggesting that the major contribution of these fluorine atoms to the binding is hydrophobic.</div><div class="NLM_table-wrap" id="tbl6e"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6.5. MR Activity of 1,4-Benzoxazin-3-one-Containing Pyrazole Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0047.gif" alt="" id="fx38" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="(" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="("> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">MR binding<a class="ref internalNav" href="#t6efn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="(">MR activity<a class="ref internalNav" href="#t6efn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6u</b></td><td class="colsep0 rowsep0" align="left">n-Pr</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char="(">45 (0%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6v</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char="(">33 (6%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6w</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="(">18 (4%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6x</b></td><td class="colsep0 rowsep0" align="left">CF<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char="(">27 (11%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6y</b></td><td class="colsep0 rowsep0" align="left">3-Py</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char="(">36 (−4%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6z</b></td><td class="colsep0 rowsep0" align="left">CF<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char="(">71 (1%)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6efn1"><div class="footnote" id="t6efn1"><sup>a</sup><p class="last">Competitive binding assay using [<sup>3</sup>H]-aldosterone</p></div><div class="footnote" id="t6efn2"><sup>b</sup><p class="last">Cell-based reporter gene assay. Antagonist activity and, in parentheses, agonist activity at 10 μM concentration.</p></div></div></div><div class="NLM_p">Pfizer has also explored compounds with a morpholine central ring (<a class="ref internalNav" href="#tbl6f" aria-label="Table 6.6">Table 6.6</a>). They observed that the incorporation at morpholine N4 of benzoxazin-3-one, <b>6aa</b>, or pyridoxazinone moieties, <b>6ab</b>–<b>6ae</b>, led to derivatives with IC<sub>50</sub> values below 100 nM, nevertheless the former provide the most active derivative.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> There was a decrease in affinity caused either by the removal of the aromatic ring at position 5 (IC<sub>50</sub> = 3050 nM) or the methyl at position 2 (IC<sub>50</sub> = 1970 nM) in derivative <b>6ab</b>. It was also observed that the incorporation of a fluorine atom in the ortho or meta-position of the phenyl ring keeps the affinity (<b>6ac</b>, <b>6ad</b>), whereas it is detrimental in the para-position.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_table-wrap" id="tbl6f"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6.6. MR IC<sub>50</sub> of 1,4-Benzoxazin-3-one-Containing Morpholine Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0048.gif" alt="" id="fx39" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center" char=".">MR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6ffn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6aa</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6ab</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" rowspan="3" align="left">N</td><td class="colsep0 rowsep0" rowspan="3" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">44.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6ac</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">33.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6ad</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6ae</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">53.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6ffn1"><div class="footnote" id="t6ffn1"><sup>a</sup><p class="last">Gal4/LBD cell-based reporter gene assay.</p></div></div></div></div><div id="sec2_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">6.2 1,3-Benzoxazin-2-ones</h4><div class="NLM_p">1,3-Benzoxazin-2-one and -2-thione derivatives also provided compounds able to interact with the MR, which are collected in two Knobbe Martens Olson & Bear LLP patents<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a> and one from Dainippon Sumitomo Pharma Co (<b>6af</b>, SM-368229, <a class="ref internalNav" href="#fig6_4" aria-label="Figure 6.4">Figure 6.4</a>).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> In particular, a study on the pharmacological profile of <b>6af</b> indicated that this compound was able to increase urinary Na<sup>+</sup>/K<sup>+</sup> ratio in adrenalectomized rats treated with deoxycorticosterone acetate. Even at doses of 300 mg/kg, only very weak antiandrogenic effects were observed in methyltestosterone-treated male rats.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><figure id="fig6.4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6.4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0007.jpeg" id="GRAPHIC-d7e5038-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6.4. 1,3-Benzoxazin-2-ona derivative from Dainippon Sumitomo Pharma Co.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig6.4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Mitsubishi Tanabe has investigated related compounds derived from 2<i>H</i>-1,3-benzoxazine (Y = N, <b>6ag</b>, <b>6ah</b>) and 2<i>H</i>-chromene (Y = C, <b>6ai</b>, <b>6aj</b>), reporting several compounds that showed sub-micromolar MR dissociation constants (<a class="ref internalNav" href="#tbl6g" aria-label="Table 6.7">Table 6.7</a>).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Most of them have a phenyl ring at position 4 of the scaffold, although there is an example with a benzothiophene ring. The most frequent substituents at position 2 are methyl groups, whereas either methyl or hydrogen are suitable at position 5. In the chromene (Y = C) scaffold, H, CN, and Br are adequate as R<sup>4</sup> substituents for interacting with the MR (<i>K</i><sub>i</sub> < 500 nM).</div><div class="NLM_table-wrap" id="tbl6g"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6.7. Examples of 2<i>H</i>-1,3-Benzoxazine and 2<i>H</i>-Chromene Derivatives with MR <i>K</i><sub>i</sub> Values below 500 nM<a class="ref internalNav" href="#t6gfn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0049.gif" alt="" id="fx40" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6ag</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6ah</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6ai</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6aj</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6gfn1"><div class="footnote" id="t6gfn1"><sup>a</sup><p class="last">Competitive binding assay using [<sup>3</sup>H]-aldosterone.</p></div></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45">7 Macrolide MR Antagonists</h3><div class="NLM_p">In an screening program to search for non-steroidal MR antagonist, compound <b>7a</b>, methyllasiodiplodin, was found and reported as the first macrolide MR antagonist (<a class="ref internalNav" href="#tbl7a" aria-label="Table 7.1">Table 7.1</a>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The antagonist effect increased for the diacetylated analogue <b>7b</b>, however further increase of the steric hindrance at R<sup>1</sup> and R<sup>2</sup> substituents (Et, iPr, or n-Pr) tended to decrease activity.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The influence of the ring size was also investigated from the 11- to 14-membered lactone ring; the 11-membered ring derivative <b>7c</b> showed the best inhibitory activity.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_table-wrap" id="tbl7a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7.1. Inhibitory Activity of <i>O</i>-methyllasiodiplodin Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0050.gif" alt="" id="fx41" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t7afn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">8930</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">Ac</td><td class="colsep0 rowsep0" align="left">Ac</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2780</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">Ac</td><td class="colsep0 rowsep0" align="left">Ac</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">580</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7afn1"><div class="footnote" id="t7afn1"><sup>a</sup><p class="last">Values determined using a yeast two-hybrid assay to asses inhibition of MR interaction with a co-regulator.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47">8 Fused Heterotricyclic Derivatives as MR Ligands</h3><div class="NLM_p">Eli Lilly and Company described a series of tricyclic steroid hormone receptor modulators with the capacity to bind to the MR and the GR with <i>K</i><sub>i</sub> ≤ 500 nM. The general structures are shown in <a class="ref internalNav" href="#fig8a" aria-label="Figure 8.1">Figure 8.1</a>. For derivatives of general formula III, the tricyclic structure of the reported compounds with <i>K</i><sub>i</sub> lower than 500 nM corresponds mainly to a thioxanthene scaffold (X = S), but there are also examples in which X is a methylene group or an oxygen atom. R<sup>1</sup> is usually hydrogen or methyl, and Ar is an aromatic group such as phenyl, benzimidazol-2-one, benzoxazol-2-one, or benzothiazol-2-one.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> A tricyclic structure with a seven-membered ring has also been explored, structure <b>IV</b> (<a class="ref internalNav" href="#fig8a" aria-label="Figure 8.1">Figure 8.1</a>), and the authors reported almost 200 compounds with significant <i>K</i><sub>i</sub> values. In particular, within these compounds the most recurrent were dihydrobenzo[<i>a</i>,<i>d</i>][7]annulene derivatives (X = Y= C and two phenyl moieties flanking the seven membered ring). However, there are also several examples where X = S, SO, SO<sub>2</sub>, or O (Y = C), or alternatively Y could be an oxygen atom, and X could be a carbon. As for R<sup>8</sup>, it is mainly a hydrogen atom.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> More variety of substituents is observed in the C ring, which might be a phenyl, benzimidazol-2-one, benzimidazole, indolyl-2-one, benzoxazol-2-one, or benzothiazol-2-one. Subsequent patents focused on a tricyclic scaffold with a central seven-membered ring of general formula <b>V</b> (<a class="ref internalNav" href="#fig8a" aria-label="Figure 8.1">Figure 8.1</a> and <a class="ref internalNav" href="#tbl8a" aria-label="Table 8.1">Table 8.1</a>). A 2005 patent described a series of derivatives with either a tricyclic dihydrodibenz[<i>b</i>,<i>e</i>]oxepine (X = O) or dihydrodibenz[<i>a</i>,<i>d</i>][7]annulene (X = CH<sub>2</sub>) showing good <i>K</i><sub>i</sub> values.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> For the active compounds reported, R<sup>1</sup> and R<sup>2</sup> are independently selected from hydrogen or fluorine, and at the R<sup>3</sup> position a variety of heterocycles are suitable (<a class="ref internalNav" href="#fig8a" aria-label="Figure 8.1">Figure 8.1</a>, formula <b>V</b>, <a class="ref internalNav" href="#tbl8a" aria-label="Table 8.1">Table 8.1</a>).<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85, 86)</a> Within this family, compound <b>8a</b> showed good affinity for the MR and selectivity over the AR, BR, and PR, and behaved as a potent and selective antagonist of the hMR (IC<sub>50</sub>= 21 nM in functional assays).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> In <i>in vivo</i> models, <b>8a</b> displayed potent reno-protective activity, antihypertensive effects, and a reduced probability of producing hyperkalemia.</div><figure id="fig8a" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8.1. General structures of tricyclic scaffolds developed at Eli Lilly that led to compounds with inhibitory constants lower that 500 nM for MR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig8a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl8a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8.1. Tricyclic Compounds with <i>K</i><sub>i</sub> ≤ 10 nM for hMR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0051.gif" alt="" id="fx42" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0052.gif" alt="" id="fx43" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8afn1"><div class="footnote" id="t8afn1"><sup>Table a</sup><p class="last"><b>8a</b>–<b>8n</b>: competitive binding assay using [<sup>3</sup>H]-aldosterone. <b>8o</b>, <b>8p</b>: MR competitive binding assay using [<sup>3</sup>H]-cortisol.</p></div></div><div></div></div><div class="NLM_p">In 2009, Eli Lilly and Company focused on a series of dihydrodibenz[<i>b</i>,<i>e</i>]oxepines based on the previously reported tricyclic steroid hormone receptor modulators (<a class="ref internalNav" href="#fig8a" aria-label="Figure 8.1">Figure 8.1</a>, <b>IV</b> and <b>V</b>).<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83, 84)</a> Representative compounds with <i>K</i><sub>i</sub> ≤ 10 nM are collected in <a class="ref internalNav" href="#tbl8a" aria-label="Table 8.1">Table 8.1</a>. At R<sup>3</sup> position several heterocycles led to compounds with significant activity, where R<sup>4</sup> was O, N-CN, or N-CONH<sub>2</sub>. Interestingly, these derivatives have at least one fluorine atom at the C3 position, and the authors analyzed systematically the presence of another fluorine either at R<sup>1</sup> or R<sup>2</sup>. In general, for each R<sup>3</sup> and R<sup>4</sup> substituent, the corresponding 3-fluoro (R<sup>1</sup> = H, R<sup>2</sup> = H), 3,7-difluoro (R<sup>1</sup> = H, R<sup>2</sup> = F), and 3,8-difluoro (R<sup>1</sup> = F, R<sup>2</sup> = H) derivatives have been prepared and evaluated (i.e., <b>8a</b>–<b>c</b> or <b>8d</b>–<b>f</b>).<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85, 86)</a></div><div class="NLM_p">The authors also carried out an exhaustive modification of the configuration of the chiral centers of R<sup>3</sup> substituents, and for the reported examples, <i>K</i><sub>i</sub> values were below 10 nM regardless of their stereochemistry (<b>8a</b>–<b>8c</b> vs <b>8d</b>–<b>8f</b>, or <b>8h</b>–<b>8k</b>).<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85, 86)</a> Several of the prepared compounds were tested in a functional assay and behaved as antagonists of the hMR. Moreover, three of them, namely <b>8b</b> (0.79 nM), <b>8g</b> (0.08 nM), and <b>8h</b> (0.23 nM), with <i>K</i><sub>i</sub> values below 1 nM, demonstrated <i>in vivo</i> renal protective activity in a rat model of aldosterone-mediated renal disease.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p">Compound <b>8m</b> showed a good selectivity for binding the MR, from 800- to 7500-fold over GR, AR, and PR, and was selected for a combination therapy with tadalafil for the treatment of resistant hypertension.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Taladafil is a phosphodiesterase type 5 (PDE5) inhibitor and behaves as a mild vasodilator. Authors also indicated that this therapeutic combination would alleviate PDE5-monotherapy resistant erectile dysfuntion.</div><div class="NLM_p">An Eli Lilly and Company derivative, LY2623091 (structure not disclosed), entered phase II clinical studies for the treatment of hypertension and chronic kidney disease. Although to the best of our knowledge there is no publication that revealed its structure, on the Internet this compound has been associated with derivative <b>8m</b>.<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88, 89)</a></div><div class="NLM_p">In 2016, Vitae pharmaceuticals explored several linkers between the tricyclic scaffold and a series of bicyclic moieties (<a class="ref internalNav" href="#tbl8a" aria-label="Table 8.1">Table 8.1</a>, <b>8o</b>, <b>8p</b>, <a class="ref internalNav" href="#fig8b" aria-label="Figure 8.2">Figure 8.2</a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The selection of the bicyclic system was based on previous SAR studies, which suggested the 1,4 benzoxazin-3-one (<b>8q</b>), 1,3-benzoxazin-2-thione (<b>8r</b>), and several spirooxindoles (<b>8s</b>–<b>8u</b>) as suitable sub-groups.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Interestingly, an X-ray structure was described for the MR LBD complex with compound <b>8q</b> (2.5 Å, PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HCV">5HCV</a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> In a similar way to previous X-ray structures, there are two hydrogen bonds involving Asn770 and the NH group and carbonyl oxygen of the benzoxazinone moiety, besides one more between the carbonyl group and the Thr945 side chain (<a class="ref internalNav" href="#fig8c" aria-label="Figure 8.3">Figure 8.3</a>). In contrast, no hydrogen bond is observed between the receptor and the tricyclic structure.</div><figure id="fig8b" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8.2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8.2. Structures of tricyclic scaffolds developed at Vitae Pharmaceuticals that led to compounds able to bind to MR LBD. Competitive binding assay using [<sup>3</sup>H]-cortisol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig8b"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8c" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8.3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8.3. (A) Close-up view of the X-ray structure of the MR<sub>C808S/S810L</sub>-LBD double mutant bound to <b>8q</b> (cyan) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HCV">5HCV</a>). (B) Superimposition of the X-ray structures of compound <b>8q</b> (cyan) and spironolactone (orange) bound to the MR<sub>C808S/S810L</sub>-LBD (PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HCV">5HCV</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHU">3VHU</a>, respectively). The hydrogen bonds and water molecules are depicted as yellow dashed lines and red spheres, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig8c"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49">9 Peptide MR Ligands</h3><div class="NLM_p">The MR LBD, the key regulatory domain of MR, contains an activation function-2 domain (AF-2) in addition to the binding pocket for the endogenous ligands. The AF-2 domain has been implicated in the interaction with co-activators that contain multiple LXXLL motifs, organized as α-helices. These co-regulators are critical for MR-mediated gene expression and may confer specificity to MR-mediated responses. Thus, there is a great interest in knowing whether different MR ligands can induce distinct MR conformations that might lead to different co-regulator recruitment and ligand-specific gene regulation.</div><div class="NLM_p">Hultman et al. focused on co-activator and co-repressor peptides and their interaction with the LBD of the MR in the presence of various MR ligands.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> They analyzed 50 co-regulator peptides, derived from 23 co-activators and co-repressors, containing the NR-box or CoRNR-box motifs (small peptide motifs that are necessary and sufficient to interact with NRs). Only a few of these peptides showed strong interactions with the MR LBD in the presence of aldosterone or the glucocorticoid cortisol. These include peptides derived from SRC1, PGC1α, PGC1β, and ASC2 co-activators, which have an extra leucine before the LXXLL motif in the NR-box. However, not all LLXXLL-containing peptides were capable of strong interactions. In the presence of eplerenone the recruitment of these peptides is blocked, indicating that eplerenone changes the conformation of the MR LBD.</div><div class="NLM_p">Li et al. also focused on peptides derived from known co-activators containing LXXLL motifs (<a class="ref internalNav" href="#tbl9a" aria-label="Table 9.1">Table 9.1</a>). They also found a preferential binding of the fourth LXXLL motif of steroid receptor co-activator-1 (SRC1-4).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In contrast, a weaker interaction was established for the first motif of SRC1-1 and SRC3-1 (over 16 μM).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Interestingly, the X-ray structure of the MR LBD bound to corticosterone and SRC1-4 (1.95 Å, PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A3I">2A3I</a><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a>) suggested two molecular structural features that could account for the high affinity of SRC1-4. First, the glutamic acid at position +7 (relative to the first leucine in the LXXLL motif) that is hydrogen bonded with K782 of MR. Second, the high stability of the SRC1-4 helix due to the existence of several intramolecular hydrogen bonds between Q+3 and K–3 as well as Q+2 and S–2.</div><div class="NLM_table-wrap" id="tbl9a"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9.1. Peptides Derived from Co-activators with LXXLL Motifs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t9afn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRC2-1</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRC1-2</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRC2-2</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRC3-2</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRC1-3</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRC2-3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRC3-3</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SRC1-4</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PGC1α-1</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PGC1α-2</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9afn1"><div class="footnote" id="t9afn1"><sup>a</sup><p class="last"><i>In vitro</i> peptide competition experiments using AlphaScreen Assays (PerkinElmer).</p></div></div></div><div class="NLM_p">In order to identify antagonist peptides able to interact with the MR in a ligand-selective manner, Yang et al. recently used two phage libraries, expressing 19mer peptides, to screen 10<sup>8</sup> peptides for MR binding in the presence of three different agonists: aldosterone, cortisol, and deoxycorticosterone (<a class="ref internalNav" href="#tbl9_2" aria-label="Table 9.2">Table 9.2</a>).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> One of the libraries was designed to target the AF-2 region of the MR, and consequently included a central LXXLL motif flanked by seven random amino acids on either side. The other was a random library created to identify peptides that could bind to any site on the MR. The analysis of the 165 peptides using the mammalian two-hybrid assay showed that 18 peptides had an enhanced interaction by the addition of the ligand, one from the random library and 17 from the LXXLL-constrained phage library (<b>9a</b>–<b>9d</b>).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Within these latter peptides, approximately 50% of them contained the unique motif MPXLXXLL. Six of these 18 peptides were selective for the MR, five of them from the constrained phage library, and interacted significantly better in the presence of aldosterone (<b>9e</b>–<b>9g</b>), while the one from the random library (<b>9h</b>) showed increased interaction in the presence of cortisol.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Thus, these studies have demonstrated that different peptides interact differentially with the MR in the presence of different ligands, thus suggesting that agonists can induce different conformational changes in the MR that might lead to the recruitment of specific co-regulatory proteins.</div><div class="NLM_table-wrap" id="tbl9.2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9.2. Peptides Identified as MR Antagonists Using Phage Display</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">V</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">G</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">V</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">W</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">M</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">G</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">G</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">E</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">W</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">V</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">S</td></tr></tbody></table></div></div><div class="NLM_p last">Rogerson et al., with the aim of identifying co-regulatory molecules that could exhibit a ligand-specific interaction with the MR LBD, screened a yeast-2-hybrid kidney cDNA library in the presence of aldosterone and cortisol.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> A clone encoding the region of the tesmin (metallothionein-like 5) gene that has two LXXLL motifs provided a 7-fold greater response in the presence of aldosterone over cortisol. Therefore, tesmin was a ligand-selective co-activator of the hMR, providing further evidence of the adoption of ligand-dependent conformations by the MR-LBD. The understanding of these interactions may open the venue for the development of selective MR modulators.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The MR is a member of the nuclear receptor family that plays an important role in regulating genes involved in cardiovascular diseases and electrolyte homeostasis. The two currently marketed MR antagonists, eplerenone and spironolactone, both with a structure similar to that of steroid hormones, have proven to be effective in the treatment of hypertension or congestive heart failure. However, their therapeutic use is limited due to unwanted side effects. These limitations have propelled the search of new non-steroidal MR antagonists able to circumvent these drawbacks. Over the past years this search has been intensified and has mainly been undertaken by pharmaceutical companies. In general, the research has started with a HTS, which allowed the identification of a hit able to interact with the MR. Next, hit-to-lead optimization processes were carried out to improve potency and selectivity as well as pharmacokinetic properties. These medicinal chemistry approaches have provided a series of scaffolds, such as five- and six-membered heterocyclic rings or bicyclic and tricyclic skeletons, able to support key pharmacophore groups in the right 3D disposition to interact with the MR, thus leading to novel MR antagonists. Interestingly, several of the non-steroid derivatives showed excellent potency toward the MR and selectivity against other nuclear receptors and displayed <i>in vivo</i> activity.</div><div class="NLM_p">Recently, X-ray structures describing the MR LBD not only bound to steroid ligands but also in complex with non-steroidal compounds have become available. These structures are valuable tools for the computer-assisted design of new MR ligands, or to guide the hit to lead optimization process. In fact, as above indicated, docking studies have proved to be useful to optimize initial HTS hits, leading to compounds with improved PK and PD properties. The resolution of complexes of the MR LBD bound to other families of antagonists could provide further insight into the binding mode of these compounds.</div><div class="NLM_p"><i>In vivo</i> studies with the most promising compounds have shown that MR antagonists are able to reduce blood pressure and protect against aldosterone-mediated renal and cardiovascular injuries. Moreover, some compounds have proved to reduce sex-hormone-related adverse effects and to lower the incidence of hyperkalemia compared with the marketed steroid-like antagonists. Several non-steroidal compounds are currently in clinical evaluation for congestive heart failure, hypertension, or diabetic nephropathy. These derivatives belong to different chemical families and have been designated as <b>1p</b>, <b>2k</b>, LY2623091 (structure not disclosed), and MT-3995 (a Mitsubishi Tanabe Pharma Corporation non-steroidal derivative in phase II studies for diabetic nephropathy, structure not disclosed to the best of our knowledge).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> These promising results have encouraged the search of novel non-steroidal MR antagonists that overcome the limitations of steroid molecules.</div><div class="NLM_p last">Over the past few years, a variety of tissue-specific MR targets with prominent roles in several physiological and pathophysiological processes played by MR have been described. Thus, it is now clear that many of the most important MR target genes are highly tissue-specific. This, together with the similarities of the MR with other steroid receptors, highlights the importance of finding tissue-selective non-steroidal MR antagonists with the desired therapeutic potential and diminished adverse effects. The determinants of the MR tissue-specific regulation of genes are unclear, but presumably the process is at least partially based on differential interaction with co-regulators of transcription. Therefore, the search of compounds able to bind to the MR LBD and modulate the recruitment of different coactivators, together with allosteric modulators of the MR action targeting protein–protein interaction, may be interesting areas to explore.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01065" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66820" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66820" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mercedes Martín-Martínez</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica (IQM-CSIC), Juan de la Cierva, 3, 28006 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6449-0905" title="Orcid link">http://orcid.org/0000-0002-6449-0905</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e18c84938284858492a188908ccf82928882cf8492"><span class="__cf_email__" data-cfemail="80ede5f2e3e5e4e5f3c0e9f1edaee3f3e9e3aee5f3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Felipe L. Pérez-Gordillo</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica (IQM-CSIC), Juan de la Cierva, 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diego Álvarez de la Rosa</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biomedical Technologies and Department of Physiology, Campus de
Ciencias de la Salud, Facultad de Medicina, Universidad de La Laguna, 38204 Tenerife, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoel Rodríguez</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacological Sciences, Icahn School
of Medicine at Mount Sinai, New
York, New York 10029, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Natural Sciences, Hostos Community College
of CUNY, 475 Grand Concourse, Bronx, New York 10451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guillermo Gerona-Navarro</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Brooklyn College, 2900 Bedford Avenue, Brooklyn, New York 11210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosario González-Muñiz</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica (IQM-CSIC), Juan de la Cierva, 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming-Ming Zhou</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacological Sciences, Icahn School
of Medicine at Mount Sinai, New
York, New York 10029, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Mercedes Martín-Martínez</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=BIO-d7e7024-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mercedes Martín-Martínez</b> received her B.Sc. and Ph.D. (1996) in chemistry from Complutense University in Madrid. After her Ph.D. she joined the group of Prof. Tom Blundell at Cambridge University (U.K.), where she got expertise in structure-based computer-aided drug design. In 1999, she moved back to the Medicinal Chemistry Institute (IQM-CSIC), where she is currently a staff scientific researcher and a member of the peptidomimetics group. Her research interests focus on the application of molecular modeling tools to the design of novel molecular entities able to modulate protein interactions. One of her currently interests is the search of non-steroidal modulators of MR.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Felipe L. Pérez-Gordillo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=BIO-d7e7029-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Felipe L. Pérez-Gordillo</b> received his B.Sc. in chemistry from the University of Granada, Spain, in 1997, and became a specialist in clinical biochemistry at Hospital Universitario La Paz, Madrid, in 2004. He joined the Spanish National Council for Scientific Research (CSIC) as a research collaborator in 2009. He is currently pursuing a Ph.D. under the supervision of Dr. Mercedes Martín-Martínez. He has a strong interest in drug discovery, especially in small-molecule inhibitors for MR. His expertise is in the development and synthesis of druglike compounds and computational modeling.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Diego Álvarez de la Rosa</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=BIO-d7e7034-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Diego Álvarez de la Rosa</b> has been a professor of physiology at Universidad de La Laguna (Spain) since 2009. He established his research group at the university as a junior group leader in 2005, after completing postdoctoral training at Yale University School of Medicine (1999–2004). His research focuses on mineralocorticoid hormone actions, with special focus on molecular mechanisms of receptor modulation and characterization of target genes.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Yoel Rodríguez</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=BIO-d7e7039-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yoel Rodríguez</b> received his B.S. in chemistry from Havana University in 1995, and his Ph.D. in chemistry/theoretical biophysics at Complutense University of Madrid, Spain, in 2002 with Dr. Francisco Montero Carnerero, both summa cum laude. He conducted postdoctoral research in computational biophysics with Dr. Roman Osman at Mount Sinai School of Medicine (MSSM), New York, from 2003 to 2007. In 2008, Rodríguez was appointed Assistant Professor of Physics and Chemistry in the Natural Sciences Department of Hostos Community College of CUNY, where he is currently Associate Professor. He is also a visiting professor at MSSM in the Department of Pharmacological Science, where he collaborates with Dr. Ming-Ming Zhou. His research focuses on applying computational theoretical biophysics methods to investigate molecular mechanisms in biological processes.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Guillermo Gerona-Navarro</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=BIO-d7e7044-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Guillermo Gerona-Navarro</b> received his B.S. in chemistry from Havana University in 1996, and his Ph.D. in chemistry/medicinal chemistry at Complutense University of Madrid, Spain, in 2002 with Dr. Rosario Gonzalez-Muñiz, both summa cum laude. He conducted postdoctoral research with Prof. Samie Jaffrey at Weill Medical College of Cornell University from 2003 to 2006, and with Dr. Ming-Ming Zhou at Mount Sinai School of Medicine (MSSM) from 2007 to 2012, both in chemical biology. In 2013, Dr. Gerona-Navarro was appointed assistant professor in the Chemistry Department of Brooklyn College of CUNY. His research laboratory at Brooklyn College focuses on developing chemical probes targeting protein–protein interactions inside of the cell to investigate the role of these biologically relevant proteins in human biology and disease.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Rosario González-Muñiz</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=BIO-d7e7049-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Rosario González-Muñiz</b> completed a Ph.D. in chemistry from Autónoma University in Madrid, Spain (1987), and a post-doctoral stay at René Descartes University (Paris V, 1988-1990). She currently is a staff senior scientific researcher at the Medicinal Chemistry Institute (IQM-CSIC), where she was the Deputy Director (2005–2011) and is currently the head of the peptidomimetics group. She is a specialist in peptides, peptidomimetics, and bioactive small-molecules, and her recent research interests include the design and synthesis of new modulators of protein–protein interactions and of different types of ion channels and associated proteins.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Ming-Ming Zhou</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=BIO-d7e7054-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ming-Ming Zhou</b>, Ph.D., is the Dr. Harold and Golden Lamport Professor and Chairman of Department of Pharmacological Sciences, and Co-Director of Experimental Therapeutics Institute at Icahn School of Medicine at Mount Sinai. His research interest lies in basic molecular mechanisms of epigenetic control of gene transcription. Among his contributions are the discovery of the bromodomain as the acetyl-lysine binding domain (<i>Nature</i>, 1999) and validation of bromodomain proteins as drug targets for cancer and inflammation (<i>Cancer Cell</i> 2014). Dr. Zhou received a Ph.D. degree in chemistry at Purdue University, did postdoctoral studies at Abbott Laboratories, and has published over 150 research papers. Dr. Zhou is a Director at New York Structural Biology Center and a fellow of the American Association for the Advancement of Science (2012).</p></figure></div><div class="ack" id="ACK-d7e7020-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Supported by grants from Ministerio de Economía y Competitividad (MINECO, Spain; grants BFU2012-39092-C02-02, BFU2013-47089-R, and SAF2015-66275-C2-R), European Cooperation in Science and Technology (COST) action ADMIRE (BM-1301), the European Union Seventh Framework Program “Capacities” (FP7-REGPOT-2012-CT2012-31637-IMBRAIN), and CSIC (201280E096). Y.R. is grateful to CUNY for being a recipient of the CUNY Chancellor’s Research Fellowship Award for the 2015 - 20162015–2016 Academic Year.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 93 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Arriza, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handelin, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Housman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span> </span><span class="NLM_article-title">Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1126/science.3037703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1126%2Fscience.3037703" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1987&pages=268-275&author=J.+L.+Arrizaauthor=C.+Weinbergerauthor=G.+Cerelliauthor=T.+M.+Glaserauthor=B.+L.+Handelinauthor=D.+E.+Housmanauthor=R.+M.+Evans&title=Cloning+of+human+mineralocorticoid+receptor+complementary+DNA%3A+structural+and+functional+kinship+with+the+glucocorticoid+receptor&doi=10.1126%2Fscience.3037703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.3037703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.3037703%26sid%3Dliteratum%253Aachs%26aulast%3DArriza%26aufirst%3DJ.%2BL.%26aulast%3DWeinberger%26aufirst%3DC.%26aulast%3DCerelli%26aufirst%3DG.%26aulast%3DGlaser%26aufirst%3DT.%2BM.%26aulast%3DHandelin%26aufirst%3DB.%2BL.%26aulast%3DHousman%26aufirst%3DD.%2BE.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DCloning%2520of%2520human%2520mineralocorticoid%2520receptor%2520complementary%2520DNA%253A%2520structural%2520and%2520functional%2520kinship%2520with%2520the%2520glucocorticoid%2520receptor%26jtitle%3DScience%26date%3D1987%26volume%3D237%26spage%3D268%26epage%3D275%26doi%3D10.1126%2Fscience.3037703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lifton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharavi, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geller, D. S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of human hypertension</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1016/S0092-8674(01)00241-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2FS0092-8674%2801%2900241-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=11239411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1Kks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=545-556&author=R.+P.+Liftonauthor=A.+G.+Gharaviauthor=D.+S.+Geller&title=Molecular+mechanisms+of+human+hypertension&doi=10.1016%2FS0092-8674%2801%2900241-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of human hypertension</span></div><div class="casAuthors">Lifton, Richard P.; Gharavi, Ali G.; Geller, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 91 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdcj9eT2Wj5LVg90H21EOLACvtfcHk0lhivvIIBdOdnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1Kks7w%253D&md5=e806749fa26b727de84ff2856dcb1e62</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900241-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900241-0%26sid%3Dliteratum%253Aachs%26aulast%3DLifton%26aufirst%3DR.%2BP.%26aulast%3DGharavi%26aufirst%3DA.%2BG.%26aulast%3DGeller%26aufirst%3DD.%2BS.%26atitle%3DMolecular%2520mechanisms%2520of%2520human%2520hypertension%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D545%26epage%3D556%26doi%3D10.1016%2FS0092-8674%2801%2900241-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Nguyen Dinh Cat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaisser, F.</span><span> </span><span class="NLM_article-title">Extrarenal effects of aldosterone</span> <span class="citation_source-journal">Curr. Opin. Nephrol. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1097/MNH.0b013e32834fb25b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FMNH.0b013e32834fb25b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=147-156&author=A.+Nguyen+Dinh+Catauthor=F.+Jaisser&title=Extrarenal+effects+of+aldosterone&doi=10.1097%2FMNH.0b013e32834fb25b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FMNH.0b013e32834fb25b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNH.0b013e32834fb25b%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%2BDinh%2BCat%26aufirst%3DA.%26aulast%3DJaisser%26aufirst%3DF.%26atitle%3DExtrarenal%2520effects%2520of%2520aldosterone%26jtitle%3DCurr.%2520Opin.%2520Nephrol.%2520Hypertens.%26date%3D2012%26volume%3D21%26spage%3D147%26epage%3D156%26doi%3D10.1097%2FMNH.0b013e32834fb25b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J.</span><span> </span><span class="NLM_article-title">11Beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span><span class="refDoi"> DOI: 10.1152/physrev.00020.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1152%2Fphysrev.00020.2012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=1139-1206&author=K.+Chapmanauthor=M.+Holmesauthor=J.+Seckl&title=11Beta-hydroxysteroid+dehydrogenases%3A+intracellular+gate-keepers+of+tissue+glucocorticoid+action&doi=10.1152%2Fphysrev.00020.2012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00020.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00020.2012%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DHolmes%26aufirst%3DM.%26aulast%3DSeckl%26aufirst%3DJ.%26atitle%3D11Beta-hydroxysteroid%2520dehydrogenases%253A%2520intracellular%2520gate-keepers%2520of%2520tissue%2520glucocorticoid%2520action%26jtitle%3DPhysiol.%2520Rev.%26date%3D2013%26volume%3D93%26spage%3D1139%26epage%3D1206%26doi%3D10.1152%2Fphysrev.00020.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Farman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">Multiple aspects of mineralocorticoid selectivity</span> <span class="citation_source-journal">Am. J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">F181</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2001&pages=F181-192&author=N.+Farmanauthor=M.+E.+Rafestin-Oblin&title=Multiple+aspects+of+mineralocorticoid+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarman%26aufirst%3DN.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DMultiple%2520aspects%2520of%2520mineralocorticoid%2520selectivity%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2001%26volume%3D280%26spage%3DF181%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Bledsoe, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apolito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trump, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span> </span><span class="NLM_article-title">A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">31283</span><span class="NLM_x">–</span> <span class="NLM_lpage">31293</span><span class="refDoi"> DOI: 10.1074/jbc.M504098200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1074%2Fjbc.M504098200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15967794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=31283-31293&author=R.+K.+Bledsoeauthor=K.+P.+Madaussauthor=J.+A.+Holtauthor=C.+J.+Apolitoauthor=M.+H.+Lambertauthor=K.+H.+Pearceauthor=T.+B.+Stanleyauthor=E.+L.+Stewartauthor=R.+P.+Trumpauthor=T.+M.+Willsonauthor=S.+P.+Williams&title=A+ligand-mediated+hydrogen+bond+network+required+for+the+activation+of+the+mineralocorticoid+receptor&doi=10.1074%2Fjbc.M504098200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor</span></div><div class="casAuthors">Bledsoe, Randy K.; Madauss, Kevin P.; Holt, Jason A.; Apolito, Christopher J.; Lambert, Millard H.; Pearce, Kenneth H.; Stanley, Thomas B.; Stewart, Eugene L.; Trump, Ryan P.; Willson, Timothy M.; Williams, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">31283-31293</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Ligand binding is the first step in hormone regulation of mineralocorticoid receptor (MR) activity.  Here, the authors report multiple crystal structures of MR (NR3C2) bound to both agonist and antagonists.  These structures combined with mutagenesis studies reveal that maximal receptor activation involves an intricate ligand-mediated hydrogen bond network with Asn770 which serves dual roles: stabilization of the loop preceding the C-terminal activation function-2 helix and direct contact with the hormone ligand.  In addn., most activating ligands hydrogen bond to Thr945 on helix 10.  Structural characterization of the naturally occurring S810L mutant explains how stabilization of a helix 3/helix 5 interaction can circumvent the requirement for this hydrogen bond network.  Taken together, these results explain the potency of MR activation by aldosterone, the weak activation induced by progesterone and the antihypertensive agent spironolactone, and the binding selectivity of cortisol over cortisone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE7HiXGk8tJLVg90H21EOLACvtfcHk0liPq6V78kJC1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmu7g%253D&md5=36afe797ab0337f5309aec7652f45012</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504098200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504098200%26sid%3Dliteratum%253Aachs%26aulast%3DBledsoe%26aufirst%3DR.%2BK.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DHolt%26aufirst%3DJ.%2BA.%26aulast%3DApolito%26aufirst%3DC.%2BJ.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DPearce%26aufirst%3DK.%2BH.%26aulast%3DStanley%26aufirst%3DT.%2BB.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DTrump%26aufirst%3DR.%2BP.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26atitle%3DA%2520ligand-mediated%2520hydrogen%2520bond%2520network%2520required%2520for%2520the%2520activation%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D31283%26epage%3D31293%26doi%3D10.1074%2Fjbc.M504098200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugherty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span> </span><span class="NLM_article-title">Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.molcel.2005.06.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=367-380&author=Y.+Liauthor=K.+Suinoauthor=J.+Daughertyauthor=H.+E.+Xu&title=Structural+and+biochemical+mechanisms+for+the+specificity+of+hormone+binding+and+coactivator+assembly+by+mineralocorticoid+receptor&doi=10.1016%2Fj.molcel.2005.06.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSuino%26aufirst%3DK.%26aulast%3DDaugherty%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520and%2520biochemical%2520mechanisms%2520for%2520the%2520specificity%2520of%2520hormone%2520binding%2520and%2520coactivator%2520assembly%2520by%2520mineralocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D367%26epage%3D380%26doi%3D10.1016%2Fj.molcel.2005.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hasui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ora, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyabu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishigaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoyaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siedem, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meese, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, S.</span><span> </span><span class="NLM_article-title">Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8616</span><span class="NLM_x">–</span> <span class="NLM_lpage">8631</span><span class="refDoi"> DOI: 10.1021/jm2011645</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2011645" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCgtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8616-8631&author=T.+Hasuiauthor=N.+Matsunagaauthor=T.+Oraauthor=N.+Ohyabuauthor=N.+Nishigakiauthor=Y.+Imuraauthor=Y.+Igataauthor=H.+Matsuiauthor=T.+Motoyajiauthor=T.+Tanakaauthor=N.+Habukaauthor=S.+Sogabeauthor=M.+Onoauthor=C.+S.+Siedemauthor=T.+P.+Tangauthor=C.+Gauthierauthor=L.+A.+De+Meeseauthor=S.+A.+Boydauthor=S.+Fukumoto&title=Identification+of+benzoxazin-3-one+derivatives+as+novel%2C+potent%2C+and+selective+nonsteroidal+mineralocorticoid+receptor+antagonists&doi=10.1021%2Fjm2011645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists</span></div><div class="casAuthors">Hasui, Tomoaki; Matsunaga, Nobuyuki; Ora, Taiichi; Ohyabu, Norio; Nishigaki, Nobuhiro; Imura, Yoshimi; Igata, Yumiko; Matsui, Hideki; Motoyaji, Takashi; Tanaka, Toshimasa; Habuka, Noriyuki; Sogabe, Satoshi; Ono, Midori; Siedem, Christopher S.; Tang, Tony P.; Gauthier, Cassandra; De Meese, Lisa A.; Boyd, Steven A.; Fukumoto, Shoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8616-8631</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mineralocorticoid receptor (MR) blockade has come into focus as a promising approach for the treatment of cardiovascular diseases such as hypertension and congestive heart failure.  In order to identify a novel class of nonsteroidal MR antagonists that exhibit significant potency and good selectivity over other steroidal hormone receptors, the authors designed a novel series of benzoxazin-3-one derivs. and synthesized them from 6-(7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-6-yl)-2H-1,4-benzoxazin-3(4H)-one (I), high-throughput screening (HTS) hit compd.  Their design was based on a crystal structure of an MR/compd. complex and a docking model.  In the course of lead generation from I, a 1,2-diaryl framework was characterized as a key structure with high binding affinity.  On the basis of scaffold hopping and optimization studies, benzoxazin-3-one derivs. possessing 1-phenyl-3-trifluoromethylpyrazol-5-yl moiety at the 6-position were identified as a novel series of potent and selective MR antagonists.  Among these compds., 6-[1-(4-fluoro-2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]-2H-1,4-benzoxazin-3(4H)-one (II) showed highly potent activity and good selectivity and also exhibited a significant antihypertensive effect in deoxycorticosterone acetate-salt hypertensive rats.  On the basis of these results, compd. II was progressed for further pharmacol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQN1Fg3saUUrVg90H21EOLACvtfcHk0liPq6V78kJC1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCgtLrF&md5=48d1e524152c039ccebc9c371e89fae1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm2011645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011645%26sid%3Dliteratum%253Aachs%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DOra%26aufirst%3DT.%26aulast%3DOhyabu%26aufirst%3DN.%26aulast%3DNishigaki%26aufirst%3DN.%26aulast%3DImura%26aufirst%3DY.%26aulast%3DIgata%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DMotoyaji%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSiedem%26aufirst%3DC.%2BS.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DGauthier%26aufirst%3DC.%26aulast%3DDe%2BMeese%26aufirst%3DL.%2BA.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520benzoxazin-3-one%2520derivatives%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8616%26epage%3D8631%26doi%3D10.1021%2Fjm2011645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Huyet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">Structural basis of spirolactone recognition by the mineralocorticoid receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span><span class="refDoi"> DOI: 10.1124/mol.107.036459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1124%2Fmol.107.036459" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=563-571&author=J.+Huyetauthor=G.+M.+Pinonauthor=M.+R.+Fayauthor=J.+Fagartauthor=M.+E.+Rafestin-Oblin&title=Structural+basis+of+spirolactone+recognition+by+the+mineralocorticoid+receptor&doi=10.1124%2Fmol.107.036459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.036459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.036459%26sid%3Dliteratum%253Aachs%26aulast%3DHuyet%26aufirst%3DJ.%26aulast%3DPinon%26aufirst%3DG.%2BM.%26aulast%3DFay%26aufirst%3DM.%2BR.%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DStructural%2520basis%2520of%2520spirolactone%2520recognition%2520by%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D563%26epage%3D571%26doi%3D10.1124%2Fmol.107.036459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Geller, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fradley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigler, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifton, R. P.</span><span> </span><span class="NLM_article-title">Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1126/science.289.5476.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1126%2Fscience.289.5476.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10884226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1eltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=119-123&author=D.+S.+Gellerauthor=A.+Farhiauthor=N.+Pinkertonauthor=M.+Fradleyauthor=M.+Moritzauthor=A.+Spitzerauthor=G.+Meinkeauthor=F.+T.+Tsaiauthor=P.+B.+Siglerauthor=R.+P.+Lifton&title=Activating+mineralocorticoid+receptor+mutation+in+hypertension+exacerbated+by+pregnancy&doi=10.1126%2Fscience.289.5476.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy</span></div><div class="casAuthors">Geller, David S.; Farhi, Anita; Pinkerton, Nikki; Fradley, Michael; Moritz, Michael; Spitzer, Adrian; Meinke, Gretchen; Tsai, Francis T. F.; Sigler, Paul B.; Lifton, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5476</span>),
    <span class="NLM_cas:pages">119-123</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Hypertension and pregnancy-related hypertension are major public health problems of largely unknown causes.  We describe a mutation in the mineralocorticoid receptor (MR), S810L, that causes early-onset hypertension that is markedly exacerbated in pregnancy.  This mutation results in constitutive MR activity and alters receptor specificity, with progesterone and other steroids lacking 21-hydroxyl groups, normally MR antagonists, becoming potent agonists.  Structural and biochem. studies indicate that the mutation results in the gain of a van der Waals interaction between helix 5 and helix 3 that substitutes for interaction of the steroid 21-hydroxyl group with helix 3 in the wild-type receptor.  This helix 5-helix 3 interaction is highly conserved among diverse nuclear hormone receptors, suggesting its general role in receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiplVKXUuefrVg90H21EOLACvtfcHk0lg_AT-iwjO98g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1eltL0%253D&md5=19f09bc885f7668f8ad07d2ea3a9126e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5476.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5476.119%26sid%3Dliteratum%253Aachs%26aulast%3DGeller%26aufirst%3DD.%2BS.%26aulast%3DFarhi%26aufirst%3DA.%26aulast%3DPinkerton%26aufirst%3DN.%26aulast%3DFradley%26aufirst%3DM.%26aulast%3DMoritz%26aufirst%3DM.%26aulast%3DSpitzer%26aufirst%3DA.%26aulast%3DMeinke%26aufirst%3DG.%26aulast%3DTsai%26aufirst%3DF.%2BT.%26aulast%3DSigler%26aufirst%3DP.%2BB.%26aulast%3DLifton%26aufirst%3DR.%2BP.%26atitle%3DActivating%2520mineralocorticoid%2520receptor%2520mutation%2520in%2520hypertension%2520exacerbated%2520by%2520pregnancy%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D119%26epage%3D123%26doi%3D10.1126%2Fscience.289.5476.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huyet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1038/nsmb939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1038%2Fnsmb939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15908963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks12rtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=554-555&author=J.+Fagartauthor=J.+Huyetauthor=G.+M.+Pinonauthor=M.+Rochelauthor=C.+Mayerauthor=M.+E.+Rafestin-Oblin&title=Crystal+structure+of+a+mutant+mineralocorticoid+receptor+responsible+for+hypertension&doi=10.1038%2Fnsmb939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension</span></div><div class="casAuthors">Fagart, Jerome; Huyet, Jessica; Pinon, Gregory M.; Rochel, Marina; Mayer, Claudine; Rafestin-Oblin, Marie-Edith</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">554-555</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The S810L mutation within the human mineralocorticoid receptor (MR S810L) induces severe hypertension and switches progesterone from antagonist to agonist.  Here we report the crystal structures of the ligand-binding domain of MR S810L in complex with progesterone and deoxycorticosterone, an agonist of both wild-type and mutant MRs.  These structures, the first for MR, identify the specific contacts created by Leu810 and clarify the mechanism of activation of MR S810L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiXZ_3ggvfcLVg90H21EOLACvtfcHk0lg_AT-iwjO98g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks12rtro%253D&md5=5d06e52f69c10ab6c3528d516bab0375</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnsmb939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb939%26sid%3Dliteratum%253Aachs%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DHuyet%26aufirst%3DJ.%26aulast%3DPinon%26aufirst%3DG.%2BM.%26aulast%3DRochel%26aufirst%3DM.%26aulast%3DMayer%26aufirst%3DC.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520a%2520mutant%2520mineralocorticoid%2520receptor%2520responsible%2520for%2520hypertension%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D554%26epage%3D555%26doi%3D10.1038%2Fnsmb939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Huyet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagart, J.</span><span> </span><span class="NLM_article-title">Structural determinants of ligand binding to the mineralocorticoid receptor</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1016/j.mce.2011.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.mce.2011.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=21820032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2012&pages=187-195&author=J.+Huyetauthor=G.+M.+Pinonauthor=M.+R.+Fayauthor=M.+E.+Rafestin-Oblinauthor=J.+Fagart&title=Structural+determinants+of+ligand+binding+to+the+mineralocorticoid+receptor&doi=10.1016%2Fj.mce.2011.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of ligand binding to the mineralocorticoid receptor</span></div><div class="casAuthors">Huyet, Jessica; Pinon, Gregory Maurice; Fay, Michel Raymond; Rafestin-Oblin, Marie-Edith; Fagart, Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The first and crit. step in the mechanism of aldosterone action is its binding to the mineralocorticoid receptor (MR), a member of the nuclear receptor superfamily.  Over the last 40 years, numerous studies have attempted to det. the structural determinants of ligand-binding to MR.  An initial set of data showed that hsp90 is bound to the receptor via specific regions and maintains it in a ligand-binding competent state.  Site-directed mutagenesis and functional studies guided by a 3D model of the MR ligand-binding domain (LBD) made it possible to identify the residues responsible for the high affinity and selectivity for aldosterone, and to characterize the mechanisms of MR activation and inactivation.  The recent detn. of the X-ray crystal structures of the LBD of the wild-type MR and MRS810L, which is responsible for a familial form of hypertension, has made it possible to elucidate the peculiar mechanism of activation of MRS810L and established a clear structure/activity relationship for steroidal and non-steroidal MR antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Bzgw8GjgC7Vg90H21EOLACvtfcHk0liyC2D7rz8Alw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GisLc%253D&md5=43f3130c45a5395decbbf447741753dd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2011.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2011.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DHuyet%26aufirst%3DJ.%26aulast%3DPinon%26aufirst%3DG.%2BM.%26aulast%3DFay%26aufirst%3DM.%2BR.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26aulast%3DFagart%26aufirst%3DJ.%26atitle%3DStructural%2520determinants%2520of%2520ligand%2520binding%2520to%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2012%26volume%3D350%26spage%3D187%26epage%3D195%26doi%3D10.1016%2Fj.mce.2011.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Alvarez de la Rosa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro-Gonzalez, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldez, T.</span><span> </span><span class="NLM_article-title">ENaC modulators and renal disease</span> <span class="citation_source-journal">Curr. Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.2174/1874467211306010005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.2174%2F1874467211306010005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=23547933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSms7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=35-43&author=D.+Alvarez+de+la+Rosaauthor=J.+F.+Navarro-Gonzalezauthor=T.+Giraldez&title=ENaC+modulators+and+renal+disease&doi=10.2174%2F1874467211306010005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">ENaC modulators and renal disease</span></div><div class="casAuthors">Alvarez de la Rosa, Diego; Navarro-Gonzalez, Juan F.; Giraldez, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-43</span>CODEN:
                <span class="NLM_cas:coden">CMPUB6</span>;
        ISSN:<span class="NLM_cas:issn">1874-4672</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The epithelial sodium channel (ENaC) plays an essential role in transepithelial sodium reabsorption in the renal connecting tubule and collecting duct.  Therefore, controlling ENaC activity is an important regulatory event in electrolyte and extracellular vol. homeostasis, and thus in the control of blood pressure.  Many independent signaling pathways converge on ENaC, although the most important for its physiol. role is the enhancement of channel activity by the steroid hormone aldosterone.  In this review, we briefly summarize current knowledge about ENaC regulation and the different chem. compds. available to directly or indirectly modify channel function.  In addn., current and possible clin. uses of ENaC and aldosterone antagonists are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvfs0U2VCOybVg90H21EOLACvtfcHk0liyC2D7rz8Alw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSms7vJ&md5=285db4dd7400fcebf280c30f0df0d13a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1874467211306010005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874467211306010005%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%2Bde%2Bla%2BRosa%26aufirst%3DD.%26aulast%3DNavarro-Gonzalez%26aufirst%3DJ.%2BF.%26aulast%3DGiraldez%26aufirst%3DT.%26atitle%3DENaC%2520modulators%2520and%2520renal%2520disease%26jtitle%3DCurr.%2520Mol.%2520Pharmacol.%26date%3D2013%26volume%3D6%26spage%3D35%26epage%3D43%26doi%3D10.2174%2F1874467211306010005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Brilla, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, K. T.</span><span> </span><span class="NLM_article-title">Mineralocorticoid excess, dietary sodium, and myocardial fibrosis</span> <span class="citation_source-journal">J. Lab. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1992&pages=893-901&author=C.+G.+Brillaauthor=K.+T.+Weber&title=Mineralocorticoid+excess%2C+dietary+sodium%2C+and+myocardial+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrilla%26aufirst%3DC.%2BG.%26aulast%3DWeber%26aufirst%3DK.%2BT.%26atitle%3DMineralocorticoid%2520excess%252C%2520dietary%2520sodium%252C%2520and%2520myocardial%2520fibrosis%26jtitle%3DJ.%2520Lab.%2520Clin.%2520Med.%26date%3D1992%26volume%3D120%26spage%3D893%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remme, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palensky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittes, J.</span><span> </span><span class="NLM_article-title">The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span><span class="refDoi"> DOI: 10.1056/NEJM199909023411001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1056%2FNEJM199909023411001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10471456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVyrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=709-717&author=B.+Pittauthor=F.+Zannadauthor=W.+J.+Remmeauthor=R.+Codyauthor=A.+Castaigneauthor=A.+Perezauthor=J.+Palenskyauthor=J.+Wittes&title=The+effect+of+spironolactone+on+morbidity+and+mortality+in+patients+with+severe+heart+failure.+Randomized+aldactone+evaluation+study+investigators&doi=10.1056%2FNEJM199909023411001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of spironolactone on morbidity and mortality in patients with severe heart failure</span></div><div class="casAuthors">Pitt, Bertram; Zannad, Faiez; Remme, Willem J.; Cody, Robert; Castaigne, Alain; Perez, Alfonso; Palensky, Jolie; Wittes, Janet</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">709-717</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Aldosterone is important in the pathophysiol. of heart failure.  In a double-blind study, we enrolled 1663 patients who had severe heart failure and a left ventricular ejection fraction of no more than 35 percent and who were being treated with an angiotensin-converting-enzyme inhibitor, a loop diuretic, and in most cases digoxin.  A total of 822 patients were randomly assigned to receive 25 mg of spironolactone daily, and 841 to receive placebo.  The primary end point was death from all causes.  The trial was discontinued early, after a mean follow-up period of 24 mo, because an interim anal. detd. that spironolactone was efficacious.  There were 386 deaths in the placebo group (46 percent) and 284 in the spironolactone group (35 percent; relative risk of death, 0.70; 95 percent confidence interval, 0.60 to 0.82; P<0.001).  This 30 percent redn. in the risk of death among patients in the spironolactone group was attributed to a lower risk of both death from progressive heart failure and sudden death from cardiac causes.  The frequency of hospitalization for worsening heart failure was 35 percent lower in the spironolactone group than in the placebo group (relative risk of hospitalization, 0.65; 95 percent confidence interval, 0.54 to 0.77; P<0.001).  In addn., patients who received spironolactone had a significant improvement in the symptoms of heart failure, as assessed on the basis of the New York Heart Assocn. functional class (P<0.001).  Gynecomastia or breast pain was reported in 10 percent of men who were treated with spironolactone, as compared with 1 percent of men in the placebo group (P<0.001).  The incidence of serious hyperkalemia was minimal in both groups of patients.  Blockade of aldosterone receptors by spironolactone, in addn. to std. therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwOy-U1QzrSbVg90H21EOLACvtfcHk0liyC2D7rz8Alw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVyrurk%253D&md5=3e34cf3cd2ac38b96cefdfda593a02f5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJM199909023411001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199909023411001%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DRemme%26aufirst%3DW.%2BJ.%26aulast%3DCody%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DPalensky%26aufirst%3DJ.%26aulast%3DWittes%26aufirst%3DJ.%26atitle%3DThe%2520effect%2520of%2520spironolactone%2520on%2520morbidity%2520and%2520mortality%2520in%2520patients%2520with%2520severe%2520heart%2520failure.%2520Randomized%2520aldactone%2520evaluation%2520study%2520investigators%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D709%26epage%3D717%26doi%3D10.1056%2FNEJM199909023411001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remme, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roniker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, M.</span><span> </span><span class="NLM_article-title">Eplerenone post-acute myocardial infarction heart failure eficacy and survival study investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1321</span><span class="refDoi"> DOI: 10.1056/NEJMoa030207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1056%2FNEJMoa030207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=12668699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1ehurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1309-1321&author=B.+Pittauthor=W.+Remmeauthor=F.+Zannadauthor=J.+Neatonauthor=F.+Martinezauthor=B.+Ronikerauthor=R.+Bittmanauthor=S.+Hurleyauthor=J.+Kleimanauthor=M.+Gatlin&title=Eplerenone+post-acute+myocardial+infarction+heart+failure+eficacy+and+survival+study+investigators.+Eplerenone%2C+a+selective+aldosterone+blocker%2C+in+patients+with+left+ventricular+dysfunction+after+myocardial+infarction&doi=10.1056%2FNEJMoa030207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction</span></div><div class="casAuthors">Pitt, Bertram; Remme, Willem; Zannad, Faiez; Neaton, James; Martinez, Felipe; Roniker, Barbara; Bittman, Richard; Hurley, Steve; Kleiman, Jay; Gatlin, Marjorie; Ambrosioni, E.; Anderson, J. L.; Apetrei, E.; Aschermann, M.; Banas, J.; Cardoso, S.; Caspi, A.; Chung, N.; Corbalan, R.; Dargie, H. J.; Bietz, R.; Erhardt, L.; Garcia-Castillo, A.; Gheorghiade, M.; Hernandez, E.; Hess, O.; Jamerson, K.; Kjekshus, J.; Klug, E.; Krum, H.; Lee, Y.-T.; Lopez, N.; Lopez-Sendon, J.-L.; Martinez, F.; Murin, J.; Neaton, J.; Nicolau, J.-C.; Ostor, E.; Parkhomenko, A.; Pitt, B.; Ross, H.; Stepinska, J.; Torp-Pedersen, C.; Van Mieghem, W.; van Veldhuisen, D.-J.; White, H.; Wilvox, R. G.; Willenbrock, R.; Yotov, Y.-T.; Zannad, F.; Boissel, J.-P.; Furberg, C.; Julian, D.; Kulbertus, H.; Pocock, S.; Wittes, J.; Battler, A.; Blumenfeld, J.; Brilla, C.; Duprez, D.; Fowler, M.; Gavazzi, A.; Hildebrandt, P.; Komajda, M.; Korewicki, J.; Kosturakis, D.; Marin-Neto, J. A.; Miller, A.; Munoz Aguilera, R.; Oliveri, R.; Remme, W.; White, M.; Widimsky, P.; Bakris, G.; Castaigne, A.; Deedwania, P.; Duprez, D.; Ketelslegers, J. M.; Liu, P.; Mancia, G.; Nicklas, J.; Rouleau, J.-L.; Ruilope, L.; Sasayama, S.; Schiffrin, E.; Spertus, J.; Struthers, A.; Vaughan, D.; Weber, M.; Williams, G.; Abinader, E.; Adams, J.; Adams, P. C.; Adamus, J.; Ahlstrom, P.; Akesson, H. S.; Akhmedzhanov, N.; Alcasena Juango, S.; Ali Khan, S.; Alonso Garcia, A.; Amat, G.; Amerena, J.; Arnosova, K. M.; Andreoli, L.; Angelo-Nielsen, K.; Antonio de Velasco, J.; Apetrei, E.; Aroutiounov, G.; Aschermann, M.; Asklund, M.; Assmann, I.; Aumont, M.-C.; Avtandilov, A.; Azarin, O.; Bada, V.; Bakoumov, P.; Balazovjech, L.; Baldjiev, E.; Baluda, M.; Barrazueta, R.; Barsi, B.; Bashir, Y.; Batin, P. D.; Belenky, D.; Belyi, Y.; Bendermacher, P. E. F.; Berget, K.; Bergmeier, C.; Berning, J.; Berrazueta-Fernandez, J. R.; Block, P.; Boberg, G.; Bocek, P.; Bohlscheid, V.; Bokarev, I.; Bolinska, H.; Boman, K.; Bondarev, S.; Bonzel, T.; Boreux, J.-L.; Borggrefe, M.; Borisov, M.; Boxho, G.; Boyarkin, M.; Brachmann, J.; Brack, M.; Branea, I.; Breivik, K.; Brigden, G. S.; Bronzwaer, P. N. A.; Bruce, D.; Bruckner, I.; Brunvand, H.; Bryukhovetski, A.; Buser, P.; Campbell, T.; Campeanu, A.; Capucci, A.; Carasca, E.; Cardoso, J.; Carrageta, M.; Caspi, A.; Cassim, S.; Caturla, J.; Ceia, F.; Cernosek, B.; Channer, K.; Chati, Z.; Christensen, P. D.; Chung, N. S.; Cinteza, M.; Cleland, J. G. F.; Cocchieri, M.; Commerford, P.; Conti, U.; Corsini, G.; Cortina Liosa, A.; Coupez, J.-M.; Cribier, A.; Csillag, J.; Cyran, J.; Dahlstrom, U.; Dalby, A.; Dalin, L. J.; Dalkowski, M.; Dargie, H. J.; Darius, H.; Datcu, D. M.; David, D.; De Myttenaere, M.; De Teresa, E.; De Velasco, J.; de Vries, A. G.; den Hartog, F. R.; Desjoyaux, E.; Dezerbi, A.; Dhawan, J.; Biaz Molina, B.; Dickstein, K.; Dorobantu, M.; Doschitsin, V.; Doubell, A.; Dovgalevsky, P.; Dragulescu, S. I.; Drapkina, O.; Dubourg, O.; Dunselman, P. H. J. M.; Dyadyk, O. I.; Dykun, Y. V.; Dzyak, G. V.; Egorova, L. P.; Egstrup, K.; Eha, J.; Ehrenbergerova, M.; El Allaf, D.; Elenkova, A.; Ellis, C. J.; Engbers, J. G.; Fainyk, A. F.; Falck, G.; Fanelli, R.; Farre-Mun, J.; Favier, J.; Ferrari, G.; Ferreira, I.; Rischer, H.; Fotyanov, S.; Freericks, M. P.; Froeland, G.; Galve, E.; Garcia, M. M.; Garcia, A. A.; Garnier, L. F.; Gazaryan, G.; Georgescu, C.; Geraedts, J.; Glezer, M. G.; Goloborodko, B. I.; Goloshchekin, B.; Gonsorcik, J.; Gotchev, D.; Gotcheva, N.; Gottwik, M. G.; Grande, P.; Gratsiansky, N.; Grishina, E. I.; Groch, L.; Gruzdev, A.; Guenova, D.; Gundersen, T.; Hagerman, I.; Hambrecht, R.; Hammermann, H.; Hansen, O.; Hansteen, V.; Hart, H.; Hauf, G. F.; Hecker, U.; Hegyi, I.; Herlitz, J.; Hertzberger, D. P.; Herweijer, A. H.; Heyndrickx, G. R.; Hittinger, L.; Hoang, V.; Hobbach, H.-P.; Hofman-Bang, C.; Holwerda, N. J.; Hong, K. P.; Horacek, T.; Hormann, J.; Horowitz, J. D.; Hradec, J.; Hurtig, U.; Ikram, H.; Ioan, A.; Jaarsma, W.; Jadraque, L. M.; Jakobsen, T. J.; Janicki, K. J.; Jankelow, D.; Janosi, A.; Jansky, P.; Janssens, L.; Janzen, I.; Jensen, P.; Jirmar, R.; Jobic, Y.; Jones, A.; Jonsson, J.; Kahles, H.; Kaliska, G.; Kamensky, G.; Kappenberger, L.; Karlsson, J. E.; Karpati, P.; Karpenko, O. I.; Karpov, Y.; Kawecka-Jaszcz, J.; Keeling, P. J.; Keren, G.; Khalife, K.; Khrakovskaya, M.; Khrustalev, O. A.; Klarlund, K. K.; Kleber, E.-X.; Klug, E.; Koenig, W.; Komarek, J.; Kononenko, L. G.; Konz, K.; Komacewicz-Jach, Z.; Kostenko, V.; Kotous, J.; Kovalsky, I.; Kozak, P.; Kreider-Stempfle, H. U.; Kromer, E. P.; Krum, H.; Krzeminska-Pakula, M.; Kuc, K.; Kucera, P.; Kurowski, M.; Lach, L.; Lai, C.; Lane, G.; Lang, E.; Lankes, W.; Lankisch, P.-G.; Laraudogoitia, E.; Larsen, J.; Larsson, L.-E.; Laruelle, C.; Lazar, A.; Lee, Y.-T.; Legkonogov, A. V.; Leitch, J.; Lengfelder, W.; Lescot, C. D.; Lewis, B. S.; Lewis, P.; Libov, I. A.; Liel-Cohen, N.; Lim, H. K.; Lin, C.-S.; Linssen, G. C. M.; Liu, C.-P.; Lok, D. J. A.; Lopatin, Y. M.; Lopez De Sa, E.; Lotan, C.; Lousada, N.; Lucas, C.; Lucatti, A.; Lusov, V.; Mabin, T. A.; Macleod, D. C.; Maeurer, W.; Magnusson, J.-O.; Maisch, B.; Malinski, A.; Maltchougine, M.; Manga, P.; Mantov, S.; Marchi, S.; Marcinowska-Suchowierska, E.; Marenne, F.; Maresca, F. S.; Markov, V.; Marmor, A. T.; Martines, C.; Martinez, A.; Martin-Jadraque, L.; Martins, L. F. R.; Martos Ferres, R.; Mary, D. A. S. G.; Masini, F.; Matta, F.; Maurer, W.; Mazzini, A. C.; McDonald, K. M. A.; Meeder, J. G.; Melandri, F.; Melin, J.; Menezes, C.; Michels, H. R.; Missault, L.; Mitrovic, V.; Mntla, P.; Mobilij, A.; Mogilevsky, A.; Moiseev, V.; Mokan, M.; Moeller, B.; Moreira, I.; Mouhoub, D.; Moura, B.; Muders, E.; Mudra, H.; Munz, J.; Murin, J.; Musial, W. J.; Myburgh, D. P.; Naqvi, N.; Naumann, G.; Nazimov, S. V.; Nadelec, G.; Nedogoda, S. V.; Nielsen, I.; Nielsen, T.; Nierop, P. R.; Nilsson, G.; Notaristefano, A.; Novitsky, I. N.; Nykl, L.; Ofner, P.; Olariu, C.; Olbrich, H. G.; Oldroyd, K. G.; Olinic, N.; Oliveira, J.; Omland, T.; Orus, J.; Owensby, D.; Page, A.; Park, K. S.; Parkhomenko, O. M.; Pasotti, C.; Pasowicz, M.; Pecce, P.; Pell, A. C. H.; Penkov, N. I.; Perez de Juan, M.; Perez, H.; Petersen, M.; Petrov, A. A.; Peuhkurinen, K.; Philonenko, X.; Pieper, M.; Pieske, B.; Pluta, W.; Podzemska, B.; Popeye, R.; Prost, C.; Purcaro, A.; Put, P.; Radchenko, V.; Radoi, M.; Rae, A. P.; Raev, D.; Ramik, C.; Rasmussen, S. L.; Reisin, L.; Renker, B.; Ribeiro, V. G.; Richardt, G.; Rjecansky, I.; Risenfors, M.; Rivis, I. A.; Robson, R. H.; Rocher, R.; Rodriquez Padial, L.; Rose, E. L.; Rosen, S. D.; Rosenfeld, T.; Rowlands, D. B.; Rozkovec, A.; Rudas, L.; Rudenko, L. V.; Ruiz-Rejon, F.; Rutsch, W.; Rybar, R.; Rybka, J.; Saetre, H. A.; Sarosi, I.; Savalle, L. H.; Schmidt, A.; Schuren, K. P.; Schwartz, Y.; Schwinger, R.; Schwob, J. P.; Scott, D.; Sechtem, U.; Sela, O.; Semrad, B.; Senni, M.; Shilkina, N. P.; Shpektor, A.; Silas, J.; Sindone, A.; Sinescu, C. J.; Sipila, R.; Sirek, J.; Skagen, K.; Shura, M.; Slanina, M.; Slowinski, S.; Smid, J.; Smielak-Korombel, W.; Solodky, A.; Spacek, R.; Squire, I.; Steingo, L.; Stepinska, J.; Stogowski, A.; Storzhakov, G.; Striouk, R.; Strunge, P.; Suter, T.; Svitil, P.; Swedberg, K.; Swidzinski, M.; Syvolap, V. D.; Sztajzel, J.; Tahk, S. J.; Tans, A. C.; Tans, J. G. M.; Targonski, R.; Tarjan, J.; Tartagni, F.; Tchartchoglian, R.; Tebloev, K.; Teesalu, R.; Ten Kate, J. B. L.; Terrosu, P.; Thompson, P. L.; Thybo, N. K.; Thygesen, K.; Tilon, P. A.; Timar, S.; Titkov, Y.; Titlbach, O. J.; Torp-Pedersen, C.; Torvik, D. T.; Touboul, P.; Trelawny, J. M.; Trillo Nouche, R.; Trochina, E.; Trojnar, R.; Tzekova, M. L.; Tzivoni, D.; Vahula, V.; Valagussa, F.; Valdes, M.; Van Der Heijden, R.; Van Der Sloot, J. A. P.; Van Hal, J. M. C.; Van Kempen, L. H. J.; Van Mieghem, W.; Van Rugge, F. P.; Van Veldhuisen, D. J.; Van Vlies, B.; Van Wijk, L. M.; Vasyuk, Y.; Vatutin, M.; Vered, Z.; Vergoni, W.; Vertkine, A.; Vigholt, E.; Vishnevskiy, A.; Voegelin, H.-P.; Voipio-Pulkki, L. M.; Von Mengden, H.-J.; Waites, J.; Watson, R. D. S.; Weiss, A. T.; Werner, H. A.; Wesdorp, J. C. L.; White, H.; Wiggers, P.; Wilcox, R. G.; Wilkinson, P.; Willems, A. R.; Willenbrock, R.; Wirth, M.; Wojciechowski, D.; Worth, H.; Wray, R.; Wu, C.-J.; Yakusevich, V. V.; Yang, S.-P.; Yarohno, N.; Zadionchenko, V. S.; Zaleska, T.; Zalewski, M.; Zannad, F.; Zateyshchikov, D.; Zeltin-Abramov, E.; Zeymer, U.; Zimmermann, R.; Albuquerque, D. C.; Alcaino, M.; Allall, O. A.; Beer, N.; Bortman, G.; Botero, R.; Cardoso, J. S.; Carrageta, M.; Carrillo, E.; Carvalho, A. C.; Castano, R.; Ceia, F.; Cesar, L. A. M.; Chevez, E.; Coelho, O. R.; Colombo, H. R.; Corbalan, R.; Doval, H.; Dutra, O.; Franken, R. A.; Gallardo, L.; Garcia, A.; Garcia, J.; Gomez, E. A.; Gomez, E.; Gonzalez, J.; Gonzalez, R. A.; Greque, G. V.; Guzman, L.; Haiek, J. C.; Hernandez, E.; Hominal, M. A.; Isea, J.; Lanas, F.; Leiva, J. L.; Lemus, J.; Llancaqueo, A.; Lopez, N.; Lousada, N.; Maia, L. N.; Maranhao, M. F.; Martinez, J. A.; Martinez, F. A.; Martins, F. A.; Martins, L.; Matadamas, N.; Matiz, H.; Mendoza, I.; Menezes, C.; Moises, O.; Moreira, J. I.; Moura, J. C.; Nicolau, J. C.; Nobrega, J.; Null, D.; Oliveira, M. S.; Palacios, A. O.; Pazin Filho, A.; Perrone, S. V.; Peigas, L. S.; Prieto, J. C.; Junior, A. R.; Rassi, S.; Ribeiro, V. G.; Rico, J. N.; Rivera, J. M.; Robledo, G.; Rodriguez, H.; Rosenthal, J.; Rossi, P. R. F.; Saraiva, J. F.; Soifer, S.; Sosa Liprandi, A.; Torres, H. G.; Uruchurtu, E.; Velasco, R. G.; Velasquez, J. G.; Vita, N.; Waich, S.; Zelaya, F. R.; Abariotis, N.; Abdollah, H.; Abraham, W.; Alaie, D.; Allison, W.; Ameen, A.; Amidi, M.; Anand, I.; Anderson, J. L.; Andreae, G. E.; Aquino, V.; Ballard, W.; Banas, J. S.; Baron, S. B.; Bata, I.; Berk, M. R.; Bhesania, T.; Binkley, P.; Booth, D. C.; Borts, D.; Brookfield, L. A.; Brown, C. S.; Browne, K. F.; Butman, S. M.; Capodilupo, R. C.; Caralis, D. G.; Carr, K. W.; Castan, R.; Chadow, H.; Chalavarya, G. K.; Chua, G. L.; Cinderella, J. A.; Clavette, P.; Clemson, B. S.; Cohen, T. J.; Colfer, H. T.; Corder, C. N.; Courtade, D. J.; Courtney, D. L.; Coutu, B.; Cucher, F. H.; Czarnecki, W.; Danisa, K.; D'Astous, M.; Dauber, I.; Davies, R.; Deedwania, P. C.; Delehanty, J. M.; Denny, D. M.; Denys, B. G.; DeYoung, P. J. P.; Dion, D.; Donohue, T. J.; El Shahawy, M.; Elkayam, U.; Escabi, J.; Essandoh, L. K.; Felicetta, J. V.; Fintel, D.; Fontaine, J. M.; Foster, R. E.; Frank, T. A.; Gin, K.; Goldberg, M. C.; Goldman, S.; Gossard, D.; Gosselin, G.; Gradman, A. H.; Grandmont, D.; Hack, T.; Hagar, J.; Haikal, M.; Hall, S. A.; Halpern, S.; Hanley, H. G.; Hanovich, G. D.; Hargrove, J. L.; Harlamert, E. A.; Hastings, T. E.; Hathaway, W. R.; Haught, W. H.; Hilliard, G. K.; Hodsden, J.; Hui, W.; Hurley, W.; Ibrahim, H. M.; Jafri, S.; Jain, A.; Jennison, S.; Jesse, R. L.; Joseph, J.; Kalman, J.; Karisberg, R. P.; Khant, R.; Koren, M.; Kosinski, E. J.; Kosolcharoen, P.; Kostuk, W. J.; Kouz, S. M.; Lai, C.; Langholz, D. E.; LeJemtel, T. H.; Leader, R.; Leblanc, M.-H.; Lee, H.; Lepage, S.; Lopez, M.; Lu, D. Y.; Lubelsky, B. J.; Luckasen, G. J.; Ma, P.-T.-S.; MacCallum, C. G.; Madu, E. C.; Maisel, A. S.; Mallis, G. I.; Mann, J. T.; Marr, D. R.; McGrew, F. A., III; McKay, R. J.; Mclellan, B.; Meisner, J.; Meyer, T.; Mikati, I.; Miller, L. A.; Miller, L. W.; Moe, G. W.; Mohiuddin, S. M.; Moir, G. D.; Morgan, A. W.; Morris, A.; Murphy, B. J.; Nallasivan, M.; Narula, J.; Nicklas, J. M.; Niederman, A. L.; Nitkin, R.; O'Keefe, J. H.; Oken, K. R.; O'Neill, P. G.; Orchard, R. C.; O'Riordan, W. D.; Paraboschi, C. F.; Patel, R. I.; Pennock, G.; Pesant, Y.; Phaneuf, D.; Phillips, D. F.; Plehn, J.; Promisloff, S.; Rajakumar, A. J.; Ramadurai, R.; Rashkow, A.; Rauh, R. A.; Rebane, T. M.; Riba, A. L.; Richard, C.; Riddle, J. C.; Ringuette, G.; Rivera, E.; Rockson, S.; Rogers, E.; Ross, H.; Roux, R.; Rupka, D.; Saenz, A.; Sampson, J.; Schulman, S. P.; Schuyler, G.; Sequeira, R. F.; Shah, A. R.; Shah, P. K.; Shakar, S. F.; Shalev, Y.; Sheikh, K. H.; Shettigar, U. R.; Siegel, R. M.; Sigal, S. L.; Singh, V. N.; Sotolongo, C. M.; Soucier, R. J.; Stagaman, D. J.; Stephan, W. J.; Stine, M.; Stoever, W. W.; Talano, J. V.; Tan, J. L.; Tanser, P. H.; Taussig, A. S.; Thadani, U.; Timmis, S. B. H.; Timothee, J. R.; Tragoon, S.; Tremblay, B.; Upadhya, K. J.; Vijay, N. K.; Wagoner, L. E.; Walker, J. L.; Wickemeyer, W. J.; Williams, G. A.; Williams, M. B.; Williams, R. E.; Wiseman, A. H.; Wool, K. J.; Yasin, M.; Zabalgoitia, M.; Zarich, S.; Zimmermann, R.; Zucker, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1309-1321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Aldosterone blockade reduces mortality and morbidity among patients with severe heart failure.  We conducted a double-blind, placebo-controlled study evaluating the effect of eplerenone, a selective aldosterone blocker, on morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.  Methods: Patients were randomly assigned to eplerenone (25 mg per day initially, titrated to a max. of 50 mg per day; 3313 patients) or placebo (3319 patients) in addn. to optimal medical therapy.  The study continued until 1012 deaths occurred.  The primary end points were death from any cause and death from cardiovascular causes or hospitalization for heart failure, acute myocardial infarction, stroke, or ventricular arrhythmia.  Results: During a mean follow-up of 16 mo, there were 478 deaths in the eplerenone group and 554 deaths in the placebo group (relative risk, 0.85; 95 percent confidence interval, 0.75 to 0.96; P=0.008).  Of these deaths, 407 in the eplerenone group and 483 in the placebo group were attributed to cardiovascular causes (relative risk, 0.83; 95 percent confidence interval, 0.72 to 0.94; P= 0.005).  The rate of the other primary end point, death from cardiovascular causes or hospitalization for cardiovascular events, was reduced by eplerenone (relative risk, 0.87; 95 percent confidence interval, 0.79 to 0.95; P=0.002), as was the secondary end point of death from any cause or any hospitalization (relative risk, 0.92; 95 percent confidence interval, 0.86 to 0.98; P=0.02).  There was also a redn. in the rate of sudden death from cardiac causes (relative risk, 0.79; 95 percent confidence interval, 0.64 to 0.97; P=0.03).  The rate of serious hyperkalemia was 5.5 percent in the eplerenone group and 3.9 percent in the placebo group (P=0.002), whereas the rate of hypokalemia was 8.4 percent in the eplerenone group and 13.1 percent in the placebo group (P<0.001).  Conclusions: The addn. of eplerenone to optimal medical therapy reduces morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXvg9fCdjlrVg90H21EOLACvtfcHk0lhHFOwDIczE2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1ehurY%253D&md5=cee432bc75bcca5f33098fe3bc8575df</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030207%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DRemme%26aufirst%3DW.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DNeaton%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DF.%26aulast%3DRoniker%26aufirst%3DB.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DHurley%26aufirst%3DS.%26aulast%3DKleiman%26aufirst%3DJ.%26aulast%3DGatlin%26aufirst%3DM.%26atitle%3DEplerenone%2520post-acute%2520myocardial%2520infarction%2520heart%2520failure%2520eficacy%2520and%2520survival%2520study%2520investigators.%2520Eplerenone%252C%2520a%2520selective%2520aldosterone%2520blocker%252C%2520in%2520patients%2520with%2520left%2520ventricular%2520dysfunction%2520after%2520myocardial%2520infarction%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D1309%26epage%3D1321%26doi%3D10.1056%2FNEJMoa030207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Luther, J. M.</span><span> </span><span class="NLM_article-title">Is there a new dawn for selective mineralocorticoid receptor antagonism?</span> <span class="citation_source-journal">Curr. Opin. Nephrol. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1097/MNH.0000000000000051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FMNH.0000000000000051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=456-461&author=J.+M.+Luther&title=Is+there+a+new+dawn+for+selective+mineralocorticoid+receptor+antagonism%3F&doi=10.1097%2FMNH.0000000000000051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1097%2FMNH.0000000000000051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNH.0000000000000051%26sid%3Dliteratum%253Aachs%26aulast%3DLuther%26aufirst%3DJ.%2BM.%26atitle%3DIs%2520there%2520a%2520new%2520dawn%2520for%2520selective%2520mineralocorticoid%2520receptor%2520antagonism%253F%26jtitle%3DCurr.%2520Opin.%2520Nephrol.%2520Hypertens.%26date%3D2014%26volume%3D23%26spage%3D456%26epage%3D461%26doi%3D10.1097%2FMNH.0000000000000051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gomez-Sanchez, E. P.</span><span> </span><span class="NLM_article-title">Third-generation mineralocorticoid receptor antagonists: why do we need a fourth?</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FFJC.0000000000000329" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=26-38&author=E.+P.+Gomez-Sanchez&title=Third-generation+mineralocorticoid+receptor+antagonists%3A+why+do+we+need+a+fourth%3F&doi=10.1097%2FFJC.0000000000000329"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000329%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Sanchez%26aufirst%3DE.%2BP.%26atitle%3DThird-generation%2520mineralocorticoid%2520receptor%2520antagonists%253A%2520why%2520do%2520we%2520need%2520a%2520fourth%253F%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2016%26volume%3D67%26spage%3D26%26epage%3D38%26doi%3D10.1097%2FFJC.0000000000000329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Roscioni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zeeuw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, S. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambers Heerspink, H. J.</span><span> </span><span class="NLM_article-title">Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy</span> <span class="citation_source-journal">Nat. Rev. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1038/nrneph.2012.217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1038%2Fnrneph.2012.217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=23070570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGksr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=691-699&author=S.+S.+Roscioniauthor=D.+de+Zeeuwauthor=S.+J.+L.+Bakkerauthor=H.+J.+Lambers+Heerspink&title=Management+of+hyperkalaemia+consequent+to+mineralocorticoid-receptor+antagonist+therapy&doi=10.1038%2Fnrneph.2012.217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy</span></div><div class="casAuthors">Roscioni, Sara S.; de Zeeuw, Dick; Bakker, Stephan J. L.; Lambers Heerspink, Hiddo J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Nephrology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">691-699</span>CODEN:
                <span class="NLM_cas:coden">NRNABO</span>;
        ISSN:<span class="NLM_cas:issn">1759-5061</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mineralocorticoid-receptor antagonists (MRAs) reduce blood pressure and albuminuria in patients treated with angiotensin-converting-enzyme inhibitors or angiotensin-II-receptor blockers.  The use of MRAs, however, is limited by the occurrence of hyperkalemia, which frequently occurs in patients older than 65 years with impaired kidney function, and/or diabetes.  Patients with these characteristics might still benefit from MRA therapy, however, and should not be excluded from this treatment option.  This limitation raises the question of how to optimize the therapeutic use of MRAs in this population of patients.  Understanding the individual variability in patients' responses to MRAs, in terms of albuminuria, blood pressure and serum potassium levels, might lead to targeted intervention.  MRA use might be restricted to patients with high levels of mineralocorticoid activity, evaluated by circulating renin and aldosterone levels or renal excretion of potassium.  In addn., reviewing the patient's diet and concomitant medications might prove useful in reducing the risk of developing subsequent hyperkalemia.  If hyperkalemia does develop, treatment options exist to decrease potassium levels, including administration of calcium gluconate, insulin, β2-agonists, diuretics and cation-exchange resins.  In combination with novel aldosterone blockers, these strategies might offer a rationale with which to optimize therapeutic intervention and extend the population of patients who can benefit from use of MRAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQwV24gpYwZbVg90H21EOLACvtfcHk0lhHFOwDIczE2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGksr3P&md5=b1d64db0ec8ce244a70827ffb52010cc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrneph.2012.217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneph.2012.217%26sid%3Dliteratum%253Aachs%26aulast%3DRoscioni%26aufirst%3DS.%2BS.%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DBakker%26aufirst%3DS.%2BJ.%2BL.%26aulast%3DLambers%2BHeerspink%26aufirst%3DH.%2BJ.%26atitle%3DManagement%2520of%2520hyperkalaemia%2520consequent%2520to%2520mineralocorticoid-receptor%2520antagonist%2520therapy%26jtitle%3DNat.%2520Rev.%2520Nephrol.%26date%3D2012%26volume%3D8%26spage%3D691%26epage%3D699%26doi%3D10.1038%2Fnrneph.2012.217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Vardeny, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claggett, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossignol, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, S. D.</span><span> </span><span class="NLM_article-title">Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist</span> <span class="citation_source-journal">Circ.: Heart Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span><span class="refDoi"> DOI: 10.1161/CIRCHEARTFAILURE.114.001104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1161%2FCIRCHEARTFAILURE.114.001104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=24812304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyksrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=573-579&author=O.+Vardenyauthor=B.+Claggettauthor=I.+Anandauthor=P.+Rossignolauthor=A.+S.+Desaiauthor=F.+Zannadauthor=B.+Pittauthor=S.+D.+Solomon&title=Incidence%2C+predictors%2C+and+outcomes+related+to+hypo-+and+hyperkalemia+in+patients+with+severe+heart+failure+treated+with+a+mineralocorticoid+receptor+antagonist&doi=10.1161%2FCIRCHEARTFAILURE.114.001104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist</span></div><div class="casAuthors">Vardeny, Orly; Claggett, Brian; Anand, Inder; Rossignol, Patrick; Desai, Akshay S.; Zannad, Faiez; Pitt, Bertram; Solomon, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation: Heart Failure</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">573-579</span>CODEN:
                <span class="NLM_cas:coden">CHFICM</span>;
        ISSN:<span class="NLM_cas:issn">1941-3289</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: Mineralocorticoid receptor antagonists reduce morbidity and mortality in patients with heart failure but can cause hyperkalemia, which contributes to reduced use of these drugs.  Hypokalemia also leads to worse outcomes in patients with heart failure and may be attenuated by mineralocorticoid receptor antagonists.  METHODS AND RESULTS-: We assessed incidence and predictors of hyperkalemia (potassium ≥5.5 mmol/L) and hypokalemia (potassium <3.5 mmol/L) and the relationship to outcomes in 1663 patients with class III or IV heart failure and left ventricular ejection fraction <35% randomized to treatment with spironolactone 25 mg or placebo in the Randomized Aldactone Evaluation Study (RALES) trial.  All-cause mortality rates and the influence of potassium levels on the effectiveness of spironolactone were assessed in a landmark anal. and in relation to time-varying potassium levels.  After 1 mo, mean potassium levels increased in the spironolactone group but not in the placebo group (4.54±0.49 vs. 4.28±0.50 mmol/L; P<0.001) and remained elevated during the trial.  Although the extremes of hypokalemia and hyperkalemia at 4 wk were assocd. with increased risk of mortality in both treatment arms, participants in the spironolactone arm had lower mortality rates at all potassium levels throughout the duration of the trial.  The treatment benefit of spironolactone was maintained at least until potassium exceeded 5.5 mmol/L.  CONCLUSIONS-: With appropriate surveillance of potassium and creatinine, the use of spironolactone was assocd. with less hypokalemia and improved survival in patients with severe heart failure even in the setting of moderate hyperkalemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbC_SI3ttkHLVg90H21EOLACvtfcHk0lhkrmP9XJqiiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyksrnF&md5=3cd6ebac5ef36419d40be309d507b03f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1161%2FCIRCHEARTFAILURE.114.001104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCHEARTFAILURE.114.001104%26sid%3Dliteratum%253Aachs%26aulast%3DVardeny%26aufirst%3DO.%26aulast%3DClaggett%26aufirst%3DB.%26aulast%3DAnand%26aufirst%3DI.%26aulast%3DRossignol%26aufirst%3DP.%26aulast%3DDesai%26aufirst%3DA.%2BS.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26atitle%3DIncidence%252C%2520predictors%252C%2520and%2520outcomes%2520related%2520to%2520hypo-%2520and%2520hyperkalemia%2520in%2520patients%2520with%2520severe%2520heart%2520failure%2520treated%2520with%2520a%2520mineralocorticoid%2520receptor%2520antagonist%26jtitle%3DCirc.%253A%2520Heart%2520Failure%26date%3D2014%26volume%3D7%26spage%3D573%26epage%3D579%26doi%3D10.1161%2FCIRCHEARTFAILURE.114.001104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eitner, F.</span><span> </span><span class="NLM_article-title">Nonsteroidal antagonists of the mineralocorticoid receptor</span> <span class="citation_source-journal">Curr. Opin. Nephrol. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span><span class="refDoi"> DOI: 10.1097/MNH.0000000000000147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FMNH.0000000000000147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=417-424&author=P.+Kolkhofauthor=C.+Nowackauthor=F.+Eitner&title=Nonsteroidal+antagonists+of+the+mineralocorticoid+receptor&doi=10.1097%2FMNH.0000000000000147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2FMNH.0000000000000147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNH.0000000000000147%26sid%3Dliteratum%253Aachs%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DNowack%26aufirst%3DC.%26aulast%3DEitner%26aufirst%3DF.%26atitle%3DNonsteroidal%2520antagonists%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DCurr.%2520Opin.%2520Nephrol.%2520Hypertens.%26date%3D2015%26volume%3D24%26spage%3D417%26epage%3D424%26doi%3D10.1097%2FMNH.0000000000000147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7957</span><span class="NLM_x">–</span> <span class="NLM_lpage">7966</span><span class="refDoi"> DOI: 10.1021/jm300806c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300806c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7957-7966&author=D.+W.+Piotrowski&title=Mineralocorticoid+receptor+antagonists+for+the+treatment+of+hypertension+and+diabetic+nephropathy&doi=10.1021%2Fjm300806c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm300806c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300806c%26sid%3Dliteratum%253Aachs%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520hypertension%2520and%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7957%26epage%3D7966%26doi%3D10.1021%2Fjm300806c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolten, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.107.103580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1161%2FHYPERTENSIONAHA.107.103580" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=742-748&author=J.+D.+Dietzauthor=S.+Duauthor=C.+W.+Boltenauthor=M.+A.+Payneauthor=C.+Xiaauthor=J.+R.+Blinnauthor=J.+W.+Funderauthor=X.+Hu&title=A+number+of+marketed+dihydropyridine+calcium+channel+blockers+have+mineralocorticoid+receptor+antagonist+activity&doi=10.1161%2FHYPERTENSIONAHA.107.103580"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.107.103580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.107.103580%26sid%3Dliteratum%253Aachs%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DBolten%26aufirst%3DC.%2BW.%26aulast%3DPayne%26aufirst%3DM.%2BA.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DFunder%26aufirst%3DJ.%2BW.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DA%2520number%2520of%2520marketed%2520dihydropyridine%2520calcium%2520channel%2520blockers%2520have%2520mineralocorticoid%2520receptor%2520antagonist%2520activity%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D742%26epage%3D748%26doi%3D10.1161%2FHYPERTENSIONAHA.107.103580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyanar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numann, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span> </span><span class="NLM_article-title">Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4300</span><span class="NLM_x">–</span> <span class="NLM_lpage">4304</span><span class="refDoi"> DOI: 10.1021/jm1002827</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1002827" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4300-4304&author=G.+B.+Arhancetauthor=S.+S.+Woodardauthor=J.+D.+Dietzauthor=D.+J.+Garlandauthor=G.+M.+Wagnerauthor=K.+Iyanarauthor=J.+T.+Collinsauthor=J.+R.+Blinnauthor=R.+E.+Numannauthor=X.+Huauthor=H.+C.+Huang&title=Stereochemical+requirements+for+the+mineralocorticoid+receptor+antagonist+activity+of+dihydropyridines&doi=10.1021%2Fjm1002827"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm1002827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002827%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DWoodard%26aufirst%3DS.%2BS.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DWagner%26aufirst%3DG.%2BM.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DNumann%26aufirst%3DR.%2BE.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26atitle%3DStereochemical%2520requirements%2520for%2520the%2520mineralocorticoid%2520receptor%2520antagonist%2520activity%2520of%2520dihydropyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4300%26epage%3D4304%26doi%3D10.1021%2Fjm1002827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bärfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa-Pérez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckroth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitsche, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ergüden, J.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gielen-Haertwig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlemmer, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platzek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span> </span><span class="NLM_article-title">Discovery of BAY 94–8862: A nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1385</span><span class="NLM_x">–</span> <span class="NLM_lpage">1403</span><span class="refDoi"> DOI: 10.1002/cmdc.201200081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1002%2Fcmdc.201200081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1385-1403&author=L.+B%C3%A4rfackerauthor=A.+Kuhlauthor=A.+Hillischauthor=R.+Grosserauthor=S.+Figueroa-P%C3%A9rezauthor=H.+Heckrothauthor=A.+Nitscheauthor=J.-K.+Erg%C3%BCdenauthor=H.+Gielen-Haertwigauthor=K.-H.+Schlemmerauthor=J.+Mittendorfauthor=H.+Paulsenauthor=J.+Platzekauthor=P.+Kolkhof&title=Discovery+of+BAY+94%E2%80%938862%3A+A+nonsteroidal+antagonist+of+the+mineralocorticoid+receptor+for+the+treatment+of+cardiorenal+diseases&doi=10.1002%2Fcmdc.201200081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200081%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26aulast%3DKuhl%26aufirst%3DA.%26aulast%3DHillisch%26aufirst%3DA.%26aulast%3DGrosser%26aufirst%3DR.%26aulast%3DFigueroa-P%25C3%25A9rez%26aufirst%3DS.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DNitsche%26aufirst%3DA.%26aulast%3DErg%25C3%25BCden%26aufirst%3DJ.-K.%26aulast%3DGielen-Haertwig%26aufirst%3DH.%26aulast%3DSchlemmer%26aufirst%3DK.-H.%26aulast%3DMittendorf%26aufirst%3DJ.%26aulast%3DPaulsen%26aufirst%3DH.%26aulast%3DPlatzek%26aufirst%3DJ.%26aulast%3DKolkhof%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520BAY%252094%25E2%2580%25938862%253A%2520A%2520nonsteroidal%2520antagonist%2520of%2520the%2520mineralocorticoid%2520receptor%2520for%2520the%2520treatment%2520of%2520cardiorenal%2520diseases%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1385%26epage%3D1403%26doi%3D10.1002%2Fcmdc.201200081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyanar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerndle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomposiello, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. F.</span><span> </span><span class="NLM_article-title">Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5970</span><span class="NLM_x">–</span> <span class="NLM_lpage">5978</span><span class="refDoi"> DOI: 10.1021/jm100506y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100506y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5970-5978&author=G.+B.+Arhancetauthor=S.+S.+Woodardauthor=K.+Iyanarauthor=B.+L.+Caseauthor=R.+Woerndleauthor=J.+D.+Dietzauthor=D.+J.+Garlandauthor=J.+T.+Collinsauthor=M.+A.+Payneauthor=J.+R.+Blinnauthor=S.+I.+Pomposielloauthor=X.+Huauthor=M.+I.+Heronauthor=H.-C.+Huangauthor=L.+F.+Lee&title=Discovery+of+novel+cyanodihydropyridines+as+potent+mineralocorticoid+receptor+antagonists&doi=10.1021%2Fjm100506y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm100506y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100506y%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DWoodard%26aufirst%3DS.%2BS.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DCase%26aufirst%3DB.%2BL.%26aulast%3DWoerndle%26aufirst%3DR.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DPayne%26aufirst%3DM.%2BA.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DPomposiello%26aufirst%3DS.%2BI.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHeron%26aufirst%3DM.%2BI.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DLee%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520of%2520novel%2520cyanodihydropyridines%2520as%2520potent%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5970%26epage%3D5978%26doi%3D10.1021%2Fjm100506y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huyet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bärfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pook, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span> </span><span class="NLM_article-title">A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">29932</span><span class="NLM_x">–</span> <span class="NLM_lpage">29940</span><span class="refDoi"> DOI: 10.1074/jbc.M110.131342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1074%2Fjbc.M110.131342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=29932-29940&author=J.+Fagartauthor=A.+Hillischauthor=J.+Huyetauthor=L.+B%C3%A4rfackerauthor=M.+Fayauthor=U.+Pleissauthor=E.+Pookauthor=S.+Sch%C3%A4ferauthor=M.-E.+Rafestin-Oblinauthor=P.+Kolkhof&title=A+new+mode+of+mineralocorticoid+receptor+antagonism+by+a+potent+and+selective+nonsteroidal+molecule&doi=10.1074%2Fjbc.M110.131342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.131342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.131342%26sid%3Dliteratum%253Aachs%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DHillisch%26aufirst%3DA.%26aulast%3DHuyet%26aufirst%3DJ.%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26aulast%3DFay%26aufirst%3DM.%26aulast%3DPleiss%26aufirst%3DU.%26aulast%3DPook%26aufirst%3DE.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DS.%26aulast%3DRafestin-Oblin%26aufirst%3DM.-E.%26aulast%3DKolkhof%26aufirst%3DP.%26atitle%3DA%2520new%2520mode%2520of%2520mineralocorticoid%2520receptor%2520antagonism%2520by%2520a%2520potent%2520and%2520selective%2520nonsteroidal%2520molecule%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D29932%26epage%3D29940%26doi%3D10.1074%2Fjbc.M110.131342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ergüden, J.-K. D.; Kolkhof, P. D.; Sandner, P. D.; Kuhl, A. D.; Stasch, J.-P. D.; Pook, E. D.; Schlemmer, K.-H. D.</span><span> </span><span class="NLM_article-title">Fluorenone 1,4-dihydropyridin derivatives</span>. International Patent WO2005/087740,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.-K.+D.+Erg%C3%BCden&author=P.+D.+Kolkhof&author=P.+D.+Sandner&author=A.+D.+Kuhl&author=J.-P.+D.+Stasch&author=E.+D.+Pook&author=K.-H.+D.+Schlemmer&title=Fluorenone+1%2C4-dihydropyridin+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DErg%25C3%25BCden%26aufirst%3DJ.-K.%2BD.%26atitle%3DFluorenone%25201%252C4-dihydropyridin%2520derivatives%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kuhl, A.; Kolkhof, P.; Heckroth, H.; Schlemmer, K.-H.; Flamme, I.; Gigueroa Perez, S.; Gielen-Haertwig, H.; Grosser, R.; Ergüden, J.-K.; Lang, D.</span><span> </span><span class="NLM_article-title">4-Chromenonyl-1,4-dihydropyridines and their use</span>. U.S. Patent US2010/022484A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Kuhl&author=P.+Kolkhof&author=H.+Heckroth&author=K.-H.+Schlemmer&author=I.+Flamme&author=S.+Gigueroa+Perez&author=H.+Gielen-Haertwig&author=R.+Grosser&author=J.-K.+Erg%C3%BCden&author=D.+Lang&title=4-Chromenonyl-1%2C4-dihydropyridines+and+their+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuhl%26aufirst%3DA.%26atitle%3D4-Chromenonyl-1%252C4-dihydropyridines%2520and%2520their%2520use%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lavall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böhm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufs, U.</span><span> </span><span class="NLM_article-title">The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">6656</span><span class="NLM_x">–</span> <span class="NLM_lpage">6668</span><span class="refDoi"> DOI: 10.1074/jbc.M113.519256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1074%2Fjbc.M113.519256" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=6656-6668&author=D.+Lavallauthor=C.+Selzerauthor=P.+Schusterauthor=M.+Lenskiauthor=O.+Adamauthor=H.-J.+Sch%C3%A4fersauthor=M.+B%C3%B6hmauthor=U.+Laufs&title=The+mineralocorticoid+receptor+promotes+fibrotic+remodeling+in+atrial+fibrillation&doi=10.1074%2Fjbc.M113.519256"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.519256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.519256%26sid%3Dliteratum%253Aachs%26aulast%3DLavall%26aufirst%3DD.%26aulast%3DSelzer%26aufirst%3DC.%26aulast%3DSchuster%26aufirst%3DP.%26aulast%3DLenski%26aufirst%3DM.%26aulast%3DAdam%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DH.-J.%26aulast%3DB%25C3%25B6hm%26aufirst%3DM.%26aulast%3DLaufs%26aufirst%3DU.%26atitle%3DThe%2520mineralocorticoid%2520receptor%2520promotes%2520fibrotic%2520remodeling%2520in%2520atrial%2520fibrillation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D6656%26epage%3D6668%26doi%3D10.1074%2Fjbc.M113.519256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellal-Levy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">Antagonism in the human mineralocorticoid receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3317</span><span class="NLM_x">–</span> <span class="NLM_lpage">3325</span><span class="refDoi"> DOI: 10.1093/emboj/17.12.3317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1093%2Femboj%2F17.12.3317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=9628869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADyaK1cXksFClt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=3317-3325&author=J.+Fagartauthor=J.+M.+Wurtzauthor=A.+Souqueauthor=C.+Hellal-Levyauthor=D.+Morasauthor=M.+E.+Rafestin-Oblin&title=Antagonism+in+the+human+mineralocorticoid+receptor&doi=10.1093%2Femboj%2F17.12.3317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism in the human mineralocorticoid receptor</span></div><div class="casAuthors">Fagart, Jerome; Wurtz, Jean-Marie; Souque, Anny; Hellal-Levy, Chantal; Moras, Dino; Rafestin-Oblin, Marie-Edith</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3317-3325</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Key residues of the human mineralocorticoid receptor (hMR) involved in the recognition of agonist and antagonist ligands were identified by alanine-scanning mutagenesis based on a homol. model of the hMR ligand-binding domain.  They were tested for their transactivation capacity and ability to bind agonists (aldosterone, cortisol) and antagonists (progesterone, RU26752).  The three-dimensional model reveals two polar sites located at the extremities of the elongated hydrophobic ligand-binding pocket.  Mutations of Gln 776 and Arg 817 in site I reduce the affinity of hMR for both agonists and antagonists and affect the capacity of hMR to activate transcription, suggesting that the C3-ketone group, common to all ligands, is anchored by these two residues conserved within the nuclear steroid receptor family.  In contrast, mutations of Asn 770 and Thr 945 in the opposite site only affect the binding of agonists bearing the C21-hydroxyl group.  The binding of hMR antagonists that exhibit a smaller size and faster off-rate kinetics compared with agonists is not affected.  In the light of the hMR homol. model, a new mechanism of antagonism is proposed in which the AF2-AD core region is destabilized by the loss of contacts between the antagonist and the helix H12 region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZn20LQzJbSbVg90H21EOLACvtfcHk0lhG8HnD77Gxdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksFClt7Y%253D&md5=fcfe9c946d95e732ac3ce19fac4bb5b0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.12.3317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.12.3317%26sid%3Dliteratum%253Aachs%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DWurtz%26aufirst%3DJ.%2BM.%26aulast%3DSouque%26aufirst%3DA.%26aulast%3DHellal-Levy%26aufirst%3DC.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DAntagonism%2520in%2520the%2520human%2520mineralocorticoid%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D3317%26epage%3D3325%26doi%3D10.1093%2Femboj%2F17.12.3317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Auzou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellal-Levy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">A single amino acid mutation of Ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=684-691&author=G.+Auzouauthor=J.+Fagartauthor=A.+Souqueauthor=C.+Hellal-Levyauthor=J.+M.+Wurtzauthor=D.+Morasauthor=M.+E.+Rafestin-Oblin&title=A+single+amino+acid+mutation+of+Ala-773+in+the+mineralocorticoid+receptor+confers+agonist+properties+to+11beta-substituted+spirolactones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAuzou%26aufirst%3DG.%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DSouque%26aufirst%3DA.%26aulast%3DHellal-Levy%26aufirst%3DC.%26aulast%3DWurtz%26aufirst%3DJ.%2BM.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DA%2520single%2520amino%2520acid%2520mutation%2520of%2520Ala-773%2520in%2520the%2520mineralocorticoid%2520receptor%2520confers%2520agonist%2520properties%2520to%252011beta-substituted%2520spirolactones%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D684%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bärfacker, L.; Kolkhof, P.; Schlemmer, K. H.; Grosser, R.; Nitsche, A.; Klein, M.; Münter, K.; Albrecht-Küpper, B.; Hartmann, E.</span><span> </span><span class="NLM_article-title">Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof</span>. U.S. Patent US20100136142A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+B%C3%A4rfacker&author=P.+Kolkhof&author=K.+H.+Schlemmer&author=R.+Grosser&author=A.+Nitsche&author=M.+Klein&author=K.+M%C3%BCnter&author=B.+Albrecht-K%C3%BCpper&author=E.+Hartmann&title=Substituted-4-aryl-1%2C4-dihydro-1%2C6-naphthyridinamides+and+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26atitle%3DSubstituted-4-aryl-1%252C4-dihydro-1%252C6-naphthyridinamides%2520and%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kober, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponikowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheorghiade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippatos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span> </span><span class="NLM_article-title">Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94–8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2453</span><span class="NLM_x">–</span> <span class="NLM_lpage">2463</span><span class="refDoi"> DOI: 10.1093/eurheartj/eht187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1093%2Feurheartj%2Feht187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=23713082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yrs7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=2453-2463&author=B.+Pittauthor=L.+Koberauthor=P.+Ponikowskiauthor=M.+Gheorghiadeauthor=G.+Filippatosauthor=H.+Krumauthor=C.+Nowackauthor=P.+Kolkhofauthor=S.-Y.+Kimauthor=F.+Zannad&title=Safety+and+tolerability+of+the+novel+non-steroidal+mineralocorticoid+receptor+antagonist+BAY+94%E2%80%938862+in+patients+with+chronic+heart+failure+and+mild+or+moderate+chronic+kidney+disease%3A+a+randomized%2C+double-blind+trial&doi=10.1093%2Feurheartj%2Feht187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial</span></div><div class="casAuthors">Pitt, Bertram; Kober, Lars; Ponikowski, Piotr; Gheorghiade, Mihai; Filippatos, Gerasimos; Krum, Henry; Nowack, Christina; Kolkhof, Peter; Kim, So-Young; Zannad, Faiez</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">2453-2463</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims: Mineralocorticoid receptor antagonists (MRAs) improve outcomes in patients with heart failure and reduced left ventricular ejection fraction (HFrEF), but their use is limited by hyperkalemia and/or worsening renal function (WRF).  BAY 94-8862 is a highly selective and strongly potent non-steroidal MRA.  We investigated its safety and tolerability in patients with HFrEF assocd. with mild or moderate chronic kidney disease (CKD).  Methods and results: This randomized, controlled, phase II trial consisted of two parts.  In part A, the safety and tolerability of oral BAY 94-8862 [2.5, 5, or 10 mg once daily (q.d.)] was assessed in 65 patients with HFrEF and mild CKD.  In part B, BAY 94-8862 (2.5, 5, or 10 mg q.d., or 5 mg twice daily) was compared with placebo and open-label spironolactone (25 or 50 mg/day) in 392 patients with HFrEF and moderate CKD.  BAY 94-8862 was assocd. with significantly smaller mean increases in serum potassium concn. than spironolactone (0.04-0.30 and 0.45 mmol/L, resp., P < 0.0001-0.0107) and lower incidences of hyperkalemia (5.3 and 12.7%, resp., P = 0.048) and WRF.  BAY 94-8862 decreased the levels of B-type natriuretic peptide (BNP), amino-terminal proBNP, and albuminuria at least as much as spironolactone.  Adverse events related to BAY 94-8862 were infrequent and mostly mild.  Conclusion: In patients with HFrEF and moderate CKD, BAY 94-8862 5-10 mg/day was at least as effective as spironolactone 25 or 50 mg/day in decreasing biomarkers of haemodynamic stress, but it was assocd. with lower incidences of hyperkalemia and WRF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsBCQjGJJltLVg90H21EOLACvtfcHk0lhG8HnD77Gxdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yrs7%252FI&md5=81f43b800b29f20aaf13c7fba31588b9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Feht187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Feht187%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DKober%26aufirst%3DL.%26aulast%3DPonikowski%26aufirst%3DP.%26aulast%3DGheorghiade%26aufirst%3DM.%26aulast%3DFilippatos%26aufirst%3DG.%26aulast%3DKrum%26aufirst%3DH.%26aulast%3DNowack%26aufirst%3DC.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.-Y.%26aulast%3DZannad%26aufirst%3DF.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520the%2520novel%2520non-steroidal%2520mineralocorticoid%2520receptor%2520antagonist%2520BAY%252094%25E2%2580%25938862%2520in%2520patients%2520with%2520chronic%2520heart%2520failure%2520and%2520mild%2520or%2520moderate%2520chronic%2520kidney%2520disease%253A%2520a%2520randomized%252C%2520double-blind%2520trial%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2013%26volume%3D34%26spage%3D2453%26epage%3D2463%26doi%3D10.1093%2Feurheartj%2Feht187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretschmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bärfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eitner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht-Küpper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, S.</span><span> </span><span class="NLM_article-title">Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FFJC.0000000000000091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=69-78&author=P.+Kolkhofauthor=M.+Delbeckauthor=A.+Kretschmerauthor=W.+Steinkeauthor=E.+Hartmannauthor=L.+B%C3%A4rfackerauthor=F.+Eitnerauthor=B.+Albrecht-K%C3%BCpperauthor=S.+Sch%C3%A4fer&title=Finerenone%2C+a+novel+selective+nonsteroidal+mineralocorticoid+receptor+antagonist+protects+from+rat+cardiorenal+injury&doi=10.1097%2FFJC.0000000000000091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000091%26sid%3Dliteratum%253Aachs%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DDelbeck%26aufirst%3DM.%26aulast%3DKretschmer%26aufirst%3DA.%26aulast%3DSteinke%26aufirst%3DW.%26aulast%3DHartmann%26aufirst%3DE.%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26aulast%3DEitner%26aufirst%3DF.%26aulast%3DAlbrecht-K%25C3%25BCpper%26aufirst%3DB.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DS.%26atitle%3DFinerenone%252C%2520a%2520novel%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonist%2520protects%2520from%2520rat%2520cardiorenal%2520injury%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2014%26volume%3D64%26spage%3D69%26epage%3D78%26doi%3D10.1097%2FFJC.0000000000000091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Bakris, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gansevoort, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossing, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmieder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmeskamp-Kirschbaum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruilope, L. M.</span><span> </span><span class="NLM_article-title">Effect of finerenone on albuminuria in patients with diabetic nephropathy: A randomized clinical trial</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span><span class="refDoi"> DOI: 10.1001/jama.2015.10081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1001%2Fjama.2015.10081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2015&pages=884-894&author=G.+L.+Bakrisauthor=R.+Agarwalauthor=J.+C.+Chanauthor=M.+E.+Cooperauthor=R.+T.+Gansevoortauthor=H.+Hallerauthor=G.+Remuzziauthor=P.+Rossingauthor=R.+E.+Schmiederauthor=C.+Nowackauthor=P.+Kolkhofauthor=A.+Josephauthor=A.+Pieperauthor=N.+Kimmeskamp-Kirschbaumauthor=L.+M.+Ruilope&title=Effect+of+finerenone+on+albuminuria+in+patients+with+diabetic+nephropathy%3A+A+randomized+clinical+trial&doi=10.1001%2Fjama.2015.10081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1001%2Fjama.2015.10081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2015.10081%26sid%3Dliteratum%253Aachs%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DAgarwal%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DJ.%2BC.%26aulast%3DCooper%26aufirst%3DM.%2BE.%26aulast%3DGansevoort%26aufirst%3DR.%2BT.%26aulast%3DHaller%26aufirst%3DH.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DRossing%26aufirst%3DP.%26aulast%3DSchmieder%26aufirst%3DR.%2BE.%26aulast%3DNowack%26aufirst%3DC.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DJoseph%26aufirst%3DA.%26aulast%3DPieper%26aufirst%3DA.%26aulast%3DKimmeskamp-Kirschbaum%26aufirst%3DN.%26aulast%3DRuilope%26aufirst%3DL.%2BM.%26atitle%3DEffect%2520of%2520finerenone%2520on%2520albuminuria%2520in%2520patients%2520with%2520diabetic%2520nephropathy%253A%2520A%2520randomized%2520clinical%2520trial%26jtitle%3DJAMA%26date%3D2015%26volume%3D314%26spage%3D884%26epage%3D894%26doi%3D10.1001%2Fjama.2015.10081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Haller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menne, J.</span><span> </span><span class="NLM_article-title">Finerenone: a new mineralocorticoid receptor antagonist without hyperkalemia: an opportunity in patients with CKD?</span> <span class="citation_source-journal">Curr. Hypertens. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1007/s11906-016-0649-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1007%2Fs11906-016-0649-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=26694820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFyqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=1-9&author=H.+Hallerauthor=A.+Bertramauthor=K.+Stahlauthor=J.+Menne&title=Finerenone%3A+a+new+mineralocorticoid+receptor+antagonist+without+hyperkalemia%3A+an+opportunity+in+patients+with+CKD%3F&doi=10.1007%2Fs11906-016-0649-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?</span></div><div class="casAuthors">Haller, Hermann; Bertram, Anna; Stahl, Klaus; Menne, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current Hypertension Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CHRUCG</span>;
        ISSN:<span class="NLM_cas:issn">1522-6417</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aldosterone binds to the mineralocorticoid receptor and has an important regulatory role in body fluid and electrolyte balance.  It also influences a variety of different cell functions such as oxidative stress, inflammation and organ fibrosis.  The important role of the tissue-specific mineralocorticoid receptors in cardiovascular and renal injury has been shown in knockout animals and in clin. studies Mineralocorticoid receptor antagonists seem to exert their beneficial effects via anti-oxidative, anti-inflammatory and anti-fibrotic effects.  Spironolactone and eplerenone were the first steroidal mineralocorticoid receptor antagonist.  The established steroidal mineralocorticoid receptor antagonists show important therapeutic effects but are hampered by a variety of side effects, most importantly clin. significant hyperkaliemia.  Selective non-steroidal mineralocorticoid receptor antagonists have been recently developed and demonstrate effectiveness in early clin. trials.  Finereroneholds promise for the future application of this new mineralocorticoid receptor antagonist class in patients with chronic kidney disease since it has shown a significant redn. in UACR combined with a safety profile similar to that in the placebo group.  However, further long-term studies investigating relevant clin. end points like redn. in cardiovascular or renal event rate are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriRvqUcZd4rrVg90H21EOLACvtfcHk0lgqLyUhc5rdoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFyqur8%253D&md5=887086700e3bf061978de5c752bb16c9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs11906-016-0649-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11906-016-0649-2%26sid%3Dliteratum%253Aachs%26aulast%3DHaller%26aufirst%3DH.%26aulast%3DBertram%26aufirst%3DA.%26aulast%3DStahl%26aufirst%3DK.%26aulast%3DMenne%26aufirst%3DJ.%26atitle%3DFinerenone%253A%2520a%2520new%2520mineralocorticoid%2520receptor%2520antagonist%2520without%2520hyperkalemia%253A%2520an%2520opportunity%2520in%2520patients%2520with%2520CKD%253F%26jtitle%3DCurr.%2520Hypertens.%2520Rep.%26date%3D2016%26volume%3D18%26spage%3D1%26epage%3D9%26doi%3D10.1007%2Fs11906-016-0649-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, P.</span><span> </span><span class="NLM_article-title">FInerenone for albuminuria in patients with diabetic nephropathy</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span><span class="refDoi"> DOI: 10.1001/jama.2015.15996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1001%2Fjama.2015.15996" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2016&pages=305-306&author=Y.+Fengauthor=X.+Zengauthor=P.+Fu&title=FInerenone+for+albuminuria+in+patients+with+diabetic+nephropathy&doi=10.1001%2Fjama.2015.15996"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1001%2Fjama.2015.15996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2015.15996%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DP.%26atitle%3DFInerenone%2520for%2520albuminuria%2520in%2520patients%2520with%2520diabetic%2520nephropathy%26jtitle%3DJAMA%26date%3D2016%26volume%3D315%26spage%3D305%26epage%3D306%26doi%3D10.1001%2Fjama.2015.15996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Filippatos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anker, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böhm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheorghiade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Køber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggioni, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponikowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voors, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmeskamp-Kirschbaum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, B.</span><span> </span><span class="NLM_article-title">A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2105</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span><span class="refDoi"> DOI: 10.1093/eurheartj/ehw132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1093%2Feurheartj%2Fehw132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=27130705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A280%3ADC%252BC28bkvVGktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=2105-2114&author=G.+Filippatosauthor=S.+D.+Ankerauthor=M.+B%C3%B6hmauthor=M.+Gheorghiadeauthor=L.+K%C3%B8berauthor=H.+Krumauthor=A.+P.+Maggioniauthor=P.+Ponikowskiauthor=A.+A.+Voorsauthor=F.+Zannadauthor=S.-Y.+Kimauthor=C.+Nowackauthor=G.+Palomboauthor=P.+Kolkhofauthor=N.+Kimmeskamp-Kirschbaumauthor=A.+Pieperauthor=B.+Pitt&title=A+randomized+controlled+study+of+finerenone+vs.+eplerenone+in+patients+with+worsening+chronic+heart+failure+and+diabetes+mellitus+and%2For+chronic+kidney+disease&doi=10.1093%2Feurheartj%2Fehw132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease</span></div><div class="casAuthors">Filippatos Gerasimos; Anker Stefan D; Bohm Michael; Gheorghiade Mihai; Kober Lars; Krum Henry; Maggioni Aldo P; Ponikowski Piotr; Voors Adriaan A; Zannad Faiez; Kim So-Young; Nowack Christina; Palombo Giovanni; Kolkhof Peter; Kimmeskamp-Kirschbaum Nina; Pieper Alexander; Pitt Bertram</div><div class="citationInfo"><span class="NLM_cas:title">European heart journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">2105-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and reduced ejection fraction and chronic kidney disease and/or diabetes mellitus.  METHODS AND RESULTS:  Miner Alocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF) was a randomized, double-blind, phase 2b multicentre study (ClinicalTrials.gov: NCT01807221).  Of 1286 screened patients, 1066 were randomized.  Patients received oral, once-daily finerenone (2.5, 5, 7.5, 10, or 15 mg, uptitrated to 5, 10, 15, 20, or 20 mg, respectively, on Day 30) or eplerenone (25 mg every other day, increased to 25 mg once daily on Day 30, and to 50 mg once daily on Day 60) for 90 days.  The primary endpoint was the percentage of individuals with a decrease of >30% in plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) from baseline to Day 90.  A key exploratory endpoint was a composite clinical endpoint of death from any cause, cardiovascular hospitalizations, or emergency presentation for worsening HF until Day 90.  Mean age ranged from 69.2 to 72.5 years in different treatment groups (standard deviation 9.7-10.6 years).  Decreases in NT-proBNP of >30% from baseline occurred in 37.2% of patients in the eplerenone group and 30.9, 32.5, 37.3, 38.8, and 34.2% in the 2.5→5, 5→10, 7.5→15, 10→20, and 15→20 mg finerenone groups, respectively (P = 0.42-0.88).  Except for the 2.5→5 mg finerenone group, the composite clinical endpoint occurred numerically less frequently in finerenone-treated patients compared with eplerenone; this difference reached nominal statistical significance in the 10→20 mg group (hazard ratio 0.56, 95% confidence interval, CI, 0.35; 0.90; nominal P = 0.02), despite the fact that this phase 2 study was not designed to detect statistical significant differences.  A potassium level increase to ≥5.6 mmol/L at any time point occurred in 4.3% of patients, with a balanced distribution among all treatment groups.  CONCLUSION:  Finerenone was well tolerated and induced a 30% or greater decrease in NT-proBNP levels in a similar proportion of patients to eplerenone.  The finding of reduced clinical events in the finerenone 10→20 mg group should be further explored in a large outcomes trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwlJaoNg6yx8ve_zCu79I8fW6udTcc2eYHTi8y8LnEZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bkvVGktw%253D%253D&md5=aa17a02b00280f014fac4e07eca5b12a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehw132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehw132%26sid%3Dliteratum%253Aachs%26aulast%3DFilippatos%26aufirst%3DG.%26aulast%3DAnker%26aufirst%3DS.%2BD.%26aulast%3DB%25C3%25B6hm%26aufirst%3DM.%26aulast%3DGheorghiade%26aufirst%3DM.%26aulast%3DK%25C3%25B8ber%26aufirst%3DL.%26aulast%3DKrum%26aufirst%3DH.%26aulast%3DMaggioni%26aufirst%3DA.%2BP.%26aulast%3DPonikowski%26aufirst%3DP.%26aulast%3DVoors%26aufirst%3DA.%2BA.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DS.-Y.%26aulast%3DNowack%26aufirst%3DC.%26aulast%3DPalombo%26aufirst%3DG.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DKimmeskamp-Kirschbaum%26aufirst%3DN.%26aulast%3DPieper%26aufirst%3DA.%26aulast%3DPitt%26aufirst%3DB.%26atitle%3DA%2520randomized%2520controlled%2520study%2520of%2520finerenone%2520vs.%2520eplerenone%2520in%2520patients%2520with%2520worsening%2520chronic%2520heart%2520failure%2520and%2520diabetes%2520mellitus%2520and%252For%2520chronic%2520kidney%2520disease%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2016%26volume%3D37%26spage%3D2105%26epage%3D2114%26doi%3D10.1093%2Feurheartj%2Fehw132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Amazit, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Billan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamribet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viengchareun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombès, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagart, J.</span><span> </span><span class="NLM_article-title">Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of ateroid recpetor coactivator-1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">21876</span><span class="NLM_x">–</span> <span class="NLM_lpage">21889</span><span class="refDoi"> DOI: 10.1074/jbc.M115.657957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1074%2Fjbc.M115.657957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=21876-21889&author=L.+Amazitauthor=F.+Le+Billanauthor=P.+Kolkhofauthor=K.+Lamribetauthor=S.+Viengchareunauthor=M.+R.+Fayauthor=J.+A.+Khanauthor=A.+Hillischauthor=M.+Lomb%C3%A8sauthor=M.-E.+Rafestin-Oblinauthor=J.+Fagart&title=Finerenone+impedes+aldosterone-dependent+nuclear+import+of+the+mineralocorticoid+receptor+and+prevents+genomic+recruitment+of+ateroid+recpetor+coactivator-1&doi=10.1074%2Fjbc.M115.657957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.657957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.657957%26sid%3Dliteratum%253Aachs%26aulast%3DAmazit%26aufirst%3DL.%26aulast%3DLe%2BBillan%26aufirst%3DF.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DLamribet%26aufirst%3DK.%26aulast%3DViengchareun%26aufirst%3DS.%26aulast%3DFay%26aufirst%3DM.%2BR.%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DHillisch%26aufirst%3DA.%26aulast%3DLomb%25C3%25A8s%26aufirst%3DM.%26aulast%3DRafestin-Oblin%26aufirst%3DM.-E.%26aulast%3DFagart%26aufirst%3DJ.%26atitle%3DFinerenone%2520impedes%2520aldosterone-dependent%2520nuclear%2520import%2520of%2520the%2520mineralocorticoid%2520receptor%2520and%2520prevents%2520genomic%2520recruitment%2520of%2520ateroid%2520recpetor%2520coactivator-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D21876%26epage%3D21889%26doi%3D10.1074%2Fjbc.M115.657957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Brandish, P.; Fraley, E.; Mark, E.; Hershey, J. C.; Steem, J. T.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor modulators</span>. International Patent WO2009/078934A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Brandish&author=E.+Fraley&author=E.+Mark&author=J.+C.+Hershey&author=J.+T.+Steem&title=Mineralocorticoid+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandish%26aufirst%3DP.%26atitle%3DMineralocorticoid%2520receptor%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubukata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sada, T.</span><span> </span><span class="NLM_article-title">Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">761</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.ejphar.2015.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=26073023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2iur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=761&publication_year=2015&pages=226-234&author=K.+Araiauthor=T.+Hommaauthor=Y.+Morikawaauthor=N.+Ubukataauthor=H.+Tsuruokaauthor=K.+Aokiauthor=H.+Ishikawaauthor=M.+Mizunoauthor=T.+Sada&title=Pharmacological+profile+of+CS-3150%2C+a+novel%2C+highly+potent+and+selective+non-steroidal+mineralocorticoid+receptor+antagonist&doi=10.1016%2Fj.ejphar.2015.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist</span></div><div class="casAuthors">Arai, Kiyoshi; Homma, Tsuyoshi; Morikawa, Yuka; Ubukata, Naoko; Tsuruoka, Hiyoyuki; Aoki, Kazumasa; Ishikawa, Hirokazu; Mizuno, Makoto; Sada, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">761</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">226-234</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study was designed to characterize the pharmacol. profile of CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist.  In the radioligand-binding assay, CS-3150 inhibited 3H-aldosterone binding to mineralocorticoid receptor with an IC50 value of 9.4 nM, and its potency was superior to that of spironolactone and eplerenone, whose IC50s were 36 and 713 nM, resp.  CS-3150 also showed at least 1000-fold higher selectivity for mineralocorticoid receptor over other steroid hormone receptors, glucocorticoid receptor, androgen receptor and progesterone receptor.  In the reporter gene assay, CS-3150 inhibited aldosterone-induced transcriptional activation of human mineralocorticoid receptor with an IC50 value of 3.7 nM, and its potency was superior to that of spironolactone and eplerenone, whose IC50s were 66 and 970 nM, resp.  CS-3150 had no agonistic effect on mineralocorticoid receptor and did not show any antagonistic or agonistic effect on glucocorticoid receptor, androgen receptor and progesterone receptor even at the high concn. of 5 μM.  In adrenalectomized rats, single oral administration of CS-3150 suppressed aldosterone-induced decrease in urinary Na+/K+ ratio, an index of in vivo mineralocorticoid receptor activation, and this suppressive effect was more potent and longer-lasting than that of spironolactone and eplerenone.  Chronic treatment with CS-3150 inhibited blood pressure elevation induced by deoxycorticosterone acetate (DOCA)/salt-loading to rats, and this antihypertensive effect was more potent than that of spironolactone and eplerenone.  These findings indicate that CS-3150 is a selective and highly potent mineralocorticoid receptor antagonist with long-lasting oral activity.  This agent could be useful for the treatment of hypertension, cardiovascular and renal disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6nBWXLrrQLVg90H21EOLACvtfcHk0liPG0D38Js1OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2iur%252FK&md5=89919d8637cc9cc23d1915e987b086d5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DK.%26aulast%3DHomma%26aufirst%3DT.%26aulast%3DMorikawa%26aufirst%3DY.%26aulast%3DUbukata%26aufirst%3DN.%26aulast%3DTsuruoka%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DM.%26aulast%3DSada%26aufirst%3DT.%26atitle%3DPharmacological%2520profile%2520of%2520CS-3150%252C%2520a%2520novel%252C%2520highly%2520potent%2520and%2520selective%2520non-steroidal%2520mineralocorticoid%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D761%26spage%3D226%26epage%3D234%26doi%3D10.1016%2Fj.ejphar.2015.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Canne, B. L.; Chen, J.; Dalrymple, L. E.; Flatt, B. T.; Forsyth, T. P.; Gu, X. H.; Mac, M. B.; Mann, G.; Mann, L. W.; Martin, R.</span><span> </span><span class="NLM_article-title">Pyrrole derivatives as pharmaceutical agents</span>. International Patent WO2006/012642,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=B.+L.+Canne&author=J.+Chen&author=L.+E.+Dalrymple&author=B.+T.+Flatt&author=T.+P.+Forsyth&author=X.+H.+Gu&author=M.+B.+Mac&author=G.+Mann&author=L.+W.+Mann&author=R.+Martin&title=Pyrrole+derivatives+as+pharmaceutical+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCanne%26aufirst%3DB.%2BL.%26atitle%3DPyrrole%2520derivatives%2520as%2520pharmaceutical%2520agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Nuss, J.; Williams, M.; Mohan, R.; Martin, R.; Wang, T. L.; Aoki, K.; Tsuruoka, H.; Hayashi, N.; Homma, T.</span><span> </span><span class="NLM_article-title">Atropisomers of (hydroxyalkyl) pyrrole derivatives</span>. International Patent WO2010/042622A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Nuss&author=M.+Williams&author=R.+Mohan&author=R.+Martin&author=T.+L.+Wang&author=K.+Aoki&author=H.+Tsuruoka&author=N.+Hayashi&author=T.+Homma&title=Atropisomers+of+%28hydroxyalkyl%29+pyrrole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%26atitle%3DAtropisomers%2520of%2520%2528hydroxyalkyl%2529%2520pyrrole%2520derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Nuss, J.; Williams, M.; Mohan, R.; Martin, R.; Wang, T. L.; Tsuruoka, H.; Aoki, K.; Honzumi, M.; Asoh, Y.; Saito, K.</span><span> </span><span class="NLM_article-title">1-Phenylpyrrole compounds</span>. International Patent WO2010/042626,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Nuss&author=M.+Williams&author=R.+Mohan&author=R.+Martin&author=T.+L.+Wang&author=H.+Tsuruoka&author=K.+Aoki&author=M.+Honzumi&author=Y.+Asoh&author=K.+Saito&title=1-Phenylpyrrole+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%26atitle%3D1-Phenylpyrrole%2520compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, T.</span><span> </span><span class="NLM_article-title">CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">769</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.ejphar.2015.11.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=26607463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFCltr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=769&publication_year=2015&pages=266-273&author=K.+Araiauthor=H.+Tsuruokaauthor=T.+Homma&title=CS-3150%2C+a+novel+non-steroidal+mineralocorticoid+receptor+antagonist%2C+prevents+hypertension+and+cardiorenal+injury+in+Dahl+salt-sensitive+hypertensive+rats&doi=10.1016%2Fj.ejphar.2015.11.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats</span></div><div class="casAuthors">Arai, Kiyoshi; Tsuruoka, Hiroyuki; Homma, Tsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">769</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">266-273</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study was designed to evaluate the antihypertensive and cardiorenal protective effects of CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, in Dahl salt-sensitive hypertensive rats (DS rats), and to compare the effects with spironolactone and eplerenone.  DS rats were fed a control diet (0.3% NaCl) or high salt diet (8% NaCl) from 7 wk of age.  CS-3150 (0.25-2 mg/kg), spironolactone (10-100 mg/kg) or eplerenone (10-100 mg/kg) were orally administered once a day to DS rats fed a high salt diet for 7 wk.  The high salt diet significantly increased systolic blood pressure, which was prevented by treatment with CS-3150 in a dose-dependent manner with no hyperkalemia (>5.5 mEq/L).  The antihypertensive effect of CS-3150 (0.5 mg/kg) was equiv. to that of spironolactone (100 mg/kg) and eplerenone (100 mg/kg).  CS-3150 also suppressed proteinuria and renal hypertrophy induced by the high salt diet.  Histopathol. examn. of kidneys showed that CS-3150 markedly ameliorated glomerulosclerosis, tubular injury and tubulointerstitial fibrosis.  In addn., CS-3150 inhibited left ventricular hypertrophy and elevation of plasma brain natriuretic peptide level.  In contrast, the cardiorenal protective effects of spironolactone or eplerenone were partial, and the dose-dependency was not clear, esp. in eplerenone-treated rats.  These results indicate that chronic treatment with CS-3150 exerts antihypertensive and cardiorenal protective effects in a DS hypertensive rat model, and its potency is much superior to that of spironolactone or eplerenone.  Thus, CS-3150 could be a promising agent for the treatment of hypertension and cardiorenal disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDe-OsNWJ98bVg90H21EOLACvtfcHk0ljRAL9ia0HMAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFCltr7P&md5=e6779bb7b61a07a2023f433a169079ef</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DK.%26aulast%3DTsuruoka%26aufirst%3DH.%26aulast%3DHomma%26aufirst%3DT.%26atitle%3DCS-3150%252C%2520a%2520novel%2520non-steroidal%2520mineralocorticoid%2520receptor%2520antagonist%252C%2520prevents%2520hypertension%2520and%2520cardiorenal%2520injury%2520in%2520Dahl%2520salt-sensitive%2520hypertensive%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D769%26spage%3D266%26epage%3D273%26doi%3D10.1016%2Fj.ejphar.2015.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockerman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendling, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span><span class="NLM_x">–</span> <span class="NLM_lpage">6002</span><span class="refDoi"> DOI: 10.1021/jm100505n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100505n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5979-6002&author=M.+J.+Meyersauthor=G.+B.+Arhancetauthor=S.+L.+Hockermanauthor=X.+Chenauthor=S.+A.+Longauthor=M.+W.+Mahoneyauthor=J.+R.+Ricoauthor=D.+J.+Garlandauthor=J.+R.+Blinnauthor=J.+T.+Collinsauthor=S.+Yangauthor=H.-C.+Huangauthor=K.+F.+McGeeauthor=J.+M.+Wendlingauthor=J.+D.+Dietzauthor=M.+A.+Payneauthor=B.+L.+Homerauthor=M.+I.+Heronauthor=D.+B.+Reitzauthor=X.+Hu&title=Discovery+of+%283S%2C3aR%29-2-%283-chloro-4-cyanophenyl%29-3-cyclopentyl-3%2C3a%2C4%2C5-tetrahydro-2H-benzo%5Bg%5Dindazole-7-carboxylic+Acid+%28PF-3882845%29%2C+an+orally+efficacious+mineralocorticoid+receptor+%28MR%29+antagonist+for+hypertension+and+nephropathy&doi=10.1021%2Fjm100505n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm100505n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100505n%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DHockerman%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DRico%26aufirst%3DJ.%2BR.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DMcGee%26aufirst%3DK.%2BF.%26aulast%3DWendling%26aufirst%3DJ.%2BM.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DPayne%26aufirst%3DM.%2BA.%26aulast%3DHomer%26aufirst%3DB.%2BL.%26aulast%3DHeron%26aufirst%3DM.%2BI.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520%25283S%252C3aR%2529-2-%25283-chloro-4-cyanophenyl%2529-3-cyclopentyl-3%252C3a%252C4%252C5-tetrahydro-2H-benzo%255Bg%255Dindazole-7-carboxylic%2520Acid%2520%2528PF-3882845%2529%252C%2520an%2520orally%2520efficacious%2520mineralocorticoid%2520receptor%2520%2528MR%2529%2520antagonist%2520for%2520hypertension%2520and%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5979%26epage%3D6002%26doi%3D10.1021%2Fjm100505n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Arhancet, G. B.; Casimiro-Garcia, A.; Chen, X.; Hepworth, D.; Meyers, M. J.; Piotrowski, D. W.; Raheja, R. K.</span><span> </span><span class="NLM_article-title">4,5-Dihydro-1h-pyrazole compounds and their pharmaceutical uses</span>. International Patent WO2010/116282 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+B.+Arhancet&author=A.+Casimiro-Garcia&author=X.+Chen&author=D.+Hepworth&author=M.+J.+Meyers&author=D.+W.+Piotrowski&author=R.+K.+Raheja&title=4%2C5-Dihydro-1h-pyrazole+compounds+and+their+pharmaceutical+uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26atitle%3D4%252C5-Dihydro-1h-pyrazole%2520compounds%2520and%2520their%2520pharmaceutical%2520uses%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Meyers, M. J.; Arhancet, G. B.; Chen, X.; Hockerman, S.; Long, S. A.; Mahoney, M. W.; Reitz, D. B.; Rico, J. G.</span><span> </span><span class="NLM_article-title">Pyrazoline compounds</span>. U.S. Patent US2008/0167294 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+J.+Meyers&author=G.+B.+Arhancet&author=X.+Chen&author=S.+Hockerman&author=S.+A.+Long&author=M.+W.+Mahoney&author=D.+B.+Reitz&author=J.+G.+Rico&title=Pyrazoline+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26atitle%3DPyrazoline%2520compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Casimiro-Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banker, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boustany-Kari, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eudy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulford, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loria, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raheja, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrieze, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span> </span><span class="NLM_article-title">Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-me thoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4273</span><span class="NLM_x">–</span> <span class="NLM_lpage">4288</span><span class="refDoi"> DOI: 10.1021/jm500206r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500206r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4273-4288&author=A.+Casimiro-Garciaauthor=D.+W.+Piotrowskiauthor=C.+Amblerauthor=G.+B.+Arhancetauthor=M.+E.+Bankerauthor=T.+Banksauthor=C.+M.+Boustany-Kariauthor=C.+Caiauthor=X.+Chenauthor=R.+Eudyauthor=D.+Hepworthauthor=C.+A.+Hulfordauthor=S.+M.+Jenningsauthor=P.+M.+Loriaauthor=M.+J.+Meyersauthor=D.+N.+Petersenauthor=N.+K.+Rahejaauthor=M.+Sammonsauthor=L.+Sheauthor=K.+Songauthor=D.+Vriezeauthor=L.+Wei&title=Identification+of+%28R%29-6-%281-%284-cyano-3-methylphenyl%29-5-cyclopentyl-4%2C5-dihydro-1H-pyrazol-3-yl%29-2-me+thoxynicotinic+acid%2C+a+highly+potent+and+selective+nonsteroidal+mineralocorticoid+receptor+antagonist&doi=10.1021%2Fjm500206r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm500206r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500206r%26sid%3Dliteratum%253Aachs%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DAmbler%26aufirst%3DC.%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DBanks%26aufirst%3DT.%26aulast%3DBoustany-Kari%26aufirst%3DC.%2BM.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DEudy%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHulford%26aufirst%3DC.%2BA.%26aulast%3DJennings%26aufirst%3DS.%2BM.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DPetersen%26aufirst%3DD.%2BN.%26aulast%3DRaheja%26aufirst%3DN.%2BK.%26aulast%3DSammons%26aufirst%3DM.%26aulast%3DShe%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DVrieze%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520%2528R%2529-6-%25281-%25284-cyano-3-methylphenyl%2529-5-cyclopentyl-4%252C5-dihydro-1H-pyrazol-3-yl%2529-2-me%2520thoxynicotinic%2520acid%252C%2520a%2520highly%2520potent%2520and%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4273%26epage%3D4288%26doi%3D10.1021%2Fjm500206r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Dehring, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandagere, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, S. K.</span><span> </span><span class="NLM_article-title">Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span><span class="refDoi"> DOI: 10.1016/j.jpba.2004.07.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.jpba.2004.07.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15522517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=447-456&author=K.+A.+Dehringauthor=H.+L.+Workmanauthor=K.+D.+Millerauthor=A.+Mandagereauthor=S.+K.+Poole&title=Automated+robotic+liquid+handling%2Flaser-based+nephelometry+system+for+high+throughput+measurement+of+kinetic+aqueous+solubility&doi=10.1016%2Fj.jpba.2004.07.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility</span></div><div class="casAuthors">Dehring, Karen A.; Workman, Heather L.; Miller, Keith D.; Mandagere, Arun; Poole, Salwa K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">447-456</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability to rapidly and consistently measure aq. soly. in a preclin. environment is crit. to the successful identification of promising discovery compds.  The advantage of an early soly. screen is timely attrition of compds. likely to fail due to poor absorption or low bioavailability before more costly screens are performed.  However, due to the large no. of compds. and limited sample amts., thermodn. soly. measurements are not feasible at this stage.  A kinetic soly. measurement is an alternative to thermodn. measurements at the discovery stage that provides a rank listing of soly. values with minimal sample requirements.  A kinetic soly. measurement is attractive from an automation vantage because it features rapid data acquisition and is amenable to multi-well formats.  We describe the use of a robotic liq./plate handler coupled to nephelometry detection for the measurement of kinetic soly.  We highlight the liq. handling validation, serial diln. parameters, and a comparison to the previous method.  Expts. to further enhance throughput, or increase confidence in the automation steps, were described and the effects of these expts. were presented.  In our integrated nephelometry method, we observe rapid liq. handling with an error of less than 10%, after a series of validation studies, and a sample throughput up to 1800 compds. per wk.  We compare the nephelometry method with our semi-thermodn. flow-injection anal. (FIA) method, and find a 75% bin agreement between the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmDRCDyzX6LbVg90H21EOLACvtfcHk0lip1EKoIq3oQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOqurs%253D&md5=0f39feaad6b2416aee99d5949e7350da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2004.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2004.07.022%26sid%3Dliteratum%253Aachs%26aulast%3DDehring%26aufirst%3DK.%2BA.%26aulast%3DWorkman%26aufirst%3DH.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DMandagere%26aufirst%3DA.%26aulast%3DPoole%26aufirst%3DS.%2BK.%26atitle%3DAutomated%2520robotic%2520liquid%2520handling%252Flaser-based%2520nephelometry%2520system%2520for%2520high%2520throughput%2520measurement%2520of%2520kinetic%2520aqueous%2520solubility%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2004%26volume%3D36%26spage%3D447%26epage%3D456%26doi%3D10.1016%2Fj.jpba.2004.07.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Brandish, P. E.; Fraley, M. E.; Hershey, J. C.; Steen, J. T.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor modulators</span>. International Patent WO2008/118319A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+E.+Brandish&author=M.+E.+Fraley&author=J.+C.+Hershey&author=J.+T.+Steen&title=Mineralocorticoid+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandish%26aufirst%3DP.%2BE.%26atitle%3DMineralocorticoid%2520receptor%2520modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Brandish, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczerba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hershey, J. C.</span><span> </span><span class="NLM_article-title">Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1016/j.vascn.2008.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.vascn.2008.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=18304838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlaqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=155-160&author=P.+E.+Brandishauthor=H.+Chenauthor=P.+Szczerbaauthor=J.+C.+Hershey&title=Development+of+a+simplified+assay+for+determination+of+the+antimineralocorticoid+activity+of+compounds+dosed+in+rats&doi=10.1016%2Fj.vascn.2008.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats</span></div><div class="casAuthors">Brandish, Philip E.; Chen, Hongxing; Szczerba, Peter; Hershey, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-160</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: Mineralocorticoid receptor (MR) antagonists are useful for the treatment of hypertension and heart failure.  In the present work we sought to develop a simplified protocol for measuring the acute activity of MR antagonists on urinary excretion of sodium and potassium in rats based on the original studies of mineralocorticoids in adrenalectomized rats reported by Kagawa et al. (Kagawa, C. M., & Jacobs Jr., R. S. (1960) Mineralocorticoid effects of 9α-fluorodeoxycorticosterone in adrenalectomized rats; Proceedings of the Society for Exptl. Biol. and Medicine, 104, 60-62).  Methods: Rats with intact adrenal glands were treated with test compds. and challenged with a bolus oral dose of saline.  Urine was collected over 4 h in metab. cages and urinary sodium and potassium concns. were measured.  Results: Aldosterone had no significant effect on sodium or potassium excretion and MR antagonists dose-dependently increased the ratio of sodium to potassium.  Diuretics with distinct mechanisms of action were differentiated via their relative effects on sodium, potassium and urine vols. and the new assay protocol was used to characterize a novel MR antagonist.  Discussion: A facile and robust protocol for the measurement of antagonism of renal MRs was established.  This protocol used fewer animals than previously described methods and did not require preparative surgery, factors which contributed favorably to cost, exptl. throughput and animal use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7BDEtZGFFBbVg90H21EOLACvtfcHk0lip1EKoIq3oQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlaqtbo%253D&md5=e98f6bc0acd37a14075402d93958ebf1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2008.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2008.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DBrandish%26aufirst%3DP.%2BE.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSzczerba%26aufirst%3DP.%26aulast%3DHershey%26aufirst%3DJ.%2BC.%26atitle%3DDevelopment%2520of%2520a%2520simplified%2520assay%2520for%2520determination%2520of%2520the%2520antimineralocorticoid%2520activity%2520of%2520compounds%2520dosed%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2008%26volume%3D57%26spage%3D155%26epage%3D160%26doi%3D10.1016%2Fj.vascn.2008.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamlynny, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltsie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Calvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, P.</span><span> </span><span class="NLM_article-title">Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4388</span><span class="NLM_x">–</span> <span class="NLM_lpage">4392</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2013.05.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=23777778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsV2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4388-4392&author=C.+Yangauthor=H.+C.+Shenauthor=Z.+Wuauthor=H.+D.+Chuauthor=J.+M.+Coxauthor=J.+Balsellsauthor=A.+Crespoauthor=P.+Brownauthor=B.+Zamlynnyauthor=J.+Wiltsieauthor=J.+Clemasauthor=J.+Gibsonauthor=L.+Continoauthor=J.+Lisnockauthor=G.+Zhouauthor=M.+Garcia-Calvoauthor=T.+Batemanauthor=L.+Xuauthor=X.+Tongauthor=M.+Crookauthor=P.+Sinclair&title=Discovery+of+novel+oxazolidinedione+derivatives+as+potent+and+selective+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmcl.2013.05.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists</span></div><div class="casAuthors">Yang, Christine; Shen, Hong C.; Wu, Zhicai; Chu, Hong D.; Cox, Jason M.; Balsells, Jaume; Crespo, Alejandro; Brown, Patricia; Zamlynny, Beata; Wiltsie, Judyann; Clemas, Joseph; Gibson, Jack; Contino, Lisa; Lisnock, JeanMarie; Zhou, Gaochao; Garcia-Calvo, Margarita; Bateman, Tom; Xu, Ling; Tong, Xinchun; Crook, Martin; Sinclair, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4388-4392</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel oxazolidinedione analogs were discovered as potent and selective mineralocorticoid receptor (MR) antagonists.  Structure-activity relationship (SAR) studies were focused on improving the potency and microsomal stability.  Selected compds. demonstrated excellent MR activity, reasonable nuclear hormone receptor selectivity, and acceptable rat pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiNiKrj7j4IbVg90H21EOLACvtfcHk0liuav3rScPKMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsV2hurY%253D&md5=2d53fa2b008ce84410103da9649d81f4</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.077%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DChu%26aufirst%3DH.%2BD.%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DZamlynny%26aufirst%3DB.%26aulast%3DWiltsie%26aufirst%3DJ.%26aulast%3DClemas%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DJ.%26aulast%3DContino%26aufirst%3DL.%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DBateman%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DCrook%26aufirst%3DM.%26aulast%3DSinclair%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520novel%2520oxazolidinedione%2520derivatives%2520as%2520potent%2520and%2520selective%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4388%26epage%3D4392%26doi%3D10.1016%2Fj.bmcl.2013.05.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Shen, H.; Cox, J. M.; Yang, C.; Wu, Z.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists</span>. International Patent WO2013/055606,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Shen&author=J.+M.+Cox&author=C.+Yang&author=Z.+Wu&title=Mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="note"><p class="first last">PathHunter protein–protein interaction cell-based assay that measures the ability of compounds to antagonize full-length human MR binding to a coactivator peptide, DiscoverX.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Shen, H.; Cox, J. M.; Chu, H. D.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists</span>. International Patent WO2013/055608,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Shen&author=J.+M.+Cox&author=H.+D.+Chu&title=Mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Shen, H.; Yang, C.; Cox, J. M.; Liu, K.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonist</span>. International Patent WO2013/055607,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Shen&author=C.+Yang&author=J.+M.+Cox&author=K.+Liu&title=Mineralocorticoid+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26atitle%3DMineralocorticoid%2520receptor%2520antagonist%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamlynny, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltsie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Calvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, P.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists: Identification of heterocyclic amide replacements in the oxazolidinedione series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1681</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.02.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2014.02.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=24630411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlGhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1681-1684&author=J.+M.+Coxauthor=H.+D.+Chuauthor=C.+Yangauthor=H.+C.+Shenauthor=Z.+Wuauthor=J.+Balsellsauthor=A.+Crespoauthor=P.+Brownauthor=B.+Zamlynnyauthor=J.+Wiltsieauthor=J.+Clemasauthor=J.+Gibsonauthor=L.+Continoauthor=J.+Lisnockauthor=G.+Zhouauthor=M.+Garcia-Calvoauthor=T.+Batemanauthor=L.+Xuauthor=X.+Tongauthor=M.+Crookauthor=P.+Sinclair&title=Mineralocorticoid+receptor+antagonists%3A+Identification+of+heterocyclic+amide+replacements+in+the+oxazolidinedione+series&doi=10.1016%2Fj.bmcl.2014.02.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Mineralocorticoid receptor antagonists: Identification of heterocyclic amide replacements in the oxazolidinedione series</span></div><div class="casAuthors">Cox, Jason M.; Chu, Hong D.; Yang, Christine; Shen, Hong C.; Wu, Zhicai; Balsells, Jaume; Crespo, Alejandro; Brown, Patricia; Zamlynny, Beata; Wiltsie, Judyann; Clemas, Joseph; Gibson, Jack; Contino, Lisa; Lisnock, JeanMarie; Zhou, Gaochao; Garcia-Calvo, Margarita; Bateman, Thomas; Xu, Ling; Tong, Xinchun; Crook, Martin; Sinclair, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1681-1684</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel potent and selective mineralocorticoid receptor antagonists were identified, utilizing heterocyclic amide replacements in the oxazolidinedione series.  Structure-activity relationship (SAR) efforts focused on improving lipophilic ligand efficiency (LLE) while maintaining nuclear hormone receptor selectivity and reasonable pharmacokinetic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrFpeeyyhxQ7Vg90H21EOLACvtfcHk0liuav3rScPKMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlGhtbc%253D&md5=9101ecc76caf233b6608f90e9e6a0a30</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.02.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.02.057%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DChu%26aufirst%3DH.%2BD.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DZamlynny%26aufirst%3DB.%26aulast%3DWiltsie%26aufirst%3DJ.%26aulast%3DClemas%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DJ.%26aulast%3DContino%26aufirst%3DL.%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DBateman%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DCrook%26aufirst%3DM.%26aulast%3DSinclair%26aufirst%3DP.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%253A%2520Identification%2520of%2520heterocyclic%2520amide%2520replacements%2520in%2520the%2520oxazolidinedione%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1681%26epage%3D1684%26doi%3D10.1016%2Fj.bmcl.2014.02.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamlynny, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltsie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Calvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span> </span><span class="NLM_article-title">Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFKlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=461-465&author=C.+Yangauthor=J.+Balsellsauthor=H.+D.+Chuauthor=J.+M.+Coxauthor=A.+Crespoauthor=X.+Maauthor=L.+Continoauthor=P.+Brownauthor=S.+Gaoauthor=B.+Zamlynnyauthor=J.+Wiltsieauthor=J.+Clemasauthor=J.+Lisnockauthor=J.+Gibsonauthor=G.+Zhouauthor=M.+Garcia-Calvoauthor=T.+J.+Batemanauthor=V.+Tongauthor=L.+Xuauthor=M.+Crookauthor=P.+Sinclairauthor=H.+C.+Shen&title=Discovery+of+benzimidazole+oxazolidinediones+as+novel+and+selective+nonsteroidal+mineralocorticoid+receptor+antagonists&doi=10.1021%2Facsmedchemlett.5b00010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzimidazole Oxazolidinediones as Novel and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists</span></div><div class="casAuthors">Yang, Christine; Balsells, Jaume; Chu, Hong D.; Cox, Jason M.; Crespo, Alejandro; Ma, Xiuying; Contino, Lisa; Brown, Patricia; Gao, Sheng; Zamlynny, Beata; Wiltsie, Judyann; Clemas, Joseph; Lisnock, JeanMarie; Gibson, Jack; Zhou, Gaochao; Garcia-Calvo, Margarita; Bateman, Thomas J.; Tong, Vincent; Xu, Ling; Crook, Martin; Sinclair, Peter; Shen, Hong C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">461-465</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Elaboration of the oxazolidinedione series led to replacement of the exocyclic amides with substituted benzimidazoles.  The structure-activity relationship exploration resulted in the discovery of potent and selective nonsteroidal mineralocorticoid receptor antagonists with significantly improved microsomal stability and pharmacokinetic profile relative to the HTS hit.  One compd. I possessed comparable efficacy as spironolactone at 100 mg/kg (p.o.) in the rat natriuresis model.  As such, this series was validated as a lead series for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSk1XzA7Ae7Vg90H21EOLACvtfcHk0lhlHOk_LESoKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFKlt7Y%253D&md5=b50611ee593d602ada48e35d4a0b9dcb</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00010%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DH.%2BD.%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DContino%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DZamlynny%26aufirst%3DB.%26aulast%3DWiltsie%26aufirst%3DJ.%26aulast%3DClemas%26aufirst%3DJ.%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DBateman%26aufirst%3DT.%2BJ.%26aulast%3DTong%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DCrook%26aufirst%3DM.%26aulast%3DSinclair%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DH.%2BC.%26atitle%3DDiscovery%2520of%2520benzimidazole%2520oxazolidinediones%2520as%2520novel%2520and%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D461%26epage%3D465%26doi%3D10.1021%2Facsmedchemlett.5b00010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Futatsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casimiro-Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loria, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banker, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, N. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of aryl sulfonamide-based nonsteroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6239</span><span class="NLM_x">–</span> <span class="NLM_lpage">6242</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2013.09.099" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6239-6242&author=K.+Futatsugiauthor=D.+W.+Piotrowskiauthor=A.+Casimiro-Garciaauthor=S.+Robinsonauthor=M.+Sammonsauthor=P.+M.+Loriaauthor=M.+E.+Bankerauthor=D.+N.+Petersenauthor=N.+J.+Schmidt&title=Design+and+synthesis+of+aryl+sulfonamide-based+nonsteroidal+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmcl.2013.09.099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.099%26sid%3Dliteratum%253Aachs%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DSammons%26aufirst%3DM.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DPetersen%26aufirst%3DD.%2BN.%26aulast%3DSchmidt%26aufirst%3DN.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520aryl%2520sulfonamide-based%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6239%26epage%3D6242%26doi%3D10.1016%2Fj.bmcl.2013.09.099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogDoct: A tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span><span class="refDoi"> DOI: 10.1021/jm0100990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFOmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+A+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds&doi=10.1021%2Fjm0100990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds</span></div><div class="casAuthors">Lombardo, Franco; Shalaeva, Marina Y.; Tupper, Karl A.; Gao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2490-2497</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an RP-HPLC method for the detn. of the octanol-water distribution coeffs. at pH 7.4, as log Doct7.4 values, for neutral and basic drugs, which combines ease of operation with high accuracy.  The method is shown to work for a training set of 90 mols. comprised largely of drugs, and it was also applied to a test set of 10 proprietary compds.  This work expands the applicability of the method presented in our earlier report, for the detn. of logPoct for neutral compds. (J. Med. Chem. 2000, 43, 2922-2928), and it offers the same general features but widens the scope.  Generally, the method (i) is compd. sparing (≤1 mL of a 50-100 μg/mL soln. needed), (ii) is insensitive to concn. and phase ratio effects obsd. in some shake-flask detns., (iii) is amenable to rapid detns. (≤20 min on av.), (iv) is insensitive to impurities, (v) possesses a wide lipophilicity range (>7 log Doct7.4 units), and (vi) offers a good accuracy, (vii) an excellent reproducibility, (viii) and an excellent potential for automation.  To the best of our knowledge, a similar performance, on a set of noncongeneric drugs, has not been previously reported.  We refer to the value generated via this method as ElogDoct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrynjvQ2-0sibVg90H21EOLACvtfcHk0lhlHOk_LESoKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFOmtbc%253D&md5=e390cfeacbb1cab5660909eccfeb7eb2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520A%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497%26doi%3D10.1021%2Fjm0100990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Katayama, S.; Hori, S.; Hasegawa, F.; Suzuki, K.</span><span> </span><span class="NLM_article-title">Biaryl amide derivative or pharmaceutically acceptable salt thereof</span>. U.S. Patent US2013/116227A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Katayama&author=S.+Hori&author=F.+Hasegawa&author=K.+Suzuki&title=Biaryl+amide+derivative+or+pharmaceutically+acceptable+salt+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DS.%26atitle%3DBiaryl%2520amide%2520derivative%2520or%2520pharmaceutically%2520acceptable%2520salt%2520thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Boyer, S.; Guo, X.; Wu, D.; Wu, F.</span><span> </span><span class="NLM_article-title">Pyridyl ureas as mineralocorticoid receptor antagonists</span>. International Patent WO2012/064631A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+Boyer&author=X.+Guo&author=D.+Wu&author=F.+Wu&title=Pyridyl+ureas+as+mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DS.%26atitle%3DPyridyl%2520ureas%2520as%2520mineralocorticoid%2520receptor%2520antagonists%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Neel, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grese, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defauw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doti, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, P. K.</span><span> </span><span class="NLM_article-title">3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2553</span><span class="NLM_x">–</span> <span class="NLM_lpage">2557</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2005.03.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15863315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslyrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2553-2557&author=D.+A.+Neelauthor=M.+L.+Brownauthor=P.+A.+Landerauthor=T.+A.+Greseauthor=J.+M.+Defauwauthor=R.+A.+Dotiauthor=T.+Fieldsauthor=S.+A.+Kelleyauthor=S.+Smithauthor=K.+M.+Zimmermanauthor=M.+I.+Steinbergauthor=P.+K.+Jadhav&title=3%2C3-Bisaryloxindoles+as+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmcl.2005.03.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists</span></div><div class="casAuthors">Neel, David A.; Brown, Matthew L.; Lander, Peter A.; Grese, Timothy A.; Defauw, Jean M.; Doti, Robert A.; Fields, Todd; Kelley, Sally Ann; Smith, Stephon; Zimmerman, Karen M.; Steinberg, Mitchell I.; Jadhav, Prabhakar K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2553-2557</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Syntheses and SAR studies of 3,3-bisaryloxindole analogs, e.g., I, provided potent mineralocorticoid receptor antagonists that were selective over other steroid nuclear hormone receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosTkFqjoQg1bVg90H21EOLACvtfcHk0ljrxoz07cIZdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslyrurs%253D&md5=22f58f43e64831e7878640cced07a188</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.086%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DD.%2BA.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DLander%26aufirst%3DP.%2BA.%26aulast%3DGrese%26aufirst%3DT.%2BA.%26aulast%3DDefauw%26aufirst%3DJ.%2BM.%26aulast%3DDoti%26aufirst%3DR.%2BA.%26aulast%3DFields%26aufirst%3DT.%26aulast%3DKelley%26aufirst%3DS.%2BA.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DZimmerman%26aufirst%3DK.%2BM.%26aulast%3DSteinberg%26aufirst%3DM.%2BI.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26atitle%3D3%252C3-Bisaryloxindoles%2520as%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2553%26epage%3D2557%26doi%3D10.1016%2Fj.bmcl.2005.03.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Bell, M. G.; Gavardinas, K.; Gernert, D. L.; Grese, T. A.; Jadhav, P. K.; Lander, P. A.; Steinberg, M. I.</span><span> </span><span class="NLM_article-title">Indole-derivative modulators of steroid hormone nuclear receptors</span>. International Patent WO2004/067529A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+G.+Bell&author=K.+Gavardinas&author=D.+L.+Gernert&author=T.+A.+Grese&author=P.+K.+Jadhav&author=P.+A.+Lander&author=M.+I.+Steinberg&title=Indole-derivative+modulators+of+steroid+hormone+nuclear+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BG.%26atitle%3DIndole-derivative%2520modulators%2520of%2520steroid%2520hormone%2520nuclear%2520receptors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Bell, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gernert, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grese, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvo, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borromeo, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, P. K.</span><span> </span><span class="NLM_article-title">(S)-N-{3-[1-Cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: A potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6443</span><span class="NLM_x">–</span> <span class="NLM_lpage">6445</span><span class="refDoi"> DOI: 10.1021/jm701186z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701186z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6443-6445&author=M.+G.+Bellauthor=D.+L.+Gernertauthor=T.+A.+Greseauthor=M.+D.+Belvoauthor=P.+S.+Borromeoauthor=S.+A.+Kelleyauthor=J.+H.+Kennedyauthor=S.+P.+Kolisauthor=P.+A.+Landerauthor=R.+Richeyauthor=V.+S.+Sharpauthor=G.+A.+Stephensonauthor=J.+D.+Williamsauthor=H.+Yuauthor=K.+M.+Zimmermanauthor=M.+I.+Steinbergauthor=P.+K.+Jadhav&title=%28S%29-N-%7B3-%5B1-Cyclopropyl-1-%282%2C4-difluoro-phenyl%29-ethyl%5D-1H-indol-7-yl%7D-methanesulfonamide%3A+A+potent%2C+nonsteroidal%2C+functional+antagonist+of+the+mineralocorticoid+receptor&doi=10.1021%2Fjm701186z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm701186z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701186z%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BG.%26aulast%3DGernert%26aufirst%3DD.%2BL.%26aulast%3DGrese%26aufirst%3DT.%2BA.%26aulast%3DBelvo%26aufirst%3DM.%2BD.%26aulast%3DBorromeo%26aufirst%3DP.%2BS.%26aulast%3DKelley%26aufirst%3DS.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BH.%26aulast%3DKolis%26aufirst%3DS.%2BP.%26aulast%3DLander%26aufirst%3DP.%2BA.%26aulast%3DRichey%26aufirst%3DR.%26aulast%3DSharp%26aufirst%3DV.%2BS.%26aulast%3DStephenson%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DK.%2BM.%26aulast%3DSteinberg%26aufirst%3DM.%2BI.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26atitle%3D%2528S%2529-N-%257B3-%255B1-Cyclopropyl-1-%25282%252C4-difluoro-phenyl%2529-ethyl%255D-1H-indol-7-yl%257D-methanesulfonamide%253A%2520A%2520potent%252C%2520nonsteroidal%252C%2520functional%2520antagonist%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6443%26epage%3D6445%26doi%3D10.1021%2Fjm701186z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Cernak, T. A.; Dykstra, K. D.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists</span>. International Patent WO2014/014794A2,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+A.+Cernak&author=K.+D.+Dykstra&title=Mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%2BA.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Michellys, P. Y.; Pei, W.; Petrassi, H. M.; Richmond, W.</span><span> </span><span class="NLM_article-title">Compounds and compositions as modulators of steroid hormone nuclear receptors</span>. International Patent WO2006/015259,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+Y.+Michellys&author=W.+Pei&author=H.+M.+Petrassi&author=W.+Richmond&title=Compounds+and+compositions+as+modulators+of+steroid+hormone+nuclear+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMichellys%26aufirst%3DP.%2BY.%26atitle%3DCompounds%2520and%2520compositions%2520as%2520modulators%2520of%2520steroid%2520hormone%2520nuclear%2520receptors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Lotesta, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noto, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandpal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhtiyarov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lala, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span> </span><span class="NLM_article-title">Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1384</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmc.2016.02.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1384-1391&author=S.+D.+Lotestaauthor=A.+P.+Marcusauthor=Y.+Zhengauthor=K.+Leftherisauthor=P.+B.+Notoauthor=S.+Mengauthor=G.+Kandpalauthor=G.+Chenauthor=J.+Zhouauthor=B.+McKeeverauthor=Y.+Bukhtiyarovauthor=Y.+Zhaoauthor=D.+S.+Lalaauthor=S.+B.+Singhauthor=G.+M.+McGeehan&title=Identification+of+spirooxindole+and+dibenzoxazepine+motifs+as+potent+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmc.2016.02.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DLotesta%26aufirst%3DS.%2BD.%26aulast%3DMarcus%26aufirst%3DA.%2BP.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DNoto%26aufirst%3DP.%2BB.%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DKandpal%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMcKeever%26aufirst%3DB.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26atitle%3DIdentification%2520of%2520spirooxindole%2520and%2520dibenzoxazepine%2520motifs%2520as%2520potent%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1384%26epage%3D1391%26doi%3D10.1016%2Fj.bmc.2016.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Iijima, T.; Yamamoto, Y.; Akatsuka, H.; Kawaguchi, T.</span><span> </span><span class="NLM_article-title">Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents</span>. International Patent WO2007/089034,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Iijima&author=Y.+Yamamoto&author=H.+Akatsuka&author=T.+Kawaguchi&title=Benzoxazines+and+related+nitrogen-containing+heterobicyclic+compounds+useful+as+mineralocorticoid+receptor+modulating+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIijima%26aufirst%3DT.%26atitle%3DBenzoxazines%2520and%2520related%2520nitrogen-containing%2520heterobicyclic%2520compounds%2520useful%2520as%2520mineralocorticoid%2520receptor%2520modulating%2520agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Fukumoto, S.; Matsunaga, N.; Ohra, T.; Ohyabu, N.; Hasui, T.; Motoyaji, T.; Siedem, C. S.; Tang, T. P.; Demeese, L. A.; Gauthier, C.</span><span> </span><span class="NLM_article-title">Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands</span>. U.S. Patent US2009/0253687,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Fukumoto&author=N.+Matsunaga&author=T.+Ohra&author=N.+Ohyabu&author=T.+Hasui&author=T.+Motoyaji&author=C.+S.+Siedem&author=T.+P.+Tang&author=L.+A.+Demeese&author=C.+Gauthier&title=Fused+heterocyclic+compounds+and+their+use+as+mineralocorticoid+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DFused%2520heterocyclic%2520compounds%2520and%2520their%2520use%2520as%2520mineralocorticoid%2520receptor%2520ligands%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Hasui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyabu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siedem, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meese, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5983</span><span class="NLM_x">–</span> <span class="NLM_lpage">5994</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.07.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmc.2013.07.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=5983-5994&author=T.+Hasuiauthor=T.+Ohraauthor=N.+Ohyabuauthor=K.+Asanoauthor=H.+Matsuiauthor=A.+Mizukamiauthor=N.+Habukaauthor=S.+Sogabeauthor=S.+Endoauthor=C.+S.+Siedemauthor=T.+P.+Tangauthor=C.+Gauthierauthor=L.+A.+De+Meeseauthor=S.+A.+Boydauthor=S.+Fukumoto&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+of+dihydrofuran-2-one+and+dihydropyrrol-2-one+derivatives+as+novel+benzoxazin-3-one-based+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmc.2013.07.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.07.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.07.043%26sid%3Dliteratum%253Aachs%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DOhra%26aufirst%3DT.%26aulast%3DOhyabu%26aufirst%3DN.%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DMizukami%26aufirst%3DA.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSiedem%26aufirst%3DC.%2BS.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DGauthier%26aufirst%3DC.%26aulast%3DDe%2BMeese%26aufirst%3DL.%2BA.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520dihydrofuran-2-one%2520and%2520dihydropyrrol-2-one%2520derivatives%2520as%2520novel%2520benzoxazin-3-one-based%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D5983%26epage%3D5994%26doi%3D10.1016%2Fj.bmc.2013.07.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Fukumoto, S.; Ohyabu, N.; Ohra, T.; Sugimoto, T.; Hasui, T.; Fuji, K.; SIEDEM, C. S.; Gauthier, C.</span><span> </span><span class="NLM_article-title">Pyrazole compounds</span>. U.S. Patent US2010/0094000,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Fukumoto&author=N.+Ohyabu&author=T.+Ohra&author=T.+Sugimoto&author=T.+Hasui&author=K.+Fuji&author=C.+S.+SIEDEM&author=C.+Gauthier&title=Pyrazole+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DPyrazole%2520compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Hasui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyabu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oosawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishigaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siedem, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meese, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, S.</span><span> </span><span class="NLM_article-title">Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5428</span><span class="NLM_x">–</span> <span class="NLM_lpage">5445</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmc.2014.07.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5428-5445&author=T.+Hasuiauthor=N.+Ohyabuauthor=T.+Ohraauthor=K.+Fujiauthor=T.+Sugimotoauthor=J.+Fujimotoauthor=K.+Asanoauthor=M.+Oosawaauthor=S.+Shiotaniauthor=N.+Nishigakiauthor=K.+Kusumotoauthor=H.+Matsuiauthor=A.+Mizukamiauthor=N.+Habukaauthor=S.+Sogabeauthor=S.+Endoauthor=M.+Onoauthor=C.+S.+Siedemauthor=T.+P.+Tangauthor=C.+Gauthierauthor=L.+A.+De+Meeseauthor=S.+A.+Boydauthor=S.+Fukumoto&title=Discovery+of+6-%5B5-%284-fluorophenyl%29-3-methyl-pyrazol-4-yl%5D-benzoxazin-3-one+derivatives+as+novel+selective+nonsteroidal+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmc.2014.07.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DOhyabu%26aufirst%3DN.%26aulast%3DOhra%26aufirst%3DT.%26aulast%3DFuji%26aufirst%3DK.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DJ.%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DOosawa%26aufirst%3DM.%26aulast%3DShiotani%26aufirst%3DS.%26aulast%3DNishigaki%26aufirst%3DN.%26aulast%3DKusumoto%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DMizukami%26aufirst%3DA.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSiedem%26aufirst%3DC.%2BS.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DGauthier%26aufirst%3DC.%26aulast%3DDe%2BMeese%26aufirst%3DL.%2BA.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25206-%255B5-%25284-fluorophenyl%2529-3-methyl-pyrazol-4-yl%255D-benzoxazin-3-one%2520derivatives%2520as%2520novel%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5428%26epage%3D5445%26doi%3D10.1016%2Fj.bmc.2014.07.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Casimiro-Garcia, A.; Futatsugi, K.; Piotrowski, D. W.</span><span> </span><span class="NLM_article-title">Morpholine compounds as mineralocorticoid receptor antagonists</span>. International Patent WO2011/141848A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Casimiro-Garcia&author=K.+Futatsugi&author=D.+W.+Piotrowski&title=Morpholine+compounds+as+mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26atitle%3DMorpholine%2520compounds%2520as%2520mineralocorticoid%2520receptor%2520antagonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Higuchi, R.; Zhi, L.; Karanewsky, D.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses</span>. U.S. Patent US2007/185102A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=R.+Higuchi&author=L.+Zhi&author=D.+Karanewsky&title=Mineralocorticoid+receptor+modulator+compounds%2C+processes+for+their+preparation%2C+and+their+uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHiguchi%26aufirst%3DR.%26atitle%3DMineralocorticoid%2520receptor%2520modulator%2520compounds%252C%2520processes%2520for%2520their%2520preparation%252C%2520and%2520their%2520uses%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Higuchi, R.; Zhi, L.; Adams, M.; Liu, Y.; Karanewsky, D.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses</span>. U.S. Patent US2007/197520A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=R.+Higuchi&author=L.+Zhi&author=M.+Adams&author=Y.+Liu&author=D.+Karanewsky&title=Mineralocorticoid+receptor+modulator+compounds%2C+processes+for+their+preparation%2C+and+their+uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHiguchi%26aufirst%3DR.%26atitle%3DMineralocorticoid%2520receptor%2520modulator%2520compounds%252C%2520processes%2520for%2520their%2520preparation%252C%2520and%2520their%2520uses%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Nariai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, K.</span><span> </span><span class="NLM_article-title">SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1254/jphs.10285FP</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1254%2Fjphs.10285FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=21358118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2011&pages=346-353&author=T.+Nariaiauthor=K.+Fujitaauthor=M.+Moriauthor=S.+Katayamaauthor=S.+Horiauthor=K.+Matsui&title=SM-368229%2C+a+novel+selective+and+potent+non-steroidal+mineralocorticoid+receptor+antagonist+with+strong+urinary+Na%2B+excretion+activity&doi=10.1254%2Fjphs.10285FP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity</span></div><div class="casAuthors">Nariai, Tetsuro; Fujita, Katsuya; Mori, Masaya; Katayama, Seiji; Hori, Seiji; Matsui, Kazuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-353</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Mineralocorticoid receptor (MR) antagonists, such as spironolactone (SPI) and eplerenone (EPL), are useful for the treatment of hypertension and heart failure.  However, the use of these two agents has been limited due to endocrine disturbance (SPI) and poor drug action (EPL).  In our search for safer and more effective MR antagonists, we identified SM-368229 as a novel non-steroidal MR antagonist.  SM-368229 showed strong MR inhibitory activity with IC50 values of 0.021 and 0.13 μM in the binding assay and reporter-gene assay, resp.  The selectivity of SM-368229 for MR was 18-fold higher than that for other steroid receptors, such as androgen, progesterone, and glucocorticoid receptors.  SM-368229 dose-dependently increased urinary Na+/K+ ratio with an ED50 value of 5.6 mg/kg in adrenalectomized rats treated with deoxycorticosterone acetate, and its efficacy was superior to that of SPI (ED50 = 14 mg/kg) or EPL (ED50 = 147 mg/kg).  Moreover, even at high doses of 100 and 300 mg/kg, SM-368229 showed very weak anti-androgenic effect in methyltestosterone-treated male rats and no progestagenic effect in estrus cycle synchronized female rats.  These findings indicate that SM-368229 may offer a new promising therapeutic option for the treatment of hypertension and heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp01j4ebA7L4rVg90H21EOLACvtfcHk0liu-4oXVnHq0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOktrg%253D&md5=b466e8ed04d16b667c1106d97a80d2c7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1254%2Fjphs.10285FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.10285FP%26sid%3Dliteratum%253Aachs%26aulast%3DNariai%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DS.%26aulast%3DMatsui%26aufirst%3DK.%26atitle%3DSM-368229%252C%2520a%2520novel%2520selective%2520and%2520potent%2520non-steroidal%2520mineralocorticoid%2520receptor%2520antagonist%2520with%2520strong%2520urinary%2520Na%252B%2520excretion%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D115%26spage%3D346%26epage%3D353%26doi%3D10.1254%2Fjphs.10285FP" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Takahashi, Y.; Awai, N.; Akatsuka, H.; Kawaguchi, T.; Iijima, T.</span><span> </span><span class="NLM_article-title">Fused bicyclic compound</span>. European Patent EP2179994A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+Takahashi&author=N.+Awai&author=H.+Akatsuka&author=T.+Kawaguchi&author=T.+Iijima&title=Fused+bicyclic+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DY.%26atitle%3DFused%2520bicyclic%2520compound%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Jiang, C.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtán, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.-W.</span><span> </span><span class="NLM_article-title">Synthesis, modification, and evaluation of (R)-de-O-methyllasiodiplodin and analogs as nonsteroidal antagonists of mineralocorticoid receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1175</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.12.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2010.12.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1171-1175&author=C.-S.+Jiangauthor=R.+Zhouauthor=J.-X.+Gongauthor=L.-L.+Chenauthor=T.+Kurt%C3%A1nauthor=X.+Shenauthor=Y.-W.+Guo&title=Synthesis%2C+modification%2C+and+evaluation+of+%28R%29-de-O-methyllasiodiplodin+and+analogs+as+nonsteroidal+antagonists+of+mineralocorticoid+receptor&doi=10.1016%2Fj.bmcl.2010.12.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.101%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.-S.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DGong%26aufirst%3DJ.-X.%26aulast%3DChen%26aufirst%3DL.-L.%26aulast%3DKurt%25C3%25A1n%26aufirst%3DT.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DY.-W.%26atitle%3DSynthesis%252C%2520modification%252C%2520and%2520evaluation%2520of%2520%2528R%2529-de-O-methyllasiodiplodin%2520and%2520analogs%2520as%2520nonsteroidal%2520antagonists%2520of%2520mineralocorticoid%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1171%26epage%3D1175%26doi%3D10.1016%2Fj.bmcl.2010.12.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Coghlan, M. J.; Jadhav, P. K.; Droste, J. J.; Green, J. E.; Matthews, D. P.</span><span> </span><span class="NLM_article-title">Tricyclic steroid hormone nuclear receptor modulators</span>. World Patent WO2005/066153A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+J.+Coghlan&author=P.+K.+Jadhav&author=J.+J.+Droste&author=J.+E.+Green&author=D.+P.+Matthews&title=Tricyclic+steroid+hormone+nuclear+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlan%26aufirst%3DM.%2BJ.%26atitle%3DTricyclic%2520steroid%2520hormone%2520nuclear%2520receptor%2520modulators%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Coghlan, M. J.; Green, J. E.; Grese, T. A.; Jadhav, P. K.; Matthews, D. P.; Steinberg, M. I.; Fales, K. R.; Bell, M. G.</span><span> </span><span class="NLM_article-title">Tricyclic steroid hormone nuclear receptor modulators</span>. World Patent WO2004/052847A2,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+J.+Coghlan&author=J.+E.+Green&author=T.+A.+Grese&author=P.+K.+Jadhav&author=D.+P.+Matthews&author=M.+I.+Steinberg&author=K.+R.+Fales&author=M.+G.+Bell&title=Tricyclic+steroid+hormone+nuclear+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlan%26aufirst%3DM.%2BJ.%26atitle%3DTricyclic%2520steroid%2520hormone%2520nuclear%2520receptor%2520modulators%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Gavardinas, K.; Green, J. E.; Jadhav, P. K.; Matthews, D. P.</span><span> </span><span class="NLM_article-title">Tryciclic steroid hormone nuclear receptor modulators</span>. World Patent WO2005/066161A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=K.+Gavardinas&author=J.+E.+Green&author=P.+K.+Jadhav&author=D.+P.+Matthews&title=Tryciclic+steroid+hormone+nuclear+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGavardinas%26aufirst%3DK.%26atitle%3DTryciclic%2520steroid%2520hormone%2520nuclear%2520receptor%2520modulators%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Gavardinas, K.; Jadhav, P. K.</span><span> </span><span class="NLM_article-title">6H-Dibenzo[B,E]oxepine derived nonsteroidal mineralocorticoid receptor antagonists</span>. World Patent WO2009/085584A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=K.+Gavardinas&author=P.+K.+Jadhav&title=6H-Dibenzo%5BB%2CE%5Doxepine+derived+nonsteroidal+mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGavardinas%26aufirst%3DK.%26atitle%3D6H-Dibenzo%255BB%252CE%255Doxepine%2520derived%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Coates, D. A.; Gavardinas, K.; Jadhav, P. K.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonist and methods of use</span>. World Patent WO2010/104721A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+A.+Coates&author=K.+Gavardinas&author=P.+K.+Jadhav&title=Mineralocorticoid+receptor+antagonist+and+methods+of+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCoates%26aufirst%3DD.%2BA.%26atitle%3DMineralocorticoid%2520receptor%2520antagonist%2520and%2520methods%2520of%2520use%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Kowala, M. C.</span><span> </span><span class="NLM_article-title">Combination therapy for resistant hypertension</span>. World Patent WO2015/130568<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+C.+Kowala&title=Combination+therapy+for+resistant+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKowala%26aufirst%3DM.%2BC.%26atitle%3DCombination%2520therapy%2520for%2520resistant%2520hypertension%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><a href="http://www.chemspider.com/Chemical-Structure.29361352.html" class="extLink">http://www.chemspider.com/Chemical-Structure.29361352.html</a> (accessed Nov 18,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.chemspider.com%2FChemical-Structure.29361352.html+%28accessed+Nov+18%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><a href="http://www.chemicalregister.com/LY2623091/Suppliers/pid705106.htm" class="extLink">http://www.chemicalregister.com/LY2623091/Suppliers/pid705106.htm</a> (accessed Nov 18,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.chemicalregister.com%2FLY2623091%2FSuppliers%2Fpid705106.htm+%28accessed+Nov+18%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Hultman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasnoperova, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lala, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1460</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span><span class="refDoi"> DOI: 10.1210/me.2004-0537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1210%2Fme.2004-0537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15761029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslyqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1460-1473&author=M.+L.+Hultmanauthor=N.+V.+Krasnoperovaauthor=S.+Liauthor=S.+Duauthor=C.+Xiaauthor=J.+D.+Dietzauthor=D.+S.+Lalaauthor=D.+J.+Welschauthor=X.+Hu&title=The+ligand-dependent+interaction+of+mineralocorticoid+receptor+with+coactivator+and+corepressor+peptides+suggests+multiple+activation+mechanisms&doi=10.1210%2Fme.2004-0537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms</span></div><div class="casAuthors">Hultman, Monica L.; Krasnoperova, Nataliia V.; Li, Suzhen; Du, Sarah; Xia, Chunsheng; Dietz, Jessica D.; Lala, Deepak S.; Welsch, Dean J.; Hu, Xiao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1460-1473</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">We investigated the coregulator (coactivator and corepressor) interactions with the mineralocorticoid receptor (MR) that lead to activation and inhibition of the receptor in the presence of agonist and/or antagonist.  Our results indicate that MR ligand binding domain (LBD) interacts strongly with only a few specific coactivator peptides in the presence of the agonist aldosterone and that these interactions are blocked by the antagonist eplerenone.  We also discovered that cortisol, the preferred physiol. ligand for the glucocorticoid receptor in humans, is a partial MR agonist/antagonist, providing a possible mol. explanation of the tissue-selective effects of glucocorticoids on MR.  However, when we examd. the coactivator and corepressor peptide interactions in the presence of cortisol, we found that MR bound with cortisol or aldosterone interacted with the same set of peptides.  Thus, the partial agonism shown by cortisol is unlikely to be the result of differential interaction with known coactivators and corepressors.  On the other hand, we have identified coactivator binding groove mutations that are crit. for cortisol activation but not for aldosterone activation, suggesting that the two steroids induce different MR LBD conformations.  In addn., we also show that cortisol becomes full agonist when S810L mutation is introduced in the LBD of MR.  Interestingly, MR antagonists, such as eplerenone and progesterone, become partial agonist/antagonist of S810L but are still able to recruit LXXLL peptides to the mutant receptor.  Together, these findings suggest a model to explain the MR activation by various ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDY358OY2yLbVg90H21EOLACvtfcHk0liGUHZRuMGDyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslyqtrs%253D&md5=f29e9129e4dc69f90c71a4c41335aa5e</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1210%2Fme.2004-0537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2004-0537%26sid%3Dliteratum%253Aachs%26aulast%3DHultman%26aufirst%3DM.%2BL.%26aulast%3DKrasnoperova%26aufirst%3DN.%2BV.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DWelsch%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DThe%2520ligand-dependent%2520interaction%2520of%2520mineralocorticoid%2520receptor%2520with%2520coactivator%2520and%2520corepressor%2520peptides%2520suggests%2520multiple%2520activation%2520mechanisms%26jtitle%3DMol.%2520Endocrinol.%26date%3D2005%26volume%3D19%26spage%3D1460%26epage%3D1473%26doi%3D10.1210%2Fme.2004-0537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clyne, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. J.</span><span> </span><span class="NLM_article-title">Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1210/me.2010-0193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1210%2Fme.2010-0193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=21106883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFGruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=32-43&author=J.+Yangauthor=C.-y.+Changauthor=R.+Safiauthor=J.+Morganauthor=D.+P.+McDonnellauthor=P.+J.+Fullerauthor=C.+D.+Clyneauthor=M.+J.+Young&title=Identification+of+ligand-selective+peptide+antagonists+of+the+mineralocorticoid+receptor+using+phage+display&doi=10.1210%2Fme.2010-0193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display</span></div><div class="casAuthors">Yang, Jun; Chang, Ching-yi; Safi, Rachid; Morgan, James; McDonnell, Donald P.; Fuller, Peter J.; Clyne, Colin D.; Young, Morag J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-43</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The mineralocorticoid receptor (MR) is a member of the nuclear receptor superfamily.  Pathol. activation of the MR causes cardiac fibrosis and heart failure, but clin. use of MR antagonists is limited by the renal side effect of hyperkalemia.  The glucocorticoid cortisol binds the MR with equiv. affinity to that of the mineralocorticoids aldosterone and deoxycorticosterone.  In nonepithelial tissues, including the myocardium, which do not express the cortisol-inactivating enzyme 11β hydroxysteroid dehydrogenase 2, cortisol has been implicated in the activation of MR.  The mechanisms for ligand- and tissue-specific actions of the MR are undefined.  Over the past decade, it has become clear that coregulator proteins are crit. for nuclear receptor-mediated gene expression.  A subset of these coregulators may confer specificity to MR-mediated responses.  To evaluate whether different physiol. ligands can induce distinct MR conformations that underlie differential coregulator recruitment and ligand-specific gene regulation, we utilized phage display technol. to screen 108 19mer peptides for their interaction with the MR in the presence of agonist ligands.  We identified ligand-selective MR-interacting peptides that acted as potent antagonists of MR-mediated transactivation.  This represents a novel mechanism of MR antagonism that may be manipulated in the rational design of a ligand- or tissue-selective MR modulator to treat diseases like heart failure without side effects such as hyperkalemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfSmwZVKWWELVg90H21EOLACvtfcHk0liGUHZRuMGDyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFGruro%253D&md5=86ac4cbe7c4c349301a3e480a341eb91</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1210%2Fme.2010-0193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2010-0193%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DC.-y.%26aulast%3DSafi%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DFuller%26aufirst%3DP.%2BJ.%26aulast%3DClyne%26aufirst%3DC.%2BD.%26aulast%3DYoung%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%2520ligand-selective%2520peptide%2520antagonists%2520of%2520the%2520mineralocorticoid%2520receptor%2520using%2520phage%2520display%26jtitle%3DMol.%2520Endocrinol.%26date%3D2011%26volume%3D25%26spage%3D32%26epage%3D43%26doi%3D10.1210%2Fme.2010-0193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Rogerson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, P. J.</span><span> </span><span class="NLM_article-title">Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">4200</span><span class="NLM_x">–</span> <span class="NLM_lpage">4210</span><span class="refDoi"> DOI: 10.1096/fj.13-242479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1096%2Ffj.13-242479" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=4200-4210&author=F.+M.+Rogersonauthor=Y.-Z.+Yaoauthor=M.+J.+Youngauthor=P.+J.+Fuller&title=Identification+and+characterization+of+a+ligand-selective+mineralocorticoid+receptor+coactivator&doi=10.1096%2Ffj.13-242479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1096%2Ffj.13-242479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.13-242479%26sid%3Dliteratum%253Aachs%26aulast%3DRogerson%26aufirst%3DF.%2BM.%26aulast%3DYao%26aufirst%3DY.-Z.%26aulast%3DYoung%26aufirst%3DM.%2BJ.%26aulast%3DFuller%26aufirst%3DP.%2BJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520ligand-selective%2520mineralocorticoid%2520receptor%2520coactivator%26jtitle%3DFASEB%2520J.%26date%3D2014%26volume%3D28%26spage%3D4200%26epage%3D4210%26doi%3D10.1096%2Ffj.13-242479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span>Clinical trials information: <a href="https://clinicaltrials.gov/ct2/show/NCT02676401" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02676401</a> (accessed Dec 19,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trials+information%3A+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02676401+%28accessed+Dec+19%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':[],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kenneth L. Granberg, Zhong-Qing Yuan, Bo Lindmark, Karl Edman, Johan Kajanus, Anders Hogner, Marcus Malmgren, Gavin O’Mahony, Anneli Nordqvist, Jan Lindberg, Stefan Tångefjord, Michael Kossenjans, Christian Löfberg, Jonas Brånalt, Dongmei Liu, Nidhal Selmi, Grigorios Nikitidis, Peter Nordberg, Ahlke Hayen, Anna Aagaard, Eva Hansson, Majlis Hermansson, Ida Ivarsson, Rasmus Jansson-Löfmark, Ulla Karlsson, Ulrika Johansson, Lena William-Olsson, Judith Hartleib-Geschwindner, <span class="NLM_string-name hlFld-ContribAuthor">Krister Bamberg</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Mineralocorticoid Receptor Modulators with Low Impact on Electrolyte Homeostasis but Maintained Organ Protection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1385-1406. <a href="https://doi.org/10.1021/acs.jmedchem.8b01523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BMineralocorticoid%252BReceptor%252BModulators%252Bwith%252BLow%252BImpact%252Bon%252BElectrolyte%252BHomeostasis%252Bbut%252BMaintained%252BOrgan%252BProtection%26aulast%3DGranberg%26aufirst%3DKenneth%2BL.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D30092018%26date%3D30012019%26date%3D31122018%26volume%3D62%26issue%3D3%26spage%3D1385%26epage%3D1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David W.  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Kentaro  Futatsugi</span>, <span class="hlFld-ContribAuthor ">Agustin  Casimiro-Garcia</span>, <span class="hlFld-ContribAuthor ">Liuqing  Wei</span>, <span class="hlFld-ContribAuthor ">Matthew F.  Sammons</span>, <span class="hlFld-ContribAuthor ">Michael  Herr</span>, <span class="hlFld-ContribAuthor ">Wenhua  Jiao</span>, <span class="hlFld-ContribAuthor ">Sophie Y.  Lavergne</span>, <span class="hlFld-ContribAuthor ">Steven B.  Coffey</span>, <span class="hlFld-ContribAuthor ">Stephen W.  Wright</span>, <span class="hlFld-ContribAuthor ">Kun  Song</span>, <span class="hlFld-ContribAuthor ">Paula M.  Loria</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Banker</span>, <span class="hlFld-ContribAuthor ">Donna N.  Petersen</span>, and <span class="hlFld-ContribAuthor ">Jonathan  Bauman</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Morpholino-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-ones as Nonsteroidal Mineralocorticoid Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1086-1097. <a href="https://doi.org/10.1021/acs.jmedchem.7b01515" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01515%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BMorpholino-2H-pyrido%25255B3%25252C2-b%25255D%25255B1%25252C4%25255Doxazin-3%2525284H%252529-ones%252Bas%252BNonsteroidal%252BMineralocorticoid%252BAntagonists%26aulast%3DPiotrowski%26aufirst%3DDavid%2BW.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D16102017%26date%3D23012018%26date%3D08022018%26date%3D04012018%26volume%3D61%26issue%3D3%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Wintrich</span>, <span class="hlFld-ContribAuthor ">Ingrid  Kindermann</span>, <span class="hlFld-ContribAuthor ">Christian  Ukena</span>, <span class="hlFld-ContribAuthor ">Simina  Selejan</span>, <span class="hlFld-ContribAuthor ">Christian  Werner</span>, <span class="hlFld-ContribAuthor ">Christoph  Maack</span>, <span class="hlFld-ContribAuthor ">Ulrich  Laufs</span>, <span class="hlFld-ContribAuthor ">Carsten  Tschöpe</span>, <span class="hlFld-ContribAuthor ">Stefan D.  Anker</span>, <span class="hlFld-ContribAuthor ">Carolyn S. P.  Lam</span>, <span class="hlFld-ContribAuthor ">Adriaan A.  Voors</span>, <span class="hlFld-ContribAuthor ">Michael  Böhm</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future. </span><span class="cited-content_cbyCitation_journal-name">Clinical Research in Cardiology</span><span> <strong>2020,</strong> <em>109 </em>
                                    (9)
                                     , 1079-1098. <a href="https://doi.org/10.1007/s00392-020-01633-w" title="DOI URL">https://doi.org/10.1007/s00392-020-01633-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00392-020-01633-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00392-020-01633-w%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Research%2520in%2520Cardiology%26atitle%3DTherapeutic%252Bapproaches%252Bin%252Bheart%252Bfailure%252Bwith%252Bpreserved%252Bejection%252Bfraction%25253A%252Bpast%25252C%252Bpresent%25252C%252Band%252Bfuture%26aulast%3DWintrich%26aufirst%3DJan%26date%3D2020%26date%3D2020%26volume%3D109%26issue%3D9%26spage%3D1079%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kukkamudi  Mahesh</span>, <span class="hlFld-ContribAuthor ">Kanakaraju  Ravi</span>, <span class="hlFld-ContribAuthor ">Praveen Kumar  Rathod</span>, <span class="hlFld-ContribAuthor ">Panaganti  Leelavathi</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient synthesis of quinoline-fused triazolo-azepine/oxepine derivatives through Pd-catalyzed C–H functionalisation of triazoles. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (6)
                                     , 2367-2373. <a href="https://doi.org/10.1039/C9NJ05254B" title="DOI URL">https://doi.org/10.1039/C9NJ05254B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ05254B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ05254B%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DConvenient%252Bsynthesis%252Bof%252Bquinoline-fused%252Btriazolo-azepine%25252Foxepine%252Bderivatives%252Bthrough%252BPd-catalyzed%252BC%2525E2%252580%252593H%252Bfunctionalisation%252Bof%252Btriazoles%26aulast%3DMahesh%26aufirst%3DKukkamudi%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D6%26spage%3D2367%26epage%3D2373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diego  Alvarez de la Rosa</span>, <span class="hlFld-ContribAuthor ">Natalia  Serrano-Morillas</span>. </span><span class="cited-content_cbyCitation_article-title">Post-Translational Modification of MR Activity. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.87227" title="DOI URL">https://doi.org/10.5772/intechopen.87227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.87227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.87227%26sid%3Dliteratum%253Aachs%26atitle%3DPost-Translational%252BModification%252Bof%252BMR%252BActivity%26aulast%3DAlvarez%2Bde%2Bla%2BRosa%26aufirst%3DDiego%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DAldosterone-Mineralocorticoid%252BReceptor%252B-%252BCell%252BBiology%252Bto%252BTranslational%252BMedicine%26aulast%3DHarvey%26aufirst%3DBrian%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felipe  L. Pérez-Gordillo</span>, <span class="hlFld-ContribAuthor ">Maria  Jesús Pérez de Vega</span>, <span class="hlFld-ContribAuthor ">Guillermo  Gerona-Navarro</span>, <span class="hlFld-ContribAuthor ">Yoel  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Diego  Alvarez de la Rosa</span>, <span class="hlFld-ContribAuthor ">Rosario  González-Muñiz</span>, <span class="hlFld-ContribAuthor ">Mercedes  Martín-Martínez</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Development of Non-steroidal Mineralocorticoid-receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.88417" title="DOI URL">https://doi.org/10.5772/intechopen.88417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.88417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.88417%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BNon-steroidal%252BMineralocorticoid-receptor%252BAntagonists%26aulast%3DL.%2BP%25C3%25A9rez-Gordillo%26aufirst%3DFelipe%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DAldosterone-Mineralocorticoid%252BReceptor%252B-%252BCell%252BBiology%252Bto%252BTranslational%252BMedicine%26aulast%3DHarvey%26aufirst%3DBrian%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen’kii</span>, <span class="hlFld-ContribAuthor ">Yulia. B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The literature of heterocyclic chemistry, part XVII, 2017. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 337-418. <a href="https://doi.org/10.1016/bs.aihch.2019.01.003" title="DOI URL">https://doi.org/10.1016/bs.aihch.2019.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2019.01.003%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bliterature%252Bof%252Bheterocyclic%252Bchemistry%25252C%252Bpart%252BXVII%25252C%252B2017%26aulast%3DBelen%25E2%2580%2599kii%26aufirst%3DLeonid%2BI.%26date%3D2019%26spage%3D337%26epage%3D418%26pub%3DElsevier%26date%3D2019%26volume%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carsten  Tschöpe</span>, <span class="hlFld-ContribAuthor ">Christoph  Birner</span>, <span class="hlFld-ContribAuthor ">Michael  Böhm</span>, <span class="hlFld-ContribAuthor ">Oliver  Bruder</span>, <span class="hlFld-ContribAuthor ">Stefan  Frantz</span>, <span class="hlFld-ContribAuthor ">Andreas  Luchner</span>, <span class="hlFld-ContribAuthor ">Lars  Maier</span>, <span class="hlFld-ContribAuthor ">Stefan  Störk</span>, <span class="hlFld-ContribAuthor ">Behrouz  Kherad</span>, <span class="hlFld-ContribAuthor ">Ulrich  Laufs</span>. </span><span class="cited-content_cbyCitation_article-title">Heart failure with preserved ejection fraction: current management and future strategies. </span><span class="cited-content_cbyCitation_journal-name">Clinical Research in Cardiology</span><span> <strong>2018,</strong> <em>107 </em>
                                    (1)
                                     , 1-19. <a href="https://doi.org/10.1007/s00392-017-1170-6" title="DOI URL">https://doi.org/10.1007/s00392-017-1170-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00392-017-1170-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00392-017-1170-6%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Research%2520in%2520Cardiology%26atitle%3DHeart%252Bfailure%252Bwith%252Bpreserved%252Bejection%252Bfraction%25253A%252Bcurrent%252Bmanagement%252Band%252Bfuture%252Bstrategies%26aulast%3DTsch%25C3%25B6pe%26aufirst%3DCarsten%26date%3D2018%26date%3D2017%26volume%3D107%26issue%3D1%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zi-Long  Tang</span>, <span class="hlFld-ContribAuthor ">Lian  Wang</span>, <span class="hlFld-ContribAuthor ">Jing-Zhao  Tan</span>, <span class="hlFld-ContribAuthor ">Yi-Chao  Wan</span>, <span class="hlFld-ContribAuthor ">Yin-Chun  Jiao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Fungicidal Activity of 1-(Carbamoylmethyl)-2-aryl-3,1-benzoxazines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (7)
                                     , 1103. <a href="https://doi.org/10.3390/molecules22071103" title="DOI URL">https://doi.org/10.3390/molecules22071103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22071103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22071103%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BFungicidal%252BActivity%252Bof%252B1-%252528Carbamoylmethyl%252529-2-aryl-3%25252C1-benzoxazines%26aulast%3DTang%26aufirst%3DZi-Long%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D7%26spage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pipattra  Mayurachayakul</span>, <span class="hlFld-ContribAuthor ">Wanchai  Pluempanupat</span>, <span class="hlFld-ContribAuthor ">Choladda  Srisuwannaket</span>, <span class="hlFld-ContribAuthor ">Oraphin  Chantarasriwong</span>. </span><span class="cited-content_cbyCitation_article-title">Four-component synthesis of polyhydroquinolines under catalyst- and solvent-free conventional heating conditions: mechanistic studies. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (89)
                                     , 56764-56770. <a href="https://doi.org/10.1039/C7RA13120H" title="DOI URL">https://doi.org/10.1039/C7RA13120H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA13120H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA13120H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DFour-component%252Bsynthesis%252Bof%252Bpolyhydroquinolines%252Bunder%252Bcatalyst-%252Band%252Bsolvent-free%252Bconventional%252Bheating%252Bconditions%25253A%252Bmechanistic%252Bstudies%26aulast%3DMayurachayakul%26aufirst%3DPipattra%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D89%26spage%3D56764%26epage%3D56770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0053.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2a" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2.1. Pfizer pyrazoline derivative <b>2l</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig2a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3a" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3.1. Sulfonamide-based MR antagonist identified through HTS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig3a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4a" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4.1. Example of a [(pyrazol-3-yl)pyridin-2-yl]urea MR antagonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig4a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6a" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 6.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6.1. General formulas of 1,4-benzoxazine-containing derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig6a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6b" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6.2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6.2. (A) Close-up view of the X-ray structure of the MR<sub>C808S/S810L</sub>-LBD double mutant bound to compound <b>6f</b> showing its binding mode. (B) Superimposition of the X-ray structures of compound <b>6f</b> (yellow) and spironolactone (orange) bound to the MR<sub>C808S/S810L</sub>-LBD (PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHV">3VHV</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHU">3VHU</a>, respectively). The hydrogen bonds and water molecules are depicted as yellow dashed lines and red spheres, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig6b"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6c" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6.3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6.3. Close-up views of the MR<sub>C808S/S810L</sub>-LBD double mutant bound to benzoxazin-3-one-based compounds: (A) <b>6n</b> (magenta), (B) <b>6o</b> (<i>S</i>-enantiomer, pink), and (C) <b>6z</b> (blue) (PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFF">3WFF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFG">3WFG</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PF3">4PF3</a>, respectively). The hydrogen bonds and water molecules are depicted as yellow dashed lines and red spheres, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig6c"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6.4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6.4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0007.jpeg" id="rightTab-GRAPHIC-d7e5038-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6.4. 1,3-Benzoxazin-2-ona derivative from Dainippon Sumitomo Pharma Co.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig6.4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8a" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8.1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8.1. General structures of tricyclic scaffolds developed at Eli Lilly that led to compounds with inhibitory constants lower that 500 nM for MR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig8a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8b" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8.2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8.2. Structures of tricyclic scaffolds developed at Vitae Pharmaceuticals that led to compounds able to bind to MR LBD. Competitive binding assay using [<sup>3</sup>H]-cortisol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig8b"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8c" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8.3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/medium/jm-2016-010653_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8.3. (A) Close-up view of the X-ray structure of the MR<sub>C808S/S810L</sub>-LBD double mutant bound to <b>8q</b> (cyan) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HCV">5HCV</a>). (B) Superimposition of the X-ray structures of compound <b>8q</b> (cyan) and spironolactone (orange) bound to the MR<sub>C808S/S810L</sub>-LBD (PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HCV">5HCV</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHU">3VHU</a>, respectively). The hydrogen bonds and water molecules are depicted as yellow dashed lines and red spheres, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01065/20170407/images/large/jm-2016-010653_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01065&amp;id=fig8c"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 93 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Arriza, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handelin, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Housman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span> </span><span class="NLM_article-title">Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1126/science.3037703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1126%2Fscience.3037703" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1987&pages=268-275&author=J.+L.+Arrizaauthor=C.+Weinbergerauthor=G.+Cerelliauthor=T.+M.+Glaserauthor=B.+L.+Handelinauthor=D.+E.+Housmanauthor=R.+M.+Evans&title=Cloning+of+human+mineralocorticoid+receptor+complementary+DNA%3A+structural+and+functional+kinship+with+the+glucocorticoid+receptor&doi=10.1126%2Fscience.3037703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.3037703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.3037703%26sid%3Dliteratum%253Aachs%26aulast%3DArriza%26aufirst%3DJ.%2BL.%26aulast%3DWeinberger%26aufirst%3DC.%26aulast%3DCerelli%26aufirst%3DG.%26aulast%3DGlaser%26aufirst%3DT.%2BM.%26aulast%3DHandelin%26aufirst%3DB.%2BL.%26aulast%3DHousman%26aufirst%3DD.%2BE.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26atitle%3DCloning%2520of%2520human%2520mineralocorticoid%2520receptor%2520complementary%2520DNA%253A%2520structural%2520and%2520functional%2520kinship%2520with%2520the%2520glucocorticoid%2520receptor%26jtitle%3DScience%26date%3D1987%26volume%3D237%26spage%3D268%26epage%3D275%26doi%3D10.1126%2Fscience.3037703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lifton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharavi, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geller, D. S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of human hypertension</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1016/S0092-8674(01)00241-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2FS0092-8674%2801%2900241-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=11239411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1Kks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=545-556&author=R.+P.+Liftonauthor=A.+G.+Gharaviauthor=D.+S.+Geller&title=Molecular+mechanisms+of+human+hypertension&doi=10.1016%2FS0092-8674%2801%2900241-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of human hypertension</span></div><div class="casAuthors">Lifton, Richard P.; Gharavi, Ali G.; Geller, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 91 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdcj9eT2Wj5LVg90H21EOLACvtfcHk0ljrP-ws5bCQuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1Kks7w%253D&md5=e806749fa26b727de84ff2856dcb1e62</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900241-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900241-0%26sid%3Dliteratum%253Aachs%26aulast%3DLifton%26aufirst%3DR.%2BP.%26aulast%3DGharavi%26aufirst%3DA.%2BG.%26aulast%3DGeller%26aufirst%3DD.%2BS.%26atitle%3DMolecular%2520mechanisms%2520of%2520human%2520hypertension%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D545%26epage%3D556%26doi%3D10.1016%2FS0092-8674%2801%2900241-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Nguyen Dinh Cat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaisser, F.</span><span> </span><span class="NLM_article-title">Extrarenal effects of aldosterone</span> <span class="citation_source-journal">Curr. Opin. Nephrol. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1097/MNH.0b013e32834fb25b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FMNH.0b013e32834fb25b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=147-156&author=A.+Nguyen+Dinh+Catauthor=F.+Jaisser&title=Extrarenal+effects+of+aldosterone&doi=10.1097%2FMNH.0b013e32834fb25b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FMNH.0b013e32834fb25b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNH.0b013e32834fb25b%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%2BDinh%2BCat%26aufirst%3DA.%26aulast%3DJaisser%26aufirst%3DF.%26atitle%3DExtrarenal%2520effects%2520of%2520aldosterone%26jtitle%3DCurr.%2520Opin.%2520Nephrol.%2520Hypertens.%26date%3D2012%26volume%3D21%26spage%3D147%26epage%3D156%26doi%3D10.1097%2FMNH.0b013e32834fb25b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J.</span><span> </span><span class="NLM_article-title">11Beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span><span class="refDoi"> DOI: 10.1152/physrev.00020.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1152%2Fphysrev.00020.2012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=1139-1206&author=K.+Chapmanauthor=M.+Holmesauthor=J.+Seckl&title=11Beta-hydroxysteroid+dehydrogenases%3A+intracellular+gate-keepers+of+tissue+glucocorticoid+action&doi=10.1152%2Fphysrev.00020.2012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00020.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00020.2012%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DHolmes%26aufirst%3DM.%26aulast%3DSeckl%26aufirst%3DJ.%26atitle%3D11Beta-hydroxysteroid%2520dehydrogenases%253A%2520intracellular%2520gate-keepers%2520of%2520tissue%2520glucocorticoid%2520action%26jtitle%3DPhysiol.%2520Rev.%26date%3D2013%26volume%3D93%26spage%3D1139%26epage%3D1206%26doi%3D10.1152%2Fphysrev.00020.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Farman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">Multiple aspects of mineralocorticoid selectivity</span> <span class="citation_source-journal">Am. J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">F181</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2001&pages=F181-192&author=N.+Farmanauthor=M.+E.+Rafestin-Oblin&title=Multiple+aspects+of+mineralocorticoid+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarman%26aufirst%3DN.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DMultiple%2520aspects%2520of%2520mineralocorticoid%2520selectivity%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2001%26volume%3D280%26spage%3DF181%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Bledsoe, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apolito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trump, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span> </span><span class="NLM_article-title">A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">31283</span><span class="NLM_x">–</span> <span class="NLM_lpage">31293</span><span class="refDoi"> DOI: 10.1074/jbc.M504098200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1074%2Fjbc.M504098200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15967794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=31283-31293&author=R.+K.+Bledsoeauthor=K.+P.+Madaussauthor=J.+A.+Holtauthor=C.+J.+Apolitoauthor=M.+H.+Lambertauthor=K.+H.+Pearceauthor=T.+B.+Stanleyauthor=E.+L.+Stewartauthor=R.+P.+Trumpauthor=T.+M.+Willsonauthor=S.+P.+Williams&title=A+ligand-mediated+hydrogen+bond+network+required+for+the+activation+of+the+mineralocorticoid+receptor&doi=10.1074%2Fjbc.M504098200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor</span></div><div class="casAuthors">Bledsoe, Randy K.; Madauss, Kevin P.; Holt, Jason A.; Apolito, Christopher J.; Lambert, Millard H.; Pearce, Kenneth H.; Stanley, Thomas B.; Stewart, Eugene L.; Trump, Ryan P.; Willson, Timothy M.; Williams, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">31283-31293</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Ligand binding is the first step in hormone regulation of mineralocorticoid receptor (MR) activity.  Here, the authors report multiple crystal structures of MR (NR3C2) bound to both agonist and antagonists.  These structures combined with mutagenesis studies reveal that maximal receptor activation involves an intricate ligand-mediated hydrogen bond network with Asn770 which serves dual roles: stabilization of the loop preceding the C-terminal activation function-2 helix and direct contact with the hormone ligand.  In addn., most activating ligands hydrogen bond to Thr945 on helix 10.  Structural characterization of the naturally occurring S810L mutant explains how stabilization of a helix 3/helix 5 interaction can circumvent the requirement for this hydrogen bond network.  Taken together, these results explain the potency of MR activation by aldosterone, the weak activation induced by progesterone and the antihypertensive agent spironolactone, and the binding selectivity of cortisol over cortisone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE7HiXGk8tJLVg90H21EOLACvtfcHk0lidOwcbmt4qIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmu7g%253D&md5=36afe797ab0337f5309aec7652f45012</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504098200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504098200%26sid%3Dliteratum%253Aachs%26aulast%3DBledsoe%26aufirst%3DR.%2BK.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DHolt%26aufirst%3DJ.%2BA.%26aulast%3DApolito%26aufirst%3DC.%2BJ.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DPearce%26aufirst%3DK.%2BH.%26aulast%3DStanley%26aufirst%3DT.%2BB.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DTrump%26aufirst%3DR.%2BP.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26atitle%3DA%2520ligand-mediated%2520hydrogen%2520bond%2520network%2520required%2520for%2520the%2520activation%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D31283%26epage%3D31293%26doi%3D10.1074%2Fjbc.M504098200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugherty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span> </span><span class="NLM_article-title">Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.molcel.2005.06.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=367-380&author=Y.+Liauthor=K.+Suinoauthor=J.+Daughertyauthor=H.+E.+Xu&title=Structural+and+biochemical+mechanisms+for+the+specificity+of+hormone+binding+and+coactivator+assembly+by+mineralocorticoid+receptor&doi=10.1016%2Fj.molcel.2005.06.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSuino%26aufirst%3DK.%26aulast%3DDaugherty%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520and%2520biochemical%2520mechanisms%2520for%2520the%2520specificity%2520of%2520hormone%2520binding%2520and%2520coactivator%2520assembly%2520by%2520mineralocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D367%26epage%3D380%26doi%3D10.1016%2Fj.molcel.2005.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hasui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ora, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyabu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishigaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoyaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siedem, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meese, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, S.</span><span> </span><span class="NLM_article-title">Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8616</span><span class="NLM_x">–</span> <span class="NLM_lpage">8631</span><span class="refDoi"> DOI: 10.1021/jm2011645</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2011645" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCgtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8616-8631&author=T.+Hasuiauthor=N.+Matsunagaauthor=T.+Oraauthor=N.+Ohyabuauthor=N.+Nishigakiauthor=Y.+Imuraauthor=Y.+Igataauthor=H.+Matsuiauthor=T.+Motoyajiauthor=T.+Tanakaauthor=N.+Habukaauthor=S.+Sogabeauthor=M.+Onoauthor=C.+S.+Siedemauthor=T.+P.+Tangauthor=C.+Gauthierauthor=L.+A.+De+Meeseauthor=S.+A.+Boydauthor=S.+Fukumoto&title=Identification+of+benzoxazin-3-one+derivatives+as+novel%2C+potent%2C+and+selective+nonsteroidal+mineralocorticoid+receptor+antagonists&doi=10.1021%2Fjm2011645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists</span></div><div class="casAuthors">Hasui, Tomoaki; Matsunaga, Nobuyuki; Ora, Taiichi; Ohyabu, Norio; Nishigaki, Nobuhiro; Imura, Yoshimi; Igata, Yumiko; Matsui, Hideki; Motoyaji, Takashi; Tanaka, Toshimasa; Habuka, Noriyuki; Sogabe, Satoshi; Ono, Midori; Siedem, Christopher S.; Tang, Tony P.; Gauthier, Cassandra; De Meese, Lisa A.; Boyd, Steven A.; Fukumoto, Shoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8616-8631</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mineralocorticoid receptor (MR) blockade has come into focus as a promising approach for the treatment of cardiovascular diseases such as hypertension and congestive heart failure.  In order to identify a novel class of nonsteroidal MR antagonists that exhibit significant potency and good selectivity over other steroidal hormone receptors, the authors designed a novel series of benzoxazin-3-one derivs. and synthesized them from 6-(7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-6-yl)-2H-1,4-benzoxazin-3(4H)-one (I), high-throughput screening (HTS) hit compd.  Their design was based on a crystal structure of an MR/compd. complex and a docking model.  In the course of lead generation from I, a 1,2-diaryl framework was characterized as a key structure with high binding affinity.  On the basis of scaffold hopping and optimization studies, benzoxazin-3-one derivs. possessing 1-phenyl-3-trifluoromethylpyrazol-5-yl moiety at the 6-position were identified as a novel series of potent and selective MR antagonists.  Among these compds., 6-[1-(4-fluoro-2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]-2H-1,4-benzoxazin-3(4H)-one (II) showed highly potent activity and good selectivity and also exhibited a significant antihypertensive effect in deoxycorticosterone acetate-salt hypertensive rats.  On the basis of these results, compd. II was progressed for further pharmacol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQN1Fg3saUUrVg90H21EOLACvtfcHk0lhTi2D2r97iYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCgtLrF&md5=48d1e524152c039ccebc9c371e89fae1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm2011645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011645%26sid%3Dliteratum%253Aachs%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DOra%26aufirst%3DT.%26aulast%3DOhyabu%26aufirst%3DN.%26aulast%3DNishigaki%26aufirst%3DN.%26aulast%3DImura%26aufirst%3DY.%26aulast%3DIgata%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DMotoyaji%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSiedem%26aufirst%3DC.%2BS.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DGauthier%26aufirst%3DC.%26aulast%3DDe%2BMeese%26aufirst%3DL.%2BA.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520benzoxazin-3-one%2520derivatives%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8616%26epage%3D8631%26doi%3D10.1021%2Fjm2011645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Huyet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">Structural basis of spirolactone recognition by the mineralocorticoid receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span><span class="refDoi"> DOI: 10.1124/mol.107.036459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1124%2Fmol.107.036459" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=563-571&author=J.+Huyetauthor=G.+M.+Pinonauthor=M.+R.+Fayauthor=J.+Fagartauthor=M.+E.+Rafestin-Oblin&title=Structural+basis+of+spirolactone+recognition+by+the+mineralocorticoid+receptor&doi=10.1124%2Fmol.107.036459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.036459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.036459%26sid%3Dliteratum%253Aachs%26aulast%3DHuyet%26aufirst%3DJ.%26aulast%3DPinon%26aufirst%3DG.%2BM.%26aulast%3DFay%26aufirst%3DM.%2BR.%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DStructural%2520basis%2520of%2520spirolactone%2520recognition%2520by%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D563%26epage%3D571%26doi%3D10.1124%2Fmol.107.036459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Geller, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fradley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigler, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifton, R. P.</span><span> </span><span class="NLM_article-title">Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1126/science.289.5476.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1126%2Fscience.289.5476.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10884226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1eltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=119-123&author=D.+S.+Gellerauthor=A.+Farhiauthor=N.+Pinkertonauthor=M.+Fradleyauthor=M.+Moritzauthor=A.+Spitzerauthor=G.+Meinkeauthor=F.+T.+Tsaiauthor=P.+B.+Siglerauthor=R.+P.+Lifton&title=Activating+mineralocorticoid+receptor+mutation+in+hypertension+exacerbated+by+pregnancy&doi=10.1126%2Fscience.289.5476.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy</span></div><div class="casAuthors">Geller, David S.; Farhi, Anita; Pinkerton, Nikki; Fradley, Michael; Moritz, Michael; Spitzer, Adrian; Meinke, Gretchen; Tsai, Francis T. F.; Sigler, Paul B.; Lifton, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5476</span>),
    <span class="NLM_cas:pages">119-123</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Hypertension and pregnancy-related hypertension are major public health problems of largely unknown causes.  We describe a mutation in the mineralocorticoid receptor (MR), S810L, that causes early-onset hypertension that is markedly exacerbated in pregnancy.  This mutation results in constitutive MR activity and alters receptor specificity, with progesterone and other steroids lacking 21-hydroxyl groups, normally MR antagonists, becoming potent agonists.  Structural and biochem. studies indicate that the mutation results in the gain of a van der Waals interaction between helix 5 and helix 3 that substitutes for interaction of the steroid 21-hydroxyl group with helix 3 in the wild-type receptor.  This helix 5-helix 3 interaction is highly conserved among diverse nuclear hormone receptors, suggesting its general role in receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiplVKXUuefrVg90H21EOLACvtfcHk0lhTi2D2r97iYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1eltL0%253D&md5=19f09bc885f7668f8ad07d2ea3a9126e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5476.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5476.119%26sid%3Dliteratum%253Aachs%26aulast%3DGeller%26aufirst%3DD.%2BS.%26aulast%3DFarhi%26aufirst%3DA.%26aulast%3DPinkerton%26aufirst%3DN.%26aulast%3DFradley%26aufirst%3DM.%26aulast%3DMoritz%26aufirst%3DM.%26aulast%3DSpitzer%26aufirst%3DA.%26aulast%3DMeinke%26aufirst%3DG.%26aulast%3DTsai%26aufirst%3DF.%2BT.%26aulast%3DSigler%26aufirst%3DP.%2BB.%26aulast%3DLifton%26aufirst%3DR.%2BP.%26atitle%3DActivating%2520mineralocorticoid%2520receptor%2520mutation%2520in%2520hypertension%2520exacerbated%2520by%2520pregnancy%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D119%26epage%3D123%26doi%3D10.1126%2Fscience.289.5476.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huyet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1038/nsmb939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1038%2Fnsmb939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15908963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks12rtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=554-555&author=J.+Fagartauthor=J.+Huyetauthor=G.+M.+Pinonauthor=M.+Rochelauthor=C.+Mayerauthor=M.+E.+Rafestin-Oblin&title=Crystal+structure+of+a+mutant+mineralocorticoid+receptor+responsible+for+hypertension&doi=10.1038%2Fnsmb939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension</span></div><div class="casAuthors">Fagart, Jerome; Huyet, Jessica; Pinon, Gregory M.; Rochel, Marina; Mayer, Claudine; Rafestin-Oblin, Marie-Edith</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">554-555</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The S810L mutation within the human mineralocorticoid receptor (MR S810L) induces severe hypertension and switches progesterone from antagonist to agonist.  Here we report the crystal structures of the ligand-binding domain of MR S810L in complex with progesterone and deoxycorticosterone, an agonist of both wild-type and mutant MRs.  These structures, the first for MR, identify the specific contacts created by Leu810 and clarify the mechanism of activation of MR S810L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiXZ_3ggvfcLVg90H21EOLACvtfcHk0lhTi2D2r97iYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks12rtro%253D&md5=5d06e52f69c10ab6c3528d516bab0375</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnsmb939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb939%26sid%3Dliteratum%253Aachs%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DHuyet%26aufirst%3DJ.%26aulast%3DPinon%26aufirst%3DG.%2BM.%26aulast%3DRochel%26aufirst%3DM.%26aulast%3DMayer%26aufirst%3DC.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520a%2520mutant%2520mineralocorticoid%2520receptor%2520responsible%2520for%2520hypertension%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D554%26epage%3D555%26doi%3D10.1038%2Fnsmb939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Huyet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagart, J.</span><span> </span><span class="NLM_article-title">Structural determinants of ligand binding to the mineralocorticoid receptor</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1016/j.mce.2011.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.mce.2011.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=21820032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2012&pages=187-195&author=J.+Huyetauthor=G.+M.+Pinonauthor=M.+R.+Fayauthor=M.+E.+Rafestin-Oblinauthor=J.+Fagart&title=Structural+determinants+of+ligand+binding+to+the+mineralocorticoid+receptor&doi=10.1016%2Fj.mce.2011.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of ligand binding to the mineralocorticoid receptor</span></div><div class="casAuthors">Huyet, Jessica; Pinon, Gregory Maurice; Fay, Michel Raymond; Rafestin-Oblin, Marie-Edith; Fagart, Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The first and crit. step in the mechanism of aldosterone action is its binding to the mineralocorticoid receptor (MR), a member of the nuclear receptor superfamily.  Over the last 40 years, numerous studies have attempted to det. the structural determinants of ligand-binding to MR.  An initial set of data showed that hsp90 is bound to the receptor via specific regions and maintains it in a ligand-binding competent state.  Site-directed mutagenesis and functional studies guided by a 3D model of the MR ligand-binding domain (LBD) made it possible to identify the residues responsible for the high affinity and selectivity for aldosterone, and to characterize the mechanisms of MR activation and inactivation.  The recent detn. of the X-ray crystal structures of the LBD of the wild-type MR and MRS810L, which is responsible for a familial form of hypertension, has made it possible to elucidate the peculiar mechanism of activation of MRS810L and established a clear structure/activity relationship for steroidal and non-steroidal MR antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Bzgw8GjgC7Vg90H21EOLACvtfcHk0lhTSwHREgqTaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GisLc%253D&md5=43f3130c45a5395decbbf447741753dd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2011.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2011.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DHuyet%26aufirst%3DJ.%26aulast%3DPinon%26aufirst%3DG.%2BM.%26aulast%3DFay%26aufirst%3DM.%2BR.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26aulast%3DFagart%26aufirst%3DJ.%26atitle%3DStructural%2520determinants%2520of%2520ligand%2520binding%2520to%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2012%26volume%3D350%26spage%3D187%26epage%3D195%26doi%3D10.1016%2Fj.mce.2011.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Alvarez de la Rosa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro-Gonzalez, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraldez, T.</span><span> </span><span class="NLM_article-title">ENaC modulators and renal disease</span> <span class="citation_source-journal">Curr. Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.2174/1874467211306010005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.2174%2F1874467211306010005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=23547933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSms7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=35-43&author=D.+Alvarez+de+la+Rosaauthor=J.+F.+Navarro-Gonzalezauthor=T.+Giraldez&title=ENaC+modulators+and+renal+disease&doi=10.2174%2F1874467211306010005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">ENaC modulators and renal disease</span></div><div class="casAuthors">Alvarez de la Rosa, Diego; Navarro-Gonzalez, Juan F.; Giraldez, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-43</span>CODEN:
                <span class="NLM_cas:coden">CMPUB6</span>;
        ISSN:<span class="NLM_cas:issn">1874-4672</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The epithelial sodium channel (ENaC) plays an essential role in transepithelial sodium reabsorption in the renal connecting tubule and collecting duct.  Therefore, controlling ENaC activity is an important regulatory event in electrolyte and extracellular vol. homeostasis, and thus in the control of blood pressure.  Many independent signaling pathways converge on ENaC, although the most important for its physiol. role is the enhancement of channel activity by the steroid hormone aldosterone.  In this review, we briefly summarize current knowledge about ENaC regulation and the different chem. compds. available to directly or indirectly modify channel function.  In addn., current and possible clin. uses of ENaC and aldosterone antagonists are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvfs0U2VCOybVg90H21EOLACvtfcHk0lhTSwHREgqTaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSms7vJ&md5=285db4dd7400fcebf280c30f0df0d13a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1874467211306010005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874467211306010005%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%2Bde%2Bla%2BRosa%26aufirst%3DD.%26aulast%3DNavarro-Gonzalez%26aufirst%3DJ.%2BF.%26aulast%3DGiraldez%26aufirst%3DT.%26atitle%3DENaC%2520modulators%2520and%2520renal%2520disease%26jtitle%3DCurr.%2520Mol.%2520Pharmacol.%26date%3D2013%26volume%3D6%26spage%3D35%26epage%3D43%26doi%3D10.2174%2F1874467211306010005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Brilla, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, K. T.</span><span> </span><span class="NLM_article-title">Mineralocorticoid excess, dietary sodium, and myocardial fibrosis</span> <span class="citation_source-journal">J. Lab. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1992&pages=893-901&author=C.+G.+Brillaauthor=K.+T.+Weber&title=Mineralocorticoid+excess%2C+dietary+sodium%2C+and+myocardial+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrilla%26aufirst%3DC.%2BG.%26aulast%3DWeber%26aufirst%3DK.%2BT.%26atitle%3DMineralocorticoid%2520excess%252C%2520dietary%2520sodium%252C%2520and%2520myocardial%2520fibrosis%26jtitle%3DJ.%2520Lab.%2520Clin.%2520Med.%26date%3D1992%26volume%3D120%26spage%3D893%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remme, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palensky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittes, J.</span><span> </span><span class="NLM_article-title">The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span><span class="refDoi"> DOI: 10.1056/NEJM199909023411001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1056%2FNEJM199909023411001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10471456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVyrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=709-717&author=B.+Pittauthor=F.+Zannadauthor=W.+J.+Remmeauthor=R.+Codyauthor=A.+Castaigneauthor=A.+Perezauthor=J.+Palenskyauthor=J.+Wittes&title=The+effect+of+spironolactone+on+morbidity+and+mortality+in+patients+with+severe+heart+failure.+Randomized+aldactone+evaluation+study+investigators&doi=10.1056%2FNEJM199909023411001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of spironolactone on morbidity and mortality in patients with severe heart failure</span></div><div class="casAuthors">Pitt, Bertram; Zannad, Faiez; Remme, Willem J.; Cody, Robert; Castaigne, Alain; Perez, Alfonso; Palensky, Jolie; Wittes, Janet</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">709-717</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Aldosterone is important in the pathophysiol. of heart failure.  In a double-blind study, we enrolled 1663 patients who had severe heart failure and a left ventricular ejection fraction of no more than 35 percent and who were being treated with an angiotensin-converting-enzyme inhibitor, a loop diuretic, and in most cases digoxin.  A total of 822 patients were randomly assigned to receive 25 mg of spironolactone daily, and 841 to receive placebo.  The primary end point was death from all causes.  The trial was discontinued early, after a mean follow-up period of 24 mo, because an interim anal. detd. that spironolactone was efficacious.  There were 386 deaths in the placebo group (46 percent) and 284 in the spironolactone group (35 percent; relative risk of death, 0.70; 95 percent confidence interval, 0.60 to 0.82; P<0.001).  This 30 percent redn. in the risk of death among patients in the spironolactone group was attributed to a lower risk of both death from progressive heart failure and sudden death from cardiac causes.  The frequency of hospitalization for worsening heart failure was 35 percent lower in the spironolactone group than in the placebo group (relative risk of hospitalization, 0.65; 95 percent confidence interval, 0.54 to 0.77; P<0.001).  In addn., patients who received spironolactone had a significant improvement in the symptoms of heart failure, as assessed on the basis of the New York Heart Assocn. functional class (P<0.001).  Gynecomastia or breast pain was reported in 10 percent of men who were treated with spironolactone, as compared with 1 percent of men in the placebo group (P<0.001).  The incidence of serious hyperkalemia was minimal in both groups of patients.  Blockade of aldosterone receptors by spironolactone, in addn. to std. therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwOy-U1QzrSbVg90H21EOLACvtfcHk0lhTSwHREgqTaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVyrurk%253D&md5=3e34cf3cd2ac38b96cefdfda593a02f5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJM199909023411001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199909023411001%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DRemme%26aufirst%3DW.%2BJ.%26aulast%3DCody%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DPalensky%26aufirst%3DJ.%26aulast%3DWittes%26aufirst%3DJ.%26atitle%3DThe%2520effect%2520of%2520spironolactone%2520on%2520morbidity%2520and%2520mortality%2520in%2520patients%2520with%2520severe%2520heart%2520failure.%2520Randomized%2520aldactone%2520evaluation%2520study%2520investigators%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D709%26epage%3D717%26doi%3D10.1056%2FNEJM199909023411001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remme, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roniker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, M.</span><span> </span><span class="NLM_article-title">Eplerenone post-acute myocardial infarction heart failure eficacy and survival study investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1321</span><span class="refDoi"> DOI: 10.1056/NEJMoa030207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1056%2FNEJMoa030207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=12668699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1ehurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1309-1321&author=B.+Pittauthor=W.+Remmeauthor=F.+Zannadauthor=J.+Neatonauthor=F.+Martinezauthor=B.+Ronikerauthor=R.+Bittmanauthor=S.+Hurleyauthor=J.+Kleimanauthor=M.+Gatlin&title=Eplerenone+post-acute+myocardial+infarction+heart+failure+eficacy+and+survival+study+investigators.+Eplerenone%2C+a+selective+aldosterone+blocker%2C+in+patients+with+left+ventricular+dysfunction+after+myocardial+infarction&doi=10.1056%2FNEJMoa030207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction</span></div><div class="casAuthors">Pitt, Bertram; Remme, Willem; Zannad, Faiez; Neaton, James; Martinez, Felipe; Roniker, Barbara; Bittman, Richard; Hurley, Steve; Kleiman, Jay; Gatlin, Marjorie; Ambrosioni, E.; Anderson, J. L.; Apetrei, E.; Aschermann, M.; Banas, J.; Cardoso, S.; Caspi, A.; Chung, N.; Corbalan, R.; Dargie, H. J.; Bietz, R.; Erhardt, L.; Garcia-Castillo, A.; Gheorghiade, M.; Hernandez, E.; Hess, O.; Jamerson, K.; Kjekshus, J.; Klug, E.; Krum, H.; Lee, Y.-T.; Lopez, N.; Lopez-Sendon, J.-L.; Martinez, F.; Murin, J.; Neaton, J.; Nicolau, J.-C.; Ostor, E.; Parkhomenko, A.; Pitt, B.; Ross, H.; Stepinska, J.; Torp-Pedersen, C.; Van Mieghem, W.; van Veldhuisen, D.-J.; White, H.; Wilvox, R. G.; Willenbrock, R.; Yotov, Y.-T.; Zannad, F.; Boissel, J.-P.; Furberg, C.; Julian, D.; Kulbertus, H.; Pocock, S.; Wittes, J.; Battler, A.; Blumenfeld, J.; Brilla, C.; Duprez, D.; Fowler, M.; Gavazzi, A.; Hildebrandt, P.; Komajda, M.; Korewicki, J.; Kosturakis, D.; Marin-Neto, J. A.; Miller, A.; Munoz Aguilera, R.; Oliveri, R.; Remme, W.; White, M.; Widimsky, P.; Bakris, G.; Castaigne, A.; Deedwania, P.; Duprez, D.; Ketelslegers, J. M.; Liu, P.; Mancia, G.; Nicklas, J.; Rouleau, J.-L.; Ruilope, L.; Sasayama, S.; Schiffrin, E.; Spertus, J.; Struthers, A.; Vaughan, D.; Weber, M.; Williams, G.; Abinader, E.; Adams, J.; Adams, P. C.; Adamus, J.; Ahlstrom, P.; Akesson, H. S.; Akhmedzhanov, N.; Alcasena Juango, S.; Ali Khan, S.; Alonso Garcia, A.; Amat, G.; Amerena, J.; Arnosova, K. M.; Andreoli, L.; Angelo-Nielsen, K.; Antonio de Velasco, J.; Apetrei, E.; Aroutiounov, G.; Aschermann, M.; Asklund, M.; Assmann, I.; Aumont, M.-C.; Avtandilov, A.; Azarin, O.; Bada, V.; Bakoumov, P.; Balazovjech, L.; Baldjiev, E.; Baluda, M.; Barrazueta, R.; Barsi, B.; Bashir, Y.; Batin, P. D.; Belenky, D.; Belyi, Y.; Bendermacher, P. E. F.; Berget, K.; Bergmeier, C.; Berning, J.; Berrazueta-Fernandez, J. R.; Block, P.; Boberg, G.; Bocek, P.; Bohlscheid, V.; Bokarev, I.; Bolinska, H.; Boman, K.; Bondarev, S.; Bonzel, T.; Boreux, J.-L.; Borggrefe, M.; Borisov, M.; Boxho, G.; Boyarkin, M.; Brachmann, J.; Brack, M.; Branea, I.; Breivik, K.; Brigden, G. S.; Bronzwaer, P. N. A.; Bruce, D.; Bruckner, I.; Brunvand, H.; Bryukhovetski, A.; Buser, P.; Campbell, T.; Campeanu, A.; Capucci, A.; Carasca, E.; Cardoso, J.; Carrageta, M.; Caspi, A.; Cassim, S.; Caturla, J.; Ceia, F.; Cernosek, B.; Channer, K.; Chati, Z.; Christensen, P. D.; Chung, N. S.; Cinteza, M.; Cleland, J. G. F.; Cocchieri, M.; Commerford, P.; Conti, U.; Corsini, G.; Cortina Liosa, A.; Coupez, J.-M.; Cribier, A.; Csillag, J.; Cyran, J.; Dahlstrom, U.; Dalby, A.; Dalin, L. J.; Dalkowski, M.; Dargie, H. J.; Darius, H.; Datcu, D. M.; David, D.; De Myttenaere, M.; De Teresa, E.; De Velasco, J.; de Vries, A. G.; den Hartog, F. R.; Desjoyaux, E.; Dezerbi, A.; Dhawan, J.; Biaz Molina, B.; Dickstein, K.; Dorobantu, M.; Doschitsin, V.; Doubell, A.; Dovgalevsky, P.; Dragulescu, S. I.; Drapkina, O.; Dubourg, O.; Dunselman, P. H. J. M.; Dyadyk, O. I.; Dykun, Y. V.; Dzyak, G. V.; Egorova, L. P.; Egstrup, K.; Eha, J.; Ehrenbergerova, M.; El Allaf, D.; Elenkova, A.; Ellis, C. J.; Engbers, J. G.; Fainyk, A. F.; Falck, G.; Fanelli, R.; Farre-Mun, J.; Favier, J.; Ferrari, G.; Ferreira, I.; Rischer, H.; Fotyanov, S.; Freericks, M. P.; Froeland, G.; Galve, E.; Garcia, M. M.; Garcia, A. A.; Garnier, L. F.; Gazaryan, G.; Georgescu, C.; Geraedts, J.; Glezer, M. G.; Goloborodko, B. I.; Goloshchekin, B.; Gonsorcik, J.; Gotchev, D.; Gotcheva, N.; Gottwik, M. G.; Grande, P.; Gratsiansky, N.; Grishina, E. I.; Groch, L.; Gruzdev, A.; Guenova, D.; Gundersen, T.; Hagerman, I.; Hambrecht, R.; Hammermann, H.; Hansen, O.; Hansteen, V.; Hart, H.; Hauf, G. F.; Hecker, U.; Hegyi, I.; Herlitz, J.; Hertzberger, D. P.; Herweijer, A. H.; Heyndrickx, G. R.; Hittinger, L.; Hoang, V.; Hobbach, H.-P.; Hofman-Bang, C.; Holwerda, N. J.; Hong, K. P.; Horacek, T.; Hormann, J.; Horowitz, J. D.; Hradec, J.; Hurtig, U.; Ikram, H.; Ioan, A.; Jaarsma, W.; Jadraque, L. M.; Jakobsen, T. J.; Janicki, K. J.; Jankelow, D.; Janosi, A.; Jansky, P.; Janssens, L.; Janzen, I.; Jensen, P.; Jirmar, R.; Jobic, Y.; Jones, A.; Jonsson, J.; Kahles, H.; Kaliska, G.; Kamensky, G.; Kappenberger, L.; Karlsson, J. E.; Karpati, P.; Karpenko, O. I.; Karpov, Y.; Kawecka-Jaszcz, J.; Keeling, P. J.; Keren, G.; Khalife, K.; Khrakovskaya, M.; Khrustalev, O. A.; Klarlund, K. K.; Kleber, E.-X.; Klug, E.; Koenig, W.; Komarek, J.; Kononenko, L. G.; Konz, K.; Komacewicz-Jach, Z.; Kostenko, V.; Kotous, J.; Kovalsky, I.; Kozak, P.; Kreider-Stempfle, H. U.; Kromer, E. P.; Krum, H.; Krzeminska-Pakula, M.; Kuc, K.; Kucera, P.; Kurowski, M.; Lach, L.; Lai, C.; Lane, G.; Lang, E.; Lankes, W.; Lankisch, P.-G.; Laraudogoitia, E.; Larsen, J.; Larsson, L.-E.; Laruelle, C.; Lazar, A.; Lee, Y.-T.; Legkonogov, A. V.; Leitch, J.; Lengfelder, W.; Lescot, C. D.; Lewis, B. S.; Lewis, P.; Libov, I. A.; Liel-Cohen, N.; Lim, H. K.; Lin, C.-S.; Linssen, G. C. M.; Liu, C.-P.; Lok, D. J. A.; Lopatin, Y. M.; Lopez De Sa, E.; Lotan, C.; Lousada, N.; Lucas, C.; Lucatti, A.; Lusov, V.; Mabin, T. A.; Macleod, D. C.; Maeurer, W.; Magnusson, J.-O.; Maisch, B.; Malinski, A.; Maltchougine, M.; Manga, P.; Mantov, S.; Marchi, S.; Marcinowska-Suchowierska, E.; Marenne, F.; Maresca, F. S.; Markov, V.; Marmor, A. T.; Martines, C.; Martinez, A.; Martin-Jadraque, L.; Martins, L. F. R.; Martos Ferres, R.; Mary, D. A. S. G.; Masini, F.; Matta, F.; Maurer, W.; Mazzini, A. C.; McDonald, K. M. A.; Meeder, J. G.; Melandri, F.; Melin, J.; Menezes, C.; Michels, H. R.; Missault, L.; Mitrovic, V.; Mntla, P.; Mobilij, A.; Mogilevsky, A.; Moiseev, V.; Mokan, M.; Moeller, B.; Moreira, I.; Mouhoub, D.; Moura, B.; Muders, E.; Mudra, H.; Munz, J.; Murin, J.; Musial, W. J.; Myburgh, D. P.; Naqvi, N.; Naumann, G.; Nazimov, S. V.; Nadelec, G.; Nedogoda, S. V.; Nielsen, I.; Nielsen, T.; Nierop, P. R.; Nilsson, G.; Notaristefano, A.; Novitsky, I. N.; Nykl, L.; Ofner, P.; Olariu, C.; Olbrich, H. G.; Oldroyd, K. G.; Olinic, N.; Oliveira, J.; Omland, T.; Orus, J.; Owensby, D.; Page, A.; Park, K. S.; Parkhomenko, O. M.; Pasotti, C.; Pasowicz, M.; Pecce, P.; Pell, A. C. H.; Penkov, N. I.; Perez de Juan, M.; Perez, H.; Petersen, M.; Petrov, A. A.; Peuhkurinen, K.; Philonenko, X.; Pieper, M.; Pieske, B.; Pluta, W.; Podzemska, B.; Popeye, R.; Prost, C.; Purcaro, A.; Put, P.; Radchenko, V.; Radoi, M.; Rae, A. P.; Raev, D.; Ramik, C.; Rasmussen, S. L.; Reisin, L.; Renker, B.; Ribeiro, V. G.; Richardt, G.; Rjecansky, I.; Risenfors, M.; Rivis, I. A.; Robson, R. H.; Rocher, R.; Rodriquez Padial, L.; Rose, E. L.; Rosen, S. D.; Rosenfeld, T.; Rowlands, D. B.; Rozkovec, A.; Rudas, L.; Rudenko, L. V.; Ruiz-Rejon, F.; Rutsch, W.; Rybar, R.; Rybka, J.; Saetre, H. A.; Sarosi, I.; Savalle, L. H.; Schmidt, A.; Schuren, K. P.; Schwartz, Y.; Schwinger, R.; Schwob, J. P.; Scott, D.; Sechtem, U.; Sela, O.; Semrad, B.; Senni, M.; Shilkina, N. P.; Shpektor, A.; Silas, J.; Sindone, A.; Sinescu, C. J.; Sipila, R.; Sirek, J.; Skagen, K.; Shura, M.; Slanina, M.; Slowinski, S.; Smid, J.; Smielak-Korombel, W.; Solodky, A.; Spacek, R.; Squire, I.; Steingo, L.; Stepinska, J.; Stogowski, A.; Storzhakov, G.; Striouk, R.; Strunge, P.; Suter, T.; Svitil, P.; Swedberg, K.; Swidzinski, M.; Syvolap, V. D.; Sztajzel, J.; Tahk, S. J.; Tans, A. C.; Tans, J. G. M.; Targonski, R.; Tarjan, J.; Tartagni, F.; Tchartchoglian, R.; Tebloev, K.; Teesalu, R.; Ten Kate, J. B. L.; Terrosu, P.; Thompson, P. L.; Thybo, N. K.; Thygesen, K.; Tilon, P. A.; Timar, S.; Titkov, Y.; Titlbach, O. J.; Torp-Pedersen, C.; Torvik, D. T.; Touboul, P.; Trelawny, J. M.; Trillo Nouche, R.; Trochina, E.; Trojnar, R.; Tzekova, M. L.; Tzivoni, D.; Vahula, V.; Valagussa, F.; Valdes, M.; Van Der Heijden, R.; Van Der Sloot, J. A. P.; Van Hal, J. M. C.; Van Kempen, L. H. J.; Van Mieghem, W.; Van Rugge, F. P.; Van Veldhuisen, D. J.; Van Vlies, B.; Van Wijk, L. M.; Vasyuk, Y.; Vatutin, M.; Vered, Z.; Vergoni, W.; Vertkine, A.; Vigholt, E.; Vishnevskiy, A.; Voegelin, H.-P.; Voipio-Pulkki, L. M.; Von Mengden, H.-J.; Waites, J.; Watson, R. D. S.; Weiss, A. T.; Werner, H. A.; Wesdorp, J. C. L.; White, H.; Wiggers, P.; Wilcox, R. G.; Wilkinson, P.; Willems, A. R.; Willenbrock, R.; Wirth, M.; Wojciechowski, D.; Worth, H.; Wray, R.; Wu, C.-J.; Yakusevich, V. V.; Yang, S.-P.; Yarohno, N.; Zadionchenko, V. S.; Zaleska, T.; Zalewski, M.; Zannad, F.; Zateyshchikov, D.; Zeltin-Abramov, E.; Zeymer, U.; Zimmermann, R.; Albuquerque, D. C.; Alcaino, M.; Allall, O. A.; Beer, N.; Bortman, G.; Botero, R.; Cardoso, J. S.; Carrageta, M.; Carrillo, E.; Carvalho, A. C.; Castano, R.; Ceia, F.; Cesar, L. A. M.; Chevez, E.; Coelho, O. R.; Colombo, H. R.; Corbalan, R.; Doval, H.; Dutra, O.; Franken, R. A.; Gallardo, L.; Garcia, A.; Garcia, J.; Gomez, E. A.; Gomez, E.; Gonzalez, J.; Gonzalez, R. A.; Greque, G. V.; Guzman, L.; Haiek, J. C.; Hernandez, E.; Hominal, M. A.; Isea, J.; Lanas, F.; Leiva, J. L.; Lemus, J.; Llancaqueo, A.; Lopez, N.; Lousada, N.; Maia, L. N.; Maranhao, M. F.; Martinez, J. A.; Martinez, F. A.; Martins, F. A.; Martins, L.; Matadamas, N.; Matiz, H.; Mendoza, I.; Menezes, C.; Moises, O.; Moreira, J. I.; Moura, J. C.; Nicolau, J. C.; Nobrega, J.; Null, D.; Oliveira, M. S.; Palacios, A. O.; Pazin Filho, A.; Perrone, S. V.; Peigas, L. S.; Prieto, J. C.; Junior, A. R.; Rassi, S.; Ribeiro, V. G.; Rico, J. N.; Rivera, J. M.; Robledo, G.; Rodriguez, H.; Rosenthal, J.; Rossi, P. R. F.; Saraiva, J. F.; Soifer, S.; Sosa Liprandi, A.; Torres, H. G.; Uruchurtu, E.; Velasco, R. G.; Velasquez, J. G.; Vita, N.; Waich, S.; Zelaya, F. R.; Abariotis, N.; Abdollah, H.; Abraham, W.; Alaie, D.; Allison, W.; Ameen, A.; Amidi, M.; Anand, I.; Anderson, J. L.; Andreae, G. E.; Aquino, V.; Ballard, W.; Banas, J. S.; Baron, S. B.; Bata, I.; Berk, M. R.; Bhesania, T.; Binkley, P.; Booth, D. C.; Borts, D.; Brookfield, L. A.; Brown, C. S.; Browne, K. F.; Butman, S. M.; Capodilupo, R. C.; Caralis, D. G.; Carr, K. W.; Castan, R.; Chadow, H.; Chalavarya, G. K.; Chua, G. L.; Cinderella, J. A.; Clavette, P.; Clemson, B. S.; Cohen, T. J.; Colfer, H. T.; Corder, C. N.; Courtade, D. J.; Courtney, D. L.; Coutu, B.; Cucher, F. H.; Czarnecki, W.; Danisa, K.; D'Astous, M.; Dauber, I.; Davies, R.; Deedwania, P. C.; Delehanty, J. M.; Denny, D. M.; Denys, B. G.; DeYoung, P. J. P.; Dion, D.; Donohue, T. J.; El Shahawy, M.; Elkayam, U.; Escabi, J.; Essandoh, L. K.; Felicetta, J. V.; Fintel, D.; Fontaine, J. M.; Foster, R. E.; Frank, T. A.; Gin, K.; Goldberg, M. C.; Goldman, S.; Gossard, D.; Gosselin, G.; Gradman, A. H.; Grandmont, D.; Hack, T.; Hagar, J.; Haikal, M.; Hall, S. A.; Halpern, S.; Hanley, H. G.; Hanovich, G. D.; Hargrove, J. L.; Harlamert, E. A.; Hastings, T. E.; Hathaway, W. R.; Haught, W. H.; Hilliard, G. K.; Hodsden, J.; Hui, W.; Hurley, W.; Ibrahim, H. M.; Jafri, S.; Jain, A.; Jennison, S.; Jesse, R. L.; Joseph, J.; Kalman, J.; Karisberg, R. P.; Khant, R.; Koren, M.; Kosinski, E. J.; Kosolcharoen, P.; Kostuk, W. J.; Kouz, S. M.; Lai, C.; Langholz, D. E.; LeJemtel, T. H.; Leader, R.; Leblanc, M.-H.; Lee, H.; Lepage, S.; Lopez, M.; Lu, D. Y.; Lubelsky, B. J.; Luckasen, G. J.; Ma, P.-T.-S.; MacCallum, C. G.; Madu, E. C.; Maisel, A. S.; Mallis, G. I.; Mann, J. T.; Marr, D. R.; McGrew, F. A., III; McKay, R. J.; Mclellan, B.; Meisner, J.; Meyer, T.; Mikati, I.; Miller, L. A.; Miller, L. W.; Moe, G. W.; Mohiuddin, S. M.; Moir, G. D.; Morgan, A. W.; Morris, A.; Murphy, B. J.; Nallasivan, M.; Narula, J.; Nicklas, J. M.; Niederman, A. L.; Nitkin, R.; O'Keefe, J. H.; Oken, K. R.; O'Neill, P. G.; Orchard, R. C.; O'Riordan, W. D.; Paraboschi, C. F.; Patel, R. I.; Pennock, G.; Pesant, Y.; Phaneuf, D.; Phillips, D. F.; Plehn, J.; Promisloff, S.; Rajakumar, A. J.; Ramadurai, R.; Rashkow, A.; Rauh, R. A.; Rebane, T. M.; Riba, A. L.; Richard, C.; Riddle, J. C.; Ringuette, G.; Rivera, E.; Rockson, S.; Rogers, E.; Ross, H.; Roux, R.; Rupka, D.; Saenz, A.; Sampson, J.; Schulman, S. P.; Schuyler, G.; Sequeira, R. F.; Shah, A. R.; Shah, P. K.; Shakar, S. F.; Shalev, Y.; Sheikh, K. H.; Shettigar, U. R.; Siegel, R. M.; Sigal, S. L.; Singh, V. N.; Sotolongo, C. M.; Soucier, R. J.; Stagaman, D. J.; Stephan, W. J.; Stine, M.; Stoever, W. W.; Talano, J. V.; Tan, J. L.; Tanser, P. H.; Taussig, A. S.; Thadani, U.; Timmis, S. B. H.; Timothee, J. R.; Tragoon, S.; Tremblay, B.; Upadhya, K. J.; Vijay, N. K.; Wagoner, L. E.; Walker, J. L.; Wickemeyer, W. J.; Williams, G. A.; Williams, M. B.; Williams, R. E.; Wiseman, A. H.; Wool, K. J.; Yasin, M.; Zabalgoitia, M.; Zarich, S.; Zimmermann, R.; Zucker, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1309-1321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Aldosterone blockade reduces mortality and morbidity among patients with severe heart failure.  We conducted a double-blind, placebo-controlled study evaluating the effect of eplerenone, a selective aldosterone blocker, on morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.  Methods: Patients were randomly assigned to eplerenone (25 mg per day initially, titrated to a max. of 50 mg per day; 3313 patients) or placebo (3319 patients) in addn. to optimal medical therapy.  The study continued until 1012 deaths occurred.  The primary end points were death from any cause and death from cardiovascular causes or hospitalization for heart failure, acute myocardial infarction, stroke, or ventricular arrhythmia.  Results: During a mean follow-up of 16 mo, there were 478 deaths in the eplerenone group and 554 deaths in the placebo group (relative risk, 0.85; 95 percent confidence interval, 0.75 to 0.96; P=0.008).  Of these deaths, 407 in the eplerenone group and 483 in the placebo group were attributed to cardiovascular causes (relative risk, 0.83; 95 percent confidence interval, 0.72 to 0.94; P= 0.005).  The rate of the other primary end point, death from cardiovascular causes or hospitalization for cardiovascular events, was reduced by eplerenone (relative risk, 0.87; 95 percent confidence interval, 0.79 to 0.95; P=0.002), as was the secondary end point of death from any cause or any hospitalization (relative risk, 0.92; 95 percent confidence interval, 0.86 to 0.98; P=0.02).  There was also a redn. in the rate of sudden death from cardiac causes (relative risk, 0.79; 95 percent confidence interval, 0.64 to 0.97; P=0.03).  The rate of serious hyperkalemia was 5.5 percent in the eplerenone group and 3.9 percent in the placebo group (P=0.002), whereas the rate of hypokalemia was 8.4 percent in the eplerenone group and 13.1 percent in the placebo group (P<0.001).  Conclusions: The addn. of eplerenone to optimal medical therapy reduces morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXvg9fCdjlrVg90H21EOLACvtfcHk0lhD6XQiC5y6ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1ehurY%253D&md5=cee432bc75bcca5f33098fe3bc8575df</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030207%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DRemme%26aufirst%3DW.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DNeaton%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DF.%26aulast%3DRoniker%26aufirst%3DB.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DHurley%26aufirst%3DS.%26aulast%3DKleiman%26aufirst%3DJ.%26aulast%3DGatlin%26aufirst%3DM.%26atitle%3DEplerenone%2520post-acute%2520myocardial%2520infarction%2520heart%2520failure%2520eficacy%2520and%2520survival%2520study%2520investigators.%2520Eplerenone%252C%2520a%2520selective%2520aldosterone%2520blocker%252C%2520in%2520patients%2520with%2520left%2520ventricular%2520dysfunction%2520after%2520myocardial%2520infarction%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D1309%26epage%3D1321%26doi%3D10.1056%2FNEJMoa030207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Luther, J. M.</span><span> </span><span class="NLM_article-title">Is there a new dawn for selective mineralocorticoid receptor antagonism?</span> <span class="citation_source-journal">Curr. Opin. Nephrol. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1097/MNH.0000000000000051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FMNH.0000000000000051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=456-461&author=J.+M.+Luther&title=Is+there+a+new+dawn+for+selective+mineralocorticoid+receptor+antagonism%3F&doi=10.1097%2FMNH.0000000000000051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1097%2FMNH.0000000000000051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNH.0000000000000051%26sid%3Dliteratum%253Aachs%26aulast%3DLuther%26aufirst%3DJ.%2BM.%26atitle%3DIs%2520there%2520a%2520new%2520dawn%2520for%2520selective%2520mineralocorticoid%2520receptor%2520antagonism%253F%26jtitle%3DCurr.%2520Opin.%2520Nephrol.%2520Hypertens.%26date%3D2014%26volume%3D23%26spage%3D456%26epage%3D461%26doi%3D10.1097%2FMNH.0000000000000051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gomez-Sanchez, E. P.</span><span> </span><span class="NLM_article-title">Third-generation mineralocorticoid receptor antagonists: why do we need a fourth?</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FFJC.0000000000000329" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=26-38&author=E.+P.+Gomez-Sanchez&title=Third-generation+mineralocorticoid+receptor+antagonists%3A+why+do+we+need+a+fourth%3F&doi=10.1097%2FFJC.0000000000000329"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000329%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Sanchez%26aufirst%3DE.%2BP.%26atitle%3DThird-generation%2520mineralocorticoid%2520receptor%2520antagonists%253A%2520why%2520do%2520we%2520need%2520a%2520fourth%253F%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2016%26volume%3D67%26spage%3D26%26epage%3D38%26doi%3D10.1097%2FFJC.0000000000000329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Roscioni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zeeuw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, S. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambers Heerspink, H. J.</span><span> </span><span class="NLM_article-title">Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy</span> <span class="citation_source-journal">Nat. Rev. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1038/nrneph.2012.217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1038%2Fnrneph.2012.217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=23070570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGksr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=691-699&author=S.+S.+Roscioniauthor=D.+de+Zeeuwauthor=S.+J.+L.+Bakkerauthor=H.+J.+Lambers+Heerspink&title=Management+of+hyperkalaemia+consequent+to+mineralocorticoid-receptor+antagonist+therapy&doi=10.1038%2Fnrneph.2012.217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy</span></div><div class="casAuthors">Roscioni, Sara S.; de Zeeuw, Dick; Bakker, Stephan J. L.; Lambers Heerspink, Hiddo J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Nephrology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">691-699</span>CODEN:
                <span class="NLM_cas:coden">NRNABO</span>;
        ISSN:<span class="NLM_cas:issn">1759-5061</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mineralocorticoid-receptor antagonists (MRAs) reduce blood pressure and albuminuria in patients treated with angiotensin-converting-enzyme inhibitors or angiotensin-II-receptor blockers.  The use of MRAs, however, is limited by the occurrence of hyperkalemia, which frequently occurs in patients older than 65 years with impaired kidney function, and/or diabetes.  Patients with these characteristics might still benefit from MRA therapy, however, and should not be excluded from this treatment option.  This limitation raises the question of how to optimize the therapeutic use of MRAs in this population of patients.  Understanding the individual variability in patients' responses to MRAs, in terms of albuminuria, blood pressure and serum potassium levels, might lead to targeted intervention.  MRA use might be restricted to patients with high levels of mineralocorticoid activity, evaluated by circulating renin and aldosterone levels or renal excretion of potassium.  In addn., reviewing the patient's diet and concomitant medications might prove useful in reducing the risk of developing subsequent hyperkalemia.  If hyperkalemia does develop, treatment options exist to decrease potassium levels, including administration of calcium gluconate, insulin, β2-agonists, diuretics and cation-exchange resins.  In combination with novel aldosterone blockers, these strategies might offer a rationale with which to optimize therapeutic intervention and extend the population of patients who can benefit from use of MRAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQwV24gpYwZbVg90H21EOLACvtfcHk0lhD6XQiC5y6ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGksr3P&md5=b1d64db0ec8ce244a70827ffb52010cc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrneph.2012.217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneph.2012.217%26sid%3Dliteratum%253Aachs%26aulast%3DRoscioni%26aufirst%3DS.%2BS.%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DBakker%26aufirst%3DS.%2BJ.%2BL.%26aulast%3DLambers%2BHeerspink%26aufirst%3DH.%2BJ.%26atitle%3DManagement%2520of%2520hyperkalaemia%2520consequent%2520to%2520mineralocorticoid-receptor%2520antagonist%2520therapy%26jtitle%3DNat.%2520Rev.%2520Nephrol.%26date%3D2012%26volume%3D8%26spage%3D691%26epage%3D699%26doi%3D10.1038%2Fnrneph.2012.217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Vardeny, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claggett, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossignol, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, S. D.</span><span> </span><span class="NLM_article-title">Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist</span> <span class="citation_source-journal">Circ.: Heart Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span><span class="refDoi"> DOI: 10.1161/CIRCHEARTFAILURE.114.001104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1161%2FCIRCHEARTFAILURE.114.001104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=24812304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyksrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=573-579&author=O.+Vardenyauthor=B.+Claggettauthor=I.+Anandauthor=P.+Rossignolauthor=A.+S.+Desaiauthor=F.+Zannadauthor=B.+Pittauthor=S.+D.+Solomon&title=Incidence%2C+predictors%2C+and+outcomes+related+to+hypo-+and+hyperkalemia+in+patients+with+severe+heart+failure+treated+with+a+mineralocorticoid+receptor+antagonist&doi=10.1161%2FCIRCHEARTFAILURE.114.001104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist</span></div><div class="casAuthors">Vardeny, Orly; Claggett, Brian; Anand, Inder; Rossignol, Patrick; Desai, Akshay S.; Zannad, Faiez; Pitt, Bertram; Solomon, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation: Heart Failure</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">573-579</span>CODEN:
                <span class="NLM_cas:coden">CHFICM</span>;
        ISSN:<span class="NLM_cas:issn">1941-3289</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: Mineralocorticoid receptor antagonists reduce morbidity and mortality in patients with heart failure but can cause hyperkalemia, which contributes to reduced use of these drugs.  Hypokalemia also leads to worse outcomes in patients with heart failure and may be attenuated by mineralocorticoid receptor antagonists.  METHODS AND RESULTS-: We assessed incidence and predictors of hyperkalemia (potassium ≥5.5 mmol/L) and hypokalemia (potassium <3.5 mmol/L) and the relationship to outcomes in 1663 patients with class III or IV heart failure and left ventricular ejection fraction <35% randomized to treatment with spironolactone 25 mg or placebo in the Randomized Aldactone Evaluation Study (RALES) trial.  All-cause mortality rates and the influence of potassium levels on the effectiveness of spironolactone were assessed in a landmark anal. and in relation to time-varying potassium levels.  After 1 mo, mean potassium levels increased in the spironolactone group but not in the placebo group (4.54±0.49 vs. 4.28±0.50 mmol/L; P<0.001) and remained elevated during the trial.  Although the extremes of hypokalemia and hyperkalemia at 4 wk were assocd. with increased risk of mortality in both treatment arms, participants in the spironolactone arm had lower mortality rates at all potassium levels throughout the duration of the trial.  The treatment benefit of spironolactone was maintained at least until potassium exceeded 5.5 mmol/L.  CONCLUSIONS-: With appropriate surveillance of potassium and creatinine, the use of spironolactone was assocd. with less hypokalemia and improved survival in patients with severe heart failure even in the setting of moderate hyperkalemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbC_SI3ttkHLVg90H21EOLACvtfcHk0lgbhfZDUn2xpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyksrnF&md5=3cd6ebac5ef36419d40be309d507b03f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1161%2FCIRCHEARTFAILURE.114.001104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCHEARTFAILURE.114.001104%26sid%3Dliteratum%253Aachs%26aulast%3DVardeny%26aufirst%3DO.%26aulast%3DClaggett%26aufirst%3DB.%26aulast%3DAnand%26aufirst%3DI.%26aulast%3DRossignol%26aufirst%3DP.%26aulast%3DDesai%26aufirst%3DA.%2BS.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26atitle%3DIncidence%252C%2520predictors%252C%2520and%2520outcomes%2520related%2520to%2520hypo-%2520and%2520hyperkalemia%2520in%2520patients%2520with%2520severe%2520heart%2520failure%2520treated%2520with%2520a%2520mineralocorticoid%2520receptor%2520antagonist%26jtitle%3DCirc.%253A%2520Heart%2520Failure%26date%3D2014%26volume%3D7%26spage%3D573%26epage%3D579%26doi%3D10.1161%2FCIRCHEARTFAILURE.114.001104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eitner, F.</span><span> </span><span class="NLM_article-title">Nonsteroidal antagonists of the mineralocorticoid receptor</span> <span class="citation_source-journal">Curr. Opin. Nephrol. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span><span class="refDoi"> DOI: 10.1097/MNH.0000000000000147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FMNH.0000000000000147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=417-424&author=P.+Kolkhofauthor=C.+Nowackauthor=F.+Eitner&title=Nonsteroidal+antagonists+of+the+mineralocorticoid+receptor&doi=10.1097%2FMNH.0000000000000147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2FMNH.0000000000000147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNH.0000000000000147%26sid%3Dliteratum%253Aachs%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DNowack%26aufirst%3DC.%26aulast%3DEitner%26aufirst%3DF.%26atitle%3DNonsteroidal%2520antagonists%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DCurr.%2520Opin.%2520Nephrol.%2520Hypertens.%26date%3D2015%26volume%3D24%26spage%3D417%26epage%3D424%26doi%3D10.1097%2FMNH.0000000000000147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7957</span><span class="NLM_x">–</span> <span class="NLM_lpage">7966</span><span class="refDoi"> DOI: 10.1021/jm300806c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300806c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7957-7966&author=D.+W.+Piotrowski&title=Mineralocorticoid+receptor+antagonists+for+the+treatment+of+hypertension+and+diabetic+nephropathy&doi=10.1021%2Fjm300806c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm300806c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300806c%26sid%3Dliteratum%253Aachs%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520hypertension%2520and%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7957%26epage%3D7966%26doi%3D10.1021%2Fjm300806c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolten, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.107.103580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1161%2FHYPERTENSIONAHA.107.103580" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=742-748&author=J.+D.+Dietzauthor=S.+Duauthor=C.+W.+Boltenauthor=M.+A.+Payneauthor=C.+Xiaauthor=J.+R.+Blinnauthor=J.+W.+Funderauthor=X.+Hu&title=A+number+of+marketed+dihydropyridine+calcium+channel+blockers+have+mineralocorticoid+receptor+antagonist+activity&doi=10.1161%2FHYPERTENSIONAHA.107.103580"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.107.103580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.107.103580%26sid%3Dliteratum%253Aachs%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DBolten%26aufirst%3DC.%2BW.%26aulast%3DPayne%26aufirst%3DM.%2BA.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DFunder%26aufirst%3DJ.%2BW.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DA%2520number%2520of%2520marketed%2520dihydropyridine%2520calcium%2520channel%2520blockers%2520have%2520mineralocorticoid%2520receptor%2520antagonist%2520activity%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D742%26epage%3D748%26doi%3D10.1161%2FHYPERTENSIONAHA.107.103580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyanar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numann, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span> </span><span class="NLM_article-title">Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4300</span><span class="NLM_x">–</span> <span class="NLM_lpage">4304</span><span class="refDoi"> DOI: 10.1021/jm1002827</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1002827" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4300-4304&author=G.+B.+Arhancetauthor=S.+S.+Woodardauthor=J.+D.+Dietzauthor=D.+J.+Garlandauthor=G.+M.+Wagnerauthor=K.+Iyanarauthor=J.+T.+Collinsauthor=J.+R.+Blinnauthor=R.+E.+Numannauthor=X.+Huauthor=H.+C.+Huang&title=Stereochemical+requirements+for+the+mineralocorticoid+receptor+antagonist+activity+of+dihydropyridines&doi=10.1021%2Fjm1002827"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm1002827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002827%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DWoodard%26aufirst%3DS.%2BS.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DWagner%26aufirst%3DG.%2BM.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DNumann%26aufirst%3DR.%2BE.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26atitle%3DStereochemical%2520requirements%2520for%2520the%2520mineralocorticoid%2520receptor%2520antagonist%2520activity%2520of%2520dihydropyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4300%26epage%3D4304%26doi%3D10.1021%2Fjm1002827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bärfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa-Pérez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckroth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitsche, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ergüden, J.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gielen-Haertwig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlemmer, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittendorf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platzek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span> </span><span class="NLM_article-title">Discovery of BAY 94–8862: A nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1385</span><span class="NLM_x">–</span> <span class="NLM_lpage">1403</span><span class="refDoi"> DOI: 10.1002/cmdc.201200081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1002%2Fcmdc.201200081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1385-1403&author=L.+B%C3%A4rfackerauthor=A.+Kuhlauthor=A.+Hillischauthor=R.+Grosserauthor=S.+Figueroa-P%C3%A9rezauthor=H.+Heckrothauthor=A.+Nitscheauthor=J.-K.+Erg%C3%BCdenauthor=H.+Gielen-Haertwigauthor=K.-H.+Schlemmerauthor=J.+Mittendorfauthor=H.+Paulsenauthor=J.+Platzekauthor=P.+Kolkhof&title=Discovery+of+BAY+94%E2%80%938862%3A+A+nonsteroidal+antagonist+of+the+mineralocorticoid+receptor+for+the+treatment+of+cardiorenal+diseases&doi=10.1002%2Fcmdc.201200081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200081%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26aulast%3DKuhl%26aufirst%3DA.%26aulast%3DHillisch%26aufirst%3DA.%26aulast%3DGrosser%26aufirst%3DR.%26aulast%3DFigueroa-P%25C3%25A9rez%26aufirst%3DS.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DNitsche%26aufirst%3DA.%26aulast%3DErg%25C3%25BCden%26aufirst%3DJ.-K.%26aulast%3DGielen-Haertwig%26aufirst%3DH.%26aulast%3DSchlemmer%26aufirst%3DK.-H.%26aulast%3DMittendorf%26aufirst%3DJ.%26aulast%3DPaulsen%26aufirst%3DH.%26aulast%3DPlatzek%26aufirst%3DJ.%26aulast%3DKolkhof%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520BAY%252094%25E2%2580%25938862%253A%2520A%2520nonsteroidal%2520antagonist%2520of%2520the%2520mineralocorticoid%2520receptor%2520for%2520the%2520treatment%2520of%2520cardiorenal%2520diseases%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1385%26epage%3D1403%26doi%3D10.1002%2Fcmdc.201200081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyanar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerndle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomposiello, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. F.</span><span> </span><span class="NLM_article-title">Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5970</span><span class="NLM_x">–</span> <span class="NLM_lpage">5978</span><span class="refDoi"> DOI: 10.1021/jm100506y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100506y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5970-5978&author=G.+B.+Arhancetauthor=S.+S.+Woodardauthor=K.+Iyanarauthor=B.+L.+Caseauthor=R.+Woerndleauthor=J.+D.+Dietzauthor=D.+J.+Garlandauthor=J.+T.+Collinsauthor=M.+A.+Payneauthor=J.+R.+Blinnauthor=S.+I.+Pomposielloauthor=X.+Huauthor=M.+I.+Heronauthor=H.-C.+Huangauthor=L.+F.+Lee&title=Discovery+of+novel+cyanodihydropyridines+as+potent+mineralocorticoid+receptor+antagonists&doi=10.1021%2Fjm100506y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm100506y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100506y%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DWoodard%26aufirst%3DS.%2BS.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DCase%26aufirst%3DB.%2BL.%26aulast%3DWoerndle%26aufirst%3DR.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DPayne%26aufirst%3DM.%2BA.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DPomposiello%26aufirst%3DS.%2BI.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHeron%26aufirst%3DM.%2BI.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DLee%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520of%2520novel%2520cyanodihydropyridines%2520as%2520potent%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5970%26epage%3D5978%26doi%3D10.1021%2Fjm100506y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huyet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bärfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pook, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span> </span><span class="NLM_article-title">A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">29932</span><span class="NLM_x">–</span> <span class="NLM_lpage">29940</span><span class="refDoi"> DOI: 10.1074/jbc.M110.131342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1074%2Fjbc.M110.131342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=29932-29940&author=J.+Fagartauthor=A.+Hillischauthor=J.+Huyetauthor=L.+B%C3%A4rfackerauthor=M.+Fayauthor=U.+Pleissauthor=E.+Pookauthor=S.+Sch%C3%A4ferauthor=M.-E.+Rafestin-Oblinauthor=P.+Kolkhof&title=A+new+mode+of+mineralocorticoid+receptor+antagonism+by+a+potent+and+selective+nonsteroidal+molecule&doi=10.1074%2Fjbc.M110.131342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.131342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.131342%26sid%3Dliteratum%253Aachs%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DHillisch%26aufirst%3DA.%26aulast%3DHuyet%26aufirst%3DJ.%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26aulast%3DFay%26aufirst%3DM.%26aulast%3DPleiss%26aufirst%3DU.%26aulast%3DPook%26aufirst%3DE.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DS.%26aulast%3DRafestin-Oblin%26aufirst%3DM.-E.%26aulast%3DKolkhof%26aufirst%3DP.%26atitle%3DA%2520new%2520mode%2520of%2520mineralocorticoid%2520receptor%2520antagonism%2520by%2520a%2520potent%2520and%2520selective%2520nonsteroidal%2520molecule%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D29932%26epage%3D29940%26doi%3D10.1074%2Fjbc.M110.131342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ergüden, J.-K. D.; Kolkhof, P. D.; Sandner, P. D.; Kuhl, A. D.; Stasch, J.-P. D.; Pook, E. D.; Schlemmer, K.-H. D.</span><span> </span><span class="NLM_article-title">Fluorenone 1,4-dihydropyridin derivatives</span>. International Patent WO2005/087740,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.-K.+D.+Erg%C3%BCden&author=P.+D.+Kolkhof&author=P.+D.+Sandner&author=A.+D.+Kuhl&author=J.-P.+D.+Stasch&author=E.+D.+Pook&author=K.-H.+D.+Schlemmer&title=Fluorenone+1%2C4-dihydropyridin+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DErg%25C3%25BCden%26aufirst%3DJ.-K.%2BD.%26atitle%3DFluorenone%25201%252C4-dihydropyridin%2520derivatives%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kuhl, A.; Kolkhof, P.; Heckroth, H.; Schlemmer, K.-H.; Flamme, I.; Gigueroa Perez, S.; Gielen-Haertwig, H.; Grosser, R.; Ergüden, J.-K.; Lang, D.</span><span> </span><span class="NLM_article-title">4-Chromenonyl-1,4-dihydropyridines and their use</span>. U.S. Patent US2010/022484A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Kuhl&author=P.+Kolkhof&author=H.+Heckroth&author=K.-H.+Schlemmer&author=I.+Flamme&author=S.+Gigueroa+Perez&author=H.+Gielen-Haertwig&author=R.+Grosser&author=J.-K.+Erg%C3%BCden&author=D.+Lang&title=4-Chromenonyl-1%2C4-dihydropyridines+and+their+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuhl%26aufirst%3DA.%26atitle%3D4-Chromenonyl-1%252C4-dihydropyridines%2520and%2520their%2520use%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lavall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böhm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufs, U.</span><span> </span><span class="NLM_article-title">The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">6656</span><span class="NLM_x">–</span> <span class="NLM_lpage">6668</span><span class="refDoi"> DOI: 10.1074/jbc.M113.519256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1074%2Fjbc.M113.519256" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=6656-6668&author=D.+Lavallauthor=C.+Selzerauthor=P.+Schusterauthor=M.+Lenskiauthor=O.+Adamauthor=H.-J.+Sch%C3%A4fersauthor=M.+B%C3%B6hmauthor=U.+Laufs&title=The+mineralocorticoid+receptor+promotes+fibrotic+remodeling+in+atrial+fibrillation&doi=10.1074%2Fjbc.M113.519256"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.519256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.519256%26sid%3Dliteratum%253Aachs%26aulast%3DLavall%26aufirst%3DD.%26aulast%3DSelzer%26aufirst%3DC.%26aulast%3DSchuster%26aufirst%3DP.%26aulast%3DLenski%26aufirst%3DM.%26aulast%3DAdam%26aufirst%3DO.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DH.-J.%26aulast%3DB%25C3%25B6hm%26aufirst%3DM.%26aulast%3DLaufs%26aufirst%3DU.%26atitle%3DThe%2520mineralocorticoid%2520receptor%2520promotes%2520fibrotic%2520remodeling%2520in%2520atrial%2520fibrillation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D6656%26epage%3D6668%26doi%3D10.1074%2Fjbc.M113.519256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellal-Levy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">Antagonism in the human mineralocorticoid receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3317</span><span class="NLM_x">–</span> <span class="NLM_lpage">3325</span><span class="refDoi"> DOI: 10.1093/emboj/17.12.3317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1093%2Femboj%2F17.12.3317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=9628869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADyaK1cXksFClt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=3317-3325&author=J.+Fagartauthor=J.+M.+Wurtzauthor=A.+Souqueauthor=C.+Hellal-Levyauthor=D.+Morasauthor=M.+E.+Rafestin-Oblin&title=Antagonism+in+the+human+mineralocorticoid+receptor&doi=10.1093%2Femboj%2F17.12.3317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism in the human mineralocorticoid receptor</span></div><div class="casAuthors">Fagart, Jerome; Wurtz, Jean-Marie; Souque, Anny; Hellal-Levy, Chantal; Moras, Dino; Rafestin-Oblin, Marie-Edith</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3317-3325</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Key residues of the human mineralocorticoid receptor (hMR) involved in the recognition of agonist and antagonist ligands were identified by alanine-scanning mutagenesis based on a homol. model of the hMR ligand-binding domain.  They were tested for their transactivation capacity and ability to bind agonists (aldosterone, cortisol) and antagonists (progesterone, RU26752).  The three-dimensional model reveals two polar sites located at the extremities of the elongated hydrophobic ligand-binding pocket.  Mutations of Gln 776 and Arg 817 in site I reduce the affinity of hMR for both agonists and antagonists and affect the capacity of hMR to activate transcription, suggesting that the C3-ketone group, common to all ligands, is anchored by these two residues conserved within the nuclear steroid receptor family.  In contrast, mutations of Asn 770 and Thr 945 in the opposite site only affect the binding of agonists bearing the C21-hydroxyl group.  The binding of hMR antagonists that exhibit a smaller size and faster off-rate kinetics compared with agonists is not affected.  In the light of the hMR homol. model, a new mechanism of antagonism is proposed in which the AF2-AD core region is destabilized by the loss of contacts between the antagonist and the helix H12 region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZn20LQzJbSbVg90H21EOLACvtfcHk0lghjUATqHUt2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksFClt7Y%253D&md5=fcfe9c946d95e732ac3ce19fac4bb5b0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.12.3317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.12.3317%26sid%3Dliteratum%253Aachs%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DWurtz%26aufirst%3DJ.%2BM.%26aulast%3DSouque%26aufirst%3DA.%26aulast%3DHellal-Levy%26aufirst%3DC.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DAntagonism%2520in%2520the%2520human%2520mineralocorticoid%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D3317%26epage%3D3325%26doi%3D10.1093%2Femboj%2F17.12.3317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Auzou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellal-Levy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M. E.</span><span> </span><span class="NLM_article-title">A single amino acid mutation of Ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=684-691&author=G.+Auzouauthor=J.+Fagartauthor=A.+Souqueauthor=C.+Hellal-Levyauthor=J.+M.+Wurtzauthor=D.+Morasauthor=M.+E.+Rafestin-Oblin&title=A+single+amino+acid+mutation+of+Ala-773+in+the+mineralocorticoid+receptor+confers+agonist+properties+to+11beta-substituted+spirolactones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAuzou%26aufirst%3DG.%26aulast%3DFagart%26aufirst%3DJ.%26aulast%3DSouque%26aufirst%3DA.%26aulast%3DHellal-Levy%26aufirst%3DC.%26aulast%3DWurtz%26aufirst%3DJ.%2BM.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DRafestin-Oblin%26aufirst%3DM.%2BE.%26atitle%3DA%2520single%2520amino%2520acid%2520mutation%2520of%2520Ala-773%2520in%2520the%2520mineralocorticoid%2520receptor%2520confers%2520agonist%2520properties%2520to%252011beta-substituted%2520spirolactones%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D684%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bärfacker, L.; Kolkhof, P.; Schlemmer, K. H.; Grosser, R.; Nitsche, A.; Klein, M.; Münter, K.; Albrecht-Küpper, B.; Hartmann, E.</span><span> </span><span class="NLM_article-title">Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof</span>. U.S. Patent US20100136142A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+B%C3%A4rfacker&author=P.+Kolkhof&author=K.+H.+Schlemmer&author=R.+Grosser&author=A.+Nitsche&author=M.+Klein&author=K.+M%C3%BCnter&author=B.+Albrecht-K%C3%BCpper&author=E.+Hartmann&title=Substituted-4-aryl-1%2C4-dihydro-1%2C6-naphthyridinamides+and+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26atitle%3DSubstituted-4-aryl-1%252C4-dihydro-1%252C6-naphthyridinamides%2520and%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kober, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponikowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheorghiade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippatos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span> </span><span class="NLM_article-title">Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94–8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2453</span><span class="NLM_x">–</span> <span class="NLM_lpage">2463</span><span class="refDoi"> DOI: 10.1093/eurheartj/eht187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1093%2Feurheartj%2Feht187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=23713082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yrs7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=2453-2463&author=B.+Pittauthor=L.+Koberauthor=P.+Ponikowskiauthor=M.+Gheorghiadeauthor=G.+Filippatosauthor=H.+Krumauthor=C.+Nowackauthor=P.+Kolkhofauthor=S.-Y.+Kimauthor=F.+Zannad&title=Safety+and+tolerability+of+the+novel+non-steroidal+mineralocorticoid+receptor+antagonist+BAY+94%E2%80%938862+in+patients+with+chronic+heart+failure+and+mild+or+moderate+chronic+kidney+disease%3A+a+randomized%2C+double-blind+trial&doi=10.1093%2Feurheartj%2Feht187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial</span></div><div class="casAuthors">Pitt, Bertram; Kober, Lars; Ponikowski, Piotr; Gheorghiade, Mihai; Filippatos, Gerasimos; Krum, Henry; Nowack, Christina; Kolkhof, Peter; Kim, So-Young; Zannad, Faiez</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">2453-2463</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims: Mineralocorticoid receptor antagonists (MRAs) improve outcomes in patients with heart failure and reduced left ventricular ejection fraction (HFrEF), but their use is limited by hyperkalemia and/or worsening renal function (WRF).  BAY 94-8862 is a highly selective and strongly potent non-steroidal MRA.  We investigated its safety and tolerability in patients with HFrEF assocd. with mild or moderate chronic kidney disease (CKD).  Methods and results: This randomized, controlled, phase II trial consisted of two parts.  In part A, the safety and tolerability of oral BAY 94-8862 [2.5, 5, or 10 mg once daily (q.d.)] was assessed in 65 patients with HFrEF and mild CKD.  In part B, BAY 94-8862 (2.5, 5, or 10 mg q.d., or 5 mg twice daily) was compared with placebo and open-label spironolactone (25 or 50 mg/day) in 392 patients with HFrEF and moderate CKD.  BAY 94-8862 was assocd. with significantly smaller mean increases in serum potassium concn. than spironolactone (0.04-0.30 and 0.45 mmol/L, resp., P < 0.0001-0.0107) and lower incidences of hyperkalemia (5.3 and 12.7%, resp., P = 0.048) and WRF.  BAY 94-8862 decreased the levels of B-type natriuretic peptide (BNP), amino-terminal proBNP, and albuminuria at least as much as spironolactone.  Adverse events related to BAY 94-8862 were infrequent and mostly mild.  Conclusion: In patients with HFrEF and moderate CKD, BAY 94-8862 5-10 mg/day was at least as effective as spironolactone 25 or 50 mg/day in decreasing biomarkers of haemodynamic stress, but it was assocd. with lower incidences of hyperkalemia and WRF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsBCQjGJJltLVg90H21EOLACvtfcHk0lg5WbgYTrND1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yrs7%252FI&md5=81f43b800b29f20aaf13c7fba31588b9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Feht187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Feht187%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DKober%26aufirst%3DL.%26aulast%3DPonikowski%26aufirst%3DP.%26aulast%3DGheorghiade%26aufirst%3DM.%26aulast%3DFilippatos%26aufirst%3DG.%26aulast%3DKrum%26aufirst%3DH.%26aulast%3DNowack%26aufirst%3DC.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.-Y.%26aulast%3DZannad%26aufirst%3DF.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520the%2520novel%2520non-steroidal%2520mineralocorticoid%2520receptor%2520antagonist%2520BAY%252094%25E2%2580%25938862%2520in%2520patients%2520with%2520chronic%2520heart%2520failure%2520and%2520mild%2520or%2520moderate%2520chronic%2520kidney%2520disease%253A%2520a%2520randomized%252C%2520double-blind%2520trial%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2013%26volume%3D34%26spage%3D2453%26epage%3D2463%26doi%3D10.1093%2Feurheartj%2Feht187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretschmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bärfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eitner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht-Küpper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, S.</span><span> </span><span class="NLM_article-title">Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1097%2FFJC.0000000000000091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=69-78&author=P.+Kolkhofauthor=M.+Delbeckauthor=A.+Kretschmerauthor=W.+Steinkeauthor=E.+Hartmannauthor=L.+B%C3%A4rfackerauthor=F.+Eitnerauthor=B.+Albrecht-K%C3%BCpperauthor=S.+Sch%C3%A4fer&title=Finerenone%2C+a+novel+selective+nonsteroidal+mineralocorticoid+receptor+antagonist+protects+from+rat+cardiorenal+injury&doi=10.1097%2FFJC.0000000000000091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000091%26sid%3Dliteratum%253Aachs%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DDelbeck%26aufirst%3DM.%26aulast%3DKretschmer%26aufirst%3DA.%26aulast%3DSteinke%26aufirst%3DW.%26aulast%3DHartmann%26aufirst%3DE.%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26aulast%3DEitner%26aufirst%3DF.%26aulast%3DAlbrecht-K%25C3%25BCpper%26aufirst%3DB.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DS.%26atitle%3DFinerenone%252C%2520a%2520novel%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonist%2520protects%2520from%2520rat%2520cardiorenal%2520injury%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2014%26volume%3D64%26spage%3D69%26epage%3D78%26doi%3D10.1097%2FFJC.0000000000000091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Bakris, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gansevoort, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossing, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmieder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmeskamp-Kirschbaum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruilope, L. M.</span><span> </span><span class="NLM_article-title">Effect of finerenone on albuminuria in patients with diabetic nephropathy: A randomized clinical trial</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span><span class="refDoi"> DOI: 10.1001/jama.2015.10081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1001%2Fjama.2015.10081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2015&pages=884-894&author=G.+L.+Bakrisauthor=R.+Agarwalauthor=J.+C.+Chanauthor=M.+E.+Cooperauthor=R.+T.+Gansevoortauthor=H.+Hallerauthor=G.+Remuzziauthor=P.+Rossingauthor=R.+E.+Schmiederauthor=C.+Nowackauthor=P.+Kolkhofauthor=A.+Josephauthor=A.+Pieperauthor=N.+Kimmeskamp-Kirschbaumauthor=L.+M.+Ruilope&title=Effect+of+finerenone+on+albuminuria+in+patients+with+diabetic+nephropathy%3A+A+randomized+clinical+trial&doi=10.1001%2Fjama.2015.10081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1001%2Fjama.2015.10081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2015.10081%26sid%3Dliteratum%253Aachs%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DAgarwal%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DJ.%2BC.%26aulast%3DCooper%26aufirst%3DM.%2BE.%26aulast%3DGansevoort%26aufirst%3DR.%2BT.%26aulast%3DHaller%26aufirst%3DH.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DRossing%26aufirst%3DP.%26aulast%3DSchmieder%26aufirst%3DR.%2BE.%26aulast%3DNowack%26aufirst%3DC.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DJoseph%26aufirst%3DA.%26aulast%3DPieper%26aufirst%3DA.%26aulast%3DKimmeskamp-Kirschbaum%26aufirst%3DN.%26aulast%3DRuilope%26aufirst%3DL.%2BM.%26atitle%3DEffect%2520of%2520finerenone%2520on%2520albuminuria%2520in%2520patients%2520with%2520diabetic%2520nephropathy%253A%2520A%2520randomized%2520clinical%2520trial%26jtitle%3DJAMA%26date%3D2015%26volume%3D314%26spage%3D884%26epage%3D894%26doi%3D10.1001%2Fjama.2015.10081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Haller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menne, J.</span><span> </span><span class="NLM_article-title">Finerenone: a new mineralocorticoid receptor antagonist without hyperkalemia: an opportunity in patients with CKD?</span> <span class="citation_source-journal">Curr. Hypertens. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1007/s11906-016-0649-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1007%2Fs11906-016-0649-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=26694820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFyqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=1-9&author=H.+Hallerauthor=A.+Bertramauthor=K.+Stahlauthor=J.+Menne&title=Finerenone%3A+a+new+mineralocorticoid+receptor+antagonist+without+hyperkalemia%3A+an+opportunity+in+patients+with+CKD%3F&doi=10.1007%2Fs11906-016-0649-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?</span></div><div class="casAuthors">Haller, Hermann; Bertram, Anna; Stahl, Klaus; Menne, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current Hypertension Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CHRUCG</span>;
        ISSN:<span class="NLM_cas:issn">1522-6417</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aldosterone binds to the mineralocorticoid receptor and has an important regulatory role in body fluid and electrolyte balance.  It also influences a variety of different cell functions such as oxidative stress, inflammation and organ fibrosis.  The important role of the tissue-specific mineralocorticoid receptors in cardiovascular and renal injury has been shown in knockout animals and in clin. studies Mineralocorticoid receptor antagonists seem to exert their beneficial effects via anti-oxidative, anti-inflammatory and anti-fibrotic effects.  Spironolactone and eplerenone were the first steroidal mineralocorticoid receptor antagonist.  The established steroidal mineralocorticoid receptor antagonists show important therapeutic effects but are hampered by a variety of side effects, most importantly clin. significant hyperkaliemia.  Selective non-steroidal mineralocorticoid receptor antagonists have been recently developed and demonstrate effectiveness in early clin. trials.  Finereroneholds promise for the future application of this new mineralocorticoid receptor antagonist class in patients with chronic kidney disease since it has shown a significant redn. in UACR combined with a safety profile similar to that in the placebo group.  However, further long-term studies investigating relevant clin. end points like redn. in cardiovascular or renal event rate are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriRvqUcZd4rrVg90H21EOLACvtfcHk0lgmDeaN7rdc2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFyqur8%253D&md5=887086700e3bf061978de5c752bb16c9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs11906-016-0649-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11906-016-0649-2%26sid%3Dliteratum%253Aachs%26aulast%3DHaller%26aufirst%3DH.%26aulast%3DBertram%26aufirst%3DA.%26aulast%3DStahl%26aufirst%3DK.%26aulast%3DMenne%26aufirst%3DJ.%26atitle%3DFinerenone%253A%2520a%2520new%2520mineralocorticoid%2520receptor%2520antagonist%2520without%2520hyperkalemia%253A%2520an%2520opportunity%2520in%2520patients%2520with%2520CKD%253F%26jtitle%3DCurr.%2520Hypertens.%2520Rep.%26date%3D2016%26volume%3D18%26spage%3D1%26epage%3D9%26doi%3D10.1007%2Fs11906-016-0649-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, P.</span><span> </span><span class="NLM_article-title">FInerenone for albuminuria in patients with diabetic nephropathy</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span><span class="refDoi"> DOI: 10.1001/jama.2015.15996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1001%2Fjama.2015.15996" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2016&pages=305-306&author=Y.+Fengauthor=X.+Zengauthor=P.+Fu&title=FInerenone+for+albuminuria+in+patients+with+diabetic+nephropathy&doi=10.1001%2Fjama.2015.15996"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1001%2Fjama.2015.15996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2015.15996%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DP.%26atitle%3DFInerenone%2520for%2520albuminuria%2520in%2520patients%2520with%2520diabetic%2520nephropathy%26jtitle%3DJAMA%26date%3D2016%26volume%3D315%26spage%3D305%26epage%3D306%26doi%3D10.1001%2Fjama.2015.15996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Filippatos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anker, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böhm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheorghiade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Køber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggioni, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponikowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voors, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmeskamp-Kirschbaum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, B.</span><span> </span><span class="NLM_article-title">A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2105</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span><span class="refDoi"> DOI: 10.1093/eurheartj/ehw132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1093%2Feurheartj%2Fehw132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=27130705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A280%3ADC%252BC28bkvVGktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=2105-2114&author=G.+Filippatosauthor=S.+D.+Ankerauthor=M.+B%C3%B6hmauthor=M.+Gheorghiadeauthor=L.+K%C3%B8berauthor=H.+Krumauthor=A.+P.+Maggioniauthor=P.+Ponikowskiauthor=A.+A.+Voorsauthor=F.+Zannadauthor=S.-Y.+Kimauthor=C.+Nowackauthor=G.+Palomboauthor=P.+Kolkhofauthor=N.+Kimmeskamp-Kirschbaumauthor=A.+Pieperauthor=B.+Pitt&title=A+randomized+controlled+study+of+finerenone+vs.+eplerenone+in+patients+with+worsening+chronic+heart+failure+and+diabetes+mellitus+and%2For+chronic+kidney+disease&doi=10.1093%2Feurheartj%2Fehw132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease</span></div><div class="casAuthors">Filippatos Gerasimos; Anker Stefan D; Bohm Michael; Gheorghiade Mihai; Kober Lars; Krum Henry; Maggioni Aldo P; Ponikowski Piotr; Voors Adriaan A; Zannad Faiez; Kim So-Young; Nowack Christina; Palombo Giovanni; Kolkhof Peter; Kimmeskamp-Kirschbaum Nina; Pieper Alexander; Pitt Bertram</div><div class="citationInfo"><span class="NLM_cas:title">European heart journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">2105-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and reduced ejection fraction and chronic kidney disease and/or diabetes mellitus.  METHODS AND RESULTS:  Miner Alocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF) was a randomized, double-blind, phase 2b multicentre study (ClinicalTrials.gov: NCT01807221).  Of 1286 screened patients, 1066 were randomized.  Patients received oral, once-daily finerenone (2.5, 5, 7.5, 10, or 15 mg, uptitrated to 5, 10, 15, 20, or 20 mg, respectively, on Day 30) or eplerenone (25 mg every other day, increased to 25 mg once daily on Day 30, and to 50 mg once daily on Day 60) for 90 days.  The primary endpoint was the percentage of individuals with a decrease of >30% in plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) from baseline to Day 90.  A key exploratory endpoint was a composite clinical endpoint of death from any cause, cardiovascular hospitalizations, or emergency presentation for worsening HF until Day 90.  Mean age ranged from 69.2 to 72.5 years in different treatment groups (standard deviation 9.7-10.6 years).  Decreases in NT-proBNP of >30% from baseline occurred in 37.2% of patients in the eplerenone group and 30.9, 32.5, 37.3, 38.8, and 34.2% in the 2.5→5, 5→10, 7.5→15, 10→20, and 15→20 mg finerenone groups, respectively (P = 0.42-0.88).  Except for the 2.5→5 mg finerenone group, the composite clinical endpoint occurred numerically less frequently in finerenone-treated patients compared with eplerenone; this difference reached nominal statistical significance in the 10→20 mg group (hazard ratio 0.56, 95% confidence interval, CI, 0.35; 0.90; nominal P = 0.02), despite the fact that this phase 2 study was not designed to detect statistical significant differences.  A potassium level increase to ≥5.6 mmol/L at any time point occurred in 4.3% of patients, with a balanced distribution among all treatment groups.  CONCLUSION:  Finerenone was well tolerated and induced a 30% or greater decrease in NT-proBNP levels in a similar proportion of patients to eplerenone.  The finding of reduced clinical events in the finerenone 10→20 mg group should be further explored in a large outcomes trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwlJaoNg6yx8ve_zCu79I8fW6udTcc2eaX8kxXE4xT0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bkvVGktw%253D%253D&md5=aa17a02b00280f014fac4e07eca5b12a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehw132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehw132%26sid%3Dliteratum%253Aachs%26aulast%3DFilippatos%26aufirst%3DG.%26aulast%3DAnker%26aufirst%3DS.%2BD.%26aulast%3DB%25C3%25B6hm%26aufirst%3DM.%26aulast%3DGheorghiade%26aufirst%3DM.%26aulast%3DK%25C3%25B8ber%26aufirst%3DL.%26aulast%3DKrum%26aufirst%3DH.%26aulast%3DMaggioni%26aufirst%3DA.%2BP.%26aulast%3DPonikowski%26aufirst%3DP.%26aulast%3DVoors%26aufirst%3DA.%2BA.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DS.-Y.%26aulast%3DNowack%26aufirst%3DC.%26aulast%3DPalombo%26aufirst%3DG.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DKimmeskamp-Kirschbaum%26aufirst%3DN.%26aulast%3DPieper%26aufirst%3DA.%26aulast%3DPitt%26aufirst%3DB.%26atitle%3DA%2520randomized%2520controlled%2520study%2520of%2520finerenone%2520vs.%2520eplerenone%2520in%2520patients%2520with%2520worsening%2520chronic%2520heart%2520failure%2520and%2520diabetes%2520mellitus%2520and%252For%2520chronic%2520kidney%2520disease%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2016%26volume%3D37%26spage%3D2105%26epage%3D2114%26doi%3D10.1093%2Feurheartj%2Fehw132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Amazit, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Billan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkhof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamribet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viengchareun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombès, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafestin-Oblin, M.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagart, J.</span><span> </span><span class="NLM_article-title">Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of ateroid recpetor coactivator-1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">21876</span><span class="NLM_x">–</span> <span class="NLM_lpage">21889</span><span class="refDoi"> DOI: 10.1074/jbc.M115.657957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1074%2Fjbc.M115.657957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=21876-21889&author=L.+Amazitauthor=F.+Le+Billanauthor=P.+Kolkhofauthor=K.+Lamribetauthor=S.+Viengchareunauthor=M.+R.+Fayauthor=J.+A.+Khanauthor=A.+Hillischauthor=M.+Lomb%C3%A8sauthor=M.-E.+Rafestin-Oblinauthor=J.+Fagart&title=Finerenone+impedes+aldosterone-dependent+nuclear+import+of+the+mineralocorticoid+receptor+and+prevents+genomic+recruitment+of+ateroid+recpetor+coactivator-1&doi=10.1074%2Fjbc.M115.657957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.657957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.657957%26sid%3Dliteratum%253Aachs%26aulast%3DAmazit%26aufirst%3DL.%26aulast%3DLe%2BBillan%26aufirst%3DF.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DLamribet%26aufirst%3DK.%26aulast%3DViengchareun%26aufirst%3DS.%26aulast%3DFay%26aufirst%3DM.%2BR.%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DHillisch%26aufirst%3DA.%26aulast%3DLomb%25C3%25A8s%26aufirst%3DM.%26aulast%3DRafestin-Oblin%26aufirst%3DM.-E.%26aulast%3DFagart%26aufirst%3DJ.%26atitle%3DFinerenone%2520impedes%2520aldosterone-dependent%2520nuclear%2520import%2520of%2520the%2520mineralocorticoid%2520receptor%2520and%2520prevents%2520genomic%2520recruitment%2520of%2520ateroid%2520recpetor%2520coactivator-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D21876%26epage%3D21889%26doi%3D10.1074%2Fjbc.M115.657957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Brandish, P.; Fraley, E.; Mark, E.; Hershey, J. C.; Steem, J. T.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor modulators</span>. International Patent WO2009/078934A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Brandish&author=E.+Fraley&author=E.+Mark&author=J.+C.+Hershey&author=J.+T.+Steem&title=Mineralocorticoid+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandish%26aufirst%3DP.%26atitle%3DMineralocorticoid%2520receptor%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubukata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sada, T.</span><span> </span><span class="NLM_article-title">Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">761</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.ejphar.2015.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=26073023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2iur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=761&publication_year=2015&pages=226-234&author=K.+Araiauthor=T.+Hommaauthor=Y.+Morikawaauthor=N.+Ubukataauthor=H.+Tsuruokaauthor=K.+Aokiauthor=H.+Ishikawaauthor=M.+Mizunoauthor=T.+Sada&title=Pharmacological+profile+of+CS-3150%2C+a+novel%2C+highly+potent+and+selective+non-steroidal+mineralocorticoid+receptor+antagonist&doi=10.1016%2Fj.ejphar.2015.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist</span></div><div class="casAuthors">Arai, Kiyoshi; Homma, Tsuyoshi; Morikawa, Yuka; Ubukata, Naoko; Tsuruoka, Hiyoyuki; Aoki, Kazumasa; Ishikawa, Hirokazu; Mizuno, Makoto; Sada, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">761</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">226-234</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study was designed to characterize the pharmacol. profile of CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist.  In the radioligand-binding assay, CS-3150 inhibited 3H-aldosterone binding to mineralocorticoid receptor with an IC50 value of 9.4 nM, and its potency was superior to that of spironolactone and eplerenone, whose IC50s were 36 and 713 nM, resp.  CS-3150 also showed at least 1000-fold higher selectivity for mineralocorticoid receptor over other steroid hormone receptors, glucocorticoid receptor, androgen receptor and progesterone receptor.  In the reporter gene assay, CS-3150 inhibited aldosterone-induced transcriptional activation of human mineralocorticoid receptor with an IC50 value of 3.7 nM, and its potency was superior to that of spironolactone and eplerenone, whose IC50s were 66 and 970 nM, resp.  CS-3150 had no agonistic effect on mineralocorticoid receptor and did not show any antagonistic or agonistic effect on glucocorticoid receptor, androgen receptor and progesterone receptor even at the high concn. of 5 μM.  In adrenalectomized rats, single oral administration of CS-3150 suppressed aldosterone-induced decrease in urinary Na+/K+ ratio, an index of in vivo mineralocorticoid receptor activation, and this suppressive effect was more potent and longer-lasting than that of spironolactone and eplerenone.  Chronic treatment with CS-3150 inhibited blood pressure elevation induced by deoxycorticosterone acetate (DOCA)/salt-loading to rats, and this antihypertensive effect was more potent than that of spironolactone and eplerenone.  These findings indicate that CS-3150 is a selective and highly potent mineralocorticoid receptor antagonist with long-lasting oral activity.  This agent could be useful for the treatment of hypertension, cardiovascular and renal disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6nBWXLrrQLVg90H21EOLACvtfcHk0ljjT1LZc-63Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2iur%252FK&md5=89919d8637cc9cc23d1915e987b086d5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DK.%26aulast%3DHomma%26aufirst%3DT.%26aulast%3DMorikawa%26aufirst%3DY.%26aulast%3DUbukata%26aufirst%3DN.%26aulast%3DTsuruoka%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DM.%26aulast%3DSada%26aufirst%3DT.%26atitle%3DPharmacological%2520profile%2520of%2520CS-3150%252C%2520a%2520novel%252C%2520highly%2520potent%2520and%2520selective%2520non-steroidal%2520mineralocorticoid%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D761%26spage%3D226%26epage%3D234%26doi%3D10.1016%2Fj.ejphar.2015.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Canne, B. L.; Chen, J.; Dalrymple, L. E.; Flatt, B. T.; Forsyth, T. P.; Gu, X. H.; Mac, M. B.; Mann, G.; Mann, L. W.; Martin, R.</span><span> </span><span class="NLM_article-title">Pyrrole derivatives as pharmaceutical agents</span>. International Patent WO2006/012642,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=B.+L.+Canne&author=J.+Chen&author=L.+E.+Dalrymple&author=B.+T.+Flatt&author=T.+P.+Forsyth&author=X.+H.+Gu&author=M.+B.+Mac&author=G.+Mann&author=L.+W.+Mann&author=R.+Martin&title=Pyrrole+derivatives+as+pharmaceutical+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCanne%26aufirst%3DB.%2BL.%26atitle%3DPyrrole%2520derivatives%2520as%2520pharmaceutical%2520agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Nuss, J.; Williams, M.; Mohan, R.; Martin, R.; Wang, T. L.; Aoki, K.; Tsuruoka, H.; Hayashi, N.; Homma, T.</span><span> </span><span class="NLM_article-title">Atropisomers of (hydroxyalkyl) pyrrole derivatives</span>. International Patent WO2010/042622A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Nuss&author=M.+Williams&author=R.+Mohan&author=R.+Martin&author=T.+L.+Wang&author=K.+Aoki&author=H.+Tsuruoka&author=N.+Hayashi&author=T.+Homma&title=Atropisomers+of+%28hydroxyalkyl%29+pyrrole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%26atitle%3DAtropisomers%2520of%2520%2528hydroxyalkyl%2529%2520pyrrole%2520derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Nuss, J.; Williams, M.; Mohan, R.; Martin, R.; Wang, T. L.; Tsuruoka, H.; Aoki, K.; Honzumi, M.; Asoh, Y.; Saito, K.</span><span> </span><span class="NLM_article-title">1-Phenylpyrrole compounds</span>. International Patent WO2010/042626,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Nuss&author=M.+Williams&author=R.+Mohan&author=R.+Martin&author=T.+L.+Wang&author=H.+Tsuruoka&author=K.+Aoki&author=M.+Honzumi&author=Y.+Asoh&author=K.+Saito&title=1-Phenylpyrrole+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%26atitle%3D1-Phenylpyrrole%2520compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Arai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, T.</span><span> </span><span class="NLM_article-title">CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">769</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.ejphar.2015.11.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=26607463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFCltr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=769&publication_year=2015&pages=266-273&author=K.+Araiauthor=H.+Tsuruokaauthor=T.+Homma&title=CS-3150%2C+a+novel+non-steroidal+mineralocorticoid+receptor+antagonist%2C+prevents+hypertension+and+cardiorenal+injury+in+Dahl+salt-sensitive+hypertensive+rats&doi=10.1016%2Fj.ejphar.2015.11.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats</span></div><div class="casAuthors">Arai, Kiyoshi; Tsuruoka, Hiroyuki; Homma, Tsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">769</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">266-273</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study was designed to evaluate the antihypertensive and cardiorenal protective effects of CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, in Dahl salt-sensitive hypertensive rats (DS rats), and to compare the effects with spironolactone and eplerenone.  DS rats were fed a control diet (0.3% NaCl) or high salt diet (8% NaCl) from 7 wk of age.  CS-3150 (0.25-2 mg/kg), spironolactone (10-100 mg/kg) or eplerenone (10-100 mg/kg) were orally administered once a day to DS rats fed a high salt diet for 7 wk.  The high salt diet significantly increased systolic blood pressure, which was prevented by treatment with CS-3150 in a dose-dependent manner with no hyperkalemia (>5.5 mEq/L).  The antihypertensive effect of CS-3150 (0.5 mg/kg) was equiv. to that of spironolactone (100 mg/kg) and eplerenone (100 mg/kg).  CS-3150 also suppressed proteinuria and renal hypertrophy induced by the high salt diet.  Histopathol. examn. of kidneys showed that CS-3150 markedly ameliorated glomerulosclerosis, tubular injury and tubulointerstitial fibrosis.  In addn., CS-3150 inhibited left ventricular hypertrophy and elevation of plasma brain natriuretic peptide level.  In contrast, the cardiorenal protective effects of spironolactone or eplerenone were partial, and the dose-dependency was not clear, esp. in eplerenone-treated rats.  These results indicate that chronic treatment with CS-3150 exerts antihypertensive and cardiorenal protective effects in a DS hypertensive rat model, and its potency is much superior to that of spironolactone or eplerenone.  Thus, CS-3150 could be a promising agent for the treatment of hypertension and cardiorenal disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDe-OsNWJ98bVg90H21EOLACvtfcHk0ljfwUvkers0Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFCltr7P&md5=e6779bb7b61a07a2023f433a169079ef</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DK.%26aulast%3DTsuruoka%26aufirst%3DH.%26aulast%3DHomma%26aufirst%3DT.%26atitle%3DCS-3150%252C%2520a%2520novel%2520non-steroidal%2520mineralocorticoid%2520receptor%2520antagonist%252C%2520prevents%2520hypertension%2520and%2520cardiorenal%2520injury%2520in%2520Dahl%2520salt-sensitive%2520hypertensive%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D769%26spage%3D266%26epage%3D273%26doi%3D10.1016%2Fj.ejphar.2015.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockerman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendling, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span><span class="NLM_x">–</span> <span class="NLM_lpage">6002</span><span class="refDoi"> DOI: 10.1021/jm100505n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100505n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5979-6002&author=M.+J.+Meyersauthor=G.+B.+Arhancetauthor=S.+L.+Hockermanauthor=X.+Chenauthor=S.+A.+Longauthor=M.+W.+Mahoneyauthor=J.+R.+Ricoauthor=D.+J.+Garlandauthor=J.+R.+Blinnauthor=J.+T.+Collinsauthor=S.+Yangauthor=H.-C.+Huangauthor=K.+F.+McGeeauthor=J.+M.+Wendlingauthor=J.+D.+Dietzauthor=M.+A.+Payneauthor=B.+L.+Homerauthor=M.+I.+Heronauthor=D.+B.+Reitzauthor=X.+Hu&title=Discovery+of+%283S%2C3aR%29-2-%283-chloro-4-cyanophenyl%29-3-cyclopentyl-3%2C3a%2C4%2C5-tetrahydro-2H-benzo%5Bg%5Dindazole-7-carboxylic+Acid+%28PF-3882845%29%2C+an+orally+efficacious+mineralocorticoid+receptor+%28MR%29+antagonist+for+hypertension+and+nephropathy&doi=10.1021%2Fjm100505n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm100505n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100505n%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DHockerman%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DRico%26aufirst%3DJ.%2BR.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DMcGee%26aufirst%3DK.%2BF.%26aulast%3DWendling%26aufirst%3DJ.%2BM.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DPayne%26aufirst%3DM.%2BA.%26aulast%3DHomer%26aufirst%3DB.%2BL.%26aulast%3DHeron%26aufirst%3DM.%2BI.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520%25283S%252C3aR%2529-2-%25283-chloro-4-cyanophenyl%2529-3-cyclopentyl-3%252C3a%252C4%252C5-tetrahydro-2H-benzo%255Bg%255Dindazole-7-carboxylic%2520Acid%2520%2528PF-3882845%2529%252C%2520an%2520orally%2520efficacious%2520mineralocorticoid%2520receptor%2520%2528MR%2529%2520antagonist%2520for%2520hypertension%2520and%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5979%26epage%3D6002%26doi%3D10.1021%2Fjm100505n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Arhancet, G. B.; Casimiro-Garcia, A.; Chen, X.; Hepworth, D.; Meyers, M. J.; Piotrowski, D. W.; Raheja, R. K.</span><span> </span><span class="NLM_article-title">4,5-Dihydro-1h-pyrazole compounds and their pharmaceutical uses</span>. International Patent WO2010/116282 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+B.+Arhancet&author=A.+Casimiro-Garcia&author=X.+Chen&author=D.+Hepworth&author=M.+J.+Meyers&author=D.+W.+Piotrowski&author=R.+K.+Raheja&title=4%2C5-Dihydro-1h-pyrazole+compounds+and+their+pharmaceutical+uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26atitle%3D4%252C5-Dihydro-1h-pyrazole%2520compounds%2520and%2520their%2520pharmaceutical%2520uses%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Meyers, M. J.; Arhancet, G. B.; Chen, X.; Hockerman, S.; Long, S. A.; Mahoney, M. W.; Reitz, D. B.; Rico, J. G.</span><span> </span><span class="NLM_article-title">Pyrazoline compounds</span>. U.S. Patent US2008/0167294 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+J.+Meyers&author=G.+B.+Arhancet&author=X.+Chen&author=S.+Hockerman&author=S.+A.+Long&author=M.+W.+Mahoney&author=D.+B.+Reitz&author=J.+G.+Rico&title=Pyrazoline+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26atitle%3DPyrazoline%2520compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Casimiro-Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banker, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boustany-Kari, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eudy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulford, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loria, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raheja, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrieze, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span> </span><span class="NLM_article-title">Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-me thoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4273</span><span class="NLM_x">–</span> <span class="NLM_lpage">4288</span><span class="refDoi"> DOI: 10.1021/jm500206r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500206r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4273-4288&author=A.+Casimiro-Garciaauthor=D.+W.+Piotrowskiauthor=C.+Amblerauthor=G.+B.+Arhancetauthor=M.+E.+Bankerauthor=T.+Banksauthor=C.+M.+Boustany-Kariauthor=C.+Caiauthor=X.+Chenauthor=R.+Eudyauthor=D.+Hepworthauthor=C.+A.+Hulfordauthor=S.+M.+Jenningsauthor=P.+M.+Loriaauthor=M.+J.+Meyersauthor=D.+N.+Petersenauthor=N.+K.+Rahejaauthor=M.+Sammonsauthor=L.+Sheauthor=K.+Songauthor=D.+Vriezeauthor=L.+Wei&title=Identification+of+%28R%29-6-%281-%284-cyano-3-methylphenyl%29-5-cyclopentyl-4%2C5-dihydro-1H-pyrazol-3-yl%29-2-me+thoxynicotinic+acid%2C+a+highly+potent+and+selective+nonsteroidal+mineralocorticoid+receptor+antagonist&doi=10.1021%2Fjm500206r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm500206r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500206r%26sid%3Dliteratum%253Aachs%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DAmbler%26aufirst%3DC.%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DBanks%26aufirst%3DT.%26aulast%3DBoustany-Kari%26aufirst%3DC.%2BM.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DEudy%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHulford%26aufirst%3DC.%2BA.%26aulast%3DJennings%26aufirst%3DS.%2BM.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DPetersen%26aufirst%3DD.%2BN.%26aulast%3DRaheja%26aufirst%3DN.%2BK.%26aulast%3DSammons%26aufirst%3DM.%26aulast%3DShe%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DVrieze%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520%2528R%2529-6-%25281-%25284-cyano-3-methylphenyl%2529-5-cyclopentyl-4%252C5-dihydro-1H-pyrazol-3-yl%2529-2-me%2520thoxynicotinic%2520acid%252C%2520a%2520highly%2520potent%2520and%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4273%26epage%3D4288%26doi%3D10.1021%2Fjm500206r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Dehring, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandagere, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, S. K.</span><span> </span><span class="NLM_article-title">Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span><span class="refDoi"> DOI: 10.1016/j.jpba.2004.07.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.jpba.2004.07.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15522517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=447-456&author=K.+A.+Dehringauthor=H.+L.+Workmanauthor=K.+D.+Millerauthor=A.+Mandagereauthor=S.+K.+Poole&title=Automated+robotic+liquid+handling%2Flaser-based+nephelometry+system+for+high+throughput+measurement+of+kinetic+aqueous+solubility&doi=10.1016%2Fj.jpba.2004.07.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility</span></div><div class="casAuthors">Dehring, Karen A.; Workman, Heather L.; Miller, Keith D.; Mandagere, Arun; Poole, Salwa K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">447-456</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability to rapidly and consistently measure aq. soly. in a preclin. environment is crit. to the successful identification of promising discovery compds.  The advantage of an early soly. screen is timely attrition of compds. likely to fail due to poor absorption or low bioavailability before more costly screens are performed.  However, due to the large no. of compds. and limited sample amts., thermodn. soly. measurements are not feasible at this stage.  A kinetic soly. measurement is an alternative to thermodn. measurements at the discovery stage that provides a rank listing of soly. values with minimal sample requirements.  A kinetic soly. measurement is attractive from an automation vantage because it features rapid data acquisition and is amenable to multi-well formats.  We describe the use of a robotic liq./plate handler coupled to nephelometry detection for the measurement of kinetic soly.  We highlight the liq. handling validation, serial diln. parameters, and a comparison to the previous method.  Expts. to further enhance throughput, or increase confidence in the automation steps, were described and the effects of these expts. were presented.  In our integrated nephelometry method, we observe rapid liq. handling with an error of less than 10%, after a series of validation studies, and a sample throughput up to 1800 compds. per wk.  We compare the nephelometry method with our semi-thermodn. flow-injection anal. (FIA) method, and find a 75% bin agreement between the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmDRCDyzX6LbVg90H21EOLACvtfcHk0lg8cK9nF4_ynA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOqurs%253D&md5=0f39feaad6b2416aee99d5949e7350da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2004.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2004.07.022%26sid%3Dliteratum%253Aachs%26aulast%3DDehring%26aufirst%3DK.%2BA.%26aulast%3DWorkman%26aufirst%3DH.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DMandagere%26aufirst%3DA.%26aulast%3DPoole%26aufirst%3DS.%2BK.%26atitle%3DAutomated%2520robotic%2520liquid%2520handling%252Flaser-based%2520nephelometry%2520system%2520for%2520high%2520throughput%2520measurement%2520of%2520kinetic%2520aqueous%2520solubility%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2004%26volume%3D36%26spage%3D447%26epage%3D456%26doi%3D10.1016%2Fj.jpba.2004.07.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Brandish, P. E.; Fraley, M. E.; Hershey, J. C.; Steen, J. T.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor modulators</span>. International Patent WO2008/118319A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+E.+Brandish&author=M.+E.+Fraley&author=J.+C.+Hershey&author=J.+T.+Steen&title=Mineralocorticoid+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandish%26aufirst%3DP.%2BE.%26atitle%3DMineralocorticoid%2520receptor%2520modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Brandish, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczerba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hershey, J. C.</span><span> </span><span class="NLM_article-title">Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1016/j.vascn.2008.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.vascn.2008.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=18304838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlaqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=155-160&author=P.+E.+Brandishauthor=H.+Chenauthor=P.+Szczerbaauthor=J.+C.+Hershey&title=Development+of+a+simplified+assay+for+determination+of+the+antimineralocorticoid+activity+of+compounds+dosed+in+rats&doi=10.1016%2Fj.vascn.2008.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats</span></div><div class="casAuthors">Brandish, Philip E.; Chen, Hongxing; Szczerba, Peter; Hershey, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-160</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: Mineralocorticoid receptor (MR) antagonists are useful for the treatment of hypertension and heart failure.  In the present work we sought to develop a simplified protocol for measuring the acute activity of MR antagonists on urinary excretion of sodium and potassium in rats based on the original studies of mineralocorticoids in adrenalectomized rats reported by Kagawa et al. (Kagawa, C. M., & Jacobs Jr., R. S. (1960) Mineralocorticoid effects of 9α-fluorodeoxycorticosterone in adrenalectomized rats; Proceedings of the Society for Exptl. Biol. and Medicine, 104, 60-62).  Methods: Rats with intact adrenal glands were treated with test compds. and challenged with a bolus oral dose of saline.  Urine was collected over 4 h in metab. cages and urinary sodium and potassium concns. were measured.  Results: Aldosterone had no significant effect on sodium or potassium excretion and MR antagonists dose-dependently increased the ratio of sodium to potassium.  Diuretics with distinct mechanisms of action were differentiated via their relative effects on sodium, potassium and urine vols. and the new assay protocol was used to characterize a novel MR antagonist.  Discussion: A facile and robust protocol for the measurement of antagonism of renal MRs was established.  This protocol used fewer animals than previously described methods and did not require preparative surgery, factors which contributed favorably to cost, exptl. throughput and animal use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7BDEtZGFFBbVg90H21EOLACvtfcHk0ljL5Kt2jzz7VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlaqtbo%253D&md5=e98f6bc0acd37a14075402d93958ebf1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2008.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2008.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DBrandish%26aufirst%3DP.%2BE.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSzczerba%26aufirst%3DP.%26aulast%3DHershey%26aufirst%3DJ.%2BC.%26atitle%3DDevelopment%2520of%2520a%2520simplified%2520assay%2520for%2520determination%2520of%2520the%2520antimineralocorticoid%2520activity%2520of%2520compounds%2520dosed%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2008%26volume%3D57%26spage%3D155%26epage%3D160%26doi%3D10.1016%2Fj.vascn.2008.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamlynny, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltsie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Calvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, P.</span><span> </span><span class="NLM_article-title">Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4388</span><span class="NLM_x">–</span> <span class="NLM_lpage">4392</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2013.05.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=23777778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsV2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4388-4392&author=C.+Yangauthor=H.+C.+Shenauthor=Z.+Wuauthor=H.+D.+Chuauthor=J.+M.+Coxauthor=J.+Balsellsauthor=A.+Crespoauthor=P.+Brownauthor=B.+Zamlynnyauthor=J.+Wiltsieauthor=J.+Clemasauthor=J.+Gibsonauthor=L.+Continoauthor=J.+Lisnockauthor=G.+Zhouauthor=M.+Garcia-Calvoauthor=T.+Batemanauthor=L.+Xuauthor=X.+Tongauthor=M.+Crookauthor=P.+Sinclair&title=Discovery+of+novel+oxazolidinedione+derivatives+as+potent+and+selective+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmcl.2013.05.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists</span></div><div class="casAuthors">Yang, Christine; Shen, Hong C.; Wu, Zhicai; Chu, Hong D.; Cox, Jason M.; Balsells, Jaume; Crespo, Alejandro; Brown, Patricia; Zamlynny, Beata; Wiltsie, Judyann; Clemas, Joseph; Gibson, Jack; Contino, Lisa; Lisnock, JeanMarie; Zhou, Gaochao; Garcia-Calvo, Margarita; Bateman, Tom; Xu, Ling; Tong, Xinchun; Crook, Martin; Sinclair, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4388-4392</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel oxazolidinedione analogs were discovered as potent and selective mineralocorticoid receptor (MR) antagonists.  Structure-activity relationship (SAR) studies were focused on improving the potency and microsomal stability.  Selected compds. demonstrated excellent MR activity, reasonable nuclear hormone receptor selectivity, and acceptable rat pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiNiKrj7j4IbVg90H21EOLACvtfcHk0ljL5Kt2jzz7VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsV2hurY%253D&md5=2d53fa2b008ce84410103da9649d81f4</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.077%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DChu%26aufirst%3DH.%2BD.%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DZamlynny%26aufirst%3DB.%26aulast%3DWiltsie%26aufirst%3DJ.%26aulast%3DClemas%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DJ.%26aulast%3DContino%26aufirst%3DL.%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DBateman%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DCrook%26aufirst%3DM.%26aulast%3DSinclair%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520novel%2520oxazolidinedione%2520derivatives%2520as%2520potent%2520and%2520selective%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4388%26epage%3D4392%26doi%3D10.1016%2Fj.bmcl.2013.05.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Shen, H.; Cox, J. M.; Yang, C.; Wu, Z.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists</span>. International Patent WO2013/055606,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Shen&author=J.+M.+Cox&author=C.+Yang&author=Z.+Wu&title=Mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="note"><p class="first last">PathHunter protein–protein interaction cell-based assay that measures the ability of compounds to antagonize full-length human MR binding to a coactivator peptide, DiscoverX.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Shen, H.; Cox, J. M.; Chu, H. D.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists</span>. International Patent WO2013/055608,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Shen&author=J.+M.+Cox&author=H.+D.+Chu&title=Mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Shen, H.; Yang, C.; Cox, J. M.; Liu, K.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonist</span>. International Patent WO2013/055607,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Shen&author=C.+Yang&author=J.+M.+Cox&author=K.+Liu&title=Mineralocorticoid+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26atitle%3DMineralocorticoid%2520receptor%2520antagonist%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamlynny, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltsie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Calvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, P.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists: Identification of heterocyclic amide replacements in the oxazolidinedione series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1681</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.02.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2014.02.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=24630411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlGhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1681-1684&author=J.+M.+Coxauthor=H.+D.+Chuauthor=C.+Yangauthor=H.+C.+Shenauthor=Z.+Wuauthor=J.+Balsellsauthor=A.+Crespoauthor=P.+Brownauthor=B.+Zamlynnyauthor=J.+Wiltsieauthor=J.+Clemasauthor=J.+Gibsonauthor=L.+Continoauthor=J.+Lisnockauthor=G.+Zhouauthor=M.+Garcia-Calvoauthor=T.+Batemanauthor=L.+Xuauthor=X.+Tongauthor=M.+Crookauthor=P.+Sinclair&title=Mineralocorticoid+receptor+antagonists%3A+Identification+of+heterocyclic+amide+replacements+in+the+oxazolidinedione+series&doi=10.1016%2Fj.bmcl.2014.02.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Mineralocorticoid receptor antagonists: Identification of heterocyclic amide replacements in the oxazolidinedione series</span></div><div class="casAuthors">Cox, Jason M.; Chu, Hong D.; Yang, Christine; Shen, Hong C.; Wu, Zhicai; Balsells, Jaume; Crespo, Alejandro; Brown, Patricia; Zamlynny, Beata; Wiltsie, Judyann; Clemas, Joseph; Gibson, Jack; Contino, Lisa; Lisnock, JeanMarie; Zhou, Gaochao; Garcia-Calvo, Margarita; Bateman, Thomas; Xu, Ling; Tong, Xinchun; Crook, Martin; Sinclair, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1681-1684</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel potent and selective mineralocorticoid receptor antagonists were identified, utilizing heterocyclic amide replacements in the oxazolidinedione series.  Structure-activity relationship (SAR) efforts focused on improving lipophilic ligand efficiency (LLE) while maintaining nuclear hormone receptor selectivity and reasonable pharmacokinetic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrFpeeyyhxQ7Vg90H21EOLACvtfcHk0ljU5eInuYCxqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlGhtbc%253D&md5=9101ecc76caf233b6608f90e9e6a0a30</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.02.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.02.057%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DChu%26aufirst%3DH.%2BD.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DZamlynny%26aufirst%3DB.%26aulast%3DWiltsie%26aufirst%3DJ.%26aulast%3DClemas%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DJ.%26aulast%3DContino%26aufirst%3DL.%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DBateman%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DCrook%26aufirst%3DM.%26aulast%3DSinclair%26aufirst%3DP.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%253A%2520Identification%2520of%2520heterocyclic%2520amide%2520replacements%2520in%2520the%2520oxazolidinedione%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1681%26epage%3D1684%26doi%3D10.1016%2Fj.bmcl.2014.02.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamlynny, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltsie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Calvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H. C.</span><span> </span><span class="NLM_article-title">Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFKlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=461-465&author=C.+Yangauthor=J.+Balsellsauthor=H.+D.+Chuauthor=J.+M.+Coxauthor=A.+Crespoauthor=X.+Maauthor=L.+Continoauthor=P.+Brownauthor=S.+Gaoauthor=B.+Zamlynnyauthor=J.+Wiltsieauthor=J.+Clemasauthor=J.+Lisnockauthor=J.+Gibsonauthor=G.+Zhouauthor=M.+Garcia-Calvoauthor=T.+J.+Batemanauthor=V.+Tongauthor=L.+Xuauthor=M.+Crookauthor=P.+Sinclairauthor=H.+C.+Shen&title=Discovery+of+benzimidazole+oxazolidinediones+as+novel+and+selective+nonsteroidal+mineralocorticoid+receptor+antagonists&doi=10.1021%2Facsmedchemlett.5b00010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzimidazole Oxazolidinediones as Novel and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists</span></div><div class="casAuthors">Yang, Christine; Balsells, Jaume; Chu, Hong D.; Cox, Jason M.; Crespo, Alejandro; Ma, Xiuying; Contino, Lisa; Brown, Patricia; Gao, Sheng; Zamlynny, Beata; Wiltsie, Judyann; Clemas, Joseph; Lisnock, JeanMarie; Gibson, Jack; Zhou, Gaochao; Garcia-Calvo, Margarita; Bateman, Thomas J.; Tong, Vincent; Xu, Ling; Crook, Martin; Sinclair, Peter; Shen, Hong C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">461-465</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Elaboration of the oxazolidinedione series led to replacement of the exocyclic amides with substituted benzimidazoles.  The structure-activity relationship exploration resulted in the discovery of potent and selective nonsteroidal mineralocorticoid receptor antagonists with significantly improved microsomal stability and pharmacokinetic profile relative to the HTS hit.  One compd. I possessed comparable efficacy as spironolactone at 100 mg/kg (p.o.) in the rat natriuresis model.  As such, this series was validated as a lead series for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSk1XzA7Ae7Vg90H21EOLACvtfcHk0ljBSKOmhBsmjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFKlt7Y%253D&md5=b50611ee593d602ada48e35d4a0b9dcb</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00010%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DH.%2BD.%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DContino%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DZamlynny%26aufirst%3DB.%26aulast%3DWiltsie%26aufirst%3DJ.%26aulast%3DClemas%26aufirst%3DJ.%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DBateman%26aufirst%3DT.%2BJ.%26aulast%3DTong%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DCrook%26aufirst%3DM.%26aulast%3DSinclair%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DH.%2BC.%26atitle%3DDiscovery%2520of%2520benzimidazole%2520oxazolidinediones%2520as%2520novel%2520and%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D461%26epage%3D465%26doi%3D10.1021%2Facsmedchemlett.5b00010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Futatsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casimiro-Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loria, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banker, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, N. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of aryl sulfonamide-based nonsteroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6239</span><span class="NLM_x">–</span> <span class="NLM_lpage">6242</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2013.09.099" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6239-6242&author=K.+Futatsugiauthor=D.+W.+Piotrowskiauthor=A.+Casimiro-Garciaauthor=S.+Robinsonauthor=M.+Sammonsauthor=P.+M.+Loriaauthor=M.+E.+Bankerauthor=D.+N.+Petersenauthor=N.+J.+Schmidt&title=Design+and+synthesis+of+aryl+sulfonamide-based+nonsteroidal+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmcl.2013.09.099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.099%26sid%3Dliteratum%253Aachs%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DSammons%26aufirst%3DM.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DPetersen%26aufirst%3DD.%2BN.%26aulast%3DSchmidt%26aufirst%3DN.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520aryl%2520sulfonamide-based%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6239%26epage%3D6242%26doi%3D10.1016%2Fj.bmcl.2013.09.099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogDoct: A tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span><span class="refDoi"> DOI: 10.1021/jm0100990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFOmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+A+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds&doi=10.1021%2Fjm0100990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds</span></div><div class="casAuthors">Lombardo, Franco; Shalaeva, Marina Y.; Tupper, Karl A.; Gao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2490-2497</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an RP-HPLC method for the detn. of the octanol-water distribution coeffs. at pH 7.4, as log Doct7.4 values, for neutral and basic drugs, which combines ease of operation with high accuracy.  The method is shown to work for a training set of 90 mols. comprised largely of drugs, and it was also applied to a test set of 10 proprietary compds.  This work expands the applicability of the method presented in our earlier report, for the detn. of logPoct for neutral compds. (J. Med. Chem. 2000, 43, 2922-2928), and it offers the same general features but widens the scope.  Generally, the method (i) is compd. sparing (≤1 mL of a 50-100 μg/mL soln. needed), (ii) is insensitive to concn. and phase ratio effects obsd. in some shake-flask detns., (iii) is amenable to rapid detns. (≤20 min on av.), (iv) is insensitive to impurities, (v) possesses a wide lipophilicity range (>7 log Doct7.4 units), and (vi) offers a good accuracy, (vii) an excellent reproducibility, (viii) and an excellent potential for automation.  To the best of our knowledge, a similar performance, on a set of noncongeneric drugs, has not been previously reported.  We refer to the value generated via this method as ElogDoct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrynjvQ2-0sibVg90H21EOLACvtfcHk0lhRPqEfeJ-M9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFOmtbc%253D&md5=e390cfeacbb1cab5660909eccfeb7eb2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520A%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497%26doi%3D10.1021%2Fjm0100990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Katayama, S.; Hori, S.; Hasegawa, F.; Suzuki, K.</span><span> </span><span class="NLM_article-title">Biaryl amide derivative or pharmaceutically acceptable salt thereof</span>. U.S. Patent US2013/116227A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Katayama&author=S.+Hori&author=F.+Hasegawa&author=K.+Suzuki&title=Biaryl+amide+derivative+or+pharmaceutically+acceptable+salt+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DS.%26atitle%3DBiaryl%2520amide%2520derivative%2520or%2520pharmaceutically%2520acceptable%2520salt%2520thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Boyer, S.; Guo, X.; Wu, D.; Wu, F.</span><span> </span><span class="NLM_article-title">Pyridyl ureas as mineralocorticoid receptor antagonists</span>. International Patent WO2012/064631A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+Boyer&author=X.+Guo&author=D.+Wu&author=F.+Wu&title=Pyridyl+ureas+as+mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DS.%26atitle%3DPyridyl%2520ureas%2520as%2520mineralocorticoid%2520receptor%2520antagonists%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Neel, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grese, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defauw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doti, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, P. K.</span><span> </span><span class="NLM_article-title">3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2553</span><span class="NLM_x">–</span> <span class="NLM_lpage">2557</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2005.03.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15863315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslyrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2553-2557&author=D.+A.+Neelauthor=M.+L.+Brownauthor=P.+A.+Landerauthor=T.+A.+Greseauthor=J.+M.+Defauwauthor=R.+A.+Dotiauthor=T.+Fieldsauthor=S.+A.+Kelleyauthor=S.+Smithauthor=K.+M.+Zimmermanauthor=M.+I.+Steinbergauthor=P.+K.+Jadhav&title=3%2C3-Bisaryloxindoles+as+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmcl.2005.03.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists</span></div><div class="casAuthors">Neel, David A.; Brown, Matthew L.; Lander, Peter A.; Grese, Timothy A.; Defauw, Jean M.; Doti, Robert A.; Fields, Todd; Kelley, Sally Ann; Smith, Stephon; Zimmerman, Karen M.; Steinberg, Mitchell I.; Jadhav, Prabhakar K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2553-2557</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Syntheses and SAR studies of 3,3-bisaryloxindole analogs, e.g., I, provided potent mineralocorticoid receptor antagonists that were selective over other steroid nuclear hormone receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosTkFqjoQg1bVg90H21EOLACvtfcHk0lhRPqEfeJ-M9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslyrurs%253D&md5=22f58f43e64831e7878640cced07a188</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.086%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DD.%2BA.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DLander%26aufirst%3DP.%2BA.%26aulast%3DGrese%26aufirst%3DT.%2BA.%26aulast%3DDefauw%26aufirst%3DJ.%2BM.%26aulast%3DDoti%26aufirst%3DR.%2BA.%26aulast%3DFields%26aufirst%3DT.%26aulast%3DKelley%26aufirst%3DS.%2BA.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DZimmerman%26aufirst%3DK.%2BM.%26aulast%3DSteinberg%26aufirst%3DM.%2BI.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26atitle%3D3%252C3-Bisaryloxindoles%2520as%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2553%26epage%3D2557%26doi%3D10.1016%2Fj.bmcl.2005.03.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Bell, M. G.; Gavardinas, K.; Gernert, D. L.; Grese, T. A.; Jadhav, P. K.; Lander, P. A.; Steinberg, M. I.</span><span> </span><span class="NLM_article-title">Indole-derivative modulators of steroid hormone nuclear receptors</span>. International Patent WO2004/067529A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+G.+Bell&author=K.+Gavardinas&author=D.+L.+Gernert&author=T.+A.+Grese&author=P.+K.+Jadhav&author=P.+A.+Lander&author=M.+I.+Steinberg&title=Indole-derivative+modulators+of+steroid+hormone+nuclear+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BG.%26atitle%3DIndole-derivative%2520modulators%2520of%2520steroid%2520hormone%2520nuclear%2520receptors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Bell, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gernert, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grese, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvo, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borromeo, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, P. K.</span><span> </span><span class="NLM_article-title">(S)-N-{3-[1-Cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: A potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6443</span><span class="NLM_x">–</span> <span class="NLM_lpage">6445</span><span class="refDoi"> DOI: 10.1021/jm701186z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701186z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6443-6445&author=M.+G.+Bellauthor=D.+L.+Gernertauthor=T.+A.+Greseauthor=M.+D.+Belvoauthor=P.+S.+Borromeoauthor=S.+A.+Kelleyauthor=J.+H.+Kennedyauthor=S.+P.+Kolisauthor=P.+A.+Landerauthor=R.+Richeyauthor=V.+S.+Sharpauthor=G.+A.+Stephensonauthor=J.+D.+Williamsauthor=H.+Yuauthor=K.+M.+Zimmermanauthor=M.+I.+Steinbergauthor=P.+K.+Jadhav&title=%28S%29-N-%7B3-%5B1-Cyclopropyl-1-%282%2C4-difluoro-phenyl%29-ethyl%5D-1H-indol-7-yl%7D-methanesulfonamide%3A+A+potent%2C+nonsteroidal%2C+functional+antagonist+of+the+mineralocorticoid+receptor&doi=10.1021%2Fjm701186z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm701186z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701186z%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BG.%26aulast%3DGernert%26aufirst%3DD.%2BL.%26aulast%3DGrese%26aufirst%3DT.%2BA.%26aulast%3DBelvo%26aufirst%3DM.%2BD.%26aulast%3DBorromeo%26aufirst%3DP.%2BS.%26aulast%3DKelley%26aufirst%3DS.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BH.%26aulast%3DKolis%26aufirst%3DS.%2BP.%26aulast%3DLander%26aufirst%3DP.%2BA.%26aulast%3DRichey%26aufirst%3DR.%26aulast%3DSharp%26aufirst%3DV.%2BS.%26aulast%3DStephenson%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DK.%2BM.%26aulast%3DSteinberg%26aufirst%3DM.%2BI.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26atitle%3D%2528S%2529-N-%257B3-%255B1-Cyclopropyl-1-%25282%252C4-difluoro-phenyl%2529-ethyl%255D-1H-indol-7-yl%257D-methanesulfonamide%253A%2520A%2520potent%252C%2520nonsteroidal%252C%2520functional%2520antagonist%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6443%26epage%3D6445%26doi%3D10.1021%2Fjm701186z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Cernak, T. A.; Dykstra, K. D.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonists</span>. International Patent WO2014/014794A2,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+A.+Cernak&author=K.+D.+Dykstra&title=Mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%2BA.%26atitle%3DMineralocorticoid%2520receptor%2520antagonists%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Michellys, P. Y.; Pei, W.; Petrassi, H. M.; Richmond, W.</span><span> </span><span class="NLM_article-title">Compounds and compositions as modulators of steroid hormone nuclear receptors</span>. International Patent WO2006/015259,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+Y.+Michellys&author=W.+Pei&author=H.+M.+Petrassi&author=W.+Richmond&title=Compounds+and+compositions+as+modulators+of+steroid+hormone+nuclear+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMichellys%26aufirst%3DP.%2BY.%26atitle%3DCompounds%2520and%2520compositions%2520as%2520modulators%2520of%2520steroid%2520hormone%2520nuclear%2520receptors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Lotesta, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noto, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandpal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhtiyarov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lala, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span> </span><span class="NLM_article-title">Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1384</span><span class="NLM_x">–</span> <span class="NLM_lpage">1391</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmc.2016.02.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1384-1391&author=S.+D.+Lotestaauthor=A.+P.+Marcusauthor=Y.+Zhengauthor=K.+Leftherisauthor=P.+B.+Notoauthor=S.+Mengauthor=G.+Kandpalauthor=G.+Chenauthor=J.+Zhouauthor=B.+McKeeverauthor=Y.+Bukhtiyarovauthor=Y.+Zhaoauthor=D.+S.+Lalaauthor=S.+B.+Singhauthor=G.+M.+McGeehan&title=Identification+of+spirooxindole+and+dibenzoxazepine+motifs+as+potent+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmc.2016.02.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DLotesta%26aufirst%3DS.%2BD.%26aulast%3DMarcus%26aufirst%3DA.%2BP.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DNoto%26aufirst%3DP.%2BB.%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DKandpal%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMcKeever%26aufirst%3DB.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26atitle%3DIdentification%2520of%2520spirooxindole%2520and%2520dibenzoxazepine%2520motifs%2520as%2520potent%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1384%26epage%3D1391%26doi%3D10.1016%2Fj.bmc.2016.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Iijima, T.; Yamamoto, Y.; Akatsuka, H.; Kawaguchi, T.</span><span> </span><span class="NLM_article-title">Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents</span>. International Patent WO2007/089034,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Iijima&author=Y.+Yamamoto&author=H.+Akatsuka&author=T.+Kawaguchi&title=Benzoxazines+and+related+nitrogen-containing+heterobicyclic+compounds+useful+as+mineralocorticoid+receptor+modulating+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIijima%26aufirst%3DT.%26atitle%3DBenzoxazines%2520and%2520related%2520nitrogen-containing%2520heterobicyclic%2520compounds%2520useful%2520as%2520mineralocorticoid%2520receptor%2520modulating%2520agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Fukumoto, S.; Matsunaga, N.; Ohra, T.; Ohyabu, N.; Hasui, T.; Motoyaji, T.; Siedem, C. S.; Tang, T. P.; Demeese, L. A.; Gauthier, C.</span><span> </span><span class="NLM_article-title">Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands</span>. U.S. Patent US2009/0253687,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Fukumoto&author=N.+Matsunaga&author=T.+Ohra&author=N.+Ohyabu&author=T.+Hasui&author=T.+Motoyaji&author=C.+S.+Siedem&author=T.+P.+Tang&author=L.+A.+Demeese&author=C.+Gauthier&title=Fused+heterocyclic+compounds+and+their+use+as+mineralocorticoid+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DFused%2520heterocyclic%2520compounds%2520and%2520their%2520use%2520as%2520mineralocorticoid%2520receptor%2520ligands%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Hasui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyabu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siedem, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meese, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5983</span><span class="NLM_x">–</span> <span class="NLM_lpage">5994</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.07.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmc.2013.07.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=5983-5994&author=T.+Hasuiauthor=T.+Ohraauthor=N.+Ohyabuauthor=K.+Asanoauthor=H.+Matsuiauthor=A.+Mizukamiauthor=N.+Habukaauthor=S.+Sogabeauthor=S.+Endoauthor=C.+S.+Siedemauthor=T.+P.+Tangauthor=C.+Gauthierauthor=L.+A.+De+Meeseauthor=S.+A.+Boydauthor=S.+Fukumoto&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+of+dihydrofuran-2-one+and+dihydropyrrol-2-one+derivatives+as+novel+benzoxazin-3-one-based+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmc.2013.07.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.07.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.07.043%26sid%3Dliteratum%253Aachs%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DOhra%26aufirst%3DT.%26aulast%3DOhyabu%26aufirst%3DN.%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DMizukami%26aufirst%3DA.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSiedem%26aufirst%3DC.%2BS.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DGauthier%26aufirst%3DC.%26aulast%3DDe%2BMeese%26aufirst%3DL.%2BA.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520dihydrofuran-2-one%2520and%2520dihydropyrrol-2-one%2520derivatives%2520as%2520novel%2520benzoxazin-3-one-based%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D5983%26epage%3D5994%26doi%3D10.1016%2Fj.bmc.2013.07.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Fukumoto, S.; Ohyabu, N.; Ohra, T.; Sugimoto, T.; Hasui, T.; Fuji, K.; SIEDEM, C. S.; Gauthier, C.</span><span> </span><span class="NLM_article-title">Pyrazole compounds</span>. U.S. Patent US2010/0094000,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Fukumoto&author=N.+Ohyabu&author=T.+Ohra&author=T.+Sugimoto&author=T.+Hasui&author=K.+Fuji&author=C.+S.+SIEDEM&author=C.+Gauthier&title=Pyrazole+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DPyrazole%2520compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Hasui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyabu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oosawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishigaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sogabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siedem, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meese, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, S.</span><span> </span><span class="NLM_article-title">Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5428</span><span class="NLM_x">–</span> <span class="NLM_lpage">5445</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmc.2014.07.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5428-5445&author=T.+Hasuiauthor=N.+Ohyabuauthor=T.+Ohraauthor=K.+Fujiauthor=T.+Sugimotoauthor=J.+Fujimotoauthor=K.+Asanoauthor=M.+Oosawaauthor=S.+Shiotaniauthor=N.+Nishigakiauthor=K.+Kusumotoauthor=H.+Matsuiauthor=A.+Mizukamiauthor=N.+Habukaauthor=S.+Sogabeauthor=S.+Endoauthor=M.+Onoauthor=C.+S.+Siedemauthor=T.+P.+Tangauthor=C.+Gauthierauthor=L.+A.+De+Meeseauthor=S.+A.+Boydauthor=S.+Fukumoto&title=Discovery+of+6-%5B5-%284-fluorophenyl%29-3-methyl-pyrazol-4-yl%5D-benzoxazin-3-one+derivatives+as+novel+selective+nonsteroidal+mineralocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmc.2014.07.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DOhyabu%26aufirst%3DN.%26aulast%3DOhra%26aufirst%3DT.%26aulast%3DFuji%26aufirst%3DK.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DJ.%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DOosawa%26aufirst%3DM.%26aulast%3DShiotani%26aufirst%3DS.%26aulast%3DNishigaki%26aufirst%3DN.%26aulast%3DKusumoto%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DMizukami%26aufirst%3DA.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSiedem%26aufirst%3DC.%2BS.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DGauthier%26aufirst%3DC.%26aulast%3DDe%2BMeese%26aufirst%3DL.%2BA.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25206-%255B5-%25284-fluorophenyl%2529-3-methyl-pyrazol-4-yl%255D-benzoxazin-3-one%2520derivatives%2520as%2520novel%2520selective%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5428%26epage%3D5445%26doi%3D10.1016%2Fj.bmc.2014.07.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Casimiro-Garcia, A.; Futatsugi, K.; Piotrowski, D. W.</span><span> </span><span class="NLM_article-title">Morpholine compounds as mineralocorticoid receptor antagonists</span>. International Patent WO2011/141848A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Casimiro-Garcia&author=K.+Futatsugi&author=D.+W.+Piotrowski&title=Morpholine+compounds+as+mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26atitle%3DMorpholine%2520compounds%2520as%2520mineralocorticoid%2520receptor%2520antagonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Higuchi, R.; Zhi, L.; Karanewsky, D.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses</span>. U.S. Patent US2007/185102A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=R.+Higuchi&author=L.+Zhi&author=D.+Karanewsky&title=Mineralocorticoid+receptor+modulator+compounds%2C+processes+for+their+preparation%2C+and+their+uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHiguchi%26aufirst%3DR.%26atitle%3DMineralocorticoid%2520receptor%2520modulator%2520compounds%252C%2520processes%2520for%2520their%2520preparation%252C%2520and%2520their%2520uses%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Higuchi, R.; Zhi, L.; Adams, M.; Liu, Y.; Karanewsky, D.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses</span>. U.S. Patent US2007/197520A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=R.+Higuchi&author=L.+Zhi&author=M.+Adams&author=Y.+Liu&author=D.+Karanewsky&title=Mineralocorticoid+receptor+modulator+compounds%2C+processes+for+their+preparation%2C+and+their+uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHiguchi%26aufirst%3DR.%26atitle%3DMineralocorticoid%2520receptor%2520modulator%2520compounds%252C%2520processes%2520for%2520their%2520preparation%252C%2520and%2520their%2520uses%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Nariai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, K.</span><span> </span><span class="NLM_article-title">SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1254/jphs.10285FP</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1254%2Fjphs.10285FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=21358118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2011&pages=346-353&author=T.+Nariaiauthor=K.+Fujitaauthor=M.+Moriauthor=S.+Katayamaauthor=S.+Horiauthor=K.+Matsui&title=SM-368229%2C+a+novel+selective+and+potent+non-steroidal+mineralocorticoid+receptor+antagonist+with+strong+urinary+Na%2B+excretion+activity&doi=10.1254%2Fjphs.10285FP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity</span></div><div class="casAuthors">Nariai, Tetsuro; Fujita, Katsuya; Mori, Masaya; Katayama, Seiji; Hori, Seiji; Matsui, Kazuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-353</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Mineralocorticoid receptor (MR) antagonists, such as spironolactone (SPI) and eplerenone (EPL), are useful for the treatment of hypertension and heart failure.  However, the use of these two agents has been limited due to endocrine disturbance (SPI) and poor drug action (EPL).  In our search for safer and more effective MR antagonists, we identified SM-368229 as a novel non-steroidal MR antagonist.  SM-368229 showed strong MR inhibitory activity with IC50 values of 0.021 and 0.13 μM in the binding assay and reporter-gene assay, resp.  The selectivity of SM-368229 for MR was 18-fold higher than that for other steroid receptors, such as androgen, progesterone, and glucocorticoid receptors.  SM-368229 dose-dependently increased urinary Na+/K+ ratio with an ED50 value of 5.6 mg/kg in adrenalectomized rats treated with deoxycorticosterone acetate, and its efficacy was superior to that of SPI (ED50 = 14 mg/kg) or EPL (ED50 = 147 mg/kg).  Moreover, even at high doses of 100 and 300 mg/kg, SM-368229 showed very weak anti-androgenic effect in methyltestosterone-treated male rats and no progestagenic effect in estrus cycle synchronized female rats.  These findings indicate that SM-368229 may offer a new promising therapeutic option for the treatment of hypertension and heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp01j4ebA7L4rVg90H21EOLACvtfcHk0ljcg3LQVgSJQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOktrg%253D&md5=b466e8ed04d16b667c1106d97a80d2c7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1254%2Fjphs.10285FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.10285FP%26sid%3Dliteratum%253Aachs%26aulast%3DNariai%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DS.%26aulast%3DMatsui%26aufirst%3DK.%26atitle%3DSM-368229%252C%2520a%2520novel%2520selective%2520and%2520potent%2520non-steroidal%2520mineralocorticoid%2520receptor%2520antagonist%2520with%2520strong%2520urinary%2520Na%252B%2520excretion%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D115%26spage%3D346%26epage%3D353%26doi%3D10.1254%2Fjphs.10285FP" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Takahashi, Y.; Awai, N.; Akatsuka, H.; Kawaguchi, T.; Iijima, T.</span><span> </span><span class="NLM_article-title">Fused bicyclic compound</span>. European Patent EP2179994A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+Takahashi&author=N.+Awai&author=H.+Akatsuka&author=T.+Kawaguchi&author=T.+Iijima&title=Fused+bicyclic+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DY.%26atitle%3DFused%2520bicyclic%2520compound%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Jiang, C.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtán, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.-W.</span><span> </span><span class="NLM_article-title">Synthesis, modification, and evaluation of (R)-de-O-methyllasiodiplodin and analogs as nonsteroidal antagonists of mineralocorticoid receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1175</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.12.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1016%2Fj.bmcl.2010.12.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1171-1175&author=C.-S.+Jiangauthor=R.+Zhouauthor=J.-X.+Gongauthor=L.-L.+Chenauthor=T.+Kurt%C3%A1nauthor=X.+Shenauthor=Y.-W.+Guo&title=Synthesis%2C+modification%2C+and+evaluation+of+%28R%29-de-O-methyllasiodiplodin+and+analogs+as+nonsteroidal+antagonists+of+mineralocorticoid+receptor&doi=10.1016%2Fj.bmcl.2010.12.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.101%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.-S.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DGong%26aufirst%3DJ.-X.%26aulast%3DChen%26aufirst%3DL.-L.%26aulast%3DKurt%25C3%25A1n%26aufirst%3DT.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DY.-W.%26atitle%3DSynthesis%252C%2520modification%252C%2520and%2520evaluation%2520of%2520%2528R%2529-de-O-methyllasiodiplodin%2520and%2520analogs%2520as%2520nonsteroidal%2520antagonists%2520of%2520mineralocorticoid%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1171%26epage%3D1175%26doi%3D10.1016%2Fj.bmcl.2010.12.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Coghlan, M. J.; Jadhav, P. K.; Droste, J. J.; Green, J. E.; Matthews, D. P.</span><span> </span><span class="NLM_article-title">Tricyclic steroid hormone nuclear receptor modulators</span>. World Patent WO2005/066153A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+J.+Coghlan&author=P.+K.+Jadhav&author=J.+J.+Droste&author=J.+E.+Green&author=D.+P.+Matthews&title=Tricyclic+steroid+hormone+nuclear+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlan%26aufirst%3DM.%2BJ.%26atitle%3DTricyclic%2520steroid%2520hormone%2520nuclear%2520receptor%2520modulators%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Coghlan, M. J.; Green, J. E.; Grese, T. A.; Jadhav, P. K.; Matthews, D. P.; Steinberg, M. I.; Fales, K. R.; Bell, M. G.</span><span> </span><span class="NLM_article-title">Tricyclic steroid hormone nuclear receptor modulators</span>. World Patent WO2004/052847A2,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+J.+Coghlan&author=J.+E.+Green&author=T.+A.+Grese&author=P.+K.+Jadhav&author=D.+P.+Matthews&author=M.+I.+Steinberg&author=K.+R.+Fales&author=M.+G.+Bell&title=Tricyclic+steroid+hormone+nuclear+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlan%26aufirst%3DM.%2BJ.%26atitle%3DTricyclic%2520steroid%2520hormone%2520nuclear%2520receptor%2520modulators%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Gavardinas, K.; Green, J. E.; Jadhav, P. K.; Matthews, D. P.</span><span> </span><span class="NLM_article-title">Tryciclic steroid hormone nuclear receptor modulators</span>. World Patent WO2005/066161A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=K.+Gavardinas&author=J.+E.+Green&author=P.+K.+Jadhav&author=D.+P.+Matthews&title=Tryciclic+steroid+hormone+nuclear+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGavardinas%26aufirst%3DK.%26atitle%3DTryciclic%2520steroid%2520hormone%2520nuclear%2520receptor%2520modulators%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Gavardinas, K.; Jadhav, P. K.</span><span> </span><span class="NLM_article-title">6H-Dibenzo[B,E]oxepine derived nonsteroidal mineralocorticoid receptor antagonists</span>. World Patent WO2009/085584A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=K.+Gavardinas&author=P.+K.+Jadhav&title=6H-Dibenzo%5BB%2CE%5Doxepine+derived+nonsteroidal+mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGavardinas%26aufirst%3DK.%26atitle%3D6H-Dibenzo%255BB%252CE%255Doxepine%2520derived%2520nonsteroidal%2520mineralocorticoid%2520receptor%2520antagonists%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Coates, D. A.; Gavardinas, K.; Jadhav, P. K.</span><span> </span><span class="NLM_article-title">Mineralocorticoid receptor antagonist and methods of use</span>. World Patent WO2010/104721A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+A.+Coates&author=K.+Gavardinas&author=P.+K.+Jadhav&title=Mineralocorticoid+receptor+antagonist+and+methods+of+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCoates%26aufirst%3DD.%2BA.%26atitle%3DMineralocorticoid%2520receptor%2520antagonist%2520and%2520methods%2520of%2520use%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Kowala, M. C.</span><span> </span><span class="NLM_article-title">Combination therapy for resistant hypertension</span>. World Patent WO2015/130568<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+C.+Kowala&title=Combination+therapy+for+resistant+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKowala%26aufirst%3DM.%2BC.%26atitle%3DCombination%2520therapy%2520for%2520resistant%2520hypertension%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><a href="http://www.chemspider.com/Chemical-Structure.29361352.html" class="extLink">http://www.chemspider.com/Chemical-Structure.29361352.html</a> (accessed Nov 18,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.chemspider.com%2FChemical-Structure.29361352.html+%28accessed+Nov+18%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><a href="http://www.chemicalregister.com/LY2623091/Suppliers/pid705106.htm" class="extLink">http://www.chemicalregister.com/LY2623091/Suppliers/pid705106.htm</a> (accessed Nov 18,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.chemicalregister.com%2FLY2623091%2FSuppliers%2Fpid705106.htm+%28accessed+Nov+18%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Hultman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasnoperova, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lala, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1460</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span><span class="refDoi"> DOI: 10.1210/me.2004-0537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1210%2Fme.2004-0537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=15761029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslyqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1460-1473&author=M.+L.+Hultmanauthor=N.+V.+Krasnoperovaauthor=S.+Liauthor=S.+Duauthor=C.+Xiaauthor=J.+D.+Dietzauthor=D.+S.+Lalaauthor=D.+J.+Welschauthor=X.+Hu&title=The+ligand-dependent+interaction+of+mineralocorticoid+receptor+with+coactivator+and+corepressor+peptides+suggests+multiple+activation+mechanisms&doi=10.1210%2Fme.2004-0537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms</span></div><div class="casAuthors">Hultman, Monica L.; Krasnoperova, Nataliia V.; Li, Suzhen; Du, Sarah; Xia, Chunsheng; Dietz, Jessica D.; Lala, Deepak S.; Welsch, Dean J.; Hu, Xiao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1460-1473</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">We investigated the coregulator (coactivator and corepressor) interactions with the mineralocorticoid receptor (MR) that lead to activation and inhibition of the receptor in the presence of agonist and/or antagonist.  Our results indicate that MR ligand binding domain (LBD) interacts strongly with only a few specific coactivator peptides in the presence of the agonist aldosterone and that these interactions are blocked by the antagonist eplerenone.  We also discovered that cortisol, the preferred physiol. ligand for the glucocorticoid receptor in humans, is a partial MR agonist/antagonist, providing a possible mol. explanation of the tissue-selective effects of glucocorticoids on MR.  However, when we examd. the coactivator and corepressor peptide interactions in the presence of cortisol, we found that MR bound with cortisol or aldosterone interacted with the same set of peptides.  Thus, the partial agonism shown by cortisol is unlikely to be the result of differential interaction with known coactivators and corepressors.  On the other hand, we have identified coactivator binding groove mutations that are crit. for cortisol activation but not for aldosterone activation, suggesting that the two steroids induce different MR LBD conformations.  In addn., we also show that cortisol becomes full agonist when S810L mutation is introduced in the LBD of MR.  Interestingly, MR antagonists, such as eplerenone and progesterone, become partial agonist/antagonist of S810L but are still able to recruit LXXLL peptides to the mutant receptor.  Together, these findings suggest a model to explain the MR activation by various ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDY358OY2yLbVg90H21EOLACvtfcHk0liTMlbAp0GCOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslyqtrs%253D&md5=f29e9129e4dc69f90c71a4c41335aa5e</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1210%2Fme.2004-0537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2004-0537%26sid%3Dliteratum%253Aachs%26aulast%3DHultman%26aufirst%3DM.%2BL.%26aulast%3DKrasnoperova%26aufirst%3DN.%2BV.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DWelsch%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DThe%2520ligand-dependent%2520interaction%2520of%2520mineralocorticoid%2520receptor%2520with%2520coactivator%2520and%2520corepressor%2520peptides%2520suggests%2520multiple%2520activation%2520mechanisms%26jtitle%3DMol.%2520Endocrinol.%26date%3D2005%26volume%3D19%26spage%3D1460%26epage%3D1473%26doi%3D10.1210%2Fme.2004-0537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clyne, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. J.</span><span> </span><span class="NLM_article-title">Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1210/me.2010-0193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1210%2Fme.2010-0193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=21106883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFGruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=32-43&author=J.+Yangauthor=C.-y.+Changauthor=R.+Safiauthor=J.+Morganauthor=D.+P.+McDonnellauthor=P.+J.+Fullerauthor=C.+D.+Clyneauthor=M.+J.+Young&title=Identification+of+ligand-selective+peptide+antagonists+of+the+mineralocorticoid+receptor+using+phage+display&doi=10.1210%2Fme.2010-0193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display</span></div><div class="casAuthors">Yang, Jun; Chang, Ching-yi; Safi, Rachid; Morgan, James; McDonnell, Donald P.; Fuller, Peter J.; Clyne, Colin D.; Young, Morag J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-43</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The mineralocorticoid receptor (MR) is a member of the nuclear receptor superfamily.  Pathol. activation of the MR causes cardiac fibrosis and heart failure, but clin. use of MR antagonists is limited by the renal side effect of hyperkalemia.  The glucocorticoid cortisol binds the MR with equiv. affinity to that of the mineralocorticoids aldosterone and deoxycorticosterone.  In nonepithelial tissues, including the myocardium, which do not express the cortisol-inactivating enzyme 11β hydroxysteroid dehydrogenase 2, cortisol has been implicated in the activation of MR.  The mechanisms for ligand- and tissue-specific actions of the MR are undefined.  Over the past decade, it has become clear that coregulator proteins are crit. for nuclear receptor-mediated gene expression.  A subset of these coregulators may confer specificity to MR-mediated responses.  To evaluate whether different physiol. ligands can induce distinct MR conformations that underlie differential coregulator recruitment and ligand-specific gene regulation, we utilized phage display technol. to screen 108 19mer peptides for their interaction with the MR in the presence of agonist ligands.  We identified ligand-selective MR-interacting peptides that acted as potent antagonists of MR-mediated transactivation.  This represents a novel mechanism of MR antagonism that may be manipulated in the rational design of a ligand- or tissue-selective MR modulator to treat diseases like heart failure without side effects such as hyperkalemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfSmwZVKWWELVg90H21EOLACvtfcHk0lhTD4aAyP7LBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFGruro%253D&md5=86ac4cbe7c4c349301a3e480a341eb91</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1210%2Fme.2010-0193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2010-0193%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DC.-y.%26aulast%3DSafi%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DFuller%26aufirst%3DP.%2BJ.%26aulast%3DClyne%26aufirst%3DC.%2BD.%26aulast%3DYoung%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%2520ligand-selective%2520peptide%2520antagonists%2520of%2520the%2520mineralocorticoid%2520receptor%2520using%2520phage%2520display%26jtitle%3DMol.%2520Endocrinol.%26date%3D2011%26volume%3D25%26spage%3D32%26epage%3D43%26doi%3D10.1210%2Fme.2010-0193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Rogerson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, P. J.</span><span> </span><span class="NLM_article-title">Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">4200</span><span class="NLM_x">–</span> <span class="NLM_lpage">4210</span><span class="refDoi"> DOI: 10.1096/fj.13-242479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;key=10.1096%2Ffj.13-242479" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=4200-4210&author=F.+M.+Rogersonauthor=Y.-Z.+Yaoauthor=M.+J.+Youngauthor=P.+J.+Fuller&title=Identification+and+characterization+of+a+ligand-selective+mineralocorticoid+receptor+coactivator&doi=10.1096%2Ffj.13-242479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1096%2Ffj.13-242479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.13-242479%26sid%3Dliteratum%253Aachs%26aulast%3DRogerson%26aufirst%3DF.%2BM.%26aulast%3DYao%26aufirst%3DY.-Z.%26aulast%3DYoung%26aufirst%3DM.%2BJ.%26aulast%3DFuller%26aufirst%3DP.%2BJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520ligand-selective%2520mineralocorticoid%2520receptor%2520coactivator%26jtitle%3DFASEB%2520J.%26date%3D2014%26volume%3D28%26spage%3D4200%26epage%3D4210%26doi%3D10.1096%2Ffj.13-242479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span>Clinical trials information: <a href="https://clinicaltrials.gov/ct2/show/NCT02676401" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02676401</a> (accessed Dec 19,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trials+information%3A+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02676401+%28accessed+Dec+19%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A3I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A3I','PDB','2A3I'); return false;">PDB: 2A3I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ABI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ABI','PDB','2ABI'); return false;">PDB: 2ABI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHV','PDB','3VHV'); return false;">PDB: 3VHV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VHU','PDB','3VHU'); return false;">PDB: 3VHU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFF','PDB','3WFF'); return false;">PDB: 3WFF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WFG','PDB','3WFG'); return false;">PDB: 3WFG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PF3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PF3','PDB','4PF3'); return false;">PDB: 4PF3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HCV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HCV','PDB','5HCV'); return false;">PDB: 5HCV</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01065&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-7%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01065" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01065" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ba773b79221c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
